
<html lang="en"     class="pb-page"  data-request-id="80052258-d009-453b-8e3d-8a448fe74144"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c01717;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo" /></meta><meta name="dc.Creator" content="Er-Jun  Hao" /></meta><meta name="dc.Creator" content="Gong-Xin  Li" /></meta><meta name="dc.Creator" content="Yu-Ru  Liang" /></meta><meta name="dc.Creator" content="Ming-Sheng  Xie" /></meta><meta name="dc.Creator" content="Dong-Chao  Wang" /></meta><meta name="dc.Creator" content="Xiao-Han  Jiang" /></meta><meta name="dc.Creator" content="Jia-Yi  Cheng" /></meta><meta name="dc.Creator" content="Zhi-Xian  Shi" /></meta><meta name="dc.Creator" content="Yang  Wang" /></meta><meta name="dc.Creator" content="Hai-Ming  Guo" /></meta><meta name="dc.Description" content="In the present work, 103 novel acyclic nucleosides were designed, synthesized, and evaluated for their anticancer activities in vitro and in vivo. The structure–activity relationship (SAR) studies ..." /></meta><meta name="Description" content="In the present work, 103 novel acyclic nucleosides were designed, synthesized, and evaluated for their anticancer activities in vitro and in vivo. The structure–activity relationship (SAR) studies ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 4, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01717" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01717" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01717" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01717" /></link>
        
    
    

<title>Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01717" /></meta><meta property="og:title" content="Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0022.jpeg" /></meta><meta property="og:description" content="In the present work, 103 novel acyclic nucleosides were designed, synthesized, and evaluated for their anticancer activities in vitro and in vivo. The structure–activity relationship (SAR) studies revealed that most target compounds inhibited the growth of colon cancer cells in vitro, of which 3-(6-chloro-9H-purin-9-yl)dodecan-1-ol (9b) exhibited the most potent effect against the HCT-116 and SW480 cells with IC50 values of 0.89 and 1.15 μM, respectively. Furthermore, all of the (R)-configured acyclic nucleoside derivatives displayed more potent anticancer activity compared to their (S)-counterparts. Mechanistic studies revealed that compound 9b triggered apoptosis in the cancer cell lines via depolarization of the mitochondrial membrane and effectively inhibited colony formation. Importantly, compound 9b inhibited the growth of the SW480 xenograft in a mouse model with low systemic toxicity. These results indicated that acyclic nucleoside compounds are viable as potent and effective anticancer agents, and compound 9b may serve as a promising lead compound that merits further attention in future anticancer drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01717"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01717">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01717&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01717&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01717&amp;href=/doi/10.1021/acs.jmedchem.0c01717" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 2077-2109</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01677" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c01726" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents <i>In Vitro</i> and <i>In Vivo</i></span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Er-Jun Hao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Er-Jun Hao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Er-Jun++Hao">Er-Jun Hao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gong-Xin Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gong-Xin Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gong-Xin++Li">Gong-Xin Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yu-Ru Liang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yu-Ru Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yu-Ru++Liang">Yu-Ru Liang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ming-Sheng Xie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ming-Sheng Xie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Sheng++Xie">Ming-Sheng Xie</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4113-2168" title="Orcid link">http://orcid.org/0000-0003-4113-2168</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong-Chao Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong-Chao Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong-Chao++Wang">Dong-Chao Wang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5037-4727" title="Orcid link">http://orcid.org/0000-0002-5037-4727</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiao-Han Jiang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiao-Han Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiao-Han++Jiang">Xiao-Han Jiang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jia-Yi Cheng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jia-Yi Cheng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jia-Yi++Cheng">Jia-Yi Cheng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhi-Xian Shi</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhi-Xian Shi</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhi-Xian++Shi">Zhi-Xian Shi</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yang Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yang Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmacy, Fudan University, Shanghai 201203, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#f483959a938d959a93b4879c9981da919081da979a"><span class="__cf_email__" data-cfemail="acdbcdc2cbd5cdc2cbecdfc4c1d982c9c8d982cfc2">[email protected]</span></a>, Tel: 86-21-51980115.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yang++Wang">Yang Wang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Hai-Ming Guo</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Ming Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecules and Drug Innovation, Key Laboratory of Green Chemical Media and Reactions, Ministry of Education, Collaborative Innovation Center of Henan Province for Green Manufacturing of Fine Chemicals, School of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang, Henan 453007, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#02656a6f426a76772c6766772c616c"><span class="__cf_email__" data-cfemail="17707f7a577f636239727362397479">[email protected]</span></a>, Phone & Fax: (+86)3733329276.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Ming++Guo">Hai-Ming Guo</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0629-4524" title="Orcid link">http://orcid.org/0000-0003-0629-4524</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01717&amp;href=/doi/10.1021%2Facs.jmedchem.0c01717" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 2077–2109</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 4, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>30 September 2020</li><li><span class="item_label"><b>Published</b> online</span>4 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01717" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01717</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2077%26pageCount%3D33%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEr-Jun%2BHao%252C%2BGong-Xin%2BLi%252C%2BYu-Ru%2BLiang%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.0c01717%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BActivity%2BEvaluation%2Bof%2BNovel%2BAcyclic%2BNucleosides%2Bas%2BPotential%2BAnticancer%2BAgents%2BIn%2BVitro%2Band%2BIn%2BVivo%26numPages%3D33%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2109%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01717"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1423</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01717" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Activity Evaluation of Novel Acyclic Nucleosides as Potential Anticancer Agents In Vitro and In Vivo&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Er-Jun&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Gong-Xin&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yu-Ru&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Ming-Sheng&quot;,&quot;last_name&quot;:&quot;Xie&quot;},{&quot;first_name&quot;:&quot;Dong-Chao&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Xiao-Han&quot;,&quot;last_name&quot;:&quot;Jiang&quot;},{&quot;first_name&quot;:&quot;Jia-Yi&quot;,&quot;last_name&quot;:&quot;Cheng&quot;},{&quot;first_name&quot;:&quot;Zhi-Xian&quot;,&quot;last_name&quot;:&quot;Shi&quot;},{&quot;first_name&quot;:&quot;Yang&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Hai-Ming&quot;,&quot;last_name&quot;:&quot;Guo&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;04&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2077-2109&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01717&quot;},&quot;abstract&quot;:&quot;In the present work, 103 novel acyclic nucleosides were designed, synthesized, and evaluated for their anticancer activities in vitro and in vivo. The structure–activity relationship (SAR) studies revealed that most target compounds inhibited the growth of colon cancer cells in vitro, of which 3-(6-chloro-9H-purin-9-yl)dodecan-1-ol (9b) exhibited the most potent effect against the HCT-116 and SW480 cells with IC50 values of 0.89 and 1.15 μM, respectively. Furthermore, all of the (R)-configured acyclic nucleoside derivatives displayed more potent anticancer activity compared to their (S)-counterparts. Mechanistic studies revealed that compound 9b triggered apoptosis in the cancer cell lines via depolarization of the mitochondrial membrane and effectively inhibited colony formation. Importantly, compound 9b inhibited the growth of the SW480 xenograft in a mouse model with low systemic toxicity. These results indicated that acyclic nucleoside compounds are viable as potent and effective anticancer agents, and co&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01717&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01717" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01717&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01717" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01717&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01717" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01717&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01717&amp;href=/doi/10.1021/acs.jmedchem.0c01717" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01717" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01717" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01717&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01717%26sid%3Dliteratum%253Aachs%26pmid%3D33538581%26genre%3Darticle%26aulast%3DHao%26date%3D2021%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BActivity%2BEvaluation%2Bof%2BNovel%2BAcyclic%2BNucleosides%2Bas%2BPotential%2BAnticancer%2BAgents%2BIn%2BVitro%2Band%2BIn%2BVivo%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D2077%26epage%3D2109%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290661" title="Anticancer activity">Anticancer activity</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292349" title="Alkyls">Alkyls</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In the present work, 103 novel acyclic nucleosides were designed, synthesized, and evaluated for their anticancer activities <i>in vitro</i> and <i>in vivo</i>. The structure–activity relationship (SAR) studies revealed that most target compounds inhibited the growth of colon cancer cells <i>in vitro</i>, of which 3-(6-chloro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9b</b>) exhibited the most potent effect against the HCT-116 and SW480 cells with IC<sub>50</sub> values of 0.89 and 1.15 μM, respectively. Furthermore, all of the (<i>R</i>)-configured acyclic nucleoside derivatives displayed more potent anticancer activity compared to their (<i>S</i>)-counterparts. Mechanistic studies revealed that compound <b>9b</b> triggered apoptosis in the cancer cell lines <i>via</i> depolarization of the mitochondrial membrane and effectively inhibited colony formation. Importantly, compound <b>9b</b> inhibited the growth of the SW480 xenograft in a mouse model with low systemic toxicity. These results indicated that acyclic nucleoside compounds are viable as potent and effective anticancer agents, and compound <b>9b</b> may serve as a promising lead compound that merits further attention in future anticancer drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16040" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16040" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acyclic nucleoside compounds (ANCs) are one of the most versatile scaffolds in medicinal chemistry owing to their unique physicochemical and biological properties. The absence of a glycosidic bond increases the resistance of ANCs to chemical and biological degradation,<a onclick="showRef(event, 'ref1 ref2 ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3 ref4 ref5 ref6">(1−6)</a> and the flexible acyclic chain allows structural adaptability for interacting with the active site of multiple enzymes.<a onclick="showRef(event, 'ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9 ref10 ref11 ref12 ref13 ref14 ref15">(7−15)</a> Over the last few decades, R&D in ANCs has resulted in the successful launch of several approved antiviral drugs (e.g., Ganciclovir, Famciclovir, Penciclovir, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and is still providing a number of novel bioactive compounds.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Acyclic nucleoside and nucleotide drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The mature acyclic nucleoside preparation methods have provided a convenient synthesis of ANCs,<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> which have been proved to possess excellent bioactivities. Since the pioneer work of De Clercq and Holý in 1976 at the symposium on synthetic nucleosides, nucleotides, and polynucleotides, acyclic nucleoside phosphonates have been recognized as a key class of antiviral agents.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In 1977, Acyclovir with an acyclic side chain, 2-hydroxyethoxymethyl at the N9 position, was first discovered as an antiherpetic agent.<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> In 1978, De Clercq and Holý reported an acyclic nucleoside, (<i>S</i>)-9-(2,3-dihydroxypropyl)adenine, with broad-spectrum antiviral activity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> In 1999, Raić-Malić et al. developed the synthesis of acyclic nucleosides containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl, or 2,3-epoxypropyl ether moieties and their antitumor and antiviral activities.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Later, Raić-Malić et al. reported the synthesis and biological evaluation of fluorinated and iodinated acyclic purine nucleoside analogues bearing 9-(2-hydroxypropyl) and 9-(2-hydroxyethoxymethyl) side chains.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In 2006, Mintas et al. reported the synthesis of unsaturated acyclic and epoxide nucleoside analogues and evaluation of their antiviral and cytostatic activities.<a onclick="showRef(event, 'ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref24 ref25">(24,25)</a> In 2015, Raić-Malić et al. reported the discovery of new acid ceramidase-targeted acyclic 5-alkynyl and 5-heteroaryl uracil nucleosides.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Although some studies on the antitumor activities of acyclic nucleosides have been reported,<a onclick="showRef(event, 'ref27 ref28 ref29 ref30 ref31 ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30 ref31 ref32 ref33">(27−33)</a> in view of the frequent occurrence of chemoresistance against the current anticancer drugs, there is an urgent demand for developing novel chemotherapeutic agents with high potency and low toxicity. Based on our extensive research work on the synthetic methodology of acyclic nucleosides,<a onclick="showRef(event, 'ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref34 ref35 ref36">(34−36)</a> we will study the antitumor activities of the synthesized acyclic nucleosides. To this end, we constructed a library of 103 novel acyclic nucleoside derivatives and evaluated their anticancer activities through established <i>in vitro</i> and <i>in vivo</i> assays.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  Design</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55030" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55030" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">First, the side chains of Penciclovir and Adefovir are structurally analyzed. In addition to a hydroxyl group, the length of the side chain is four and two carbon atoms, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Therefore, we design the acyclic nucleosides containing a side chain with a length of three carbon atoms and a hydroxyl group (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Second, when a methyl group is introduced into the C2′-position of Adefovir, a chiral carbon emerges and a new acyclic nucleotide drug Tenofovir is formed (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>a). Thus, we design the acyclic nucleosides bearing a side chain with different alkyl groups at the C1′-position, which form a chiral center, or a C═C double bond at the C2′-position (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>b). Finally, the C2, C6, and C8 positions of the purine ring could also be altered. It should be noted that the above studies on the structure–activity relationship (SAR) of ANCs are all aimed at antiviral activities, and the SAR of antitumor activities of ANCs is less reported. In particular, the SAR of our designed ANCs containing a side chain with a length of three carbon atoms has not been systematically reported. To probe into the SAR of our designed acyclic purine nucleoside analogues, a molecular library of 103 acyclic nucleosides was synthesized and the anticancer activities were evaluated.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of acyclic nucleosides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">At first, all compounds were synthesized and isolated as racemic mixtures. Except for <b>1b</b>, <b>3b</b>, <b>16b</b>, <b>4c</b>, <b>5c</b>, <b>6c</b>, <b>5k</b>, and <b>10k</b>, all ANCs generated in the compound library were novel. Acyclic nucleoside compounds <b>1a</b>–<b>12a</b>, <b>1b</b>–<b>15b</b>, <b>4c</b>–<b>9c</b>, <b>4d</b>–<b>11d</b>, <b>5e–11e</b>, <b>5f</b>–<b>11f</b>, and <b>5i</b>–<b>9i</b> were synthesized in 26.7–89.5% overall yields <i>via</i><span class="smallcaps smallerCapital">l</span>-proline (Cat. I)-catalyzed aza-Michael addition of purine bases to α,β-unsaturated aldehydes, followed by treatment of the resulting Michael adducts with NaBH<sub>4</sub> in MeOH at 0 °C (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). In addition, the structure of the compounds <b>6a</b> and <b>8b</b> was determined <i>via</i> single-crystal X-ray diffraction analysis (Supporting Information (SI), <a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Figures S4 and S5</a>). Compound <b>13a</b> was then obtained by the nucleophilic substitution reaction of 6-chloro-2-fluoropurine with methyl 3-bromopropionate and DIBAL-H (diisobutyl aluminum hydride)-mediated reduction of the nucleophilic product giving the yield of 65.3%. Compound <b>16b</b> was obtained in 83.5% yield through the deprotection of the silyl ether group in compound <b>15b</b> by tetrabutylammonium fluoride (TBAF). Compounds <b>g</b> (<b>4g</b>–<b>11g</b>) or <b>h</b> (<b>5h</b>–<b>11h</b>) series were obtained by the nucleophilic substitution reaction of <b>b</b> or <b>c</b> series with ammonia in MeOH in the yields of 67.5–75.9% (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Finally, compounds <b>4b</b>–<b>6b</b> were dechlorinated by Pd/C-mediated hydrogenolysis in methanol to generate <b>4j</b>–<b>6j</b> in 63.1–66.5% yield. Compounds <b>5k</b>–<b>10k</b> were then obtained by introducing an olefin double bond in the side chain of 6-chloropurine from MBH adducts through allyl amination in 36.8–43.2% yield (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0012.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>1a</b>–<b>13a</b>, <b>1b</b>–<b>16b</b>, <b>4c</b>–<b>9c</b>, <b>4d</b>–<b>11d</b>, <b>5e</b>–<b>11e</b>, <b>5f</b>–<b>11f</b>, <b>4g</b>–<b>11g</b>, <b>5h</b>–<b>11h</b>, <b>5i</b>–<b>9i</b>, <b>4j</b>–<b>6j</b>, and <b>5k</b>–<b>10k</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0011.jpeg jm0c01717_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The stereochemistry of a chiral compound could usually affect its bioactivities obviously. To further elucidate the impact of stereochemistry on the anticancer activity of these novel ANCs, several chiral acyclonucleosides with (<i>R</i>)-configuration were generated in 51.3–56.2% overall yield and 91–95% ee from 6-chloro-9<i>H</i>-purine and several acroleins using (<i>R</i>)-prolinol-derived chiral secondary amine II as the organocatalyst (Cat. II) and subsequent reduction with sodium borohydride (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). The <i>S</i> enantiomers were obtained using catalyst III with opposite configuration at 50.5–54.8% overall yield and 91–95% ee (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). In addition, the absolute configuration of the compound (<i>R</i>)-<b>9b</b> was determined <i>via</i> single-crystal X-ray diffraction analysis (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0013.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Asymmetric Syntheses of (<i>R</i>)- and (<i>S</i>)-configurations of the compounds <b>7b</b>, <b>8b</b>, and <b>9b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">4.  Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4.1.  <i>In Vitro</i> Anticancer Activities</h3><div class="NLM_p">At first, all compounds were tested using their racemic mixtures against the HCT-116 and SW480 human colon cancer cell lines, using 5-fluorocrail (5-FU) as the positive control. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compounds <b>1a</b>–<b>13a</b>, <b>6b</b>–<b>11b, 4c</b>–<b>9c</b>, <b>7d</b>–<b>11d</b>, <b>7e</b>–<b>11e, 8f</b>–<b>11f, 8g</b>–<b>11g, 8h</b>–<b>11h</b>, and <b>5i</b>–<b>9i</b> exhibited moderate to potent antitumor activities against both cell lines.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Anticancer Activities of Acyclic Nucleoside Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0017.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">R<sup>4</sup></th><th class="colsep0 rowsep0" align="center">HCT-116<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">SW480<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">19.76 ± 1.46</td><td class="colsep0 rowsep0" align="left">16.83 ± 1.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">18.85 ± 1.22</td><td class="colsep0 rowsep0" align="left">19.84 ± 1.11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">16.47 ± 3.03</td><td class="colsep0 rowsep0" align="left">17.19 ± 1.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">13.46 ± 2.33</td><td class="colsep0 rowsep0" align="left">13.18 ± 2.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.66 ± 1.48</td><td class="colsep0 rowsep0" align="left">7.44 ± 1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.96 ± 0.72</td><td class="colsep0 rowsep0" align="left">12.94 ± 1.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">17.57 ± 3.96</td><td class="colsep0 rowsep0" align="left">26.12 ± 2.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">24.22 ± 4.17</td><td class="colsep0 rowsep0" align="left">14.98 ± 0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">32.05 ± 2.42</td><td class="colsep0 rowsep0" align="left">12.46 ± 2.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OBn</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.24 ± 0.65</td><td class="colsep0 rowsep0" align="left">7.17 ± 1.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OBz</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.17 ± 0.75</td><td class="colsep0 rowsep0" align="left">7.24 ± 0.92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OTBDMS</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.78 ± 1.21</td><td class="colsep0 rowsep0" align="left">8.02 ± 0.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">39.81 ± 3.72</td><td class="colsep0 rowsep0" align="left">29.70 ± 2.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11.94 ± 1.17</td><td class="colsep0 rowsep0" align="left">16.74 ± 2.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.16 ± 2.39</td><td class="colsep0 rowsep0" align="left">3.63 ± 2.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.65 ± 0.43</td><td class="colsep0 rowsep0" align="left">1.37 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.89 ± 0.21</td><td class="colsep0 rowsep0" align="left">1.15 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4.93 ± 0.69</td><td class="colsep0 rowsep0" align="left">3.16 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.59 ± 0.62</td><td class="colsep0 rowsep0" align="left">5.29 ± 0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>12</sub></sub>H<sub><sub>25</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OBn</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OBz</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OTBDMS</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">31.70 ± 4.14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16b</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OH</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15.49 ± 2.01</td><td class="colsep0 rowsep0" align="left">30.90 ± 1.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.17 ± 0.89</td><td class="colsep0 rowsep0" align="left">6.01 ± 0.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.10 ± 1.68</td><td class="colsep0 rowsep0" align="left">12.42 ± 1.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.79 ± 1.75</td><td class="colsep0 rowsep0" align="left">13.56 ± 3.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">22.15 ± 3.15</td><td class="colsep0 rowsep0" align="left">24.04 ± 2.49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">32.56 ± 3.12</td><td class="colsep0 rowsep0" align="left">36.30 ± 1.75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15.28 ± 2.53</td><td class="colsep0 rowsep0" align="left">23.92 ± 2.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.77 ± 4.15</td><td class="colsep0 rowsep0" align="left">24.55 ± 4.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.53 ± 0.25</td><td class="colsep0 rowsep0" align="left">3.25 ± 0.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">7.53 ± 0.83</td><td class="colsep0 rowsep0" align="left">8.26 ± 0.86</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.23 ± 2.18</td><td class="colsep0 rowsep0" align="left">9.70 ± 1.41</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.53 ± 3.01</td><td class="colsep0 rowsep0" align="left">15.26 ± 4.28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.73 ± 0.47</td><td class="colsep0 rowsep0" align="left">3.77 ± 0.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.41 ± 1.03</td><td class="colsep0 rowsep0" align="left">4.45 ± 0.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.70 ± 1.43</td><td class="colsep0 rowsep0" align="left">11.99 ± 1.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11e</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">NHCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">15.38 ± 2.29</td><td class="colsep0 rowsep0" align="left">12.79 ± 2.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">19.84 ± 2.67</td><td class="colsep0 rowsep0" align="left">21.61 ± 1.71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9.81 ± 0.66</td><td class="colsep0 rowsep0" align="left">12.24 ± 1.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.49 ± 1.69</td><td class="colsep0 rowsep0" align="left">3.32 ± 0.69</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11f</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">N(CH<sub>3</sub>)<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.03 ± 0.99</td><td class="colsep0 rowsep0" align="left">11.75 ± 1.00</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11.55 ± 1.81</td><td class="colsep0 rowsep0" align="left">20.68 ± 1.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">10.54 ± 2.66</td><td class="colsep0 rowsep0" align="left">6.03 ± 1.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2.59 ± 0.41</td><td class="colsep0 rowsep0" align="left">1.20 ± 0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11g</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">13.35 ± 2.66</td><td class="colsep0 rowsep0" align="left">11.61 ± 0.95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">20.99 ± 2.76</td><td class="colsep0 rowsep0" align="left">13.14 ± 2.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">14.84 ± 3.19</td><td class="colsep0 rowsep0" align="left">12.22 ± 2.30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>10</sub></sub>H<sub><sub>21</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">11.83 ± 2.00</td><td class="colsep0 rowsep0" align="left">13.13 ± 1.24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11h</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>11</sub></sub>H<sub><sub>23</sub></sub></td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">19.95 ± 2.05</td><td class="colsep0 rowsep0" align="left">17.78 ± 1.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">18.29 ± 1.33</td><td class="colsep0 rowsep0" align="left">23.81 ± 1.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">16.12 ± 1.15</td><td class="colsep0 rowsep0" align="left">14.13 ± 1.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">16.22 ± 1.69</td><td class="colsep0 rowsep0" align="left">14.44 ± 1.52</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">22.39 ± 2.07</td><td class="colsep0 rowsep0" align="left">17.78 ± 1.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9i</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Br</td><td class="colsep0 rowsep0" align="left">26.91 ± 3.79</td><td class="colsep0 rowsep0" align="left">24.98 ± 1.76</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>4</sub></sub>H<sub><sub>9</sub></sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6j</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5-FU</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10.81 ± 0.69</td><td class="colsep0 rowsep0" align="left">9.70 ± 1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">The antiproliferation activities of individual compounds against tumor cells were determined by the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2<i>H</i>-tetrazolium bromide (MTT) assay. Data are mean ± standard error of the mean (SEM) values from three independent experiments.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Both HCT-116 and SW480 are human colon carcinoma cell lines.</p></div></div></div><div class="NLM_p">In compound <b>a</b> series (R<sup>1</sup> = F, R<sup>3</sup> = Cl, R<sup>4</sup> = H), all of the acyclonucleosides with R<sup>2</sup> as H (<b>13a</b>) or C1–C9 linear alkyl (<b>1a</b>–<b>9a</b>) showed anticancer activities (IC<sub>50</sub> = 7.44–39.81 μM) and the R<sup>2</sup> on the 1′ position has a mild but regular impact on their anticancer activities, which first increased and then decreased gradually with the increase of the 1′ position alkyl chain length, with <i>n</i>-amyl (<b>5a</b>) being found to be optimal against cell lines HCT-116 and SW480 (IC<sub>50</sub> = 8.66, 7.44 μM). With the introduction of heteroatoms and a phenyl ring to the 1′-position of the purine side chain, i.e., R<sup>2</sup> = CH<sub>2</sub>OBn (<b>10a</b>), CH<sub>2</sub>OBz (<b>11a</b>), and CH<sub>2</sub>OTBDMS (<b>12a</b>), their anticancer activities (IC<sub>50</sub> = 5.17–8.02 μM) were comparable to those of <b>5a</b>.</div><div class="NLM_p">Similarly, in compound <b>b</b> series (R<sup>1</sup> = R<sup>4</sup> = H, R<sup>3</sup> = Cl), acyclonucleosides <b>1b</b>–<b>12b</b> also showed a similar trend in anticancer activities, which first increased and then decreased gradually as the 1′-position alkyl chain length increases. Compound <b>9b</b>, with the 1′-position of the purine side chain substituted by <i>n</i>-nonyl, exhibited the highest anticancer activities against cell lines HCT-116 and SW480 (IC<sub>50</sub> = 0.89, 1.15 μM), which were about 10-fold more potent than those of the positive control 5-FU (IC<sub>50</sub> = 10.81, 9.70 μM). The anticancer activities were lost when R<sup>2</sup> was replaced with CH<sub>2</sub>OBn (<b>13b</b>), CH<sub>2</sub>OBz (<b>14b</b>), CH<sub>2</sub>OTBDMS (<b>15b</b>), and CH<sub>2</sub>OH (<b>16b</b>).</div><div class="NLM_p">In compound <b>c</b> series (R<sup>1</sup> = R<sup>3</sup> = Cl, R<sup>4</sup> = H), R<sup>1</sup> of <b>a</b> series was changed from F to Cl, the resulting acyclonucleosides <b>4c</b>–<b>9c</b> showed similar anticancer activities (IC<sub>50</sub> = 6.01–36.30 μM) to those of <b>4a</b>–<b>9a</b> (IC<sub>50</sub> = 7.44–32.05 μM), and also the length of alkyl chains on the 1′-position of <b>4c</b>–<b>9c</b> has a similar impact on their anticancer activities, which first increased and then decreased gradually with the increase of 1′-position alkyl chains.</div><div class="NLM_p">In compound <b>d</b>, <b>e</b>, <b>f</b>, and <b>g</b> series (R<sup>1</sup> = R<sup>4</sup> = H, R<sup>3</sup> = OMe (<b>d</b>), NHCH<sub>3</sub> (<b>e</b>), N(CH<sub>3</sub>)<sub>2</sub> (<b>f</b>), and NH<sub>2</sub> (<b>g</b>), respectively), the data pointed toward the same trend that all <b>4d</b>–<b>11d</b>, <b>5e</b>–<b>11e</b>, <b>5f</b>–<b>11f</b>, and <b>4g</b>–<b>11g</b> displayed anticancer activities that first increased and then decreased gradually as the 1′-position alkyl chain length increases. Compound <b>10g</b>, with the 1′-position of the purine side chain substituted by <i>n</i>-decyl, exhibited the highest anticancer activities against cell lines HCT-116 and SW480 (IC<sub>50</sub> = 2.59, 1.20 μM), which were about 4–10-fold more potent than those of the positive control 5-FU (IC<sub>50</sub> = 10.81, 9.70 μM). In compound <b>h</b> series (R<sup>1</sup> = Cl, R<sup>3</sup> = NH<sub>2</sub>, R<sup>4</sup> = H), acyclonucleosides <b>5h</b>–<b>11h</b> also continued the same tendency as those of <b>d</b>, <b>e</b>, <b>f</b>, and <b>g</b> series.</div><div class="NLM_p">With the introduction of bromine to the 8-position of the purine skeleton (compound <b>i</b> series, R<sup>1</sup> = H, R<sup>3</sup> = Cl, R<sup>4</sup> = Br), all of the resulting acyclonucleosides <b>5i</b>–<b>9i</b> showed moderate and not much different anticancer activities with IC<sub>50</sub> values in the range of 14.13–26.91 μM. The length of alkyl chains on the 1′-position of <b>5i</b>–<b>9i</b> also has a slight impact on their anticancer activities, which first increased and then decreased gradually with the increase of 1′-position alkyl chains, with <i>n</i>-hexyl (<b>6i</b>) and <i>n</i>-heptyl (<b>7i</b>) being found optimal against cell lines HCT-116 and SW480 (IC<sub>50</sub> = 14.13–16.22 μM). When 2-, 6-, and 8-positions of the purine skeleton were nonsubstituted (compound <b>j</b> series, R<sup>1</sup> = R<sup>3</sup> = R<sup>4</sup> = H), acyclonucleosides <b>4j</b>–<b>6j</b> exhibited no antitumor activity, which implied that the 1–2 substituents like halogens on the purine skeleton contributed greatly to their bioactivities.</div><div class="NLM_p">Next, some selected compounds (<b>5c</b>, <b>10g</b>, <b>11a</b>, <b>9b</b>, <b>10b</b>, and <b>9e</b>) were further tested against other cancer cells including HeLa, A549, and U87MG, and all of them showed good antitumor activities, whereas 5-FU was inactive with the IC<sub>50</sub> > 50 μM (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Table S1</a>). To clarify the impact of stereochemistry on anticancer activity, both (<i>R</i>)- and (<i>S</i>)-configured chiral acyclic nucleosides (<b>7b</b>–<b>9b</b>) were synthesized asymmetrically and assessed by an MTT assay in this regard (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). All of the (<i>R</i>)-configured acyclonucleoside derivatives showed several fold better anticancer activity than their corresponding antipodes, indicating that the (<i>R</i>)-configuration of the chiral center benefited the antiproliferative activity.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibitory Effects of Compounds <b>7b</b>–<b>9b</b> (<i>rac</i>-, <i>R</i>-, and <i>S</i>-) on Cancer Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0018.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">configuration</th><th class="colsep0 rowsep0" align="center" char="±">HCT-116<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">SW480<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7b</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>7</sub>H<sub>15</sub></td><td class="colsep0 rowsep0" align="left"><i>rac</i></td><td class="colsep0 rowsep0" align="char" char="±">4.16 ± 1.39</td><td class="colsep0 rowsep0" align="char" char="±">3.63 ± 1.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char="±">2.67 ± 0.37</td><td class="colsep0 rowsep0" align="char" char="±">2.93 ± 0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char="±">10.72 ± 0.91</td><td class="colsep0 rowsep0" align="char" char="±">3.82 ± 0.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8b</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>8</sub>H<sub>17</sub></td><td class="colsep0 rowsep0" align="left"><i>rac</i></td><td class="colsep0 rowsep0" align="char" char="±">1.65 ± 0.43</td><td class="colsep0 rowsep0" align="char" char="±">1.37 ± 0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char="±">1.12 ± 0.28</td><td class="colsep0 rowsep0" align="char" char="±">0.32 ± 0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char="±">3.40 ± 0.64</td><td class="colsep0 rowsep0" align="char" char="±">2.33 ± 0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>9</sub>H<sub>19</sub></td><td class="colsep0 rowsep0" align="left"><i>rac</i></td><td class="colsep0 rowsep0" align="char" char="±">0.89 ± 0.21</td><td class="colsep0 rowsep0" align="char" char="±">1.15 ± 0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>R</i></td><td class="colsep0 rowsep0" align="char" char="±">0.45 ± 0.10</td><td class="colsep0 rowsep0" align="char" char="±">1.63 ± 0.35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>S</i></td><td class="colsep0 rowsep0" align="char" char="±">1.05 ± 0.16</td><td class="colsep0 rowsep0" align="char" char="±">3.62 ± 0.66</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5-FU</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="±">10.81 ± 0.69</td><td class="colsep0 rowsep0" align="char" char="±">9.70 ± 1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">The antiproliferation activities of individual compounds against tumor cells were determined by the MTT assay. Data are mean ± SEM values from three independent experiments.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Both HCT-116 and SW480 are human colon carcinoma cell lines.</p></div></div></div><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, the introduction of an olefin double bond to the side chain of purines resulted in acyclonucleosides <b>5k</b>–<b>10k</b> with somewhat decreased anticancer activities compared with those of corresponding compound <b>b</b> series.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibitory Effect of Compounds <b>5k</b>–<b>10k</b> on Cancer Cell Proliferation</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0019.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">HCT-116<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">SW480<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5k</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>5</sub></sub>H<sub><sub>11</sub></sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">>50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6k</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>6</sub></sub>H<sub><sub>13</sub></sub></td><td class="colsep0 rowsep0" align="left">30.21 ± 2.35</td><td class="colsep0 rowsep0" align="left">32.03 ± 2.08</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7k</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>7</sub></sub>H<sub><sub>15</sub></sub></td><td class="colsep0 rowsep0" align="left">22.39 ± 2.18</td><td class="colsep0 rowsep0" align="left">29.42 ± 2.01</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8k</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>8</sub></sub>H<sub><sub>17</sub></sub></td><td class="colsep0 rowsep0" align="left">19.43 ± 2.06</td><td class="colsep0 rowsep0" align="left">16.22 ± 1.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9k</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub><sub>9</sub></sub>H<sub><sub>19</sub></sub></td><td class="colsep0 rowsep0" align="left">>50</td><td class="colsep0 rowsep0" align="left">27.61 ± 1.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10k</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">33.33 ± 3.13</td><td class="colsep0 rowsep0" align="left">12.91 ± 3.97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5-FU</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10.81 ± 0.69</td><td class="colsep0 rowsep0" align="left">9.70 ± 1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">The antiproliferation activities of individual compounds against tumor cells were determined by the MTT assay. Data are mean ± SEM values from three independent experiments.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Both HCT-116 and SW480 are human colon carcinoma cell lines.</p></div></div></div><div class="NLM_p">Using the hydroxyl group as a handle, simple synthetic manipulation of the promising compound <b>9b</b> readily converted it into its OMs, N<sub>3</sub>, triazole, Cl, and phosphonoethyl derivatives (<b>9ba</b>–<b>9be</b>) in 63.8–75.6% yields and 90–94% <i>ee</i>. Furthermore, the diethylphosphonate function of compound <b>9b</b> could also be deprotected to generate the corresponding phosphonic acid <b>9bf</b> in 44.9% yield (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0014.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>9ba</b>–<b>9bf</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">As shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, when the hydroxyl group on the side chain of <b>9b</b> was substituted by several other types of functional groups, all of the derivatives (<b>9ba</b>–<b>9be</b>) exerted moderate to potent anticancer activities (IC<sub>50</sub> = 1.04–13.49 μM) and the azide-substituted <b>9bb</b> was found optimal to exhibit the same level of activities as those of <b>9b</b>. However, the phosphonic acid <b>9bf</b> had almost no antitumor activity. By comparing the antitumor activities of acyclic nucleoside <b>9b</b> and phosphonic acid <b>9bf</b>, it could be seen that the hydroxyl group in the side chain of <b>9b</b> does not form the corresponding nucleoside triphosphate.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Inhibitory Effect of Compounds <b>9ba</b>–<b>9be</b> on Cancer Cell Proliferation<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0020.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0021.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">The antiproliferation activities of individual compounds against tumor cells were determined by the MTT assay. Data are mean ± SEM values from three independent experiments.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Both HCT-116 and SW480 are human colon carcinoma cell lines.</p></div></div><div></div></div><div class="NLM_p last">Based on the step-by-step investigation of structure–activity relationships, compound <b>9b</b> was identified as the most active compound possessing potent <i>in vitro</i> anticancer activity against colon cancer cell lines HCT-116 and SW480 with the IC<sub>50</sub> values of 0.89 and 1.15 μM, respectively, and therefore was selected for further bioactivity evaluation.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.2.  Toxicity against Human Colon Epithelial Cell</h3><div class="NLM_p">The toxicity of compound <b>9b</b> against normal cell lines was evaluated using the normal colon epithelial cell line NCM460 with 5-FU as the positive control. As shown in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, there was no significance between compound <b>9b</b> and 5-FU on toxicity against the human colon epithelial cell line NCM460 at 2, 10, and 50 μM.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Toxicity of compound <b>9b</b> on NCM460.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.3.  Apoptosis Induced by Compound 9b</h3><div class="NLM_p">A slight G0/G1 phase arrest was caused by representative compound <b>9b</b> at 16 μM (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Figure S1</a>),<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> prompting us to explore further the cell apoptosis induced by this compound. In this analysis, colon cancer cells were treated with vehicle or a solution of compound <b>9b</b> at different concentrations (2, 4, 8, 16, or 32 μM) for 48 h sequentially and then stained with Annexin V-fluorescein isothiocyanate (FITC) and propidium iodide (PI) in a dark environment. The percentages of apoptotic cells were determined by flow cytometry.<a onclick="showRef(event, 'ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref38 ref39">(38,39)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, compound <b>9b</b> induced apoptosis in a concentration-dependent manner, and the percentage of apoptotic cells increased from 6 to 69% in SW480.</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induction of apoptosis on SW480 cells by compound <b>9b</b>. Flow cytometry analysis of apoptotic SW480 cells induced by compound <b>9b</b> at different concentrations. Cells were treated with vehicle or compound <b>9b</b> at 2, 4, 8, 16, and 32 μM for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The apoptosis induced by compound <b>9b</b> in HCT-116 cells is shown in <a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Figure S2</a> (SI). As the concentration of <b>9b</b> increased, the proportion of apoptotic cells also increased steadily from 12 to 66%. The results suggest that compound <b>9b</b> could effectively induce apoptosis in cancer cells in a dose-dependent manner.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.4.  Analysis of the Expression of Apoptosis-Related Proteins (Bax, P53, Bcl-xl, and Cleaved-PARP) Induced by Compound <b>9b</b></h3><div class="NLM_p">To probe further into the apoptosis induced by compound <b>9b</b>, Bax, P53, Bcl-xl, and Cleaved-PARP were determined with western blotting as the markers of apoptosis.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40−44)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, along with the increasing concentrations of compound <b>9b</b>, the expressions of Bax, P53, and Cleaved-PARP were also found to increase gradually, whereas the expression of Bcl-xl decreased gradually, suggesting that compound <b>9b</b> could induce apoptosis.</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Western blotting analysis of cell-apoptosis-related proteins after treatment with compound <b>9b</b> at different concentrations. (B) Relative amount of protein after treatment with compound <b>9b</b> at different concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.5.  Mitochondrial Membrane Potential (MMP) Assay</h3><div class="NLM_p">The loss of mitochondrial membrane potential (MMP) is considered to be a limiting factor in the apoptotic pathway, which has been regarded as a target for antitumor agents and hence is of high value in controlling cell apoptosis.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> To investigate the role of mitochondria in the apoptosis induced by compound <b>9b</b>, SW480 cells were stained with JC-1, and the effect of compound <b>9b</b> on MMP was measured. JC-1 is capable of selectively entering mitochondria, either to form monomers that emit green fluorescence at low MMP or to form aggregates that emit red fluorescence at high MMP. Images acquired using fluorescence microscopy showed that the green area (low MMP) was significantly enlarged with the increasing concentrations of compound <b>9b</b> (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Furthermore, flow cytometry results showed that the number of treated cells emitting red fluorescence decreased significantly, while the number of treated cells emitting green fluorescence obviously increased, indicating considerable dissipation of MMP (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). The results suggest that the dissipation of MMP may participate in the apoptosis induced by compound <b>9b</b>. However, treatment of SW480 cells for 48 h with compound <b>9b</b> and Q-VD-OPh,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> a pan-caspase inhibitor, led only to a negligible change in the proportion of apoptotic cells, suggesting that cell apoptosis induced by compound <b>9b</b> did not occur through the caspase signaling pathway (SI, <a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">Figure S3</a>).</div><figure id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Collapse of the mitochondrial membrane potential on SW480 cells treated by compound <b>9b</b>. (A) Changes in the mitochondrial membrane potential were observed using the JC-1 kit under fluorescence microscopy. (B) Flow cytometry was used to detect the mitochondrial membrane potential on SW480 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.6.  Inhibition of Colony Formation by Compound <b>9b</b></h3><div class="NLM_p">The effect of compound <b>9b</b> on the colony formation of HCT-116 and SW480 was also evaluated. Cells were treated with a solution of compound <b>9b</b> at various concentrations for 48 h and allowed to grow for another 14 days in a regular culture medium, and digital images were taken. As shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>, the exposure of HCT-116 and SW480 cells to the solutions of compound <b>9b</b> at low concentrations resulted in a significant inhibition of colony formation. Cancer cell growth was completely abolished at concentrations of 16 μM and above.</div><figure id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0008.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effects of compound <b>9b</b> on colony formation of HCT-116 cells and SW480 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.7.  Metabolic Stability <i>In Vitro</i></h3><div class="NLM_p">Metabolic stability of compound <b>9b</b> in human and mouse liver microsome was tested. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, the <i>t</i><sub>1/2</sub> of compound <b>9b</b> in human liver microsome was 10 min, which is similar to that of 5-FU in the literature.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Metabolic Stability of Compound 9b <i>In Vitro</i></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> (min)</th><th class="colsep0 rowsep0" align="center">clint <i>in vitro</i><a class="ref internalNav" href="#t5fn2" aria-label="b">b</a> (mL/min/g protein)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">10.8</td><td class="colsep0 rowsep0" align="left">195</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse</td><td class="colsep0 rowsep0" align="left">1.00</td><td class="colsep0 rowsep0" align="left">2106</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last"><i>T</i><sub>1/2</sub>: Half-life time.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Clint <i>in vitro</i>: Intrinsic clearance <i>in vitro</i>.</p></div></div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">4.8.  Acute Toxicity of Compound <b>9b</b></h3><div class="NLM_p">An acute toxicity assay was performed to assess the safety of compound <b>9b</b><i>in vivo</i>. As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, the LD<sub>50</sub> value of compound <b>9b</b> was 220 mg/kg, which is similar to that of 5-FU in the literature.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Acute Toxicity of Compound <b>9b</b> on Balb/C Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">number of dead mice</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">group</th><th class="colsep0 rowsep0" align="center">day 1</th><th class="colsep0 rowsep0" align="center">day 2</th><th class="colsep0 rowsep0" align="center">day 3</th><th class="colsep0 rowsep0" align="center">days 4–15</th><th class="colsep0 rowsep0" align="center">total death</th><th class="colsep0 rowsep0" align="center">survival (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">300 mg/kg</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">250 mg/kg</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">200 mg/kg</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">150 mg/kg</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100 mg/kg</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="left">female</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">male</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div></div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.9.  Inhibition Activities of <b>9b</b> on Tumor Growth in a Xenograft Mice Model</h3><div class="NLM_p">The <i>in vivo</i> antitumor activities of compound <b>9b</b> were evaluated on the SW480 xenograft mice model.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>, eight BALB/C mice per group were administered <i>via</i> intraperitoneal injection with vehicle, compound <b>9b</b> (at dosages of 25 and 50 mg/kg), or 5-FU at a dosage of 50 mg/kg, once every 2 days over a period of 12 days. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A–D, compound <b>9b</b> significantly inhibited tumor growth in a dose-dependent manner as measured by tumor weight and volume. At the same time, the body weight of the treated mice did not show any significant decrease, suggesting that this compound may have favorable toxicity properties. As shown in <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>E, H & E staining of the tumors showed that the tumors were significantly necrotic after the administration of compound <b>9b</b>.</div><figure id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0009.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> anticancer activity of compound <b>9b</b> on the SW480 xenograft mice model. Female BALB/C nude mice were administered by intraperitoneal injection with the vehicle, compound <b>9b</b>, at dosages of 25 and 50 mg/kg, or 5-FU at a dosage of 50 mg/kg (<i>n</i> = 8 each group), once every 2 days for 12 days. Average tumor weight (A), average body weight (B), average tumor volume (C), and the isolated tumors (D) were measured. Data are expressed as the mean ± standard error (<i>n</i> = 8). * indicates <i>P</i> < 0.05, ** indicates <i>P</i> < 0.01, and *** indicates <i>P</i> < 0.001 vs control. H & E staining analysis of tumors in nude mice on the SW480 xenograft mice model (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.10.  Fishing for Targets</h3><div class="NLM_p">To identify the targets of these compounds, the biotin-annexed probe <b>21</b> and the diazirine-based probe <b>23</b> were synthesized and their antitumor activities were tested <i>in vitro</i> (<a class="ref internalNav" href="#sch4" aria-label="Schemes 4">Schemes 4</a>, <a class="ref internalNav" href="#sch5" aria-label="5">5</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Both compounds <b>21</b> and <b>23</b> showed an inhibitory effect on cancer cell proliferation to some extent.</div><figure id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0015.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Biotin-Annexed Probe <b>21</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0016.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Diazirine-Based Probe <b>23</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Inhibitory Effect of Biotin-Annexed Probe 21 and Diazirine Photoaffinity Probe 23 on Cancer Cell Proliferation</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char="±">IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a> ± SEM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="±">HCT-116<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="±">SW480<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="char" char="±">44.74 ± 4.22</td><td class="colsep0 rowsep0" align="char" char="±">45.23 ± 3.26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char="±">21.49 ± 2.34</td><td class="colsep0 rowsep0" align="char" char="±">13.00 ± 1.65</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5-FU</b></td><td class="colsep0 rowsep0" align="char" char="±">10.81 ± 0.69</td><td class="colsep0 rowsep0" align="char" char="±">9.70 ± 1.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">The antiproliferation activities of individual compounds against tumor cells were determined by the MTT assay. Data are mean ± SEM values from three independent experiments.</p></div><div class="footnote" id="t7fn2"><sup><sup>b</sup></sup><p class="last">Both HCT-116 and SW480 are human colon carcinoma cell lines.</p></div></div></div><div class="NLM_p">The biotin-annexed compounds <b>21</b> and the diazirine-based probe <b>23</b> were tested as noncovalent and covalent binding probes, respectively, to explore the interaction between the acyclic nucleoside moiety and the target proteins. Probes were incubated with SW480 cell lysate, and the linkers were used as negative controls. After incubating overnight, the proteins bounded to probes were pulled down by streptavidin-conjugated beads. The <b>23</b>- and <b>22</b>-treated samples were separated with sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), transferred to a poly(vinylidene fluoride) (PVDF) member, and incubated with avidin-HRP antibody, which can bind to biotin. As shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A, the compound-<b>23</b>-treated group exhibited a distinct band at 75 Kd, while the linker<b>-22</b>-treated and input groups did not show any obvious band. Then, both biotin-annexed compound <b>21</b> and the diazirine-based probe <b>23</b> were separated with SDS-PAGE and stained by silver staining. The results are shown in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B,C, which are in agreement with the western blotting results, where obvious bands were discovered at 75 Kd. The silver-stained bands were separated for protein mass spectrometry. Protein mass spectrometry for the <b>22</b>-treated band and the <b>23</b>-treated band revealed that nucleolin, ezrin, ATP-dependent RNA helicase, or ATP-binding cassette protein might be the targets of these molecules. The target validation is underway in this lab.</div><figure id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0010.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Western blotting and silver staining results of the pull-down samples. (A) Merger of bright field and chemiluminescence of the PVDF member. (B) and (C) Silver staining results of the SDS-PAGE gel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28">5.  Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, a series of novel acyclic nucleoside compounds were designed, synthesized, and evaluated for their anticancer activities <i>in vitro</i> and <i>in vivo</i>. Structure–activity relationship studies revealed that many of the target compounds demonstrated <i>in vitro</i> anticancer activities, among which <b>9b</b> was discovered as the most active compound against colon cancer cells HCT-116 and SW480 with IC<sub>50</sub> values of 0.89 and 1.15 μM, respectively. All chiral acyclic nucleoside derivatives with an (<i>R</i>)-configuration showed anticancer activities several folds better than those of their (<i>S</i>)-enantiomers, and the (<i>R</i>)-<b>9b</b> showed remarkable anticancer activity against colon cancer cells HCT-116 with an IC<sub>50</sub> value of 0.45 μM.</div><div class="NLM_p">Compound <b>9b</b> was found to arrest the cell cycle slightly at the G0/G1 phase. Cell apoptosis was induced in the presence of compound <b>9b</b>, as evidenced by the significant increment on the expression of proapoptosis proteins Bax and P53, as well as the cleavage fragment of PARP. On the other hand, the antiapoptosis protein Bcl-xl was found to attenuate substantially upon treatment with compound <b>9b</b>. Further mechanistic studies suggested that the dissipation of MMP may participate in the apoptosis induced by compound <b>9b</b>, while the caspase signaling pathway inhibitor Q-VD-OPh may have little effect on cell apoptosis. Compound <b>9b</b> was also shown to have a long-term toxicity, in the sense that it can effectively inhibit the colony formation. Moreover, <i>in vivo</i> studies showed that compound <b>9b</b> could inhibit tumor growth and induce tumor necrosis without affecting the body weight of mice, indicating a potent anticancer activity and low toxicity. The LD<sub>50</sub> value and metabolic stability <i>in vitro</i> of compound <b>9b</b> is similar to that of 5-FU.</div><div class="NLM_p">As an ongoing effort to develop promising drug candidates, we are currently working to decipher the cellular targets of the anticancer ANCs reported herein. The biotin-annexed probe and the diazirine-based probe were synthesized to identify the targets of these compounds, and an obvious band was discovered at 75 Kd. The bands were separated, and the protein mass spectrometry revealed that nucleolin, ezrin, ATP-dependent RNA helicase, or ATP-binding cassette protein might be the targets of these molecules. The target validation is underway in this lab.</div><div class="NLM_p last">From a groundbreaking point of view, acyclic nucleoside compound <b>9b</b> has demonstrated remarkable potential to be used as a lead for further development of a brand-new class of anticancer agents. Therefore, this work may open an avenue to further explore the use of ANCs as new and efficacious anticancer agents and is of great significance in the development of more efficient agents for cancer therapy in the future.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">6.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 6.1. General Methods for Chemistry</h3><div class="NLM_p">The purities of all targeted compounds were confirmed to be >95% by high-performance liquid chromatography (HPLC) (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">SI</a>). All commercial reagents and solvents were purchased from commercial suppliers and used without further purification. <sup>1</sup>H and <sup>13</sup>C NMR spectral data were recorded with a Bruker 400 or 600 MHz spectrometer in CDCl<sub>3</sub>, CD<sub>3</sub>OD, D<sub>2</sub>O, or DMSO-<i>d</i><sub>6</sub> using tetramethylsilane (TMS) as the internal standard. Optical rotation was recorded on the Autopol polarimeter. All products were further characterized by high-resolution mass spectrometry (HRMS). HRMS was recorded on an ABI/Sciex QStar mass spectrometer (ESI). Chiral HPLC analysis was recorded on Thermo Scientific Dionex Ultimate 3000 and Agilent Technologies 1260 Infinity. Optical rotations were reported as follows: [α]<sub class="stack">D</sub><sup class="stack">T</sup> (<i>c</i>: = g/100 mL, in solvent). Optical rotations were recorded on an Autopol automatic polarimeter. Targeted compounds were analyzed by a Thermo Scientific UltiMate 3000 HPLC instrument with a UV–visible detector (5 μm, 4.6 mm × 150 mm Agilent C<sub>18</sub> column).</div><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31">6.1.1.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>1a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, crotonaldehyde (24.9 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by thin-layer chromatography (TLC). Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>1a</b> as a white solid in 35.6 mg (72.9% yield). White solid. mp: 109–110 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 4.98–4.87 (m, 1H), 3.72–3.63 (m, 1H), 3.44–3.35 (m, 1H), 2.30–2.25 (m, 1H), 2.25–2.11 (m, 2H), 1.71 (d, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.6, 153.5, 152.9, 152.7, 145.1, 145.0, 130.7, 130.6, 58.6, 50.1, 38.3, 20.5; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>9</sub>H<sub>11</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 245.0600; found, 245.0601.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32">6.1.2.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)pentan-1-ol (<b>2a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-pent-2-enal (29.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>2a</b> as a white solid in 38.2 mg (74.0% yield). White solid. mp: 98–100 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.69–4.59 (m, 1H), 3.69–3.61 (m, 1H), 3.37–3.28 (m, 1H), 2.45 (s, 1H), 2.28–2.17 (m, 2H), 2.17–2.09 (m, 1H), 2.08–1.96 (m, 1H), 0.83 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.8, 153.7, 152.8, 152.6, 145.73, 145.7, 130.6, 130.5, 58.5, 56.6, 36.5, 27.4, 10.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>10</sub>H<sub>13</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 259.0756; found, 259.0762.</div></div><div id="sec6_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33">6.1.3.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)hexan-1-ol (<b>3a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hex-2-enal (34.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>3a</b> as a white solid in 38.1 mg (70.0% yield). White solid. mp: 113–115 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 4.80–4.71 (m, 1H), 3.70–3.61 (m, 1H), 3.36–3.27 (m, 1H), 2.27–2.16 (m, 3H), 2.16–2.07 (m, 1H), 1.97–1.87 (m, 1H), 1.30–1.20 (m, 1H), 1.19–1.08 (m, 1H), 0.89 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.8, 153.7, 152.9, 152.7, 145.62, 145.59, 130.61, 130.57, 58.5, 54.6, 36.8, 36.2, 19.6, 13.6; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>11</sub>H<sub>15</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 273.0913; found, 273.0920.</div></div><div id="sec6_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34">6.1.4.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)heptan-1-ol (<b>4a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hept-2-enal (39.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>4a</b> as a white solid in 41.2 mg (72.0% yield). White solid. mp: 118–120 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (s, 1H), 4.76–4.67 (m, 1H), 3.67–3.60 (m, 1H), 3.35–3.27 (m, 1H), 2.82 (s, 1H), 2.27–2.14 (m, 2H), 2.14–2.06 (m, 1H), 1.99–1.89 (m, 1H), 1.32–1.19 (m, 3H), 1.09–0.96 (m, 1H), 0.80 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 156.0, 153.8, 153.7, 152.9, 152.7, 145.61, 145.58, 130.64, 130.59, 58.6, 54.9, 36.9, 33.9, 28.4, 22.2, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>12</sub>H<sub>17</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 287.1069; found, 287.1078.</div></div><div id="sec6_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35">6.1.5.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5a</b> as a white solid in 45.6 mg (76.0% yield). White solid. mp: 115–117 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.14 (s, 1H), 4.77–4.66 (m, 1H), 3.70–3.59 (m, 1H), 3.35–3.27 (m, 1H), 2.77 (s, 1H), 2.27–2.15 (m, 2H), 2.15–2.06 (m, 1H), 1.99–1.87 (m, 1H), 1.26–1.17 (m, 5H), 1.11–1.01 (m, 1H), 0.79 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.0, 155.8, 153.8, 153.6, 152.7, 152.5, 145.78, 145.75, 130.50, 130.45, 58.4, 55.0, 36.7, 34.1, 31.2, 25.9, 22.4, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>19</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 301.1226; found, 301.1235.</div></div><div id="sec6_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36">6.1.6.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6a</b> as a white solid in 49.6 mg (78.9% yield). White solid. mp: 114–116 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 4.76–4.66 (m, 1H), 3.67–3.59 (m, 1H), 3.35–3.26 (m, 1H), 2.61 (s, 1H), 2.26–2.15 (m, 2H), 2.15–2.05 (m, 1H), 1.98–1.88 (m, 1H), 1.29–1.10 (m, 7H), 1.10–0.96 (m, 1H), 0.79 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.0, 155.9, 153.8, 153.6, 152.7, 152.5, 145.74, 145.71, 130.53, 130.48, 58.4, 55.0, 36.8, 34.2, 31.5, 28.7, 26.2, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>21</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 315.1382; found, 315.1383.</div></div><div id="sec6_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37">6.1.7.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7a</b> as a white solid in 48.2 mg (73.2% yield). White solid. mp: 104–107 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.13 (s, 1H), 4.77–4.67 (m, 1H), 3.67–3.59 (m, 1H), 3.35–3.26 (m, 1H), 2.91 (s, 1H), 2.26–2.15 (m, 2H), 2.15–2.05 (m, 1H), 1.99–1.87 (m, 1H), 1.25–1.13 (m, 9H), 1.10–0.98 (m, 1H), 0.80 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.8, 153.7, 152.9, 152.7, 145.64, 145.61, 130.61, 130.56, 58.5, 54.9, 36.9, 34.2, 31.7, 29.1, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>23</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 329.1539; found, 329.1540.</div></div><div id="sec6_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38">6.1.8.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8a</b> as a white solid in 55.2 mg (80.7% yield). White solid. mp: 116–118 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 4.76–4.67 (m, 1H), 3.68–3.60 (m, 1H), 3.36–3.26 (m, 1H), 2.32 (s, 1H), 2.25–2.15 (m, 2H), 2.15–2.06 (m, 1H), 1.99–1.88 (m, 1H), 1.28–1.21 (m, 4H), 1.21–1.15 (m, 7H), 1.11–1.00 (m, 1H), 0.83 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.8, 153.7, 152.8, 152.7, 145.7, 145.6, 130.6, 130.5, 58.5, 54.9, 36.8, 34.2, 31.8, 29.3, 29.2, 29.1, 26.3, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>25</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 343.1695; found, 343.1697.</div></div><div id="sec6_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39">6.1.9.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>9a</b> as a white solid in 58.7 mg (82.4% yield). White solid. mp: 113–115 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.10 (s, 1H), 4.76–4.67 (m,1H), 3.68–3.60 (m, 1H), 3.35–3.26 (m, 1H), 2.50 (s, 1H), 2.26–2.15 (m, 2H), 2.14–2.06 (m, 1H), 1.98–1.88 (m, 1H), 1.27–1.21 (m, 4H), 1.21–1.14 (m, 9H), 1.10–1.00 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 155.9, 153.8, 153.6, 152.8, 152.6, 145.72, 145.68, 130.6, 130.5, 58.5, 55.0, 36.8, 34.2, 31.9, 29.5, 29.4, 29.3, 29.1, 26.3, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>27</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 357.1852; found, 357.1850.</div></div><div id="sec6_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40">6.1.10.  4-(Benzyloxy)-3-(6-chloro-2-fluoro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>10a</b>)</h4><div class="NLM_p last">6-Chloro-2- fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-(benzyloxy)but-2-enal (52.8 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>10a</b> as a white solid in 54.7 mg (78.2% yield). White solid. mp: 96–97 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 7.25–7.22 (m, 3H), 7.13–7.10 (m, 2H), 4.98–4.93 (m, 1H), 4.50 (d, <i>J</i> = 12.0 Hz, 1H), 4.42 (d, <i>J</i> = 12.0 Hz, 1H), 3.96 (dd, <i>J</i> = 10.2, 6.6 Hz, 1H), 3.76 (dd, <i>J</i> = 10.2, 3.6 Hz, 1H), 3.70–3.64 (m, 1H), 3.42–3.36 (m, 1H), 2.47 (s, 1H), 2.32–2.26 (m, 1H), 2.20–2.14 (m, 1H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 157.6, 156.2, 153.6, 153.5, 152.5, 152.4, 146.6, 146.5, 137.0, 130.32, 130.29, 128.5, 128.2, 127.9, 73.4, 69.8, 58.3, 54.0, 33.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>17</sub>ClFN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 351.1019; found, 351.1020.</div></div><div id="sec6_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41">6.1.11.  2-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)-4-hydroxybutyl Benzoate (<b>11a</b>)</h4><div class="NLM_p last">6-Chloro- 2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-oxobut-2-en-1-yl benzoate (57.0 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>11a</b> as a white solid in 58.7 mg (80.6% yield). White solid. mp: 138–140 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.22 (s, 1H), 7.85 (d, <i>J</i> = 7.6 Hz, 2H), 7.55 (t, <i>J</i> = 7.6 Hz, 1H), 7.40 (t, <i>J</i> = 7.6 Hz, 2H), 5.25–5.16 (m, 1H), 4.89 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 4.73 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 3.85–3.77 (m, 1H), 3.53–3.44 (m, 1H), 2.52–2.42 (m, 1H), 2.39–2.29 (m, 1H), 2.18 (s, 1H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 166.0, 157.8, 156.3, 153.7, 153.6, 153.0, 152.9, 145.94, 145.92, 133.8, 130.7, 130.6, 129.6, 128.9, 128.7, 64.9, 58.1, 53.8, 32.4; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>15</sub>ClFN<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>), 365.0811; found, 365.0809.</div></div><div id="sec6_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42">6.1.12.  4-(<i>tert</i>-Butyldimethylsilyl)-3-(6-chloro-2-fluoro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>12a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (34.5 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-((tert-butyldimethylsilyl)oxy)but-2-enal (60.0 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the target compound <b>12a</b> as a white solid in 58.9 mg (78.8% yield). White solid. mp: 83–85 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.26 (s, 1H), 4.92–4.87 (m, 1H), 4.05 (dd, <i>J</i> = 10.8, 5.4 Hz, 1H), 3.91 (dd, <i>J</i> = 10.8, 3.6 Hz, 1H), 3.73–3.69 (m, 1H), 3.47–3.42 (m, 1H), 2.41 (s, 1H), 2.33–2.27 (m, 1H), 2.21–2.14 (m, 1H), 0.80 (s, 9H), −0.06 (d, <i>J</i> = 11.4 Hz, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.1, 156.0, 153.8, 153.6, 152.7, 152.5, 146.4, 146.4, 130.24, 130.19, 64.1, 58.5, 55.3, 33.0, 25.8, 18.1, −5.5, −5.7; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>25</sub>ClFN<sub>4</sub>O<sub>2</sub>Si (M + H<sup>+</sup>), 375.1414; found, 375.1424.</div></div><div id="sec6_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43">6.1.13.  3-(6-Chloro-2-fluoro-9<i>H</i>-purin-9-yl)propan-1-ol (<b>13a</b>)</h4><div class="NLM_p last">6-Chloro-2-fluoro-9<i>H</i>-purine (1.55 g, 10 mmol), potassium carbonate (1.66 g, 12 mmol), and dry <i>N</i>,<i>N</i>-dimethylformamide (DMF) (25.0 mL) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 0 °C for 1 h under a N<sub>2</sub> atmosphere. Then, methyl 3-bromopropionate (1.3 mL, 12 mmol) was slowly added to the reaction mixture. The reaction was stirred at room temperature for 48 h and detected by TLC. Then, water was added to the reaction and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the compound methyl 3-(6-chloro-2-fluoro- 9<i>H</i>-purin-9-yl)propanoate as a pale-yellow solid in 2.08 g (80.6% yield). The solution of methyl 3-(6-chloro-2-fluoro-9<i>H</i>- purin-9-yl)propanoate (25.8 mg, 0.1 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 1.0 M in toluene, 0.3 mmol) was added dropwise at −78 °C. The reaction was stirred at −78 °C for 20 min and then stirred at room temperature until methyl 3-(6-chloro-2-fluoro-9<i>H</i>-purin-9-yl)propanoate was completely consumed. After that, the reaction was quenched with 10% NaOH solution. Then, water was added to the residue and the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>13a</b> as a white solid in 18.6 mg (80.9% yield). White solid. mp: 111–112 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 4.43 (t, <i>J</i> = 6.8 Hz, 2H), 3.65 (t, <i>J</i> = 5.4 Hz, 2H), 2.24 (s, 1H), 2.18–2.08 (m, 2H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 158.5, 156.3, 154.0, 153.8, 153.0, 152.8, 146.6, 146.5, 130.5, 130.4, 58.5, 41.4, 31.8; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>8</sub>H<sub>9</sub>ClFN<sub>4</sub>O (M + H<sup>+</sup>), 231.0443; found, 231.0442.</div></div><div id="sec6_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44">6.1.14.  3-(6-Chloro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>1b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, crotonaldehyde (24.9 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>1b</b> as a white solid in 38.0 mg (84.1% yield). White solid. mp: 104–106 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.19 (s, 1H), 5.08–4.98 (m, 1H), 3.71–3.59 (m, 1H), 3.33–3.21 (m, 1H), 2.80 (s, 1H), 2.26–2.04 (m, 2H), 1.75 (d, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 151.9, 151.7, 151.4, 144.0, 131.9, 58.4, 49.3, 39.2, 20.7; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>9</sub>H<sub>12</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 227.0694; found, 227.0694.</div></div><div id="sec6_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45">6.1.15.  3-(6-Chloro-9<i>H</i>-purin-9-yl)pentan-1-ol (<b>2b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-pent-2-enal (29.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>2b</b> as a white solid in 39.4 mg (82.1% yield). White solid. mp: 100–103 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.14 (s, 1H), 4.79–4.70 (m, 1H), 3.67–3.60 (m, 1H), 3.28–3.19 (m, 1H), 2.69 (s, 1H), 2.28–2.12 (m, 3H), 2.12–1.99 (m, 1H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.3, 144.6, 131.9, 58.4, 55.8, 37.2, 27.6, 11.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>10</sub>H<sub>14</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 241.0851; found, 241.0855.</div></div><div id="sec6_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46">6.1.16.  3-(6-Chloro-9<i>H</i>-purin-9-yl)hexan-1-ol (<b>3b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hex-2-enal (34.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>3b</b> as a white solid in 40.1 mg (78.9% yield). White solid. mp: 105–107 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.14 (s, 1H), 4.91–4.81 (m, 1H), 3.69–3.58 (m, 1H), 3.20 (t, <i>J</i> = 9.2 Hz, 1H), 2.47 (s, 1H), 2.27–2.08 (m, 3H), 2.03–1.91 (m, 1H), 1.34–1.12 (m, 2H), 0.91 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.3, 144.5, 131.9, 58.4, 53.8, 37.6, 36.4, 19.6, 13.6; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>11</sub>H<sub>16</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 255.1007; found, 255.1014.</div></div><div id="sec6_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47">6.1.17.  3-(6-Chloro-9<i>H</i>-purin-9-yl)heptan-1-ol (<b>4b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hept-2-enal (39.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>4b</b> as a white solid in 44.0 mg (82.3% yield). White solid. mp: 87–89 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.14 (s, 1H), 4.88–4.78 (m, 1H), 3.68–3.58 (m, 1H), 3.25–3.15 (m, 1H), 2.49 (s, 1H), 2.28–2.07 (m, 3H), 2.05–1.94 (m, 1H), 1.39–1.19 (m, 3H), 1.15–1.02 (m, 1H), 0.83 (t, <i>J</i> = 7.6 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.4, 144.5, 131.9, 58.4, 54.1, 37.7, 34.1, 28.5, 22.3, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>12</sub>H<sub>18</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 269.1164; found, 269.1166.</div></div><div id="sec6_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48">6.1.18.  3-(6-Chloro-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5b</b> as a white solid in 45.7 mg (81.1% yield). White solid. mp: 113–114 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.17 (m, 1H), 2.87 (s, 1H), 2.22–2.10 (m, 3H), 2.01–1.91 (m, 1H), 1.28–1.16 (m, 5H), 1.12–1.03 (m, 1H), 0.79 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.7, 131.8, 58.3, 54.2, 37.5, 34.3, 31.2, 26.0, 22.4, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>20</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 283.1320; found, 283.1330.</div></div><div id="sec6_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49">6.1.19.  3-(6-Chloro-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6b</b> as a white solid in 49.1 mg (83.2% yield). White solid. mp: 99–100 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (s, 1H), 8.13 (s, 1H), 4.88–4.77 (m, 1H), 3.66–3.58 (m, 1H), 3.26–3.16 (m, 1H), 2.59 (s, 1H), 2.27–2.08 (m, 3H), 2.03–1.93 (m, 1H), 1.29–1.15 (m, 7H), 1.14–1.05 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.4, 144.5, 131.9, 58.4, 54.1, 37.6, 34.4, 31.6, 28.8, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>22</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 297.1477; found, 297.1479.</div></div><div id="sec6_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50">6.1.20.  3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7b</b> as a white solid in 52.8 mg (85.2% yield). White solid. mp: 101–102 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>24</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 311.1633; found, 311.1633.</div></div><div id="sec6_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51">6.1.21.  (<i>R</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>R</i>)-<b>7b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol), and (<i>S</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. II) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature, and then, 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>R</i>)<b>-7b</b> as a white solid in 34.0 mg (54.8% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −8.4 (<i>c</i> = 0.14, CHCl<sub>3</sub>), 91% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 30.142 min (minor), 32.460 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>24</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 311.1633; found, 311.1633.</div></div><div id="sec6_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52">6.1.22.  (<i>S</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>S</i>)-<b>7b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol), and (<i>R</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. III) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature and then 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>S</i>)<b>-7b</b> as a white solid in 33.2 mg (53.5% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = 8.4 (<i>c</i> = 0.14, CHCl<sub>3</sub>), 91% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 29.500 min (major), 34.580 min (minor)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>24</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 311.1633; found, 311.1633.</div></div><div id="sec6_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53">6.1.23.  3-(6-Chloro-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8b</b> as a white solid in 51.1 mg (78.8% yield). White solid. mp: 106–108 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.66–3.57 (m, 1H), 3.27–3.15 (m, 1H), 2.80 (s, 1H), 2.25–2.10 (m, 3H), 2.02–1.91 (m, 1H), 1.25–1.20 (m, 4H), 1.20–1.14 (m, 7H), 1.12–1.02 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.8, 151.3, 144.6, 131.8, 58.3, 54.2, 37.5, 34.4, 31.8, 29.3, 29.2, 29.1, 26.3, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>26</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 325.1790; found, 325.1795.</div></div><div id="sec6_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54">6.1.24.  (<i>R</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>R</i>)-<b>8b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol), and (<i>S</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. II) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature, and then, 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>R</i>)<b>-8b</b> as a white solid in 34.1 mg (52.6% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −2.9 (<i>c</i> = 0.14, CHCl<sub>3</sub>), 91% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 28.368 min (minor), 30.165 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>26</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 325.1790; found, 325.1795.</div></div><div id="sec6_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55">6.1.25.  (<i>S</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>S</i>)-<b>8b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol), and (<i>R</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. III) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature, and then, 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>S</i>)<b>-8b</b> as a white solid in 32.7 mg (50.5% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = 3.0 (<i>c</i> = 0.20, CHCl<sub>3</sub>), 92% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 28.079 min (major), 32.026 min (minor)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>26</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 325.1790; found, 325.1795</div></div><div id="sec6_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56">6.1.26.  3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>9b</b> as a white solid in 52.4 mg (77.5% yield). White solid. mp: 101–102 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.17 (s, 1H), 4.86–4.77 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.17 (m, 1H), 2.93 (s, 1H), 2.23–2.10 (m, 3H), 2.01–1.90 (m, 1H), 1.25–1.20 (m, 4H), 1.20–1.14 (m, 9H), 1.11–1.02 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.7, 131.8, 58.3, 54.2, 37.5, 34.3, 31.9, 29.44, 29.36, 29.2, 29.1, 26.3, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 339.1946; found, 339.1945.</div></div><div id="sec6_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57">6.1.27.  (<i>R</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>R</i>)-<b>9b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol), and (<i>S</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. II) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature and then 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>R</i>)<b>-9b</b> as a white solid in 34.8 mg (51.5% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −5.0 (<i>c</i> = 0.12, CHCl<sub>3</sub>), 95% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 26.768 min (minor), 28.771 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 339.1946; found, 339.1945.</div></div><div id="sec6_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58">6.1.28.  (<i>S</i>)-3-(6-Chloro-9<i>H</i>-purin-9-yl)decan-1-ol ((<i>S</i>)-<b>9b</b>)</h4><div class="NLM_p last">Toluene (2.0 mL), benzoic acid (2.4 mg, 0.02 mmol), (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol), and (<i>R</i>)-2-[(bis(3,5-bis(trifluoromethyl)phenyl)trimethylsilanyloxy)methyl]pyrrolidine (Cat. III) (11.9 mg, 0.02 mmol) were added to a reaction tube with a magnetic stirring bar. The mixture was stirred for 30 min at room temperature, and then, 6-chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol) was added at −30 °C. The reaction was stirred at −30 °C for 24 h and detected by TLC. The resulting mixture was diluted with precooled MeOH (1.0 mL). NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added, and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound (<i>S</i>)<b>-9b</b> as a white solid in 33.4 mg (50.9% yield). White solid. mp: 101–102 °C. [α]<sub class="stack">D</sub><sup class="stack">20</sup> = 5.0 (<i>c</i> = 0.12, CHCl<sub>3</sub>), 95% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 25.799 min (major), 29.523 min (minor)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.13 (s, 1H), 4.86–4.76 (m, 1H), 3.65–3.57 (m, 1H), 3.26–3.16 (m, 1H), 2.84 (s, 1H), 2.25–2.09 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.12 (m, 9H), 1.10–1.01 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.7, 151.2, 144.6, 131.8, 58.3, 54.2, 37.5, 34.3, 31.7, 29.04, 29.03, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 339.1946; found, 339.1945.</div></div><div id="sec6_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59">6.1.29.  3-(6-Chloro-9<i>H</i>-purin-9-yl)tridecan-1-ol (10b)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tridec-2-enal (58.9 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>10b</b> as a white solid in 55.5 mg (78.8% yield). White solid. mp: 108–110 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.13 (s, 1H), 4.86–4.77 (m, 1H), 3.66–3.58 (m, 1H), 3.25–3.17 (m, 1H), 2.65 (s, 1H), 2.26–2.08 (m, 3H), 2.04–1.90 (m, 1H), 1.27–1.22 (m, 4H), 1.22–1.14 (m, 11H), 1.13–1.04 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.4, 144.5, 131.9, 58.4, 54.1, 37.7, 34.4, 32.0, 29.6, 29.5, 29.4, 29.36, 29.1, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>30</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 353.2103; found, 353.2102.</div></div><div id="sec6_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60">6.1.30.  3-(6-Chloro-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tetradec-2-enal (63.1 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>11b</b> as a white solid in 56.7 mg (77.4% yield). White solid. mp: 91–93 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (s, 1H), 8.13 (s, 1H), 4.87–4.78 (m, 1H), 3.66–3.59 (m, 1H), 3.25–3.17 (m, 1H), 2.65 (s, 1H), 2.26–2.08 (m, 3H), 2.02–1.92 (m, 1H), 1.28–1.16 (m, 17H), 1.12–1.02 (m, 1H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.2, 151.8, 151.4, 144.5, 131.9, 58.4, 54.1, 37.7, 34.4, 32.0, 29.7, 29.6, 29.5, 29.4, 29.1, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>32</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 367.2259; found, 367.2261.</div></div><div id="sec6_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61">6.1.31.  3-(6-Chloro-9<i>H</i>-purin-9-yl)pentadecan-1-ol (12b)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-pentadec-2-enal (67.3 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>12b</b> as a white solid in 61.6 mg (81.1% yield). White solid. mp: 112–114 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.12 (s, 1H), 4.86–4.77 (m, 1H), 3.65–3.58 (m, 1H), 3.25–3.17 (m, 1H), 2.77 (s, 1H), 2.26–2.07 (m, 3H), 2.02–1.91 (m, 1H), 1.27–1.15 (m, 19H), 1.12–1.02 (m, 1H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.1, 151.8, 151.3, 144.6, 131.9, 58.4, 54.1, 37.6, 34.4, 32.0, 29.7, 29.6, 29.5, 29.42, 29.4, 29.1, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>20</sub>H<sub>34</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 381.2416; found, 381.2424.</div></div><div id="sec6_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62">6.1.32.  4-(Benzyloxy)-3-(6-chloro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>13b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-(benzyloxy)but-2-enal (52.8 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>13b</b> as a colorless oil in 48.0 mg (72.3% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (s, 1H), 8.57 (s, 1H), 7.18–7.14 (m, 3H), 7.06–7.02 (m, 2H), 5.11–5.03 (m, 1H), 4.49 (d, <i>J</i> = 12.0 Hz, 1H), 4.39 (d, <i>J</i> = 12.0 Hz, 1H), 4.03 (dd, <i>J</i> = 10.4, 8.0 Hz, 1H), 3.83 (dd, <i>J</i> = 10.4, 4.0 Hz, 1H), 3.61–3.54 (m, 1H), 3.44–3.36 (m, 1H), 2.46–2.35 (m, 1H), 2.25–2.14 (m, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 151.9, 151.6, 151.0, 145.7, 137.0, 131.5, 128.6, 128.2, 127.8, 73.5, 70.3, 58.1, 53.3, 33.7; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>18</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 333.1113; found, 333.1117.</div></div><div id="sec6_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63">6.1.33.  2-(6-Chloro-9<i>H</i>-purin-9-yl)-4-hydroxybutyl benzoate (<b>14b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-oxobut-2-en-1-yl benzoate (57.0 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>14b</b> as a white solid in 56.5 mg (81.7% yield). White solid. mp: 137–140 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.69 (s, 1H), 8.28 (s, 1H), 7.84–7.79 (m, 2H), 7.55–7.49 (m, 1H), 7.36 (t, <i>J</i> = 8.0 Hz, 2H), 5.33–5.24 (m, 1H), 4.93 (dd, <i>J</i> = 12.0, 8.0 Hz, 1H), 4.75 (dd, <i>J</i> = 12.0, 4.0 Hz, 1H), 3.82–3.73 (m, 1H), 3.47–3.37 (m, 1H), 2.92 (s, 1H), 2.51–2.41 (m, 1H), 2.39–2.29 (m, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 166.0, 151.9, 151.3, 145.2, 133.7, 131.9, 129.6, 129.0, 128.7, 65.0, 57.9, 53.4, 32.8; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>16</sub>ClN<sub>4</sub>O<sub>3</sub> (M + H<sup>+</sup>), 347.0905; found, 347.0914.</div></div><div id="sec6_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64">6.1.34.  4-(<i>tert</i>-Butyldimethylsilyl)-3-(6-chloro-9<i>H</i>-purin-9-yl)butan-1-ol (<b>15b</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-4-((tert-butyldimethylsilyl)oxy)but-2-enal (60.0 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the target compound <b>15b</b> as a white solid in 51.4 mg (72.2% yield). White solid. mp: 105–107 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 8.32 (s, 1H), 5.01–4.93 (m, 1H), 4.08 (dd, <i>J</i> = 10.8, 5.6 Hz, 1H), 3.95 (dd, <i>J</i> = 10.8, 3.2 Hz, 1H), 3.72–3.63 (m, 1H), 3.40–3.30 (m, 1H), 3.02 (s, 1H), 2.33–2.23 (m, 1H), 2.21–2.12 (m, 1H), 0.79 (s, 9H), −0.07 (d, <i>J</i> = 7.6 Hz, 6H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.0, 151.6, 151.1, 145.6, 131.5, 64.4, 58.2, 54.8, 33.5, 25.7, 18.1, −5.6, −5.7; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>2</sub>Si (M + H<sup>+</sup>), 357.1508; found, 357.1511.</div></div><div id="sec6_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65">6.1.35.  2-(6-Chloro-9<i>H</i>-purin-9-yl)butane-1,4-diol (<b>16b</b>)</h4><div class="NLM_p last">Compound <b>15b</b> (35.6 mg, 0.1 mmol), tetrabutylammonium fluoride (52.4 mg, 0.2 mmol), and tetrahydrofuran (1.0 mL) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at room temperature for 2 h and detected by TLC. Then, the solution was concentrated in vacuo. Finally, the residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>16b</b> as a white solid in 40.4 mg (83.5% yield). White solid. mp: 143–144 °C. <sup>1</sup>H NMR (600 MHz, CD<sub>3</sub>OD) δ 8.71 (s, 1H), 8.62 (s, 1H), 4.98–4.92 (m, 1H), 4.12 (dd, <i>J</i> = 12.0, 7.8 Hz, 1H), 3.92 (dd, <i>J</i> = 12.0, 4.2 Hz, 1H), 3.62–3.56 (m, 1H), 3.44–3.38 (m, 1H), 2.42–2.35 (m, 1H), 2.24–2.16 (m, 1H); <sup>13</sup>C NMR (150 MHz, CD<sub>3</sub>OD) δ 153.5, 152.6, 151.1, 148.3, 132.5, 63.8, 59.0, 58.0, 33.6; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>9</sub>H<sub>12</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 243.0643; found, 243.0644.</div></div><div id="sec6_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66">6.1.36.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)heptan-1-ol (<b>4c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hept-2-enal (39.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>4c</b> as a white solid in 45.8 mg (75.8% yield). White solid. mp: 143–144 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.80–4.71 (m, 1H), 3.69–3.61 (m, 1H), 3.35–3.26 (m, 1H), 2.29–2.16 (m, 3H), 2.16–2.07 (m, 1H), 2.02–1.91 (m, 1H), 1.33–1.23 (m, 3H), 1.12–0.99 (m, 1H), 0.83 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.4, 152.8, 151.9, 145.5, 131.1, 58.6, 54.8, 37.1, 34.0, 28.4, 22.2, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>12</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 303.0774; found, 303.0775.</div></div><div id="sec6_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67">6.1.37.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5c</b> as a white solid in 52.6 mg (83.2% yield). White solid. mp: 113–115 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.80–4.71 (m, 1H), 3.69–3.59 (m, 1H), 3.36–3.25 (m, 1H), 2.33 (s, 1H), 2.22–2.16 (m, 2H), 2.15–2.06 (m, 1H), 1.99–1.88 (m, 1H), 1.26–1.18 (m, 5H), 1.12–1.02 (m, 1H), 0.81 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.3, 152.7, 151.8, 145.5, 131.0, 58.5, 54.9, 37.0, 34.2, 31.2, 26.0, 22.4, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 317.0930; found, 317.0939.</div></div><div id="sec6_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68">6.1.38.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6c</b> as a white solid in 51.5 mg (78.1% yield). White solid. mp: 118–119 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.80–4.71 (m, 1H), 3.68–3.60 (m, 1H), 3.35–3.26 (m, 1H), 2.42 (s, 1H), 2.23–2.16 (m, 2H), 2.16–2.06 (m, 1H), 2.00–1.89 (m, 1H), 1.27–1.12 (m, 7H), 1.10–1.00 (m, 1H), 0.81 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.3, 152.7, 151.8, 145.5, 131.0, 58.5, 54.9, 37.0, 34.3, 31.5, 28.7, 26.2, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>21</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 331.1087; found, 331.1083.</div></div><div id="sec6_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69">6.1.39.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7c</b> as a white solid in 52.7 mg (76.6% yield). White solid. mp: 111–114 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.80–4.70 (m, 1H), 3.69–3.59 (m, 1H), 3.36–3.26 (m, 1H), 2.40 (s, 1H), 2.23–2.15 (m, 2H), 2.15–2.06 (m, 1H), 2.00–1.89 (m, 1H), 1.26–1.12 (m, 9H), 1.11–0.99 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.3, 152.7, 151.8, 145.5, 131.0, 58.5, 54.9, 37.0, 34.3, 31.7, 29.0, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>23</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 345.1243; found, 345.1249.</div></div><div id="sec6_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70">6.1.40.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8c</b> as a white solid in 56.4 mg (78.8% yield). White solid. mp: 112–113 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.11 (s, 1H), 4.81–4.70 (m, 1H), 3.68–3.59 (m, 1H), 3.36–3.26 (m, 1H), 2.42 (s, 1H), 2.24–2.16 (m, 2H), 2.15–2.06 (m, 1H), 2.00–1.88 (m, 1H), 1.29–1.14 (m, 11H), 1.11–1.01 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.3, 152.7, 151.8, 145.5, 131.0, 58.5, 54.9, 37.0, 34.3, 31.8, 29.3, 29.2, 29.1, 26.3, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>25</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 359.1400; found, 359.1399.</div></div><div id="sec6_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71">6.1.41.  3-(2,6-Dichloro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9c</b>)</h4><div class="NLM_p last">2,6-Dichloro-9<i>H</i>-purine (37.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>9c</b> as a white solid in 62.6 mg (84.1% yield). White solid. mp: 94–96 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.15 (s, 1H), 4.78–4.71 (m, 1H), 3.66–3.60 (m, 1H), 3.34–3.28 (m, 1H), 2.74 (s, 1H), 2.25–2.15 (m, 2H), 2.15–2.06 (m, 1H), 1.98–1.89 (m, 1H), 1.25–1.19 (m, 5H), 1.19–1.11 (m, 8H), 1.08–1.00 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 153.4, 152.8, 151.9, 145.5, 131.0, 58.6, 54.8, 37.0, 34.3, 31.9, 29.5, 29.4, 29.3, 29.1, 26.3, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 373.1556; found, 373.1561.</div></div><div id="sec6_1_42" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72">6.1.42.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)heptan-1-ol (<b>4d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-hept-2-enal (39.3 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>4d</b> as a white solid in 43.6 mg (82.2% yield). White solid. mp: 68–71 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.51 (s, 1H), 7.94 (s, 1H), 4.83–4.76 (m, 1H), 4.19 (s, 3H), 3.61–3.55 (m, 1H), 3.27 (s, 1H), 3.12 (td, <i>J</i> = 10.8, 3.6 Hz, 1H), 2.23–2.16 (m, 1H), 2.16–2.09 (m,1H), 2.01–1.91 (m, 2H), 1.35–1.25 (m, 3H), 1.18–1.10 (m, 1H), 0.84 (t, <i>J</i> = 6.6 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 161.4, 152.5, 152.1, 140.8, 121.5, 58.2, 54.5, 52.7, 38.7, 34.2, 28.6, 22.3, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 265.1659; found, 265.1660.</div></div><div id="sec6_1_43" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73">6.1.43.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5d</b> as a white solid in 47.3 mg (85.1% yield). White solid. mp: 73–75 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (s, 1H), 7.92 (s, 1H), 4.81–4.72 (m, 1H), 4.16 (s, 3H), 3.61–3.49 (m, 2H), 3.18–3.08 (m, 1H), 2.21–2.08 (m, 2H), 2.02–1.88 (m, 2H), 1.29–1.18 (m, 5H), 1.15–1.07 (m, 1H), 0.79 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.4, 152.0, 140.9, 121.5, 58.1, 54.4, 52.9, 38.4, 34.5, 31.3, 26.0, 22.4, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>23</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 279.1816; found, 279.1812.</div></div><div id="sec6_1_44" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74">6.1.44.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6d</b> as a white solid in 48.8 mg (83.6% yield). White solid. mp: 73–74 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (s, 1H), 7.93 (s, 1H), 4.82–4.73 (m, 1H), 4.18 (s, 3H), 3.62–3.52 (m, 1H), 3.40 (s, 1H), 3.18–3.07 (m, 1H), 2.24–2.06 (m, 2H), 2.00–1.92 (m, 2H), 1.30–1.14 (m, 8H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.5, 152.0, 140.8, 121.5, 58.1, 54.4, 52.8, 38.6, 34.5, 31.6, 28.8, 26.3, 22.5, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>25</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 293.1972; found, 293.1973.</div></div><div id="sec6_1_45" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75">6.1.45.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7d</b> as a white solid in 53.0 mg (86.7% yield). White solid. mp: 69–70 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (s, 1H), 7.93 (s, 1H), 4.83–4.73 (m, 1H), 4.18 (s, 3H), 3.64–3.50 (m, 1H), 3.40 (s, 1H), 3.18–3.06 (m, 1H), 2.23–2.06 (m, 2H), 2.00–1.93 (m, 2H), 1.29–1.13 (m, 10H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.5, 152.0, 140.8, 121.5, 58.1, 54.4, 52.8, 38.6, 34.5, 31.7, 29.12, 29.08, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>27</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 307.2129; found, 307.2130.</div></div><div id="sec6_1_46" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76">6.1.46.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8d</b> as a white solid in 57.3 mg (89.5% yield). White solid. mp: 68–70 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.48 (s, 1H), 7.92 (s, 1H), 4.82–4.72 (m, 1H), 4.16 (s, 3H), 3.69–3.29 (m, 2H), 3.13 (td, <i>J</i> = 10.8, 3.6 Hz, 1H), 2.22–2.06 (m, 2H), 2.02–1.88 (m, 2H), 1.26–1.20 (m, 4H), 1.20–1.10 (m, 8H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.4, 152.0, 140.9, 121.5, 58.1, 54.4, 52.9, 38.5, 34.5, 31.8, 29.4, 29.2, 29.1, 26.4, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>29</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 321.2285; found, 321.2289.</div></div><div id="sec6_1_47" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77">6.1.47.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>9d</b> as a white solid in 58.9 mg (88.1% yield). White solid. mp: 66–68 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (s, 1H), 7.93 (s, 1H), 4.83–4.72 (m, 1H), 4.18 (s, 3H), 3.61–3.53 (m, 1H), 3.41 (s, 1H), 3.13 (td, <i>J</i> = 10.8, 3.6 Hz, 1H), 2.23–2.06 (m, 2H), 2.00–1.92 (m, 2H), 1.28–1.21 (m, 5H), 1.21–1.13 (m, 9H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.5, 152.0, 140.9, 121.5, 58.1, 54.4, 52.8, 38.6, 34.5, 31.9, 29.5, 29.4, 29.3, 29.2, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>31</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 335.2442; found, 335.2448.</div></div><div id="sec6_1_48" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78">6.1.48.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)tridecan-1-ol (<b>10d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tridec-2-enal (58.9 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>10d</b> as a white solid in 57.1 mg (82.1% yield). White solid. mp: 49–51 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (s, 1H), 7.93 (s, 1H), 4.83–4.73 (m, 1H), 4.18 (s, 3H), 3.62–3.53 (m, 1H), 3.39 (s, 1H), 3.13 (td, <i>J</i> = 11.2, 3.6 Hz, 1H), 2.24–2.07 (m, 2H), 2.01–1.90 (m, 2H), 1.28–1.22 (m, 5H), 1.22–1.16 (m, 11H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 161.3, 152.5, 152.0, 140.8, 121.5, 58.1, 54.4, 52.8, 38.6, 34.5, 32.0, 29.6, 29.5, 29.42, 29.36, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>33</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 349.2598; found, 349.2606.</div></div><div id="sec6_1_49" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79">6.1.49.  3-(6-Methoxy-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11d</b>)</h4><div class="NLM_p last">6-Methoxy-9<i>H</i>-purine (30.0 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tetradec-2-enal (63.1 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>11d</b> as a white solid in 61.9 mg (85.5% yield). White solid. mp: 57–58 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (s, 1H), 7.93 (s, 1H), 4.83–4.73 (m, 1H), 4.18 (s, 3H), 3.62–3.53 (m, 1H), 3.37 (s, 1H), 3.12 (td, <i>J</i> = 11.2, 3.6 Hz, 1H), 2.24–2.06 (m, 2H), 2.01–1.90 (m, 2H), 1.29–1.23 (m, 5H), 1.23–1.16 (m, 13H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 161.3, 152.5, 152.0, 140.8, 121.5, 58.1, 54.4, 52.8, 38.6, 34.5, 32.0, 29.66, 29.65, 29.5, 29.43, 29.41, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>20</sub>H<sub>35</sub>N<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 363.2755; found, 363.2759.</div></div><div id="sec6_1_50" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80">6.1.50.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>5e</b> as a white solid in 16.1 mg (29.1% yield). White solid. mp: 109–111 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (s, 1H), 7.72 (s, 1H), 6.48–6.41 (m, 1H), 4.75–4.65 (m, 1H), 4.34 (s, 1H), 3.57–3.50 (m, 1H), 3.23–3.08 (m, 4H), 2.19–2.09 (m, 1H), 2.09–2.00 (m, 1H), 1.95–1.83 (m, 2H), 1.25–1.10 (m, 6H), 0.79 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.7, 153.1, 149.2, 138.0, 119.6, 57.9, 52.3, 38.8, 34.5, 31.3, 27.7, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>24</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 278.1975; found, 278.1985.</div></div><div id="sec6_1_51" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81">6.1.51.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)nonan-1-ol (6e)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>6e</b> as a white solid in 15.5 mg (26.7% yield). White solid. mp: 94–96 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.33 (s, 1H), 7.74 (s, 1H), 6.41 (s, 1H), 4.75–4.66 (m, 1H), 4.31 (s, 1H), 3.59–3.51 (m, 1H), 3.26–3.06 (m, 4H), 2.20–2.10 (m, 1H), 2.10–2.00 (m, 1H), 1.97–1.83 (m, 2H), 1.27–1.12 (m, 8H), 0.80 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.7, 153.1, 149.3, 137.9, 119.7, 57.9, 52.2, 39.0, 34.5, 31.6, 28.9, 27.6, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>26</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 292.2132; found, 292.2137.</div></div><div id="sec6_1_52" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82">6.1.52.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>7e</b> as a white solid in 19.0 mg (31.1% yield). White solid. mp: 68–69 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.34 (s, 1H), 7.73 (s, 1H), 6.39–6.30 (m, 1H), 4.76–4.65 (m, 1H), 4.32 (s, 1H), 3.58–3.50 (m, 1H), 3.23–3.06 (m, 4H), 2.20–2.10 (m, 1H), 2.10–2.01 (m, 1H), 1.97–1.82 (m, 2H), 1.27–1.13 (m, 10H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.6, 153.1, 149.2, 138.0, 119.6, 57.9, 52.3, 38.8, 34.5, 31.7, 29.12, 29.06, 27.6, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>28</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 306.2288; found, 306.2288.</div></div><div id="sec6_1_53" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83">6.1.53.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>8e</b> as a white solid in 20.9 mg (32.8% yield). White solid. mp: 88–90 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.35 (s, 1H), 7.77 (s, 1H), 6.24 (s, 1H), 4.78–4.67 (m, 1H), 3.96 (s, 1H), 3.61–3.52 (m, 1H), 3.32–3.05 (m, 4H), 2.23–2.11 (m, 1H), 2.10–2.02 (m, 1H), 1.99–1.82 (m, 2H), 1.30–1.22 (m, 5H), 1.22–1.17 (m, 5H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.7, 153.1, 149.2, 138.0, 119.7, 57.9, 52.3, 38.9, 34.5, 31.8, 29.4, 29.2, 27.6, 26.4, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>30</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 320.2445; found, 320.2440.</div></div><div id="sec6_1_54" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84">6.1.54.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>9e</b> as a white solid in 18.5 mg (27.8% yield). White solid. mp: 92–94 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.38 (s, 1H), 7.75 (s, 1H), 5.93 (s, 1H), 4.81–4.66 (m, 1H), 4.01 (s, 1H), 3.61–3.51 (m, 1H), 3.22 (s, 3H), 3.09 (t, <i>J</i> = 11.6 Hz, 1H), 2.25–2.13 (m, 1H), 2.13–2.04 (m, 1H), 2.00–1.89 (m, 1H), 1.81 (t, <i>J</i> = 12.8 Hz, 1H), 1.29–1.18 (m, 14H), 0.86 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.7, 153.1, 149.4, 137.9, 119.6, 57.9, 52.3, 38.9, 34.5, 31.9, 29.5, 29.4, 29.3, 29.2, 27.7, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>32</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 334.2601; found, 334.2600.</div></div><div id="sec6_1_55" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85">6.1.55.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)tridecan-1-ol (<b>10e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tridec-2-enal (58.9 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>10e</b> as a white solid in 19.3 mg (27.8% yield). White solid. mp: 76–77 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (s, 1H), 7.74 (s, 1H), 6.09 (s, 1H), 4.78–4.65 (m, 1H), 4.08 (s, 1H), 3.60–3.51 (m, 1H), 3.21 (s, 3H), 3.14–3.04 (m, 1H), 2.22–2.13 (m, 1H), 2.13–2.04 (m, 1H), 2.00–1.89 (m, 1H), 1.87–1.76 (m, 1H), 1.29–1.24 (m, 6H), 1.23–1.19 (m, 10H), 0.86 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.7, 153.2, 149.4, 137.8, 119.7, 58.0, 52.0, 39.2, 34.5, 32.0, 29.6, 29.6, 29.5, 29.4, 29.2, 27.7, 26.5, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>34</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 348.2758; found, 348.2753.</div></div><div id="sec6_1_56" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86">6.1.56.  3-(6-(Methylamino)-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11e</b>)</h4><div class="NLM_p last"><i>N</i>-Methyl-9<i>H</i>-purin-6-amine (29.8 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tetradec-2-enal (63.1 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 25:1) to give the target compound <b>11e</b> as a white solid in 21.5 mg (29.8% yield). White solid. mp: 90–91 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.37 (s, 1H), 7.75 (s, 1H), 6.03 (s, 1H), 4.79–4.68 (m, 1H), 4.04 (s, 1H), 3.60–3.52 (m, 1H), 3.21 (s, 3H), 3.13–3.05 (m, 1H), 2.23–2.12 (m, 1H), 2.12–2.04 (m, 1H), 1.99–1.90 (m, 1H), 1.85–1.77 (m, 1H), 1.30–1.23 (m, 8H), 1.23–1.18 (m, 10H), 0.86 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.7, 153.2, 149.3, 137.8, 119.7, 58.0, 52.0, 39.3, 34.5, 32.0, 29.8, 29.6, 29.6, 29.5, 29.4, 29.3, 27.7, 26.5, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>20</sub>H<sub>36</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 362.2914; found, 362.2919.</div></div><div id="sec6_1_57" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87">6.1.57.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5f</b> as a colorless oil in 45.6 mg (78.3% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 7.71 (s, 1H), 4.74–4.64 (m, 1H), 3.96 (s, 1H), 3.72–3.30 (m, 7H), 3.05 (td, <i>J</i> = 11.2, 3.2 Hz, 1H), 2.18–1.96 (m, 2H), 1.94–1.83 (m, 1H), 1.82–1.70 (m, 1H), 1.30–1.13 (m, 6H), 0.78 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.1, 152.3, 151.0, 136.2, 119.8, 57.8, 51.5, 39.3, 38.7, 34.4, 31.4, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>26</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 292.2132; found, 292.2131.</div></div><div id="sec6_1_58" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88">6.1.58.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6f</b> as a colorless oil in 47.0 mg (77.1% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 7.70 (s, 1H), 4.73–4.64 (m, 1H), 3.94 (s, 1H), 3.68–3.27 (m, 7H), 3.05 (td, <i>J</i> = 10.8, 3.2 Hz, 1H), 2.17–2.06 (m, 1H), 2.05–1.96 (m, 1H), 1.94–1.83 (m, 1H), 1.82–1.72 (m, 1H), 1.28–1.08 (m, 8H), 0.78 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.0, 152.3, 151.0, 136.3, 119.8, 57.8, 51.6, 39.3, 38.7, 34.5, 31.6, 28.9, 26.3, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>28</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 306.2288; found, 306.2295.</div></div><div id="sec6_1_59" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89">6.1.59.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7f</b> as a colorless oil in 51.1 mg (80.1% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 7.70 (s, 1H), 4.74–4.64 (m, 1H), 4.09 (s, 1H), 3.75–3.23 (m, 7H), 3.05 (td, <i>J</i> = 11.2, 3.2 Hz, 1H), 2.16–1.96 (m, 2H), 1.94–1.82 (m, 1H), 1.82–1.71 (m, 1H), 1.26–1.08 (m, 10H), 0.78 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.0, 152.3, 151.0, 136.3, 119.8, 57.8, 51.6, 39.3, 38.7, 34.5, 31.7, 29.14, 29.06, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>30</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 320.2445; found, 320.2447.</div></div><div id="sec6_1_60" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90">6.1.60.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8f</b> as a colorless oil in 52.7 mg (79.2% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.24 (s, 1H), 7.70 (s, 1H), 4.74–4.63 (m, 1H), 4.03 (s, 1H), 3.73–3.18 (m, 7H), 3.05 (td, <i>J</i> = 10.8, 3.2 Hz, 1H), 2.16–1.96 (m, 2H), 1.93–1.82 (m, 1H), 1.82–1.71 (m, 1H), 1.25–1.09 (m, 12H), 0.79 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.1, 152.3, 151.0, 136.2, 119.8, 57.8, 51.5, 39.3, 38.6, 34.5, 31.8, 29.4, 29.18, 29.17, 26.4, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>32</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 334.2601; found, 334.2603.</div></div><div id="sec6_1_61" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91">6.1.61.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>9f</b> as a colorless oil in 51.6 mg (74.3% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.20 (s, 1H), 7.68 (s, 1H), 4.72–4.60 (m, 1H), 4.19 (s, 1H), 3.71–3.19 (m, 7H), 3.05 (td, <i>J</i> = 11.2, 3.6 Hz, 1H), 2.14–1.92 (m, 2H), 1.92–1.69 (m, 2H), 1.25–1.03 (m, 14H), 0.77 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.0, 152.2, 150.9, 136.3, 119.8, 57.8, 51.6, 39.2, 38.6, 34.5, 31.9, 29.42, 29.37, 29.2, 29.1, 26.3, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>34</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 348.2758; found, 348.2764.</div></div><div id="sec6_1_62" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92">6.1.62.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)tridecan-1-ol (<b>10f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tridec-2-enal (58.9 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>10f</b> as a colorless oil in 55.3 mg (76.6% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (s, 1H), 7.73 (s, 1H), 4.78–4.68 (m, 1H), 4.27 (s, 1H), 3.75–3.33 (m, 7H), 3.09–2.99 (m, 1H), 2.22–2.10 (m, 1H), 2.10–2.01 (m, 1H), 1.99–1.87 (m, 2H), 1.79–1.67 (m, 1H), 1.28–1.23 (m, 6H), 1.22–1.18 (m, 10H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.1, 152.4, 151.1, 136.1, 119.9, 57.9, 51.4, 39.5, 38.7, 34.5, 32.0, 29.63, 29.57, 29.5, 29.4, 29.3, 26.5, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>20</sub>H<sub>36</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 362.2914; found, 362.2917.</div></div><div id="sec6_1_63" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93">6.1.63.  3-(6-(Dimethylamino)-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11f</b>)</h4><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethyl-9<i>H</i>-purin-6-amine (32.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-tetradec-2-enal (63.1 mg, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>11f</b> as a colorless oil in 55.0 mg (73.3% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.28 (s, 1H), 7.73 (s, 1H), 4.78–4.67 (m, 1H), 4.29 (s, 1H), 3.88–3.26 (m, 7H), 3.11–2.99 (m, 1H), 2.22–2.10 (m, 1H), 2.09–2.00 (m, 1H), 2.00–1.87 (m, 1H), 1.29–1.17 (m, 18H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.1, 152.3, 151.1, 136.2, 119.8, 57.8, 51.5, 39.4, 38.7, 34.5, 32.0, 29.67, 29.66, 29.6, 29.5, 29.4, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>21</sub>H<sub>38</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 376.3071; found, 376.3076.</div></div><div id="sec6_1_64" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94">6.1.64.  3-(6-Amino-9<i>H</i>-purin-9-yl)heptan-1-ol (<b>4g</b>)</h4><div class="NLM_p last">Compound <b>4b</b> (26.9 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>4g</b> as a white solid in 17.2 mg (69.1% yield). White solid. mp: 118–121 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.30 (s, 1H), 7.81 (s, 1H), 6.27 (s, 2H), 4.79–4.67 (m, 1H), 4.19 (s, 1H), 3.61–3.53 (m, 1H), 3.20–3.09 (m, 1H), 2.23–2.03 (m, 2H), 2.00–1.86 (m, 2H), 1.34–1.22 (m, 3H), 1.21–1.09 (m, 1H), 0.83 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 155.9, 152.9, 150.5, 138.9, 119.5, 58.0, 52.4, 38.8, 34.2, 28.6, 22.3, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>12</sub>H<sub>20</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 250.1662; found, 250.1664.</div></div><div id="sec6_1_65" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95">6.1.65.  3-(6-Amino-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5g</b>)</h4><div class="NLM_p last">Compound <b>5b</b> (28.3 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>5g</b> as a white solid in 19.6 mg (74.1% yield). White solid. mp: 109–111 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.29 (s, 1H), 7.83 (s, 1H), 6.55 (s, 2H), 4.79–4.67 (m, 1H), 4.50 (s, 1H), 3.61–3.54 (m, 1H), 3.23–3.13 (m, 1H), 2.22–2.12 (m, 1H), 2.11–2.03 (m, 1H), 2.00–1.88 (m, 2H), 1.28–1.14 (m, 6H), 0.80 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.8, 153.0, 150.6, 138.8, 119.5, 58.0, 52.3, 39.0, 34.5, 31.4, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>22</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 264.1819; found, 264.1818.</div></div><div id="sec6_1_66" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96">6.1.66.  3-(6-Amino-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6g</b>)</h4><div class="NLM_p last">Compound <b>6b</b> (29.7 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>6g</b> as a white solid in 21.0 mg (75.9% yield). White solid. mp: 119–120 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.27 (s, 1H), 7.82 (s, 1H), 6.62 (s, 2H), 4.77–4.68 (m, 1H), 4.63 (s, 1H), 3.61–3.53 (m, 1H), 3.23–3.14 (m, 1H), 2.22–2.11 (m, 1H), 2.11–2.02 (m, 1H), 2.02–1.86 (m, 2H), 1.28–1.13 (m, 8H), 0.80 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.8, 153.0, 150.5, 138.9, 119.5, 58.0, 52.4, 38.9, 34.5, 31.6, 28.9, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>24</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 278.1975; found, 278.1981.</div></div><div id="sec6_1_67" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97">6.1.67.  3-(6-Amino-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7g</b>)</h4><div class="NLM_p last">Compound <b>7b</b> (31.1 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>7g</b> as a white solid in 21.0 mg (72.3% yield). White solid. mp: 124–126 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.28 (s, 1H), 7.83 (s, 1H), 6.57 (s, 2H), 4.80–4.67 (m, 1H), 4.52 (s, 1H), 3.61–3.54 (m, 1H), 3.22–3.14 (m, 1H), 2.22–2.12 (m, 1H), 2.11–2.03 (m, 1H), 2.01–1.86 (m, 2H), 1.27–1.12 (m, 10H), 0.81 (t, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.9, 152.9, 150.5, 138.9, 119.4, 58.0, 52.5, 38.8, 34.6, 31.8, 29.2, 29.1, 26.4, 22.7, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>26</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 292.2132; found, 292.2132.</div></div><div id="sec6_1_68" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98">6.1.68.  3-(6-Amino-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8g</b>)</h4><div class="NLM_p last">Compound <b>8b</b> (32.5 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>8g</b> as a white solid in 21.1 mg (69.1% yield). White solid. mp: 136–138 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.26 (s, 1H), 7.81 (s, 1H), 6.69 (s, 2H), 4.76–4.66 (m, 1H), 4.60 (s, 1H), 3.60–3.53 (m, 1H), 3.23–3.14 (m, 1H), 2.20–2.10 (m, 1H), 2.10–2.02 (m, 1H), 2.01–1.85 (m, 2H), 1.27–1.20 (m, 4H), 1.20–1.10 (m, 8H), 0.81 (t, <i>J</i> = 6.4 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.9, 152.9, 150.4, 138.9, 119.4, 58.0, 52.5, 38.7, 34.6, 31.8, 29.4, 29.2, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>28</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 306.2288; found, 306.2287.</div></div><div id="sec6_1_69" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99">6.1.69.  3-(6-Amino-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9g</b>)</h4><div class="NLM_p last">Compound <b>9b</b> (33.9 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>9g</b> as a white solid in 22.2 mg (69.5% yield). White solid. mp: 120–122 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.28 (s, 1H), 7.82 (s, 1H), 6.61 (s, 2H), 4.79–4.66 (m, 1H), 4.51 (s, 1H), 3.62–3.52 (m, 1H), 3.23–3.13 (m, 1H), 2.22–2.11 (m, 1H), 2.11–2.02 (m, 1H), 2.01–1.85 (m, 2H), 1.31–1.21 (m, 5H), 1.20–1.14 (m, 9H), 0.83 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.9, 152.9, 150.3, 138.9, 119.4, 58.0, 52.6, 38.6, 34.6, 31.9, 29.5, 29.4, 29.3, 29.2, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>30</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 320.2445; found, 320.2455.</div></div><div id="sec6_1_70" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100">6.1.70.  3-(6-Amino-9<i>H</i>-purin-9-yl)tridecan-1-ol (<b>10g</b>)</h4><div class="NLM_p last">Compound <b>10b</b> (35.3 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>10g</b> as a white solid in 22.6 mg (67.9% yield). White solid. mp: 105–106 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 1H), 7.81 (s, 1H), 6.11 (s, 2H), 4.79–4.69 (m, 1H), 4.06 (s, 1H), 3.61–3.54 (m, 1H), 3.19–3.09 (m, 1H), 2.23–2.13 (m, 1H), 2.13–2.04 (m, 1H), 2.00–1.83 (m, 2H), 1.28–1.23 (m, 5H), 1.23–1.18 (m, 11H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.8, 153,0, 150.5, 138.9, 119.4, 58.0, 52.4, 38.9, 34.5, 32.0, 29.63, 29.58, 29.5, 29.4, 29.2, 26.5, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>32</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 334.2601; found, 334.2605.</div></div><div id="sec6_1_71" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101">6.1.71.  3-(6-Amino-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11g</b>)</h4><div class="NLM_p last">Compound <b>11b</b> (36.7 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>11g</b> as a white solid in 24.7 mg (71.1% yield). White solid. mp: 93–94 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.31 (s, 1H), 7.81 (s, 1H), 6.12 (s, 2H), 4.78–4.69 (m, 1H), 4.05 (s, 1H), 3.61–3.54 (m, 1H), 3.18–3.09 (m, 1H), 2.24–2.12 (m, 1H), 2.12–2.04 (m, 1H), 2.01–1.83 (m, 2H), 1.28–1.24 (m, 5H), 1.24–1.18 (m, 13H), 0.86 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 155.8, 153.0, 150.5, 138.9, 119.4, 58.0, 52.4, 38.9, 34.5, 32.0, 29.7, 29.6, 29.5, 29.4, 29.2, 26.5, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>34</sub>N<sub>5</sub>O (M + H<sup>+</sup>), 348.2758; found, 348.2768.</div></div><div id="sec6_1_72" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102">6.1.72.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5h</b>)</h4><div class="NLM_p last">Compound <b>5c</b> (31.7 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>5h</b> as a white solid in 20.3 mg (68.3% yield). White solid. mp: 154–156 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 6.09 (s, 2H), 4.73–4.61 (m, 1H), 3.65–3.55 (m, 1H), 3.29–3.18 (m, 1H), 2.98–2.86 (m, 1H), 2.24–2.12 (m, 1H), 2.12–2.04 (m, 1H), 2.03–1.88 (m, 2H), 1.28–1.25 (m, 5H), 1.20–1.14 (m, 1H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.3, 154.1, 151.6, 139.5, 118.3, 58.4, 53.1, 38.4, 34.5, 31.4, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>21</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 298.1429; found, 298.1433.</div></div><div id="sec6_1_73" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103">6.1.73.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6h</b>)</h4><div class="NLM_p last">Compound <b>6c</b> (33.1 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>6h</b> as a white solid in 21.0 mg (67.5% yield). White solid. mp: 120–123 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.79 (s, 1H), 6.79 (s, 2H), 4.69–4.62 (m, 1H), 3.66–3.56 (m, 2H), 3.31–3.25 (m, 1H), 2.20–2.11 (m, 1H), 2.08–1.99 (m, 2H), 1.95–1.86 (m, 1H), 1.28–1.15 (m, 7H), 1.14–1.07 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.5, 154.0, 151.4, 139.5, 118.3, 58.3, 53.2, 38.2, 34.6, 31.6, 28.9, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>23</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 312.1586; found, 312.1594.</div></div><div id="sec6_1_74" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104">6.1.74.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7h</b>)</h4><div class="NLM_p last">Compound <b>7c</b> (34.5 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>7h</b> as a white solid in 23.3 mg (71.8% yield). White solid. mp: 134–136 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89 (s, 1H), 6.88 (s, 2H), 4.72–4.62 (m, 1H), 3.92 (s, 1H), 3.65–3.56 (m, 1H), 3.35–3.25 (m, 1H), 2.22–2.11 (m, 1H), 2.11–2.00 (m, 2H), 1.96–1.84 (m, 1H), 1.28–1.13 (m, 10H), 0.83 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.5, 154.0, 151.4, 139.5, 118.3, 58.3, 53.2, 38.2, 34.6, 31.8, 29.2, 29.1, 26.3, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>25</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 326.1742; found, 326.1746.</div></div><div id="sec6_1_75" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105">6.1.75.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8h</b>)</h4><div class="NLM_p last">Compound <b>8c</b> (35.9 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>8h</b> as a white solid in 25.2 mg (72.2% yield). White solid. mp: 138–140 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 6.40 (s, 2H), 4.73–4.60 (m, 1H), 3.67–3.56 (m, 1H), 3.37–3.01 (m, 2H), 2.25–2.11 (m, 1H), 2.11–1.98 (m, 2H), 1.98–1.86 (m, 1H), 1.27–1.24 (m, 5H), 1.23–1.19 (m, 6H), 1.17–1.10 (m, 1H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.4, 154.1, 151.5, 139.5, 118.3, 58.4, 53.1, 38.3, 34.6, 31.9, 29.4, 29.23, 29.21, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>27</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 340.1899; found, 340.1905.</div></div><div id="sec6_1_76" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106">6.1.76.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9h</b>)</h4><div class="NLM_p last">Compound <b>9c</b> (37.3 mg, 0.1 mmol) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>9h</b> as a white solid in 26.2 mg (74.2% yield). White solid. mp: 46–147 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.89 (s, 1H), 6.82 (s, 2H), 4.73–4.62 (m, 1H), 3.80 (s, 1H), 3.67–3.55 (m, 1H), 3.35–3.24 (m, 1H), 2.22–2.11 (m, 1H), 2.10–2.00 (m, 2H), 1.96–1.85 (m, 1H), 1.29–1.23 (m, 4H), 1.22–1.17 (m, 9H), 1.14–1.08 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H). <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 156.4, 154.1, 151.5, 139.5, 118.3, 58.4, 53.1, 38.3, 34.6, 32.0, 29.53, 29.47, 29.3, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>29</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 354.2055; found, 354.2054.</div></div><div id="sec6_1_77" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107">6.1.77.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)tridecan-1-ol (<b>10h</b>)</h4><div class="NLM_p last">3-(2,6-Dichloro-9<i>H</i>- purin-9-yl)tridecan-1-ol (38.7 mg, 0.1 mmol) (for 3-(2,6-dichloro-9<i>H</i>-purin-9-yl)tridecan-1-ol: prepared according to the procedure for the synthesis of <b>9c</b>, using 2,6-dichloro-9<i>H</i>-purine to react with (<i>E</i>)-tridec-2-enal) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>10h</b> as a white solid in 25.5 mg (69.5% yield). White solid. mp: 131–132 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 6.81 (s, 2H), 4.71–4.62 (m, 1H), 3.66–3.56 (m, 2H), 3.33–3.23 (m, 1H), 2.21–2.11 (m, 1H), 2.11–1.99 (m, 2H), 1.95–1.85 (m, 1H), 1.27–1.17 (m, 15H), 1.15–1.07 (m, 1H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.4, 154.1, 151.6, 139.5, 118.4, 58.4, 53.1, 38.4, 34.6, 29.64, 29.58, 29.5, 29.4, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>31</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 368.2212; found, 368.2214.</div></div><div id="sec6_1_78" class="NLM_sec NLM_sec_level_3"><div id="ac_i108" class="anchor-spacer"></div><h4 class="article-section__title" id="_i108">6.1.78.  3-(6-Amino-2-chloro-9<i>H</i>-purin-9-yl)tetradecan-1-ol (<b>11h</b>)</h4><div class="NLM_p last">3-(2,6-Dichloro-9<i>H</i>- purin-9-yl)tetradecan-1-ol (40.1 mg, 0.1 mmol) (for 3-(2,6-dichloro-9<i>H</i>-purin-9-yl)tridecan-1-ol: prepared according to the procedure for the synthesis of <b>9c</b>, using 2,6-dichloro-9<i>H</i>-purine to react with (<i>E</i>)-tetradec-2-enal) and ammonia (2.0 mL, 7.0 M in MeOH) were added to a reaction tube with a magnetic stirring bar. The reaction was stirred at 100 °C for 6 h and detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>11h</b> as a white solid in 27.8 mg (73.0% yield). White solid. mp: 127–128 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.78 (s, 1H), 6.80 (s, 2H), 4.71–4.61 (m, 1H), 3.61 (s, 2H), 3.34–3.22 (m, 1H), 2.22–2.10 (m, 1H), 2.10–1.98 (m, 2H), 1.96–1.84 (m, 1H), 1.27–1.16 (m, 17H), 1.16–1.07 (m, 1H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 156.6, 154. 0, 151.4, 139.6, 118.3, 58.3, 53.3, 38.2, 34.6, 32.0, 29.7, 29.6, 29.5, 29.4, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>19</sub>H<sub>33</sub>ClN<sub>5</sub>O (M + H<sup>+</sup>), 382.2368; found, 382.2365.</div></div><div id="sec6_1_79" class="NLM_sec NLM_sec_level_3"><div id="ac_i109" class="anchor-spacer"></div><h4 class="article-section__title" id="_i109">6.1.79.  3-(8-Bromo-6-chloro-9<i>H</i>-purin-9-yl)octan-1-ol (<b>5i</b>)</h4><div class="NLM_p last">8-Bromo-6-chloro-9<i>H</i>-purine (46.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-oct-2-enal (44.8 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>5i</b> as a white solid in 27.8 mg (77.1% yield). White solid. mp: 74–75 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.65 (s, 1H), 4.88 (s, 1H), 3.69–3.61 (m, 1H), 3.39–3.29 (m, 1H), 2.66 (s, 1H), 2.50–2.37 (m, 1H), 2.22–2.11 (m, 1H), 1.95–1.85 (m, 1H), 1.84–1.74 (m, 1H), 1.28–1.17 (m, 5H), 1.04–0.93 (m, 1H), 0.80 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.6, 151.4, 149.6, 136.3, 132.2, 59.0, 58.2, 35.3, 33.0, 31.3, 26.0, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>19</sub>BrClN<sub>4</sub>O (M + H<sup>+</sup>), 361.0425; found, 361.0430.</div></div><div id="sec6_1_80" class="NLM_sec NLM_sec_level_3"><div id="ac_i110" class="anchor-spacer"></div><h4 class="article-section__title" id="_i110">6.1.80.  3-(8-Bromo-6-chloro-9<i>H</i>-purin-9-yl)nonan-1-ol (<b>6i</b>)</h4><div class="NLM_p last">8-Bromo-6-chloro-9<i>H</i>-purine (46.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-non-2-enal (49.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>6i</b> as a white solid in 29.7 mg (79.5% yield). White solid. mp: 61–63 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.64 (s, 1H), 4.87 (s, 1H), 3.68–3.60 (m, 1H), 3.39–3.29 (m, 1H), 2.66 (s, 1H), 2.50–2.37 (m, 1H), 2.21–2.10 (m, 1H), 1.96–1.85 (m, 2H), 1.27–1.12 (m, 7H), 1.03–0.93 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.5, 151.4, 149.6, 136.2, 132.2, 58.9, 58.2, 35.3, 33.0, 31.6, 28.8, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>21</sub>BrClN<sub>4</sub>O (M + H<sup>+</sup>), 375.0582; found, 375.0582.</div></div><div id="sec6_1_81" class="NLM_sec NLM_sec_level_3"><div id="ac_i111" class="anchor-spacer"></div><h4 class="article-section__title" id="_i111">6.1.81.  3-(8-Bromo-6-chloro-9<i>H</i>-purin-9-yl)decan-1-ol (<b>7i</b>)</h4><div class="NLM_p last">8-Bromo-6-chloro-9<i>H</i>-purine (46.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dec-2-enal (54.7 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>7i</b> as a white solid in 32.2 mg (83.2% yield). White solid. mp: 60–62 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.64 (s, 1H), 4.85 (s, 1H), 3.67–3.61 (m, 1H), 3.37–3.30 (m, 1H), 2.67 (s, 1H), 2.49–2.38 (m, 1H), 2.20–2.12 (m, 1H), 1.96–1.84 (m, 2H), 1.31–1.25 (m, 1H), 1.24–1.19 (m, 4H), 1.19–1.13 (m, 4H), 1.02–0.94 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.6, 151.4, 149.6, 136.1, 132.2, 59.0, 58.2, 35.3, 33.0, 31.7, 29.11, 29.05, 26.3, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>23</sub>BrClN<sub>4</sub>O (M + H<sup>+</sup>), 389.0738; found, 389.0740.</div></div><div id="sec6_1_82" class="NLM_sec NLM_sec_level_3"><div id="ac_i112" class="anchor-spacer"></div><h4 class="article-section__title" id="_i112">6.1.82.  3-(8-Bromo-6-chloro-9<i>H</i>-purin-9-yl)undecan-1-ol (<b>8i</b>)</h4><div class="NLM_p last">8-Bromo-6-chloro-9<i>H</i>-purine (46.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-undec-2-enal (59.5 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>8i</b> as a white solid in 33.6 mg (83.5% yield). White solid. mp: 63–65 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 4.86 (s, 1H), 3.68–3.62 (m, 1H), 3.38–3.31 (m, 1H), 2.68 (s, 1H), 2.50–2.40 (m, 1H), 2.20–2.13 (m, 1H), 1.95–1.87 (m, 1H), 1.63 (s, 1H), 1.26–1.21 (m, 4H), 1.20–1.15 (m, 7H), 1.04–0.95 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.6, 151.4, 149.7, 136.2, 132.3, 59.0, 58.2, 35.3, 33.0, 31.9, 29.4, 29.21, 29.17, 26.3, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>25</sub>BrClN<sub>4</sub>O (M + H<sup>+</sup>), 403.0895; found, 403.0895.</div></div><div id="sec6_1_83" class="NLM_sec NLM_sec_level_3"><div id="ac_i113" class="anchor-spacer"></div><h4 class="article-section__title" id="_i113">6.1.83.  3-(8-Bromo-6-chloro-9<i>H</i>-purin-9-yl)dodecan-1-ol (<b>9i</b>)</h4><div class="NLM_p last">8-Bromo-6-chloro-9<i>H</i>-purine (46.6 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the solution was cooled to 0 °C. After that, NaBH<sub>4</sub> (22.7 mg, 0.6 mmol) was slowly added and the reaction was stirred for 10 min. Then, the reaction was quenched with a saturated ammonium chloride solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>9i</b> as a white solid in 33.5 mg (80.6% yield). White solid. mp: 70–71 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.64 (s, 1H), 4.85 (s, 1H), 3.67–3.61 (m, 1H), 3.38–3.30 (m, 1H), 2.67 (s, 1H), 2.48–2.39 (m, 1H), 2.20–2.11 (m, 1H), 1.95–1.80 (m, 2H), 1.26–1.20 (m, 4H), 1.20–1.14 (m, 9H), 1.02–0.93 (m, 1H), 0.83 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.5, 151.4, 149.6, 136.2, 132.2, 58.9, 58.2, 35.3, 33.0, 31.9, 29.5, 29.4, 29.3, 29.1, 26.3, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>27</sub>BrClN<sub>4</sub>O (M + H<sup>+</sup>), 417.1051; found, 417.1058.</div></div><div id="sec6_1_84" class="NLM_sec NLM_sec_level_3"><div id="ac_i114" class="anchor-spacer"></div><h4 class="article-section__title" id="_i114">6.1.84.  3-(9<i>H</i>-Purin-9-yl)heptan-1-ol (<b>4j</b>)</h4><div class="NLM_p last">Compound <b>4b</b> (26.9 mg, 0.1 mmol), Pd/C (10 wt %), and methanol (1.0 mL) were added to a reaction tube with a magnetic stirring bar under H<sub>2</sub> (1 atm). The reaction was stirred at room temperature until compound <b>4b</b> was completely consumed, which was detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>4j</b> as a colorless oil in 15.3 mg (65.8% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.13 (s, 1H), 8.93 (s, 1H), 8.12 (s, 1H), 4.89–4.79 (m, 1H), 3.64–3.57 (m, 1H), 3.24–3.08 (m, 2H), 2.26–2.07 (m, 3H), 2.05–1.92 (m, 1H), 1.33–1.20 (m, 3H), 1.15–1.02 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.5, 151.8, 149.0, 144.4, 134.2, 58.4, 53.1, 38.0, 34.2, 28.6, 22.3, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>), calcd C<sub>12</sub>H<sub>19</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 235.1553; found, 235.1561.</div></div><div id="sec6_1_85" class="NLM_sec NLM_sec_level_3"><div id="ac_i115" class="anchor-spacer"></div><h4 class="article-section__title" id="_i115">6.1.85.  3-(9<i>H</i>-Purin-9-yl)octan-1-ol (<b>5j</b>)</h4><div class="NLM_p last">Compound <b>5b</b> (28.3 mg, 0.1 mmol), Pd/C (10 wt %), and methanol (1.0 mL) were added to a reaction tube with a magnetic stirring bar under H<sub>2</sub> (1 atm). The reaction was stirred at room temperature until compound <b>5b</b> was completely consumed, which was detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>5j</b> as a colorless oil in 15.6 mg (63.1% yield). Colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.17 (s, 1H), 8.96 (s, 1H), 8.13 (s, 1H), 4.94–4.75 (m, 1H), 3.67–3.54 (m, 1H), 3.27–3.08 (m, 1H), 2.92 (s, 1H), 2.30–2.11 (m, 2H), 2.11–1.93 (m, 2H), 1.30–1.21 (m, 5H), 1.19–1.10 (m, 1H), 0.82 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.5, 151.9, 149.1, 144.2, 134.3, 58.4, 52.9, 38.2, 34.4, 31.4, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>13</sub>H<sub>21</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 249.1710; found, 249.1713.</div></div><div id="sec6_1_86" class="NLM_sec NLM_sec_level_3"><div id="ac_i116" class="anchor-spacer"></div><h4 class="article-section__title" id="_i116">6.1.86.  3-(9<i>H</i>-Purin-9-yl)nonan-1-ol (<b>6j</b>)</h4><div class="NLM_p last">Compound <b>6b</b> (29.7 mg, 0.1 mmol), Pd/C (10 wt %), and methanol (1.0 mL) were added to a reaction tube with a magnetic stirring bar under an atmosphere of H<sub>2</sub> (1 atm). The reaction was stirred at room temperature until compound <b>6b</b> was completely consumed, which was detected by TLC. Then, the residue was concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 30:1) to give the target compound <b>6j</b> as a colorless oil in 17.4 mg (66.5% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.18 (s, 1H), 8.97 (s, 1H), 8.13 (s, 1H), 4.92–4.81 (m, 1H), 3.66–3.57 (m, 1H), 3.22–3.13 (m, 1H), 2.60 (s, 1H), 2.28–2.13 (m, 2H), 2.10–1.96 (m, 2H), 1.28–1.24 (m, 6H), 1.22–1.20 (m, 2H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.5, 151.9, 149.1, 144.2, 134.3, 58.4, 52.9, 38.2, 34.5, 31.6, 28.9, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>23</sub>N<sub>4</sub>O (M + H<sup>+</sup>), 263.1866; found, 263.1865.</div></div><div id="sec6_1_87" class="NLM_sec NLM_sec_level_3"><div id="ac_i117" class="anchor-spacer"></div><h4 class="article-section__title" id="_i117">6.1.87.  3-(6-Chloro-9<i>H</i>-purin-9-yl)-2-methyleneoctan-1-ol (<b>5k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-methylene-3-(propionyloxy) octanoate (0.48 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the compound methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneoctanoate as a colorless oil. Then, the solution of methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneoctanoate (32.2 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneoctanoate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>5k</b> as a colorless oil in 11.0 mg (37.7% yield). Colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.75 (s, 1H), 8.18 (s, 1H), 5.36 (s, 1H), 5.36 (t, <i>J</i> = 7.2 Hz, 1H), 5.25 (s, 1H), 4.13–4.01 (m, 2H), 2.28–2.18 (m, 3H), 1.27–1.23 (m, 5H), 1.21–1.16 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 152.0, 151.4, 148.8, 146.3, 144.1, 136.1, 115.0, 64.5, 56.4, 32.5, 31.3, 26.1, 22.5, 14.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>14</sub>H<sub>20</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 295.1320; found, 295.1326.</div></div><div id="sec6_1_88" class="NLM_sec NLM_sec_level_3"><div id="ac_i118" class="anchor-spacer"></div><h4 class="article-section__title" id="_i118">6.1.88.  3-(6-Chloro-9<i>H</i>-purin-9-yl)-2-methylenenonan-1-ol (<b>6k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-methylene-3-(propionyloxy)nonanoate (0.51 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the compound methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenenonanoate as a colorless oil. Then, the solution of methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenenonanoate (33.6 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenenonanoate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>6k</b> as a colorless oil in 12.7 mg (41.1% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 8.18 (s, 1H), 5.36 (s, 1H), 5.20 (t, <i>J</i> = 8.0 Hz, 1H), 5.25 (s, 1H), 4.13–4.01 (m, 2H), 2.58 (s, 1H), 2.27–2.18 (m, 2H), 1.34–1.26 (m, 3H), 1.26–1.17 (m, 5H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.01, 151.97, 151.3, 146.2, 144.2, 131.7, 114.9, 64.4, 56.5, 32.6, 31.6, 28.8, 26.4, 22.6, 14.1; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>22</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 309.1477; found, 309.1473.</div></div><div id="sec6_1_89" class="NLM_sec NLM_sec_level_3"><div id="ac_i119" class="anchor-spacer"></div><h4 class="article-section__title" id="_i119">6.1.89.  3-(6-Chloro-9<i>H</i>-purin-9-yl)-2-methylenedecan-1-ol (<b>7k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-methylene-3-(propionyloxy)decanoate (0.54 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the compound methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenedecanoate as a colorless oil. Then, the solution of methyl 3-(6-chloro-9<i>H-</i>purin-9-yl)-2-methylenedecanoate (35.0 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenedecanoate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>7k</b> as a colorless oil in 13.9 mg (43.2% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.74 (s, 1H), 8.18 (s, 1H), 5.36 (s, 1H), 5.32 (t, <i>J</i> = 8.0 Hz, 1H), 5.25 (s, 1H), 4.14–4.01 (m, 2H), 2.38 (s, 1H), 2.27–2.18 (m, 2H), 1.33–1.27 (m, 3H), 1.26–1.19 (m, 7H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.02, 151.99, 151.3, 146.3, 144.2, 131.8, 114.9, 64.5, 56.4, 32.6, 31.8, 29.13, 29.08, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>16</sub>H<sub>24</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 323.1633; found, 323.1642.</div></div><div id="sec6_1_90" class="NLM_sec NLM_sec_level_3"><div id="ac_i120" class="anchor-spacer"></div><h4 class="article-section__title" id="_i120">6.1.90.  3-(6-Chloro-9<i>H</i>-purin-9-yl)-2-methyleneundecan-1-ol (<b>8k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-methylene-3-(propionyloxy)undecanoate (0.57 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the compound methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneundecanoate as a colorless oil. Then, the solution of methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneundecanoate (36.4 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methyleneundecanoate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>8k</b> as a colorless oil in 12.4 mg (36.8% yield). Colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.18 (s, 1H), 5.36 (s, 1H), 5.32 (t, <i>J</i> = 7.2 Hz, 1H), 5.24 (s, 1H), 4.12–4.02 (m, 2H), 2.47 (s, 1H), 2.26–2.18 (m, 2H), 1.32–1.27 (m, 2H), 1.27–1.23 (m, 3H), 1.23–1.15 (m, 7H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.03, 152.01, 151.4, 146.3, 144.1, 131.8, 114.9, 64.5, 56.4, 32.6, 31.9, 29.4, 29.23, 29.17, 26.4, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>26</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 337.1790; found, 337.1795.</div></div><div id="sec6_1_91" class="NLM_sec NLM_sec_level_3"><div id="ac_i121" class="anchor-spacer"></div><h4 class="article-section__title" id="_i121">6.1.91.  3-(6-Chloro-9<i>H</i>-purin-9-yl)-2-methylenedodecan-1-ol (<b>9k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-methylene-3-(propionyloxy)dodecanoate (0.60 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the compound methyl 3-(6-chloro-9<i>H</i>-purin-9-yl)-2-methylenedodecanoate as a colorless oil. Then, the solution of methyl 3-(6-chloro-9<i>H</i>-purin- 9-yl)-2-methylenedodecanoate (37.8 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 3-(6-chloro- 9<i>H</i>-purin-9-yl)-2-methylenedodecanoate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>9k</b> as a colorless oil in 14.1 mg (40.1% yield). Colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 8.18 (s, 1H), 5.36 (s, 1H), 5.32 (t, <i>J</i> = 8.0 Hz, 1H), 5.23 (s, 1H), 4.14–4.00 (m, 2H), 2.72 (s, 1H), 2.26–2.15 (m, 2H), 1.29–1.09 (m, 14H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.01, 151.97, 151.3, 146.2, 144.2, 131.7, 114.9, 64.4, 56.5, 32.5, 31.9, 29.5, 29.4, 29.3, 29.2, 26.4, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>28</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 351.1946; found, 351.1945.</div></div><div id="sec6_1_92" class="NLM_sec NLM_sec_level_3"><div id="ac_i122" class="anchor-spacer"></div><h4 class="article-section__title" id="_i122">6.1.92.  2-((6-Chloro-9<i>H</i>-purin-9-yl)(phenyl)methyl)prop-2-en-1-ol (<b>10k</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (0.93 g, 6 mmol), K<sub>2</sub>CO<sub>3</sub> (0.83 g, 6 mmol), DABCO (0.022 g, 0.2 mmol), and methyl 2-(phenyl(propionyloxy)methyl)acrylate (0.50 g, 2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15.0 mL) were added to a reaction tube with a magnetic stirring bar under N<sub>2</sub>. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, to the mixture was added a saturated brine solution and it was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 4:1) to give the compound methyl 2-((6-chloro-9<i>H</i>-purin-9-yl)(phenyl)methyl)acrylate as a white solid. Then, the solution of methyl 2-((6-chloro-9<i>H</i>-purin-9-yl)(phenyl) methyl)acrylate (32.8 mg, 0.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.0 mL) was cooled to −78 °C under N<sub>2</sub>. DIBAL-H (0.3 mL, 0.3 mmol, 1.0 M in toluene) was added dropwise and stirred at −78 °C for 20 min. The reaction was stirred at room temperature until methyl 2-((6-chloro-9<i>H</i>-purin-9-yl)(phenyl)methyl)acrylate was completely consumed, which was detected by TLC. The reaction was quenched with 10% NaOH solution. Then, the mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the target compound <b>10k</b> as a white solid in 12.8 mg (42.8% yield). White solid. mp: 113–115 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 7.95 (s, 1H), 7.48–7.38 (m, 3H), 7.38–7.28 (m, 2H), 6.62 (s, 1H), 5.51 (s, 1H), 4.70 (s, 1H), 4.21 (s, 2H), 2.62 (s, 1H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.2, 151.6, 151.4, 145.9, 144.8, 134.8, 131.9, 129.6, 129.57, 128.6, 115.8, 64.4, 60.0; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>15</sub>H<sub>14</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 301.0851; found, 301.0855.</div></div><div id="sec6_1_93" class="NLM_sec NLM_sec_level_3"><div id="ac_i123" class="anchor-spacer"></div><h4 class="article-section__title" id="_i123">6.1.93.  3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecyl methanesulfonate (<b>9ba</b>)</h4><div class="NLM_p last">Compound <b>9b</b> (169.1 mg, 0.5 mmol) and Et<sub>3</sub>N (173.0 μL, 1.25 mmol) were added to CH<sub>2</sub>Cl<sub>2</sub> (10.0 mL) at 0 °C. Methanesulfonyl chloride (58.0 μL, 0.75 mmol) was slowly added to the solution. The mixture was stirred for 4 h at room temperature. Then, the reaction was quenched with saturated NaHCO<sub>3</sub> solution and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic phase was dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue was further purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the target compound <b>9ba</b> as a white solid in 157.6 mg (75.6% yield). White solid. mp: 73–74 °C. For (<i>R</i>)-<b>9ba</b>: prepared according to the procedure for the synthesis of the above racemic <b>9ba</b> using (<i>R</i>)-<b>9b</b> (169.1 mg, 0.5 mmol) to replace racemic <b>9b</b> (169.1 mg, 0.5 mmol). [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −2.7 (<i>c</i> = 0.30, CHCl<sub>3</sub>), 94% ee [CHIRALCEL IA, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 47.048 min (minor), 51.301 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.71 (s, 1H), 8.12 (s, 1H), 4.75–4.65 (m, 1H), 4.25–4.18 (m, 1H), 3.98–3.90 (m, 1H), 2.91 (s, 3H), 2.71–2.60 (m, 1H), 2.47–2.35 (m, 1H), 2.24–2.14 (m, 1H), 2.00–1.88 (m, 1H), 1.26–1.13 (m, 13H), 1.07–0.95 (m, 1H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 151.9, 151.8, 151.5, 145.0, 132.3, 65.8, 54.8, 37.6, 34.2, 33.9, 31.9, 29.5, 29.4, 29.3, 29.0, 26.2, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>30</sub>ClN<sub>4</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 417.1722; found, 417.1719.</div></div><div id="sec6_1_94" class="NLM_sec NLM_sec_level_3"><div id="ac_i124" class="anchor-spacer"></div><h4 class="article-section__title" id="_i124">6.1.94.  9-(1-Azidododecan-3-yl)-6-chloro-9<i>H</i>-purine (<b>9bb</b>)</h4><div class="NLM_p last">NaN<sub>3</sub> (97.5 mg, 1.5 mmol) was added to a solution of racemic <b>9ba</b> (124.8 mg, 0.3 mmol) in DMF (5.0 mL) at 0 °C. Then, the reaction was stirred at 25 °C for 6 h and detected by TLC. After that, water (10.0 mL) was added to quench the reaction. The resulting mixture was extracted with ethyl acetate three times. The organic phases were combined and washed with saturated brine solution. The organic phase was dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue was further purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target racemic <b>9bb</b> as a colorless oil in 81.1 mg (74.5% yield). Colorless oil. For (<i>R</i>)-<b>9bb</b>: prepared according to the procedure for the synthesis of the above racemic <b>9bb</b> using (<i>R</i>)-<b>9ba</b> (124.8 mg, 0.3 mmol) to replace racemic <b>9ba</b> (124.8 mg, 0.3 mmol). [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −22.5 (<i>c</i> = 0.08, CHCl<sub>3</sub>), 94% ee [CHIRALCEL IA, <i>n</i>-hexane/2-propanol = 98/2, flow rate = 0.6 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 34.051 min (minor), 39.148 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.09 (s, 1H), 4.71–4.61 (m, 1H), 3.38–3.29 (m, 1H), 3.07–2.99 (m, 1H), 2.44–2.34 (m, 1H), 2.23–2.09 (m, 2H), 1.99–1.88 (m, 1H), 1.27–1.15 (m, 13H), 1.09–0.98 (m, 1H), 0.85 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 152.0, 151.9, 151.4, 144.6, 132.2, 55.3, 48.1, 34.3, 33.7, 31.9, 29.5, 29.4, 29.3, 29.0, 26.2, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>27</sub>ClN<sub>7</sub> (M + H<sup>+</sup>), 364.2011; found, 364.2014.</div></div><div id="sec6_1_95" class="NLM_sec NLM_sec_level_3"><div id="ac_i125" class="anchor-spacer"></div><h4 class="article-section__title" id="_i125">6.1.95.  6-Chloro-9-(1-(4-phenyl-1<i>H</i>-1,2,3-triazol-1-yl)dodecan-3-yl)-9<i>H</i>-purine (<b>9bc</b>)</h4><div class="NLM_p last">Compound <b>9bb</b> (36.3 mg, 0.1 mmol), phenylacetylene (16.5 μL, 0.15 mmol), and Cu(OAc)<sub>2</sub> (0.9 mg, 0.005 mmol) were added sequentially to acetonitrile (1.0 mL). The mixture was stirred until Cu(OAc)<sub>2</sub> was completely dissolved. Subsequently, <i>i</i>Pr<sub>2</sub>NEt (1.7 μL, 0.01 mmol) was added and the reaction mixture was stirred at 0 °C for 6 h. Then, water (2.0 mL) was added to quench the reaction. The resulting mixture was extracted with ethyl acetate three times. The organic phases were combined and washed with saturated brine solution. The organic phase was dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue was further purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target racemic <b>9bc</b> as a white solid in 32.8 mg (70.5% yield). White solid. mp: 98–100 °C. For (<i>R</i>)-<b>9bc</b>: prepared according to the procedure for the synthesis of the above racemic <b>9bc</b> using (<i>R</i>)-<b>9bb</b> (36.3 mg, 0.1 mmol) to replace racemic <b>9bb</b> (36.3 mg, 0.1 mmol). [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −48.4 (<i>c</i> = 0.22, CHCl<sub>3</sub>), 94% ee [CHIRALCEL IA, <i>n</i>-hexane/2-propanol = 70/30, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 21.317 min (major), 25.346 min (minor)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.73 (s, 1H), 8.16 (s, 1H), 7.80–7.74 (m, 2H), 7.67 (s, 1H), 7.42 (t, <i>J</i> = 7.2 Hz, 2H), 7.37–7.31 (m, 1H), 4.61–4.50 (m, 1H), 4.37–4.28 (m, 1H), 4.20–4.09 (m, 1H), 2.99–2.86 (m, 1H), 2.66–2.55 (m, 1H), 2.26–2.13 (m, 1H), 1.96–1.85 (m, 1H), 1.25–1.12 (m, 13H), 1.01–0.90 (m, 1H), 0.84 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 151.9, 151.8, 151.6, 148.1, 145.2, 132.3, 130.3, 129.1, 128.5, 125.8, 120.0, 55.6, 47.0, 34.7, 34.3, 31.9, 29.4, 29.31, 29.25, 29.0, 26.2, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>25</sub>H<sub>33</sub>ClN<sub>7</sub> (M + H<sup>+</sup>), 466.2480; found, 466.2484.</div></div><div id="sec6_1_96" class="NLM_sec NLM_sec_level_3"><div id="ac_i126" class="anchor-spacer"></div><h4 class="article-section__title" id="_i126">6.1.96.  6-Chloro-9-(1-chlorododecan-3-yl)-9<i>H</i>-purine (<b>9bd</b>)</h4><div class="NLM_p last">Compound <b>9b</b> (169.1 mg, 0.5 mmol) and pyridine (44.5 μL, 0.55 mmol) were added to CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) at −20 °C. The reaction mixture was stirred at −20 °C for 5 min. A solution of SO<sub>2</sub>Cl<sub>2</sub> (39.9 μL, 0.55 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (0.5 mL) was slowly added dropwise. The reaction mixture was stirred at −20 °C for 15 min and then at 0 °C for another 15 min. After that, the CH<sub>2</sub>Cl<sub>2</sub> was evaporated and the residue was suspended in diethyl ether. After filtration to remove the precipitate, the organic phase was evaporated in vacuo. The residue was further purified by flash column chromatography on silica gel (PE/EA = 2:1) to give the target racemic <b>9bd</b> as a colorless oil in 133.5 mg (75.0% yield). Colorless oil. For (<i>R</i>)-<b>9bd</b>: prepared according to the procedure for the synthesis of the above racemic <b>9bd</b> using (<i>R</i>)-<b>9b</b> (169.1 mg, 0.5 mmol) to replace racemic <b>9b</b> (169.1 mg, 0.5 mmol). [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −21.8 (<i>c</i> = 0.15, CHCl<sub>3</sub>), 93% ee [CHIRALCEL IA, <i>n</i>-hexane/2-propanol = 95/5, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 9.979 min (minor), 11.190 min (major)]. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.09 (s, 1H), 4.81–4.70 (m, 1H), 3.55–3.46 (m, 1H), 3.18–3.08 (m, 1H), 2.75–2.64 (m, 1H), 2.39–2.28 (m, 1H), 2.26–2.14 (m, 1H), 1.98–1.86 (m, 1H), 1.26–1.11 (m, 13H), 1.06–0.94 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 151.8, 151.7, 151.4, 145.1, 132.3, 55.6, 41.0, 36.4, 33.8, 31.9, 29.4, 29.3, 29.2, 29.0, 26.2, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>27</sub>Cl<sub>2</sub>N<sub>4</sub> (M + H<sup>+</sup>), 357.1607; found, 357.1608.</div></div><div id="sec6_1_97" class="NLM_sec NLM_sec_level_3"><div id="ac_i127" class="anchor-spacer"></div><h4 class="article-section__title" id="_i127">6.1.97.  Diethyl (((3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecyl)oxy)methyl)phosphonate (<b>9be</b>)</h4><div class="NLM_p last">A solution of <b>9b</b> (33.8 mg, 0.1 mmol) in dry THF (0.5 mL) was slowly added to a stirred suspension of NaH (12.0 mg, 0.5 mmol) in dry THF (0.5 mL) at −15 °C under N<sub>2</sub>. Then, the reaction mixture was stirred at −15 °C for 5 min. After that, a solution of ((diethoxyphosphoryl)oxy) methyl trifluoromethanesulfonate (90.0 mg, 0.3 mmol) in THF (1.0 mL) was slowly added to the above reaction mixture and the reaction mixture was stirred at 0 °C for 7 h. Then, water (10.0 mL) was added to quench the reaction. The resulting mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The organic phases were combined and washed with a saturated brine solution. The organic phase was dried over anhydrous sodium sulfate and then concentrated in vacuo. The residue was further purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 90:1) to give the target racemic <b>9be</b> as a colorless oil in 31.1 mg (63.8% yield). Colorless oil. For (<i>R</i>)-<b>9be</b>: prepared according to the procedure for the synthesis of the above racemic <b>9be</b> using (<i>R</i>)-<b>9b</b> (33.8 mg, 0.1 mmol) to replace racemic <b>9b</b> (33.8 mg, 0.1 mmol). [α]<sub class="stack">D</sub><sup class="stack">20</sup> = −1.7 (<i>c</i> = 0.23, CHCl<sub>3</sub>), 92% ee [CHIRALCEL ID, <i>n</i>-hexane/2-propanol = 80/20, flow rate = 0.8 mL/min, temperature = 25 °C, λ = 250 nm, retention time: 19.747 min (minor), 21.282 min (major)]. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.70 (s, 1H), 8.14 (s, 1H), 4.76–4.67 (m, 1H), 4.20–4.06 (m, 4H), 3.69–3.58 (m, 2H), 3.58–3.52 (m, 1H), 3.24–3.12 (m, 1H), 2.44–2.34 (m, 1H), 2.28–2.16 (m, 2H), 1.99–1.87 (m, 1H), 1.37–1.29 (m, 6H), 1.26–1.23 (m, 3H), 1.23–1.16 (m, 10H), 1.06-0.97 (m, 1H), 0.85 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 151.9, 151.7, 151.2, 145.6, 132.3, 69.6, 69.6, 65.9, 64.8, 62.54, 62.50, 55.3, 34.2, 34.1, 31.9, 29.5, 29.4, 29.3, 29.1, 26.4, 22.8, 16.7, 16.6, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>22</sub>H<sub>39</sub>ClN<sub>4</sub>O<sub>4</sub>P(M + H<sup>+</sup>), 489.2392; found, 489.2396.</div></div><div id="sec6_1_98" class="NLM_sec NLM_sec_level_3"><div id="ac_i128" class="anchor-spacer"></div><h4 class="article-section__title" id="_i128">6.1.98.  Diethyl (((3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecyl)oxy)methyl)phosphonic acid (<b>9bf</b>)</h4><div class="NLM_p last">To a solution of <b>9be</b> (48.8 mg, 0.1 mmol) in anhydrous acetonitrile was added bromotrimethylsilane (132.0 μL, 1 mmol) at 0 °C. The reaction was stirred at room temperature overnight and detected by TLC. Then, the reaction mixture was concentrated in vacuo. After that, water and CH<sub>2</sub>Cl<sub>2</sub> were added. Then, the pH value of the mixture was adjusted to 7–8 by adding 10% sodium hydroxide solution. Finally, the water phase was concentrated in vacuo. The residue was purified by reversed phase column chromatography (H<sub>2</sub>O/MeOH = 3:1) to give the target compound <b>9bf</b> as a white solid in 19.4 mg (44.9% yield). White solid. mp: <b>></b>320 °C (Note: the melting point of <b>9bf</b> exceeds the measuring range of the thermometer). <sup>1</sup>H NMR (400 MHz, D<sub>2</sub>O) δ 8.85 (s, 1H), 8.70 (s, 1H), 3.64–3.52 (m, 1H), 3.51–3.32 (m, 3H), 2.60–2.36 (m, 2H), 2.26–2.11 (m, 1H), 2.10–1.95 (m, 1H), 1.25–1.07 (m, 2H), 1.06–0.96 (m, 1H), 0.93–0.84 (m, 5H), 0.83–0.70 (m, 7H), 0.51 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (101 MHz, D<sub>2</sub>O) δ 151.63, 149.13, 145.76, 141.24, 123.45, 69.43, 68.94, 68.84, 67.93, 53.98, 34.53, 33.95, 31.09, 28.09, 28.01, 27.49, 24.81, 21.95, 13.40; <sup>31</sup>P NMR (162 MHz, D<sub>2</sub>O) δ 13.62; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>18</sub>H<sub>31</sub>ClN<sub>4</sub>O<sub>4</sub>P (M + H<sup>+</sup>), 433.1766; found, 433.1773.</div></div><div id="sec6_1_99" class="NLM_sec NLM_sec_level_3"><div id="ac_i129" class="anchor-spacer"></div><h4 class="article-section__title" id="_i129">6.1.99.  3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecanal (<b>17</b>)</h4><div class="NLM_p last">6-Chloro-9<i>H</i>-purine (30.9 mg, 0.2 mmol), <span class="smallcaps smallerCapital">l</span>-proline (2.3 mg, 0.02 mmol), benzoic acid (2.4 mg, 0.02 mmol), and methanol (1.5 mL) were added to a reaction tube with a magnetic stirring bar. Then, (<i>E</i>)-dodec-2-enal (64.4 μL, 0.3 mmol) was added to the reaction mixture. The reaction was stirred at room temperature for 24 h and detected by TLC. Then, the reaction was quenched with a saturated brine solution and concentrated in vacuo. Then, water was added to the residue and the mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 3:1) to give the target compound <b>17</b> as a white solid in 53.8 mg (80.1% yield). White solid. mp: 83–85 °C. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 9.70 (s, 1H), 8.70 (s, 1H), 8.15 (s, 1H), 5.03–4.96 (m, 1H), 3.55 (dd, <i>J</i> = 18.6, 8.4 Hz, 1H), 3.12 (dd, <i>J</i> = 18.6, 4.8 Hz, 1H), 2.29–2.21 (m, 1H), 1.96–1.88 (m, 1H), 1.28–1.21 (m, 4H), 1.21–1.15 (m, 9H), 1.05–0.98 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (150 MHz, CDCl<sub>3</sub>) δ 198.3, 151.6, 151.5, 151.3, 145.6, 132.3, 52.4, 47.5, 33.5, 31.9, 29.5, 29.3, 29.3, 28.9, 26.2, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>26</sub>ClN<sub>4</sub>O (M + H<sup>+</sup>), 337.1790; found, 337.1785.</div></div><div id="sec6_1_100" class="NLM_sec NLM_sec_level_3"><div id="ac_i130" class="anchor-spacer"></div><h4 class="article-section__title" id="_i130">6.1.100.  3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecanoic Acid (<b>18</b>)</h4><div class="NLM_p last">To a solution of compound <b>17</b> (674.4 mg, 2.0 mmol) in acetone (5 mL)/water (2 mL) was added KMnO<sub>4</sub> (632.1 mg, 4.0 mmol) in one portion. The reaction was stirred at room temperature until compound <b>17</b> was completely consumed, which was detected by TLC. Then, the reaction mixture was quenched by adding solid NaHSO<sub>3</sub> to give a thick brown sludge. After filtering through a pad of Celite using acetone/water as the eluent, a pale-yellow solution was obtained, which was concentrated in vacuo to afford a white solid. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to give the target compound <b>18</b> as a white solid in 561.4 mg (83.5% yield). White solid. mp: 167–169 °C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.72 (s, 1H), 8.19 (s, 1H), 4.93–4.83 (m, 1H), 3.64 (s, 1H), 3.34 (dd, <i>J</i> = 17.2, 9.6 Hz, 1H), 2.97 (dd, <i>J</i> = 17.2, 4.0 Hz, 1H), 2.38–2.26 (m, 1H), 2.05–1.94 (m, 1H), 1.28–1.24 (m, 4H), 1.23–1.17 (m, 9H), 1.11–1.00 (m, 1H), 0.86 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 173.2, 151.9, 151.5, 151.2, 145.9, 131.9, 55.1, 38.1, 33.3, 31.9, 29.5, 29.4, 29.3, 29.0, 26.3, 22.8, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>17</sub>H<sub>26</sub>ClN<sub>4</sub>O<sub>2</sub> (M + H<sup>+</sup>), 353.1739; found, 353.1731.</div></div><div id="sec6_1_101" class="NLM_sec NLM_sec_level_3"><div id="ac_i131" class="anchor-spacer"></div><h4 class="article-section__title" id="_i131">6.1.101.  <i>tert</i>-Butyl (5-(3-(6-Chloro-9<i>H</i>-purin-9-yl)dodecanamido)pentyl)carbamate (<b>20</b>)</h4><div class="NLM_p last">To a stirred solution of compound <b>18</b> (70.4 mg, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) at 0 °C was added dropwise triethylamine (41.6 μL, 0.3 mmol). After 20 min, isobutyl chloroformate (38.9 μL, 0.3 mmol) was added dropwise to the above reaction mixture at 0 °C and the reaction was stirred for another 30 min. Then, 5-(<i>tert</i>-butoxycarbonylamino)-pentyl amine (60.7 mg, 0.3 mmol) was added dropwise at 0 °C and the reaction mixture was stirred for 20 min. The reaction was reacted at room temperature until compound <b>18</b> was completely consumed, which was detected by TLC. After that, water (2.0 mL) was added to quench the reaction. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>20</b> as a colorless oil in 81.6 mg (76.1% yield). Colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.68 (s, 1H), 8.13 (s, 1H), 5.76 (s, 1H), 4.99–4.91 (m, 1H), 4.61 (s, 1H), 3.15–2.98 (m, 5H), 2.82 (dd, <i>J</i> = 15.0, 4.8 Hz, 1H), 2.32–2.23 (m, 1H), 1.97–1.89 (m, 1H), 1.42 (s, 9H), 1.39–1.32 (m, 2H), 1.28–1.21 (m, 6H), 1.21–1.15 (m, 9H), 1.10–1.03 (m, 2H), 1.03–0.96 (m, 1H), 0.84 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 169.0, 156.3, 151.6, 151.5, 151.2, 146.4, 132.4, 79.3, 56.1, 40.5, 40.1, 39.3, 33.3, 31.9, 29.7, 29.5, 29.4, 29.3, 29.0, 28.8, 28.6, 26.4, 23.7, 22.7, 14.2; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>27</sub>H<sub>46</sub>ClN<sub>6</sub>O<sub>3</sub> (M + H<sup>+</sup>), 537.3314; found, 537.3314.</div></div><div id="sec6_1_102" class="NLM_sec NLM_sec_level_3"><div id="ac_i132" class="anchor-spacer"></div><h4 class="article-section__title" id="_i132">6.1.102.  Biotin-Annexed Probe <b>21</b></h4><div class="NLM_p last">A solution of <b>20</b> (80.4 mg, 0.15 mmol) and CF<sub>3</sub>COOH (2 mL) in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) was stirred at room temperature for 10 min. Then, the reaction mixture was concentrated in vacuo to afford the corresponding deprotected amine. To a solution of the above deprotected amine in anhydrous DMF (7 mL), <i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU, 56.9 mg, 0.15 mmol), <i>i</i>Pr<sub>2</sub>NEt (24.8 μL, 0.3 mmol), and a solution of <i>D</i>-(+)-biotin (24.4 mg, 0.1 mmol) in anhydrous DMF (3 mL) were added subsequently. The reaction mixture was stirred at room temperature for 24 h under N<sub>2</sub> and detected by TLC. After that, water was added to the solution and the reaction mixture was extracted with ethyl acetate three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 12:1) to give the target compound <b>21</b> as a white solid in 23.8 mg (36.0% yield). White solid. mp: 54–56 °C. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75 (s, 1H), 8.72 (s, 1H), 7.86 (t, <i>J</i> = 5.6 Hz, 1H), 7.66 (t, <i>J</i> = 5.6 Hz, 1H), 6.38 (s, 1H), 6.33 (s, 1H), 5.02–4.92 (m, 1H), 4.33–4.27 (m, 1H), 4.15–4.10 (m, 1H), 3.12–3.06 (m, 1H), 2.98–2.77 (m, 8H), 2.57 (d, <i>J</i> = 12.4 Hz, 1H), 2.18–2.07 (m, 1H), 2.03 (t, <i>J</i> = 7.2 Hz, 2H), 1.92–1.81 (m, 1H), 1.66–1.56 (m, 1H), 1.54–1.40 (m, 4H), 1.26–1.23 (m, 4H), 1.18–1.11 (m, 13H), 1.06–0.99 (m, 2H), 0.98–0.90 (m, 1H), 0.82 (t, <i>J</i> = 6.8 Hz, 3H); <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ 171.7, 168.5, 162.6, 151.8, 151.1, 149.0, 147.0, 131.0, 61.0, 59.2, 55.4, 54.1, 38.2, 35.2, 33.1, 31.2, 28.7, 28.6, 28.5, 28.5, 28.1, 28.0, 25.3, 23.5, 22.0, 13.9; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>32</sub>H<sub>52</sub>ClN<sub>8</sub>O<sub>3</sub>S (M + H<sup>+</sup>), 663.3566; found, 663.3571.</div></div><div id="sec6_1_103" class="NLM_sec NLM_sec_level_3"><div id="ac_i133" class="anchor-spacer"></div><h4 class="article-section__title" id="_i133">6.1.103.  Diazirine Photoaffinity Probe <b>23</b></h4><div class="NLM_p last">To a stirred solution of compound <b>18</b> (70.4 mg, 0.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (2.0 mL) at 0 °C was added dropwise triethylamine (41.6 μL, 0.3 mmol). After 20 min, isobutyl chloroformate (38.9 μL, 0.3 mmol) was added dropwise to the above reaction mixture at 0 °C and the reaction was stirred for another 30 min. Then, 2-(3-(but-3-yn-1-yl)-3<i>H</i>-diazirin-3-yl)ethan-1-amine (38.4 μL, 0.3 mmol) was added dropwise at 0 °C and the reaction mixture was stirred for 20 min. The reaction was reacted at room temperature until compound <b>18</b> was completely consumed, which was detected by TLC. After that, water (2.0 mL) was added to quench the reaction. The reaction mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> three times. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated in vacuo. The residue was purified by flash column chromatography on silica gel (PE/EA = 1:1) to give the target compound <b>23</b> as a colorless oil in 83.8 mg (88.9% yield). Colorless oil. <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 8.66 (s, 1H), 8.11 (s, 1H), 5.84–5.78 (m, 1H), 4.96–4.89 (m, 1H), 3.15 (dd, <i>J</i> = 15.6, 9.6 Hz, 1H), 2.99–2.92 (m, 1H), 2.90–2.84 (m, 1H), 2.81 (dd, <i>J</i> = 15.0, 4.8 Hz, 1H), 2.32–2.23 (m, 1H), 1.95 (t, <i>J</i> = 2.5 Hz, 1H), 1.95–1.90 (m, 1H), 1.90–1.83 (m, 2H), 1.53–1.38 (m, 4H), 1.25–1.17 (m, 5H), 1.17–1.12 (m, 8H), 1.02–0.94 (m, 1H), 0.81 (t, <i>J</i> = 7.2 Hz, 3H); <sup>13</sup>C NMR (151 MHz, CDCl<sub>3</sub>) δ 169.07, 151.58, 151.44, 151.09, 146.28, 132.41, 82.70, 69.52, 55.90, 40.33, 34.40, 33.19, 32.13, 31.90, 31.82, 29.40, 29.31, 29.21, 28.93, 26.64, 26.30, 22.65, 14.12, 13.14; ESI-HRMS (<i>m</i>/<i>z</i>) calcd C<sub>24</sub>H<sub>35</sub>ClN<sub>7</sub>O (M + H<sup>+</sup>), 472.2586; found, 472.2585.</div></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i134" class="anchor-spacer"></div><h3 class="article-section__title" id="_i134">6.2.  Reagents and Antibodies</h3><div class="NLM_p last">These compounds were dissolved in dimethyl sulfoxide (DMSO, Kermel) at a concentration of 100 mM and stored at 4 °C. Dulbecco’s modified Eagle’s medium (DMEM), RPMI-1640 medium, McCoy’s 5A medium, phosphate buffer (PBS), and fetal bovine serum (FBS) were purchased from ThermoFisher Scientific. Poly(vinylidene fluoride) (PVDF) membrane was purchased from Millipore. Bax, Bcl-xl, and cleaved-PARP primary antibodies were purchased from Proteintech; antirabbit or antimouse IgG horseradish peroxidase (HRP) -linked secondary antibodies were purchased from Arigo (China); the cell apoptosis detection kit was purchased from BD Biosciences; P53 and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) primary antibodies, crystal violet staining solution, BCA protein assay kit, IP lysis buffer, mitochondrial membrane potential assay kit, and cell-cycle analysis kit were purchased from Beyotime (China); and Q-VD-OPh was purchased from MedChemExpress.</div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i135" class="anchor-spacer"></div><h3 class="article-section__title" id="_i135">6.3.  MTT Cell Viability Assay</h3><div class="NLM_p last">The antiproliferation activities of synthesized compounds were assessed by an MTT assay. Cells were cultured in DMEM, RPMI-1640, or McCoy’s 5A medium supplemented with 10% FBS and 1% penicillin-streptomycin solution (10 000 U/mL penicillin and 10 000 μg/mL streptomycin) at 37 °C under 5% CO<sub>2</sub>. Then, 5 × 10<sup>3</sup> cells per well were seeded into 96-well plates for 24 h and then treated with compounds at various concentrations or DMSO (diluent) for 48 h. Then, 20 μL of MTT solution (5 mg/mL in PBS) was added to each well and incubated at 37 °C for 4 h. Next, the MTT solution was replaced with DMSO (150 μL). Absorbance of each well was tested by a microplate reader (Multiskan FC, Thermo) at a 570 nm wavelength. Assays were performed in triplicates. Data were analyzed by GraphPad Prism 6. Data are mean ± SEM values from three independent experiments.</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i136" class="anchor-spacer"></div><h3 class="article-section__title" id="_i136">6.4.  Annexin V-FITC/PI Apoptosis Assay</h3><div class="NLM_p last">Around 5 × 10<sup>5</sup> SW480 cells per well were seeded into six-well plates, incubated overnight, and treated with compound <b>9b</b> at specified concentrations for 48 h. Then, the cells were collected, washed twice with PBS, and costained with Annexin V-FITC and PI in a dark place for 15 min at room temperature according to the kit manual. Apoptotic cells were detected with flow cytometry, and 10 000 cells were counted each time.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i137" class="anchor-spacer"></div><h3 class="article-section__title" id="_i137">6.5.  Western Blotting Assay</h3><div class="NLM_p last">SW480 cells were seeded into six-well plates, incubated overnight, and treated with compound <b>9b</b> at specified concentrations for 48 h. The cells were collected, and the cell samples were lysed by IP lysis buffer. Protein concentrations were quantified by the BCA protein assay kit. Cell extracts were separated by electrophoresis on sodium dodecyl sulfate polyacrylamide gels and transferred onto a poly(vinylidene fluoride) (PVDF) membrane. After blocking with 5% BSA in TBST, the membrane was interacted with GAPDH, Bax, P53, Bcl-xl, and cleaved-PARP primary antibody overnight at 1:2000 dilutions. Then, the membrane was interacted with appropriate secondary antibodies conjugated with horseradish peroxidase (HRP) at room temperature for 2 h. Protein bands are visualized by chemiluminescence reagents.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i138" class="anchor-spacer"></div><h3 class="article-section__title" id="_i138">6.6.  MMP Determination</h3><div class="NLM_p last">Around 5 × 10<sup>5</sup> SW480 cells per well were seeded into a six-well plate for 24 h at 37 °C. Then, cells were treated with diluent (DMSO) or specified concentrations of compound <b>9b</b> for 24 h. For flow cytometer detection, cells were collected with a trypsin solution, washed twice with PBS, followed by adding JC-1 binding solution, and then incubated in the incubator at 37 °C for 20 min in a dark place, centrifuged, and washed 3 times with JC-1 staining buffer. After resuspending with JC-1 staining buffer, the samples were analyzed with a flow cytometer. For fluorescence detection, cells were washed twice with PBS, stained with the JC-1 binding solution at 37 °C for 20 min in a dark place, and washed twice with JC-1 staining buffer. Images were taken under a fluorescence microscope.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i139" class="anchor-spacer"></div><h3 class="article-section__title" id="_i139">6.7.  Colony Formation Assay</h3><div class="NLM_p last">HCT-116 cells and SW480 cells were seeded in six-well plates with a density of 1500 cells per well and maintained in a regular culture medium. After 24 h, the cells were treated with compound <b>9b</b> at indicated concentrations for 48 h. The culture medium was changed every 72 h. At the end of 14 days, the wells were washed twice with PBS, fixed with methanol for 20 min, and stained with 2 mL of crystal violet staining solution for 30 min at room temperature. The wells were then washed with PBS three times and allowed to dry. Photographs were then taken.</div></div><div id="sec6_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i140" class="anchor-spacer"></div><h3 class="article-section__title" id="_i140">6.8.  Metabolic Stability Assay</h3><div class="NLM_p last">Microsomes were dissolved in 0.1 M Tris buffer (pH 7.40) containing 5 mM MgCl<sub>2</sub>, 0.1 μM compound <b>9b</b>, or 0.01% DMSO (negative control) and 0.005% bovine serum albumin (BSA) at the concentration of 0.33 mg/mL and incubated at 37 °C for 10 min. The reaction was started by the addition of NADPH (final concentration 1 mM). Aliquots were sampled at 0, 7, 17, 30, and 60 min, and methanol (cold in 4 °C) was added to terminate the reaction. After centrifugation (4000 rpm, 5 min), samples were then analyzed by LC-MS/MS.</div></div><div id="sec6_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i141" class="anchor-spacer"></div><h3 class="article-section__title" id="_i141">6.9.  Acute Toxicity Assay</h3><div class="NLM_p last">Balb/C mice were divided into six groups randomly (<i>n</i> = 10, five male and five female) and injected intraperitoneally with various dosages of compound <b>9b</b> (75, 62.5, 50, 37.5, or 25 mg/kg) or a diluent (DMSO/castor oil/PBS = 1:1:8) per 4 h; after 4 times of injection, mice were fed for 14 days and the number of dead mice were recorded every day. The LD<sub>50</sub> value was evaluated in GraphPad Prism 6.0.</div></div><div id="sec6_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i142" class="anchor-spacer"></div><h3 class="article-section__title" id="_i142">6.10.  Xenograft Tumor Growth Assay in Nude Mice</h3><div class="NLM_p last">All animal studies and procedures were approved by the Animal Ethics Committee of School of Pharmacy, Fudan University. BALB/C nude mice at 5 weeks of age were purchased from Shanghai Slac Laboratory Animal Co. Ltd. (Shanghai, China) and housed under a specific pathogen-free environment in an animal holding unit (AHU) of Fudan University (Shanghai, China). Mice were injected with SW480 cells (4 × 10<sup>6</sup> per mouse) subcutaneously. Seven days after injection, mice were randomly divided into four groups (<i>n</i> = 8) and administered intraperitoneally with 25 or 50 mg/kg compound <b>9b</b> (dissolved in PBS containing 5% ethanol and 5% cremophor EL, 0.2 mL per mouse), 5-FU at 50 mg/kg, or vehicle control (0.2 mL of the diluent) once every 2 days for 12 days. At the end of the experiment, the mice were weighed and sacrificed and tumors were collected and fixed with 4% paraformaldehyde and embedded in paraffin. H & E staining was used to further analyze the solid tumors of mice.</div></div><div id="sec6_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i143" class="anchor-spacer"></div><h3 class="article-section__title" id="_i143">6.11.  Pull-Down Assay</h3><div class="NLM_p last">The biotin-annexed probe <b>21</b> or the diazirine-based probe <b>23</b> was incubated with SW480 cell lysate at 4 °C overnight. The streptavidin conjugate beads (30 μL) were added and incubated for 8 h at 4 °C. Then, the beads were washed 10 times with Western and IP cell lysis buffer. After that, the Western and IP cell lysis buffer (20 μL) and the loading buffer (5 μL) were added and boiled for 10 min. For the diazirine-based probe <b>23</b>, after 20 min of irradiation at 360 nm, the probe <b>23</b> was incubated with the azide–PEG3–biotin conjugate for 3 h at 4 °C. After that, it was incubated with streptavidin conjugate beads. Then, the biotin-annexed probe <b>21</b> or the diazirine-based probe <b>23</b> was separated with 8–10% SDS-PAGE gel and stained with a silver staining kit according to the instruction. The gel was fixed with 50% ethyl alcohol containing 10% acetic acid for 40 min at room temperature. Then, the gel was washed with 15% ethyl alcohol and double-distilled water for 15 min, sequentially. The gel was then sensitized and colored. Specific bands were separated, and protein mass spectrometry analyses were conducted.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i144"><a href="/doi/suppl/10.1021/acs.jmedchem.0c01717" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73107" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73107" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c01717?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01717</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Experimental procedures, spectral data and purity table of target compounds, biological evaluation assay, and crystallographic data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Recommended compound characterization checklist (<a href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_003.xls" class="ext-link">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf">jm0c01717_si_001.pdf (11.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_002.csv">jm0c01717_si_002.csv (6.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_003.xls">jm0c01717_si_003.xls (354.5 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01717" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yang Wang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a7d0c6c9c0dec6c9c0e7d4cfcad289c2c3d289c4c9"><span class="__cf_email__" data-cfemail="d5a2b4bbb2acb4bbb295a6bdb8a0fbb0b1a0fbb6bb">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Ming Guo</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-0629-4524" title="Orcid link">http://orcid.org/0000-0003-0629-4524</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#bcdbd4d1fcd4c8c992d9d8c992dfd2"><span class="__cf_email__" data-cfemail="86e1eeebc6eef2f3a8e3e2f3a8e5e8">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Er-Jun Hao</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gong-Xin Li</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yu-Ru Liang</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Sheng Xie</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-4113-2168" title="Orcid link">http://orcid.org/0000-0003-4113-2168</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong-Chao Wang</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5037-4727" title="Orcid link">http://orcid.org/0000-0002-5037-4727</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiao-Han Jiang</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecules and Drug Innovation,
Key Laboratory of Green Chemical Media and Reactions, Ministry of
Education, Collaborative Innovation Center of Henan Province for Green
Manufacturing of Fine Chemicals, School of Chemistry and Chemical
Engineering, Henan Normal University, Xinxiang, Henan 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jia-Yi Cheng</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhi-Xian Shi</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmacy, Fudan University, Shanghai 201203, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>E.-J. H., G.-X. L., and Y.-R. L. are co-first authors and contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e13054-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i146">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30007" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30007" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Professors Lu Zhou and Wei Fu from Fudan University for kind discussions and suggestions. We also thank Dr. Chao Peng and Yue Yin of the Mass Spectrometry System at the National Facility for Protein Science in Shanghai (NFPS), Zhangjiang Lab, Shanghai Advanced Research Institute, Chinese Academy of Science, and Dr. Guoquan Yan of the Institutes of Biomedical Sciences, Fudan University, China, for data collection and analysis. We are grateful for the financial support from the National Natural Science Foundation of China (Nos. U1604283 and 21877015), the Science and Technology Commission of Shanghai Municipality (20S11902500), the National Government Guides Local Special Funds for the Development of Science and Technology (No. YDZX20204100001786), Zhongyuan Scholar (212101510004), and the 111 Project (No. D17007).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">ANCs</td><td class="NLM_def"><p class="first last">acyclic nucleoside compounds</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetrabutylammonium fluoride</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N,N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">standard error of the mean</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">TMS</td><td class="NLM_def"><p class="first last">tetramethylsilane</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate-buffered saline</p></td></tr><tr><td class="NLM_term">IBCF</td><td class="NLM_def"><p class="first last">isobutyl chloroformate</p></td></tr><tr><td class="NLM_term">DIBAL-H</td><td class="NLM_def"><p class="first last">diisobutyl aluminum hydride</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl-<i>O</i>-(1<i>H</i>-benzotriazol-1-yl)uronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">R&D</td><td class="NLM_def"><p class="first last">research and development</p></td></tr><tr><td class="NLM_term">H&E</td><td class="NLM_def"><p class="first last">staining, hematoxylin–eosin staining</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2<i>H</i>-tetrazolium bromide</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP-ribose polymerase</p></td></tr><tr><td class="NLM_term">MMP</td><td class="NLM_def"><p class="first last">mitochondrial membrane potential</p></td></tr><tr><td class="NLM_term">PE</td><td class="NLM_def"><p class="first last">petroleum ether</p></td></tr><tr><td class="NLM_term">EA</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i148">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48678" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48678" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 50 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The acyclic nucleoside phosphonates from inception to clinical use: historical perspective</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.antiviral.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=17116336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=1-13&author=E.+De%0AClercq&title=The+acyclic+nucleoside+phosphonates+from+inception+to+clinical+use%3A+historical+perspective&doi=10.1016%2Fj.antiviral.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The collaboration between Antonin Holy [Institute of Org. Chem. and Biochem. (IOCB, Prague, Czech Republic)] and Erik De Clercq (Rega Institute for Medical Research, K.U. Leuven, Belgium) started exactly 30 years ago.  It led to the discovery of a (rather small) series of acyclic nucleoside analogs (prototype: DHPA), followed by the discovery of a large no. of nucleotide analogs [acyclic nucleoside phosphonates (ANPs)] (prototype: HPMPA).  From HPMPA originated three compds., which have been approved by regulatory agencies worldwide for clin. use: (i) HPMPC [cidofovir (Vistide)] for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients, and "off label" for the treatment of polyoma-, papilloma-, adeno-, herpes- and poxvirus infections; (ii) PMEA [adefovir (in its oral prodrug form, adefovir dipivoxil (Hepsera))] for the treatment of chronic HBV (hepatitis B virus) infections, and (iii) PMPA [tenofovir (in its oral prodrug form, tenofovir disoproxil fumarate (Viread))] for the treatment of HIV infections (AIDS).  The latter has also been approved, in combination with emtricitabine (Truvada), and in combination with emtricitabine and efavirenz (Atripla) for the treatment of HIV infections.  Many other ANPs such as the DAP derivs. HPMPDAP, PMEDAP and PMPDAP, and the DAPy derivs. HPMPO-DAPy, PMEO-DAPy, and PMPO-DAPy, were found to exhibit an antiviral activity spectrum and potency comparable to that of the parent compds. HPMPA (and HPMPC), PMEA and PMPA, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJky28pToCfrVg90H21EOLACvtfcHk0ljR5C94SOWC_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWlu70%253D&md5=fc42d2e7dc8ca7736d94f13d877dea49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520acyclic%2520nucleoside%2520phosphonates%2520from%2520inception%2520to%2520clinical%2520use%253A%2520historical%2520perspective%26jtitle%3DAntiviral%2520Res.%26date%3D2007%26volume%3D75%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.antiviral.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baszczyňski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1002/med.21296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fmed.21296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23893552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2hu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1304-1344&author=O.+Baszczy%C5%88skiauthor=Z.+Janeba&title=Medicinal+Chemistry+of+Fluorinated+Cyclic+and+Acyclic+Nucleoside+Phosphonates&doi=10.1002%2Fmed.21296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates</span></div><div class="casAuthors">Baszczynski, Ondrej; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1304-1344</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this paper, we review the biol. properties of cyclic and acyclic nucleoside phosphonates modified by the attachment of one or more fluorine atoms to various parts of the mol., namely to nucleobases, alkylphosphonate groups, cyclic or acyclic linkers, or to prodrug moieties.  The fluorine atom plays an important role in medicinal chem. because fluorine substitution has a strong impact on the phys., chem., and biol. properties of bioactive compds.  Such fluorine modifications have also been extensively studied among the pharmaceutically important class of nucleoside phosphonates, nucleotide analogs in which the phosphate group is replaced by the enzymically and chem. stable phosphonate moiety.  The fluorinated nucleoside phosphonates abound with antiviral, antiparasitic, and anticancer properties because they are able to act as inhibitors of important enzymes of nucleoside/nucleotide metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq5rIQx12Lg7Vg90H21EOLACvtfcHk0ljR5C94SOWC_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2hu7nK&md5=c9a571c64d13ecb876a43a0b23bab270</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fmed.21296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21296%26sid%3Dliteratum%253Aachs%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Fluorinated%2520Cyclic%2520and%2520Acyclic%2520Nucleoside%2520Phosphonates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D1304%26epage%3D1344%26doi%3D10.1002%2Fmed.21296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological effects of acyclic pyrimidine nucleoside analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1021/jm00141a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00141a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL3MXlt1Gruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=1078-1083&author=A.+C.+Schroederauthor=R.+G.+Hughesauthor=A.+Bloch&title=Synthesis+and+biological+effects+of+acyclic+pyrimidine+nucleoside+analogues&doi=10.1021%2Fjm00141a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological effects of acyclic pyrimidine nucleoside analogs</span></div><div class="casAuthors">Schroeder, Alan C.; Hughes, Robert G., Jr.; Bloch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1078-83</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Twenty-two nucleoside analogs, most which are represented by I and II (R = H, Me, F, or Ac; R1 = CH2OCH2CH2O2CPh, CH2OCH2CH2N3, CH2OCH2CH2OH, etc.) were synthesized and tested for various biol. effects.  At 10-4M, none of the compds. inhibited leukemia α-1210 cell growth in culture.  Several compds. did inhibit the in vitro growth of Escherichia coli K-12.  II (R = F, R1 = CH2OCH2CH2OH)  [77474-50-1] was the most active with an IC50 (concn. for 50% inhibition) of 1.2 μM.  Some of the analogs also selectively interfered with Herpes Simplex virus replication in vitro.  None of the I analogs tested were either substrates or inhibitors of human liver nucleoside deaminase  [9073-42-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4wuQ1-vDXrVg90H21EOLACvtfcHk0lg2ovE9sQV1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlt1Gruro%253D&md5=e84514136b3ddb53e1dcb80c4b689352</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00141a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00141a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DA.%2BC.%26aulast%3DHughes%26aufirst%3DR.%2BG.%26aulast%3DBloch%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520effects%2520of%2520acyclic%2520pyrimidine%2520nucleoside%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D1078%26epage%3D1083%26doi%3D10.1021%2Fjm00141a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, A.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, M.-J.</span></span> <span> </span><span class="NLM_article-title">Acyclic Nucleoside Analogues as Novel Inhibitors of Human Mitochondrial Thymidine Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4254</span>– <span class="NLM_lpage">4263</span>, <span class="refDoi"> DOI: 10.1021/jm011128+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011128%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFSrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4254-4263&author=A.-I.+Hern%C3%A1ndezauthor=J.+Balzariniauthor=A.+Karlssonauthor=M.-J.+Camarasaauthor=M.-J.+P%C3%A9rez-P%C3%A9rez&title=Acyclic+Nucleoside+Analogues+as+Novel+Inhibitors+of+Human+Mitochondrial+Thymidine+Kinase&doi=10.1021%2Fjm011128%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Analogs as Novel Inhibitors of Human Mitochondrial Thymidine Kinase</span></div><div class="casAuthors">Hernandez, Ana-Isabel; Balzarini, Jan; Karlsson, Anna; Camarasa, Maria-Jose; Perez-Perez, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4254-4263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside analogs of 5'-O-tritylthymidine have been synthesized and evaluated as potential human mitochondrial thymidine kinase (TK-2) inhibitors.  In this series, the sugar moiety of the parent 5'-O-tritylthymidine has been replaced by aliph. chains including (E)- and (Z)-butenol, butynol, or butanol.  Among them the (Z)-butenyl deriv. [I, Q = (Z)-CH:CH] showed an IC50 against TK-2 of 1.5 μM, being 1 order of magnitude more potent than the parent 5'-O-tritylthymidine.  This lead compd. has been further modified by replacing the thymine base by other pyrimidine bases such as 5-iodouracil, 5-ethyluracil, 5-methylcytosine, 3-N-methylthymine, or 5,6-dihydrothymine, as well as by the purine base guanine.  The trityl group has also been replaced by different aliph. and arom. acyl moieties including tert-butylacetyl, hexanoyl, decanoyl, and diphenylacetyl moieties.  The evaluation of the compds. against TK-2 and the phylogenetically close HSV-1 TK has shown that the base moiety plays a crucial role in their interaction against these pyrimidine nucleoside kinases.  Also, the presence of a lipophilic substituent, preferentially an arom. moiety such as diphenylmethyl or triphenylmethyl, is required for efficient TK-2 inhibition.  Whereas some compds. showed marked specificity for either TK-2 (i.e, the 5,6-dihydrothymine deriv.) or HSV-1 TK [i.e., the butynyl deriv., I (Q = C≡C)], some others, including the (Z)-and (E)-butenyl derivs., showed significant inhibition against both enzymes.  They also proved to be inhibitory against HSV-1 TK in intact human osteosarcoma cells that were transduced with the HSV-1 TK gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJDxFPEtCb7Vg90H21EOLACvtfcHk0lg2ovE9sQV1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFSrsbg%253D&md5=f606dadd93a5c1b8abae057de0796e8f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm011128%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011128%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DA.-I.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.-J.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DM.-J.%26atitle%3DAcyclic%2520Nucleoside%2520Analogues%2520as%2520Novel%2520Inhibitors%2520of%2520Human%2520Mitochondrial%2520Thymidine%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4254%26epage%3D4263%26doi%3D10.1021%2Fjm011128%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Properties of a Novel Type of Acyclic Nucleoside Phosphonates: 2-(Purin-9-yl)ethoxyphenylphosphonic Acids</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2885</span>– <span class="NLM_lpage">2892</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fejoc.201000061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2885-2892&author=D.+Hockov%C3%A1author=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=A.+Hol%C3%BD&title=Synthesis+and+Properties+of+a+Novel+Type+of+Acyclic+Nucleoside+Phosphonates%3A+2-%28Purin-9-yl%29ethoxyphenylphosphonic+Acids&doi=10.1002%2Fejoc.201000061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000061%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Properties%2520of%2520a%2520Novel%2520Type%2520of%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%25202-%2528Purin-9-yl%2529ethoxyphenylphosphonic%2520Acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D2010%26spage%3D2885%26epage%3D2892%26doi%3D10.1002%2Fejoc.201000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Špaček, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichý, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrbková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavětínská, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2526</span>, <span class="refDoi"> DOI: 10.1021/jm301893b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301893b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2513-2526&author=D.+T.+Keoughauthor=P.+%C5%A0pa%C4%8Dekauthor=D.+Hockov%C3%A1author=T.+Tich%C3%BDauthor=S.+Vrbkov%C3%A1author=L.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=T.-H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+Are+Potent+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases+and+Have+Antimalarial+Activity&doi=10.1021%2Fjm301893b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span></div><div class="casAuthors">Keough, Dianne T.; Spacek, Petr; Hockova, Dana; Tichy, Tomas; Vrbkova, Silvie; Slavetinska, Lenka; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2526</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) that contain a 6-oxopurine base are good inhibitors of the Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) 6-oxopurine phosphoribosyltransferases (PRTs).  Chem. modifications based on the crystal structure of 2-(phosphonoethoxy)ethylguanine (PEEG) in complex with human HGPRT have led to the design of new ANPs.  These novel compds. contain a second phosphonate group attached to the ANP scaffold.  {[(2-[(Guanine-9H-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)}diphosphonic acid (I) exhibited a Ki value of 30 nM for human HGPRT and 70 nM for Pf HGXPRT.  The crystal structure of this compd. in complex with human HGPRT shows that it fills or partially fills three crit. locations in the active site: the binding sites of the purine base, the 5'-phosphate group, and pyrophosphate.  This is the first HG(X)PRT inhibitor that has been able to achieve this result.  Prodrugs have been synthesized resulting in IC50 values as low as 3.8 μM for Pf grown in cell culture, up to 25-fold lower compared to the parent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIyMCQRsPnrVg90H21EOLACvtfcHk0lg2ovE9sQV1Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D&md5=f57c4cfd4f9bcb94e6ce93894bfd4d0f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm301893b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301893b%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DTich%25C3%25BD%26aufirst%3DT.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAcyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520Are%2520Potent%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Have%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2513%26epage%3D2526%26doi%3D10.1021%2Fjm301893b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hypoxanthine-Guanine Phosphoribosy- ltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4391</span>– <span class="NLM_lpage">4399</span>, <span class="refDoi"> DOI: 10.1021/jm900267n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900267n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4391-4399&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=L.+M.+J.+Naesensauthor=T.+S.+Skinner-Adamsauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+Hypoxanthine-Guanine+Phosphoribosy-+ltransferase+by+Acyclic+Nucleoside+Phosphonates%3A+A+New+Class+of+Antimalarial+Therapeutics&doi=10.1021%2Fjm900267n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Holy, Antonin; Naesens, Lieve M. J.; Skinner-Adams, Tina S.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4391-4399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purine salvage enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is essential for purine nucleotide and hence nucleic acid synthesis in the malaria parasite, Plasmodium falciparum.  Acyclic nucleoside phosphonates (ANPs) are analogs of the nucleotide product of the reaction, comprising a purine base joined by a linker to a phosphonate moiety.  Ki values for 19 ANPs were detd. for Pf HGXPRT and the corresponding human enzyme, HGPRT.  Values for Pf HGXPRT were as low as 100 nM, with selectivity for the parasite enzyme of up to 58.  Structures of human HGPRT in complex with three ANPs are reported.  On binding, a large mobile loop in the free enzyme moves to partly cover the active site.  For three ANPs, the IC50 values for Pf grown in cell culture were 1, 14, and 46 μM, while the cytotoxic concn. for the first compd. was 489 μM.  These results provide a basis for the design of potent and selective ANP inhibitors of Pf HGXPRT as antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn8rPcoy0EBbVg90H21EOLACvtfcHk0ligUK8-vn6sBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D&md5=76746f78ec791a08ba2376beba86fa2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900267n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900267n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520Hypoxanthine-Guanine%2520Phosphoribosy-%2520ltransferase%2520by%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520A%2520New%2520Class%2520of%2520Antimalarial%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4391%26epage%3D4399%26doi%3D10.1021%2Fjm900267n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topalis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradère, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzouzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broggi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Amri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deville-Bonne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1021/jm1011462</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1011462" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaku7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=222-232&author=D.+Topalisauthor=U.+Prad%C3%A8reauthor=V.+Royauthor=C.+Caillatauthor=A.+Azzouziauthor=J.+Broggiauthor=R.+Snoeckauthor=G.+Andreiauthor=J.+Linauthor=S.+Erikssonauthor=J.+A.+C.+Alexandreauthor=C.+El-Amriauthor=D.+Deville-Bonneauthor=P.+Meyerauthor=J.+Balzariniauthor=L.+A.+Agrofoglio&title=Novel+Antiviral+C5-Substituted+Pyrimidine+Acyclic+Nucleoside+Phosphonates+Selected+as+Human+Thymidylate+Kinase+Substrates&doi=10.1021%2Fjm1011462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates</span></div><div class="casAuthors">Topalis, Dimitri; Pradere, Ugo; Roy, Vincent; Caillat, Christophe; Azzouzi, Ahmed; Broggi, Julie; Snoeck, Robert; Andrei, Graciela; Lin, Jay; Eriksson, Staffan; Alexandre, Julie A. C.; El-Amri, Chahrazade; Deville-Bonne, Dominique; Meyer, Philippe; Balzarini, Jan; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-232</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) are at the cornerstone of DNA virus and retrovirus therapies.  They reach their target, the viral DNA polymerase, after two phosphorylation steps catalyzed by cellular kinases.  New pyrimidine ANPs have been synthesized with unsatd. acyclic side chains (prop-2-enyl-, but-2-enyl-, pent-2-enyl-) and different substituents at the C5 position of the uracil nucleobase.  Several derivs. in the but-2-enyl- series, with (E) but not with (Z) configuration, were efficient substrates for human thymidine monophosphate (TMP) kinase, but not for uridine monophosphate-cytosine monophosphate (UMP-CMP) kinase, which is in contrast to cidofovir.  Human TMP kinase was successfully crystd. in a complex with phosphorylated (E)-thymidine-but-2-enyl phosphonate and ADP.  The bis-pivaloyloxymethyl (POM) esters were synthesized and shown to exert activity against herpes virus in vitro (IC50 = 3 μM) and against varicella zoster virus in vitro (IC50 = 0.19 μM), in contrast to the corresponding inactive (Z) derivs.  Thus, their antiviral activity correlates with their ability to act as thymidylate kinase substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGHHytzlkwbVg90H21EOLACvtfcHk0ligUK8-vn6sBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaku7vL&md5=c8bfe5cadc1ac2d873eb53e554175385</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm1011462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011462%26sid%3Dliteratum%253Aachs%26aulast%3DTopalis%26aufirst%3DD.%26aulast%3DPrad%25C3%25A8re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DCaillat%26aufirst%3DC.%26aulast%3DAzzouzi%26aufirst%3DA.%26aulast%3DBroggi%26aufirst%3DJ.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DS.%26aulast%3DAlexandre%26aufirst%3DJ.%2BA.%2BC.%26aulast%3DEl-Amri%26aufirst%3DC.%26aulast%3DDeville-Bonne%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DNovel%2520Antiviral%2520C5-Substituted%2520Pyrimidine%2520Acyclic%2520Nucleoside%2520Phosphonates%2520Selected%2520as%2520Human%2520Thymidylate%2520Kinase%2520Substrates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D222%26epage%3D232%26doi%3D10.1021%2Fjm1011462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, D. L. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of Novel Acyclic Nucleoside Analogues of 5-(1-Azido-2-haloethyl) uracils</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4225</span>– <span class="NLM_lpage">4229</span>, <span class="refDoi"> DOI: 10.1021/jm010227k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010227k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4225-4229&author=R.+Kumarauthor=N.+Sharmaauthor=M.+Nathauthor=H.+A.+Saffranauthor=D.+L.+J.+Tyrrell&title=Synthesis+and+Antiviral+Activity+of+Novel+Acyclic+Nucleoside+Analogues+of+5-%281-Azido-2-haloethyl%29+uracils&doi=10.1021%2Fjm010227k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Activity of Novel Acyclic Nucleoside Analogues of 5-(1-Azido-2-haloethyl)uracils</span></div><div class="casAuthors">Kumar, Rakesh; Sharma, Neerja; Nath, Mahendra; Saffran, Holly A.; Tyrrell, D. Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4229</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present the discovery of a novel category of 5-substituted acyclic pyrimidine nucleosides as potent antiviral agents.  A series of 1-[(2-hydroxyethoxy)methyl], 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl], and 1-[4-hydroxy-3-(hydroxymethyl)-1-butyl] derivs. of 5-(1-azido-2-haloethyl)uracil were synthesized and evaluated for their biol. activity in cell culture.  1-[4-Hydroxy-3-(hydroxymethyl)-1-butyl]-5-(1-azido-2-chloroethyl)uracil was the most effective antiviral agent in the in vitro assays against DHBV (EC50 = 0.31-1.55 μM) and HCMV (EC50 = 3.1 μM).  None of the compds. investigated showed any detectable toxicity to several stationary and proliferating host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2UohEtR0kIbVg90H21EOLACvtfcHk0ligUK8-vn6sBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVOiurg%253D&md5=fb6f2db86abcb3c802d23a0e757e061b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm010227k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010227k%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DNath%26aufirst%3DM.%26aulast%3DSaffran%26aufirst%3DH.%2BA.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520Novel%2520Acyclic%2520Nucleoside%2520Analogues%2520of%25205-%25281-Azido-2-haloethyl%2529%2520uracils%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4225%26epage%3D4229%26doi%3D10.1021%2Fjm010227k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derudas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanpouille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zicari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7876</span>– <span class="NLM_lpage">7896</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7876-7896&author=M.+Derudasauthor=C.+Vanpouilleauthor=D.+Cartaauthor=S.+Zicariauthor=G.+Andreiauthor=R.+Snoeckauthor=A.+Brancaleauthor=L.+Margolisauthor=J.+Balzariniauthor=C.+McGuigan&title=Virtual+Screening+of+Acyclovir+Derivatives+as+Potential+Antiviral+Agents%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+New+Acyclic+Nucleoside+ProTides&doi=10.1021%2Facs.jmedchem.7b01009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides</span></div><div class="casAuthors">Derudas, Marco; Vanpouille, Christophe; Carta, Davide; Zicari, Sonia; Andrei, Graciela; Snoeck, Robert; Brancale, Andrea; Margolis, Leonid; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7876-7896</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following our findings on the anti-human immunodeficiency virus (HIV) activity of acyclovir (ACV) phosphate prodrugs, we herein report the ProTide approach applied to a series of acyclic nucleosides aimed at the identification of novel and selective antiviral, in particular anti-HIV agents.  Acyclic nucleoside analogs used in this study were identified through a virtual screening using HIV-reverse transcriptase (RT), adenylate/guanylate kinase, and human DNA polymerase γ.  A total of 39 new phosphate prodrugs were synthesized and evaluated against HIV-1 (in vitro and ex vivo human tonsillar tissue system) and human herpes viruses.  Several ProTide compds. showed substantial potency against HIV-1 at low micromolar range while the parent nucleosides were not effective.  Also, pronounced inhibition of herpesvirus replication was obsd.  A carboxypeptidase-mediated hydrolysis study was performed for a selection of compds. to assess the formation of putative metabolites and support the biol. activity obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUSy4loWCG37Vg90H21EOLACvtfcHk0ljdTu_OhT8MRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksbzK&md5=8ef7164c409ca381e464c3689592e81a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01009%26sid%3Dliteratum%253Aachs%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DVanpouille%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DZicari%26aufirst%3DS.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DMargolis%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DVirtual%2520Screening%2520of%2520Acyclovir%2520Derivatives%2520as%2520Potential%2520Antiviral%2520Agents%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Acyclic%2520Nucleoside%2520ProTides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7876%26epage%3D7896%26doi%3D10.1021%2Facs.jmedchem.7b01009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkeri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span> <span> </span><span class="NLM_article-title">Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6220</span>– <span class="NLM_lpage">6238</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00416</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWksrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6220-6238&author=M.+Luoauthor=E.+Groazauthor=G.+Andreiauthor=R.+Snoeckauthor=R.+Kalkeriauthor=R.+G.+Ptakauthor=T.+Hartmanauthor=R.+W.+Buckheitauthor=D.+Scholsauthor=S.+De+Jongheauthor=P.+Herdewijn&title=Expanding+the+Antiviral+Spectrum+of+3-Fluoro-2-%28phosphonomethoxy%29propyl+Acyclic+Nucleoside+Phosphonates%3A+Diamyl+Aspartate+Amidate+Prodrugs&doi=10.1021%2Facs.jmedchem.7b00416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs</span></div><div class="casAuthors">Luo, Min; Groaz, Elisabetta; Andrei, Graciela; Snoeck, Robert; Kalkeri, Raj; Ptak, Roger G.; Hartman, Tracy; Buckheit, Robert W.; Schols, Dominique; De Jonghe, Steven; Herdewijn, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6220-6238</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleosides contg. a 3-fluoro-2-(phosphonomethoxy)propyl (FPMP) side chain are known to be moderately potent antihuman immunodeficiency virus (HIV) agents, while being completely devoid of antiviral activity against a wide range of DNA viruses.  The derivatization of the phosphonic acid functionality of FPMPs with a diamyl aspartate phenoxyamidate group led to a novel generation of compds. that not only demonstrate drastically improved antiretroviral potency but also are characterized by an expanded spectrum of activity that also covers hepatitis B and herpes viruses.  The best compd., the (S)-FPMPA amidate prodrug, exerts anti-HIV-1 activity in TZM-bl and peripheral blood mononuclear cells at low nanomolar concns. and displays excellent potency against hepatitis B virus (HBV) and varicella-zoster virus (VZV).  This prodrug is stable in acid and human plasma media, but it is efficiently processed in human liver microsomes with a half-life of 2 min.  The (R) isomeric guanine deriv. emerged as a selectively active anti-HIV and anti-HBV inhibitor, while being nontoxic to human hepatoblastoma cells.  Notably, the pyrimidine contg. prodrug (S)-Asp-FPMPC is the only congener within this series to demonstrate micromolar anti-human cytomegalovirus (HCMV) potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGtv8LuFewrVg90H21EOLACvtfcHk0ljdTu_OhT8MRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWksrrI&md5=679f9608498a9ed560ad5f4e90de892b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00416%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DGroaz%26aufirst%3DE.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DKalkeri%26aufirst%3DR.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DHartman%26aufirst%3DT.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DExpanding%2520the%2520Antiviral%2520Spectrum%2520of%25203-Fluoro-2-%2528phosphonomethoxy%2529propyl%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520Diamyl%2520Aspartate%2520Amidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6220%26epage%3D6238%26doi%3D10.1021%2Facs.jmedchem.7b00416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatfield, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Nucleic Acid Related Compounds. 47. Synthesis and Biological Activities of Pyrimidine and Purine “Acyclic” Nucleoside Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1021/jm00377a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00377a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL2MXitVChs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1486-1492&author=M.+J.+Robinsauthor=P.+W.+Hatfieldauthor=J.+Balzariniauthor=E.+De+Clercq&title=Nucleic+Acid+Related+Compounds.+47.+Synthesis+and+Biological+Activities+of+Pyrimidine+and+Purine+%E2%80%9CAcyclic%E2%80%9D+Nucleoside+Analogues&doi=10.1021%2Fjm00377a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleic acid related compounds.  47.  Synthesis and biological activities of pyrimidine and purine "acyclic" nucleoside analogs</span></div><div class="casAuthors">Robins, Morris J.; Hatfield, Peter W.; Balzarini, Jan; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1486-92</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Various acyclic, i.e., (2-hydroxyethoxy)methyl and (2-acetoxyethoxy)methyl, analogs of pyrimidine and purine nucleosides were prepd. and evaluated for their antiviral, antimetabolic, and cytotoxic properties.  All of the pyrimidine analogs, including (E)-5-(2-bromovinyl)-1-[(2-hydroxyethoxy)methyl]uracil and its O-acetyl deriv., were virtually devoid of antiviral, cytotoxic, and antimetabolic activities.  However, several of the 8-substituted derivs. of (I) had higher antiviral specificity in vitro than the parent drug.  The 8-methyl-, 8-bromo-, and 8-iodoacyclovir derivs. have sufficient activities to warrant further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmt5CF0CtvirVg90H21EOLACvtfcHk0lhg4h1Jygbv1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitVChs70%253D&md5=a61f988f585e2499e335c7af36a9a601</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00377a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00377a018%26sid%3Dliteratum%253Aachs%26aulast%3DRobins%26aufirst%3DM.%2BJ.%26aulast%3DHatfield%26aufirst%3DP.%2BW.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DNucleic%2520Acid%2520Related%2520Compounds.%252047.%2520Synthesis%2520and%2520Biological%2520Activities%2520of%2520Pyrimidine%2520and%2520Purine%2520%25E2%2580%259CAcyclic%25E2%2580%259D%2520Nucleoside%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D1486%26epage%3D1492%26doi%3D10.1021%2Fjm00377a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, <i>Plasmodium falciparum</i> and <i>vivax</i> 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1021/jm501416t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501416t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=827-846&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=Z.+Janebaauthor=T.-H.+Wangauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=L.+W.+Guddat&title=Aza-acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+As+Inhibitors+of+the+Human%2C+Plasmodium+falciparum+and+vivax+6-Oxopurine+Phosphoribosyltransferases+and+Their+Prodrugs+As+Antimalarial+Agents&doi=10.1021%2Fjm501416t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, Plasmodium falciparum and vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Janeba, Zlatko; Wang, Tzu-Hsuan; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">827-846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-[xanthine] phosphoribosyltransferase (HG[X]PRT) is considered an important target for antimalarial chemotherapy as it is the only pathway for the synthesis of the purine nucleoside monophosphates required for DNA/RNA prodn.  Thus, inhibition of this enzyme should result in cessation of replication.  The aza-acyclic nucleoside phosphonates (aza-ANPs) are good inhibitors of Plasmodium falciparum HGXPRT (PfHGXPRT), with Ki values as low as 0.08 and 0.01 μM for Plasmodium vivax HGPRT (PvHGPRT).  Prodrugs of these aza-ANPs exhibit antimalarial activity against Pf lines with IC50 values (0.8-6.0 μM) and have low cytotoxicity against human cells.  Crystal structures of six of these compds. in complex with human HGPRT have been detd.  These suggest that the different affinities of these aza-ANPs could be due to the flexibility of the loops surrounding the active site as well as the flexibility of the inhibitors, allowing them to adapt to fit into three binding pockets of the enzyme(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9eXB3S3z3v7Vg90H21EOLACvtfcHk0lhg4h1Jygbv1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF&md5=c7d1dad69f99a1b4928b2a65fa411670</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501416t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501416t%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAza-acyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520As%2520Inhibitors%2520of%2520the%2520Human%252C%2520Plasmodium%2520falciparum%2520and%2520vivax%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Their%2520Prodrugs%2520As%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D827%26epage%3D846%26doi%3D10.1021%2Fjm501416t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Novel <i>N</i>-Branched Acyclic Nucleoside Phosphonates As Potent and Selective Inhibitors of Human, <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> 6-Oxopurine Phosphoribosyltransferases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6209</span>– <span class="NLM_lpage">6223</span>, <span class="refDoi"> DOI: 10.1021/jm300662d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300662d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFSqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6209-6223&author=D.+Hockov%C3%A1author=D.+T.+Keoughauthor=Z.+Janebaauthor=T.-H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Synthesis+of+Novel+N-Branched+Acyclic+Nucleoside+Phosphonates+As+Potent+and+Selective+Inhibitors+of+Human%2C+Plasmodium+falciparum+and+Plasmodium+vivax+6-Oxopurine+Phosphoribosyltransferases&doi=10.1021%2Fjm300662d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Novel N-Branched Acyclic Nucleoside Phosphonates As Potent and Selective Inhibitors of Human, Plasmodium falciparum and Plasmodium vivax 6-Oxopurine Phosphoribosyltransferases</span></div><div class="casAuthors">Hockova, Dana; Keough, Dianne T.; Janeba, Zlatko; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6209-6223</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-(xanthine) phosphoribosyltransferase (HG(X)PRT) is crucial for the survival of malarial parasites Plasmodium falciparum (Pf) and Plasmodium vivax (Pv).  Acyclic nucleoside phosphonates (ANPs), e.g. I, are inhibitors of HG(X)PRT and arrest the growth of Pf in cell culture.  Here, a novel class of ANPs contg. tri-substituted nitrogen (aza-ANPs) has been synthesized.  These compds. have a wide range of Ki values and selectivity for human HGPRT, Pf-HGXPRT, and Pv-HGPRT.  The most selective and potent inhibitor of PfHGXPRT is 9-[N-(3-methoxy-3-oxopropyl)-N-(2-phosphonoethyl)-2-aminoethyl]hypoxanthine (Ki = 100 nM): no inhibition could be detected against the human enzyme.  This compd. exhibits the highest ever reported selectivity for Pf-HGXPRT compared to human HGPRT.  For PvHGPRT, 9-[N-(2-carboxyethyl)-N-(2-phosphonoethyl)-2-aminoethyl]guanine has a Ki of 50 nM, the best inhibitor discovered for this enzyme to date.  Docking of these compds. into the known structures of human HGPRT in complex with ANP-based inhibitors suggests reasons for the variations in affinity, providing insights for the design of antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAXg_dZCN5dLVg90H21EOLACvtfcHk0lhg4h1Jygbv1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFSqu7s%253D&md5=05843608636dee6cb3ef85c937d3cf3f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300662d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300662d%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DSynthesis%2520of%2520Novel%2520N-Branched%2520Acyclic%2520Nucleoside%2520Phosphonates%2520As%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%252C%2520Plasmodium%2520falciparum%2520and%2520Plasmodium%2520vivax%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6209%26epage%3D6223%26doi%3D10.1021%2Fjm300662d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Špaček, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of <i>Plasmodium falciparum</i> and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7539</span>– <span class="NLM_lpage">7554</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCgu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7539-7554&author=P.+%C5%A0pa%C4%8Dekauthor=D.+T.+Keoughauthor=M.+Chavchichauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=L.+W.+Guddatauthor=D.+Hockov%C3%A1&title=Synthesis+and+Evaluation+of+Asymmetric+Acyclic+Nucleoside+Bisphosphonates+as+Inhibitors+of+Plasmodium+falciparum+and+Human+Hypoxanthine-Guanine-%28Xanthine%29+Phosphoribosyltransferase&doi=10.1021%2Facs.jmedchem.7b00926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase</span></div><div class="casAuthors">Spacek, Petr; Keough, Dianne T.; Chavchich, Marina; Dracinsky, Martin; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Guddat, Luke W.; Hockova, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7539-7554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthine-guanine-xanthine phosphoribosyltransferase (PfHGXPRT).  On the basis of this scaffold, a new series of ANbPs was synthesized.  One of these new ANbPs, [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid, exhibited Ki values of 6 and 70 nM for human HGPRT and Pf HGXPRT, resp.  These low Ki values were achieved by inserting an extra carbon atom in the linker connecting the N9 atom of guanine to one of the phosphonate groups.  The crystal structure of this ANbP in complex with human HGPRT was detd. at 2.0 Å resoln. and shows that it fills three key pockets in the active site.  The most potent phosphoramidate prodrugs of these compds. have IC50 values in the low micromolar range in Pf lines and low toxicity in human A549 cells, demonstrating that these ANbPs are excellent antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnSzTuy4-WwrVg90H21EOLACvtfcHk0ljc5-FtP6UYEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCgu7rP&md5=9c47d1dfc40b240ad2c152b3cb542eec</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00926%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Asymmetric%2520Acyclic%2520Nucleoside%2520Bisphosphonates%2520as%2520Inhibitors%2520of%2520Plasmodium%2520falciparum%2520and%2520Human%2520Hypoxanthine-Guanine-%2528Xanthine%2529%2520Phosphoribosyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7539%26epage%3D7554%26doi%3D10.1021%2Facs.jmedchem.7b00926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, S. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and antiviral activities of acyclonucleosides</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570230201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fjhet.5570230201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL28XltlChtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1986&pages=289-319&author=C.+K.+Chuauthor=S.+J.+Cutler&title=Chemistry+and+antiviral+activities+of+acyclonucleosides&doi=10.1002%2Fjhet.5570230201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and antiviral activities of acyclonucleosides</span></div><div class="casAuthors">Chu, Chung K.; Cutler, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-319</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    </div><div class="casAbstract">A review with 212 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrddxV4eb1sg7Vg90H21EOLACvtfcHk0ljc5-FtP6UYEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltlChtrg%253D&md5=3ad93f073fe68af5e18d6310b9c21460</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570230201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570230201%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DCutler%26aufirst%3DS.%2BJ.%26atitle%3DChemistry%2520and%2520antiviral%2520activities%2520of%2520acyclonucleosides%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1986%26volume%3D23%26spage%3D289%26epage%3D319%26doi%3D10.1002%2Fjhet.5570230201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, D. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Acyclic Nucleoside and Nucleotide Analogues from Amino Acids: A Convenient Approach to a PMEA-PMPA Hybrid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5077</span>– <span class="NLM_lpage">5083</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(00)00422-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0040-4020%2800%2900422-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslWks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=5077-5083&author=A.+L.+Jefferyauthor=J.-H.+Kimauthor=D.+F.+Wiemer&title=Synthesis+of+Acyclic+Nucleoside+and+Nucleotide+Analogues+from+Amino+Acids%3A+A+Convenient+Approach+to+a+PMEA-PMPA+Hybrid&doi=10.1016%2FS0040-4020%2800%2900422-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Acyclic Nucleoside and Nucleotide Analogues from Amino Acids: A Convenient Approach to a PMEA-PMPA Hybrid</span></div><div class="casAuthors">Jeffery, A. L.; Kim, J.-H.; Wiemer, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5077-5083</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Non-racemic amino alcs. derived from common amino acids have been used to assemble acyclic nucleoside and nucleotide analogs with control of abs. stereochem.  Both (R)- and (S)-2-amino-1-propanol, readily available from D- or L-alanine, were used to prep. the nucleoside analogs (R)- and (S)-9-[1-methyl-2-hydroxyethyl]adenine, and then the nucleotide analogs (R)- and (S)-9-[1-methyl-2-phosphonomethoxyethyl]adenine.  In a similar fashion, the CBz deriv. of L-threonine was used to prep. first (1R,2R)-9-[1-hydroxymethyl-2-hydroxypropyl]adenine, and then the bis phosphonomethoxy deriv.  The bis phosphonate derived from threonine represents a unique structural hybrid of PMEA and PMPA, both of which have well established antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9xzWkkc7n8LVg90H21EOLACvtfcHk0ljc5-FtP6UYEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslWks70%253D&md5=8a7d82c6dcc825dda3c1f10ba7c5497f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2800%2900422-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252800%252900422-1%26sid%3Dliteratum%253Aachs%26aulast%3DJeffery%26aufirst%3DA.%2BL.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DSynthesis%2520of%2520Acyclic%2520Nucleoside%2520and%2520Nucleotide%2520Analogues%2520from%2520Amino%2520Acids%253A%2520A%2520Convenient%2520Approach%2520to%2520a%2520PMEA-PMPA%2520Hybrid%26jtitle%3DTetrahedron%26date%3D2000%26volume%3D56%26spage%3D5077%26epage%3D5083%26doi%3D10.1016%2FS0040-4020%2800%2900422-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Acyclic nucleoside phosphonates: a key class of antiviral drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1038/nrd1877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fnrd1877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=16264436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=928-940&author=E.+De%0AClercqauthor=A.+Hol%C3%BD&title=Acyclic+nucleoside+phosphonates%3A+a+key+class+of+antiviral+drugs&doi=10.1038%2Fnrd1877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Case history: Acyclic nucleoside phosphonates: a key class of antiviral drugs</span></div><div class="casAuthors">De Clercq, Erik; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Almost 20 years after the broad antiviral activity spectrum of the first acyclic nucleoside phosphonates was described, several of these compds. have become important therapies for DNA virus and retrovirus infections.  Here, we review the discovery and development of acyclic nucleoside phosphonates, focusing on cidofovir and its potential in the treatment of various herpes-, papilloma-, polyoma-, adeno- and pox-virus infections, adefovir for the treatment of hepatitis B and tenofovir for the treatment of AIDS and the prevention of HIV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNefpTEtM7I7Vg90H21EOLACvtfcHk0lgMdeif_YkB4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfI&md5=435eccb35f6ebdf86452f583e9e5fb72</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd1877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1877%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DAcyclic%2520nucleoside%2520phosphonates%253A%2520a%2520key%2520class%2520of%2520antiviral%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D928%26epage%3D940%26doi%3D10.1038%2Fnrd1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span> <span> </span><span class="NLM_article-title">Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">5716</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.12.5716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1073%2Fpnas.74.12.5716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=202961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVanurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=5716-5720&author=G.+B.+Elionauthor=P.+A.+Furmanauthor=J.+A.+Fyfeauthor=P.+De+Mirandaauthor=L.+Beauchampauthor=H.+J.+Schaeffer&title=Selectivity+of+action+of+an+antiherpetic+agent%2C+9-%282-hydroxyethoxymethyl%29guanine&doi=10.1073%2Fpnas.74.12.5716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine</span></div><div class="casAuthors">Elion, Gertrude B.; Furman, Phillip A.; Fyfe, James A.; De Miranda, Paulo; Beauchamp, Lilia; Schaeffer, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5716-20</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Acycloguanosine (I)  [59277-89-3] had potent antiviral activity (ED50 = 0.1 μM) against herpes simplex virus type I.  I was converted to a monophosphate  [66341-16-0] by a virus-specified thymidine kinase  [9002-06-6] and was subsequently converted to I di-  [66341-17-1] and I triphosphates  [66341-18-2].  In the uninfected host cell (Vero), these phosphorylations of I occurred at only a very limited extent.  I triphosphate inhibited herpes simplex virus DNA nucleotidyltransferase  [9012-90-2] 10-30 times more effectively than cellular (HeLa S3) DNA nucleotidyltransferase.  These factors contribute to I selectivity; inhibition of growth of the host cell requires a 3000-fold greater concn. of drug than does the inhibition of viral multiplication.  The identify of the kinase that phosphorylates I was detd. after sepn. of the cellular and virus-specified thymidine kinase activities by affinity chromatog., by reversal studies with thymidine, and by the lack of monophosphate formation in a temp.-sensitive, thymidine kinase-deficient mutant of the KOS strain of herpes simplex virus type 1 (tsA1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4WWPCnssW2bVg90H21EOLACvtfcHk0lgMdeif_YkB4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVanurw%253D&md5=ed4071cc91116c4f97715e203614b005</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.12.5716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.12.5716%26sid%3Dliteratum%253Aachs%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DFyfe%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BMiranda%26aufirst%3DP.%26aulast%3DBeauchamp%26aufirst%3DL.%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26atitle%3DSelectivity%2520of%2520action%2520of%2520an%2520antiherpetic%2520agent%252C%25209-%25282-hydroxyethoxymethyl%2529guanine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1977%26volume%3D74%26spage%3D5716%26epage%3D5720%26doi%3D10.1073%2Fpnas.74.12.5716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P.</span></span> <span> </span><span class="NLM_article-title">9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group.</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/272583a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2F272583a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=205792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXltVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1978&pages=583-585&author=H.+J.+Schaefferauthor=L.+Beauchampauthor=P.+de+Mirandaauthor=G.+B.+Elionauthor=D.+J.+Bauerauthor=P.+Collins&title=9-%282-Hydroxyethoxymethyl%29guanine+activity+against+viruses+of+the+herpes+group.&doi=10.1038%2F272583a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group</span></div><div class="casAuthors">Schaeffer, H. J.; Beauchamp, Lilia; De Miranda, P.; Elion, Gertrude B.; Bauer, D. J.; Collins, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5654</span>),
    <span class="NLM_cas:pages">583-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Of a series of nucleoside analogs synthesized, 9-(2-hydroxyethoxymethyl)guanine (I)  [59277-89-3] had marked antiviral activity with low toxicity in animal models of herpes virus infections.  In mice the oral and i.p. LD50 values for I were >10,000 and 1000 mg/kg, resp.; no toxicity was obsd. in mice given oral I (450 mg/kg) daily for 30 days.  In mice given I, 14C-labeled at the 8-position of the guanine nucleus, 82 and 94% of label was excreted in urine by 4 and 24 h, resp., essentially as unmetabolized I.  No appreciable I binding to plasma or tissues was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3OmyVfempg7Vg90H21EOLACvtfcHk0lgMdeif_YkB4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVSjsr0%253D&md5=383b527f72528e860c4b21f2fdb7fccd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F272583a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F272583a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DL.%26aulast%3Dde%2BMiranda%26aufirst%3DP.%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DBauer%26aufirst%3DD.%2BJ.%26aulast%3DCollins%26aufirst%3DP.%26atitle%3D9-%25282-Hydroxyethoxymethyl%2529guanine%2520activity%2520against%2520viruses%2520of%2520the%2520herpes%2520group.%26jtitle%3DNature%26date%3D1978%26volume%3D272%26spage%3D583%26epage%3D585%26doi%3D10.1038%2F272583a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descamps, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Somer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1126/science.200.4341.563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1126%2Fscience.200.4341.563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=17839440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXkvF2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1978&pages=563-565&author=E.+De%0AClercqauthor=J.+Descampsauthor=P.+De+Somerauthor=A.+Hol%C3%BD&title=%28S%29-9-%282%2C3-Dihydroxypropyl%29adenine%3A+An+Aliphatic+Nucleoside+Analog+with+Broad-Spectrum+Antiviral+Activity&doi=10.1126%2Fscience.200.4341.563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-9-(2,3-Dihydroxypropyl)adenine:  an aliphatic nucleoside analog with broad-spectrum antiviral activity</span></div><div class="casAuthors">De Clercq, Erik; Descamps, Johan; De Somer, Pierre; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">4341</span>),
    <span class="NLM_cas:pages">563-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">(S)-9-(2,3-Dihydroxypropyl)adenine (I)  [54262-83-8], a novel nucleoside analog, the sugar moiety of which is replaced by an aliph. chain, inhibited the replication in vitro of several DNA and RNA viruses, including vaccinia, herpes simplex (types 1 and 2), measles, and vesicular stomatitis.  It was also effective in vivo in reducing the mortality rate of mice inoculated intranasally with vesicular stomatitis virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkW_-BORiddbVg90H21EOLACvtfcHk0liAS4LE41Z3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkvF2qtbk%253D&md5=fdeb3a0d1bf06684d4fd995f6879fae2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.200.4341.563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.200.4341.563%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DDescamps%26aufirst%3DJ.%26aulast%3DDe%2BSomer%26aufirst%3DP.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3D%2528S%2529-9-%25282%252C3-Dihydroxypropyl%2529adenine%253A%2520An%2520Aliphatic%2520Nucleoside%2520Analog%2520with%2520Broad-Spectrum%2520Antiviral%2520Activity%26jtitle%3DScience%26date%3D1978%26volume%3D200%26spage%3D563%26epage%3D565%26doi%3D10.1126%2Fscience.200.4341.563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(99)80090-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0223-5234%2899%2980090-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=405-413&author=S.+Rai%C4%87-Mali%C4%87author=M.+Grdi%C5%A1aauthor=K.+Pavelicauthor=M.+Mintas&title=Synthesis+and+biological+evaluation+of+the+novel+purine+and+pyrimidine+nucleoside+analogues+containing+2%2C3-epoxypropyl%2C+3-amino-2-hydroxypropyl+or+2%2C3-epoxypropyl+ether+moieties&doi=10.1016%2FS0223-5234%2899%2980090-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties</span></div><div class="casAuthors">Raic-Malic, Silvana; Grdisa, Mira; Pavelic, Kresimir; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The novel purine and pyrimidine nucleoside analogs possessing a 2,3-epoxypropyl, 2,3-epoxypropyl ether, or 3-amino-2-hydroxypropyl, e. g. I, moiety bonded at either N-9 of the C-6 substituted purine ring or N-1 and N-3 of the pyrimidine ring, were prepd. and evaluated on their antitumor and antiviral activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD_3d-KqmH7bVg90H21EOLACvtfcHk0liAS4LE41Z3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFert7g%253D&md5=86e152aa98c60f5b73f2b6f97ab9067d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2980090-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252980090-7%26sid%3Dliteratum%253Aachs%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPavelic%26aufirst%3DK.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520novel%2520purine%2520and%2520pyrimidine%2520nucleoside%2520analogues%2520containing%25202%252C3-epoxypropyl%252C%25203-amino-2-hydroxypropyl%2520or%25202%252C3-epoxypropyl%2520ether%2520moieties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D405%26epage%3D413%26doi%3D10.1016%2FS0223-5234%2899%2980090-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prekupec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedružić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazivoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvoš-Sermek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Iodinated and Fluorinated 9-(2-Hydroxypropyl) and 9-(2-Hydroxyethoxy)methyl Purine Nucleoside Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5763</span>– <span class="NLM_lpage">5772</span>, <span class="refDoi"> DOI: 10.1021/jm0308747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0308747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptV2gu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5763-5772&author=S.+Prekupecauthor=D.+Svedru%C5%BEi%C4%87author=T.+Gazivodaauthor=D.+Mrvo%C5%A1-Sermekauthor=A.+Naglauthor=M.+Grdi%C5%A1aauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=G.+Folkersauthor=L.+Scapozzaauthor=M.+Mintasauthor=S.+Rai%C4%87-Mali%C4%87&title=Synthesis+and+Biological+Evaluation+of+Iodinated+and+Fluorinated+9-%282-Hydroxypropyl%29+and+9-%282-Hydroxyethoxy%29methyl+Purine+Nucleoside+Analogues&doi=10.1021%2Fjm0308747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Iodinated and Fluorinated 9-(2-Hydroxypropyl) and 9-(2-Hydroxyethoxy)methyl Purine Nucleoside Analogues</span></div><div class="casAuthors">Prekupec, Svjetlana; Svedruzic, Drazenka; Gazivoda, Tatjana; Mrvos-Sermek, Draginja; Nagl, Ante; Grdisa, Mira; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Folkers, Gerd; Scapozza, Leonardo; Mintas, Mladen; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5763-5772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel fluorinated and iodinated purine derivs. contg. 9-(2-hydroxypropyl) and 9-(2-hydroxyethoxymethyl) side chains were synthesized by a multistep synthetic route involving Baltz-Schiemann's fluorination and diazotation/iodination as key reactions.  An unequivocal proof for the stereostructure of 6-amino-9-[(2-hydroxyethoxy)methyl]-2-iodo-9H-purine was obtained by X-ray structure anal.  New compds. were evaluated for their cytostatic activity against murine leukemia (L1210); mammary carcinoma (FM3A); and human T-lymphocytes (Molt4/C8 and CEM), melanoma (HBL), cervical carcinoma (HeLa), colon carcinoma (HT29 and SW620), laryngeal carcinoma (Hep2), and pancreatic carcinoma (MiaPaCa2) as well as diploid fibroblasts (WI38).  Of all the compds., 9-(2-acetoxypropyl)-2-amino-1,9-dihydro-6H-purin-6-thione (I) showed the most pronounced inhibitory activity against human SW620 cells.  9-[(2-Acetoxyethoxy)methyl]-2-amino-1,9-dihydro-6H-purin-6-thione (II) exhibited the most selective inhibitory activity against human HeLa, Hep2, SW620, and murine L1210 cell proliferation as compared to normal fibroblast (WI38) cell proliferation.  None of the compds. showed inhibitory activities against HIV-1, HIV-2, HSV-1, and HSV-2, vaccinia, vesicular stomatitis, parainfluenza-3, reovirus-1, Sindbis, Coxsackie B4, or respiratory syncytial virus.  The new purine derivs., particularly I and II, appear to demonstrate sufficient cytostatic potency and selectivity to justify further evaluation of their potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWBpV-Y7BwLVg90H21EOLACvtfcHk0liAS4LE41Z3Ug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptV2gu7w%253D&md5=e09236bd61bad05795dac00d6a1a19e2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0308747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0308747%26sid%3Dliteratum%253Aachs%26aulast%3DPrekupec%26aufirst%3DS.%26aulast%3DSvedru%25C5%25BEi%25C4%2587%26aufirst%3DD.%26aulast%3DGazivoda%26aufirst%3DT.%26aulast%3DMrvo%25C5%25A1-Sermek%26aufirst%3DD.%26aulast%3DNagl%26aufirst%3DA.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DMintas%26aufirst%3DM.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Iodinated%2520and%2520Fluorinated%25209-%25282-Hydroxypropyl%2529%2520and%25209-%25282-Hydroxyethoxy%2529methyl%2520Purine%2520Nucleoside%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5763%26epage%3D5772%26doi%3D10.1021%2Fjm0308747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šuman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8126</span>– <span class="NLM_lpage">8138</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2006.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=16889965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8126-8138&author=V.+Kri%C5%A1taforauthor=S.+Rai%C4%87-Mali%C4%87author=M.+Cetinaauthor=M.+Kraljauthor=L.+%C5%A0umanauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=M.+Mintas&title=Synthesis%2C+X-ray+crystal+structural+study%2C+antiviral+and+cytostatic+evaluations+of+the+novel+unsaturated+acyclic+and+epoxide+nucleoside+analogues&doi=10.1016%2Fj.bmc.2006.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues</span></div><div class="casAuthors">Kristafor, Vedran; Raic-Malic, Silvana; Cetina, Mario; Kralj, Marijeta; Suman, Lidija; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8126-8138</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of the novel purine and pyrimidine nucleoside analogs were synthesized in which the sugar moiety was replaced by the 4-amino-2-butenyl (2-6 and 10-18) and oxiranyl (8 and 20) spacer.  The Z- (2-6) and E-isomers (10-18) of unsatd. acyclic nucleoside analogs were synthesized by condensation of 2- and 6-substituted purine and 5-substituted uracil bases with Z- (1) or E-phthalimide (9) precursors.  The oxiranyl nucleoside analogs (8 and 20) were obtained by epoxidn. of 1 and 9 with m-chloroperoxybenzoic acid and subsequent coupling with adenine.  The new compds. were evaluated for their antiviral and antitumor cell activities.  Among the olefinic nucleoside analogs, Z-isomer of adenine contg. 4-amino-2-butenyl side chain (I) exhibited the best cytostatic activities, particularly against colon carcinoma (SW 620, IC50 = 26 μM).  Its E-isomer 15 did not show any antiproliferative activity against malignant tumor cell lines, except for a slight inhibition of colon carcinoma (SW 620, IC50 = 56.5 μM) cells.  In general, Z-isomers showed better cytostatic activities than the corresponding E-isomers.  (Z)-4-Amino-2-butenyl-adenine nucleoside analog I showed albeit modest but selective activity against HIV-1 (EC50 = 4.83 μg mL-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpswH9DmWXbCrVg90H21EOLACvtfcHk0lhhkdgkFwCg4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLfE&md5=9e90bffbbfe9f50e8df2a2c0d78332a7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DKralj%26aufirst%3DM.%26aulast%3D%25C5%25A0uman%26aufirst%3DL.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520X-ray%2520crystal%2520structural%2520study%252C%2520antiviral%2520and%2520cytostatic%2520evaluations%2520of%2520the%2520novel%2520unsaturated%2520acyclic%2520and%2520epoxide%2520nucleoside%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8126%26epage%3D8138%26doi%3D10.1016%2Fj.bmc.2006.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratulić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytostatic and anti-viral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (<i>Z</i>)-4-amino-2-butenyl moiety</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1007/s00044-010-9318-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs00044-010-9318-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1ertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=280-286&author=K.+Wittineauthor=K.+Benciauthor=S.+Kraljevi%C4%87+Paveli%C4%87author=K.+Paveli%C4%87author=S.+Bratuli%C4%87author=K.+Hockauthor=J.+Balzariniauthor=M.+Mintas&title=Synthesis%2C+cytostatic+and+anti-viral+activity+evaluation+of+the+novel+acyclic+nucleoside+analogues+containing+a+sterically+constrained+%28Z%29-4-amino-2-butenyl+moiety&doi=10.1007%2Fs00044-010-9318-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytostatic and anti-viral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (Z)-4-amino-2-butenyl moiety</span></div><div class="casAuthors">Wittine, Karlo; Benci, Kresimir; Kraljevic Pavelic, Sandra; Pavelic, Kresimir; Bratulic, Sinisa; Hock, Karlo; Balzarini, Jan; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-286</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A series of the novel pyrimidine I and II [R1 = CH2CH:CHCH2NH2-(Z), R5 = H, Me] and purine III [R2 = H, NH2, R6 = NH2, R9 = CH2CH:CHCH2NH2; R2 = NH2, R6 = Cl, R9 = CH2CH:CHCH2NH2.HCl-(Z); R2 = NH2, R6 = NH2, R9 = (CH2)2NH2; R2 = H, R6 = 1-pyrrolyl, R9 = (CH2)4NH2.HCl] and IV [R2 = H, NH2, R9 = CH2CH:CHCH2NH2.HCl-(Z)] acyclic nucleoside analogs in which the sugar moiety was replaced by a sterically constrained Z-4-amino-, 4-aminohydrochloride-2-butenyl, or aliph. 4-aminohydrochloride-2-Bu moiety was synthesized and evaluated for their anti-viral and cytostatic activity potency.  Cytostatic evaluation of the novel compds. on selected panel of human tumor-cell lines showed that the majority of compds. exerted a non-specific anti-proliferative effect at the highest tested concn. (i.e. 1 × 10-4 M) against all cell lines.  Nevertheless, a rather moderate but selective anti-proliferative effects on HeLa cell cultures in comparison to normal fibroblasts WI 38, were obsd. for compds. III [R2 = NH2, R6 = Cl, R9 = CH2CH:CHCH2NH2.HCl-(Z); R2 = H, R6 = 1-pyrrolyl, R9 = (CH2)4NH2.HCl].  No anti-viral activity was obsd., except for compds. I [R1 = CH2CH:CHCH2NH2-(Z), R5 = H, Me], II [R1 = CH2CH:CHCH2NH2-(Z), R5 = Me] and IV [R2 = NH2, R9 = CH2CH:CHCH2NH2.HCl-(Z)] that showed anti-HIV activity at 50% effective concn. ranging between 10 and 96 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsjsp6bhYR7Vg90H21EOLACvtfcHk0lhhkdgkFwCg4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1ertLc%253D&md5=cc2db30af924c431bb5377d8380fc1a5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00044-010-9318-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-010-9318-1%26sid%3Dliteratum%253Aachs%26aulast%3DWittine%26aufirst%3DK.%26aulast%3DBenci%26aufirst%3DK.%26aulast%3DKraljevi%25C4%2587%2BPaveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBratuli%25C4%2587%26aufirst%3DS.%26aulast%3DHock%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520cytostatic%2520and%2520anti-viral%2520activity%2520evaluation%2520of%2520the%2520novel%2520acyclic%2520nucleoside%2520analogues%2520containing%2520a%2520sterically%2520constrained%2520%2528Z%2529-4-amino-2-butenyl%2520moiety%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2011%26volume%3D20%26spage%3D280%26epage%3D286%26doi%3D10.1007%2Fs00044-010-9318-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meščić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klobučar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glavač, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides.</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SlsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1150-1155&author=A.+Me%C5%A1%C4%8Di%C4%87author=A.+Harejauthor=M.+Klobu%C4%8Darauthor=D.+Glava%C4%8Dauthor=M.+Cetinaauthor=S.+K.+Paveli%C4%87author=S.+Rai%C4%87-Mali%C4%87&title=Discovery+of+New+Acid+Ceramidase-Targeted+Acyclic+5-Alkynyl+and+5-Heteroaryl+Uracil+Nucleosides.&doi=10.1021%2Facsmedchemlett.5b00298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new acid ceramidase-targeted acyclic 5-alkynyl and 5-heteroaryl uracil nucleosides</span></div><div class="casAuthors">Mescic, Andrijana; Harej, Anja; Klobucar, Marko; Glavac, Danijel; Cetina, Mario; Pavelic, Sandra Kraljevic; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1150-1155</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel N-acyclic uracil analogs with linear, branched, arom., and cyclopropyl-alkynyl as well as heteroaryl moieties at C-5 were prepd. using palladium catalyzed Sonogashira and Stille cross-coupling and evaluated against malignant tumor cell lines.  C-5-Furan-2-yl uracil deriv. (I) was shown to be more potent against MCF-7 than the ref. drug 5-fluorouracil (5-FU), while C-5-alkynyl uracil derivs. (II) (R1 = p-pentyl-C6H4 and cyclopropyl) exhibited antibreast cancer activities comparable to 5-FU.  Selected compds. induced cell death, partially due to apoptosis, of MCF-7 breast cancer cells.  Abrogation of acid ceramidase (ASAH1) expression of II (R1 = p-pentyl-C6H4 and cyclopropyl) indicated that these compds. could perturb ASAH1-mediated sphingolipid signaling.  The selective activity of II (R1 = p-pentyl-C6H4 and cyclopropyl) against breast cancer cells via the ASAH1-mediated signaling, as a mol. target, might have a great advantage for potential future therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJrjivXVrsErVg90H21EOLACvtfcHk0lhhkdgkFwCg4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SlsbvN&md5=0bbee8a604043417877e7f88992aba49</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00298%26sid%3Dliteratum%253Aachs%26aulast%3DMe%25C5%25A1%25C4%258Di%25C4%2587%26aufirst%3DA.%26aulast%3DHarej%26aufirst%3DA.%26aulast%3DKlobu%25C4%258Dar%26aufirst%3DM.%26aulast%3DGlava%25C4%258D%26aufirst%3DD.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DS.%2BK.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520New%2520Acid%2520Ceramidase-Targeted%2520Acyclic%25205-Alkynyl%2520and%25205-Heteroaryl%2520Uracil%2520Nucleosides.%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1150%26epage%3D1155%26doi%3D10.1021%2Facsmedchemlett.5b00298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvořáková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votruba, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and cytostatic activity of nucleosides and acyclic nucleoside analogues derived from 6-(trifluoromethyl)purines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11109</span>– <span class="NLM_lpage">11118</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(99)00615-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0040-4020%2899%2900615-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaK1MXls12qtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=11109-11118&author=D.+Hockov%C3%A1author=M.+Hocekauthor=H.+Dvo%C5%99%C3%A1kov%C3%A1author=I.+Votruba&title=Synthesis+and+cytostatic+activity+of+nucleosides+and+acyclic+nucleoside+analogues+derived+from+6-%28trifluoromethyl%29purines&doi=10.1016%2FS0040-4020%2899%2900615-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and cytostatic activity of nucleosides and acyclic nucleoside analogues derived from 6-(trifluoromethyl)purines</span></div><div class="casAuthors">Hockova, Dana; Hocek, Michal; Dvorakova, Hana; Votruba, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11109-11118</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Glycosylation and alkylation of 6-(trifluoromethyl)purine by several protected halogenoses or hydroxyalkyl chlorides afforded regio- and stereoselectively the 9-β-nucleosides or 9-alkylated purine derivs. in good yields.  Deprotection of these intermediates gave a series of nucleoside (β-D-ribofuranosyl, 2-deoxy-β-D-ribofuranosyl and β-D-arabinofuranosyl) and acyclonucleoside (2,3-dihydroxypropyl and (2-hydroxyethyl)oxymethyl) derivs. of 6-(trifluoromethyl)purine.  While 9-(β-D-ribofuranosyl)-6-(trifluoromethyl)purine showed significant cytostatic activity, the other derivs. were inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUwDWNqib82rVg90H21EOLACvtfcHk0lhryOy94Lcpdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls12qtLw%253D&md5=eddd6caa8b03f469e815b51a2e84b3ef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900615-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900615-8%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHocek%26aufirst%3DM.%26aulast%3DDvo%25C5%2599%25C3%25A1kov%25C3%25A1%26aufirst%3DH.%26aulast%3DVotruba%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520cytostatic%2520activity%2520of%2520nucleosides%2520and%2520acyclic%2520nucleoside%2520analogues%2520derived%2520from%25206-%2528trifluoromethyl%2529purines%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D11109%26epage%3D11118%26doi%3D10.1016%2FS0040-4020%2899%2900615-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prekupec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalokira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Comparative Cytostatic Activity of the New N-7 Acyclic Purine Nucleoside Analogues with Natural N-9 Regioisomers</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.3987/COM-04-10320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.3987%2FCOM-04-10320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs12qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=787-796&author=S.+Prekupecauthor=B.+Kalokiraauthor=M.+Grdi%C5%A1aauthor=K.+Paveli%C4%87author=E.+De+Clercqauthor=M.+Mintasauthor=S.+Rai%C4%87-Mali%C4%87&title=Synthesis+and+Comparative+Cytostatic+Activity+of+the+New+N-7+Acyclic+Purine+Nucleoside+Analogues+with+Natural+N-9+Regioisomers&doi=10.3987%2FCOM-04-10320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and comparative cytostatic activity of the new N-7 acyclic purine nucleoside analogues with natural N-9 regioisomers</span></div><div class="casAuthors">Prekupec, Svjetlana; Kalokira, Blanka; Grdisa, Mira; Pavelic, Kresimir; De Clereq, Erik; Mintas, Mladen; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The synthesis of purine derivs. alkylated at N-7 and N-9 with 2-acetoxyethoxymethyl side chain, and chem. transformations of keto to chloro, chloro to thio at C-6, and amino to fluoro derivs. at the C-2 position of the purine ring were described.  The N-7 regioisomers were evaluated for their cytostatic activities and their inhibitory effects were compared with those of the corresponding N-9 isomers.  A 2-aminopurine-6-thione showed the highest cytostatic activity, particularly against murine leukemia (L1210).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V1OWLKCfsrVg90H21EOLACvtfcHk0lhryOy94Lcpdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs12qsro%253D&md5=2a4ea50dc0ef304339069daaef41c590</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3987%2FCOM-04-10320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-04-10320%26sid%3Dliteratum%253Aachs%26aulast%3DPrekupec%26aufirst%3DS.%26aulast%3DKalokira%26aufirst%3DB.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Comparative%2520Cytostatic%2520Activity%2520of%2520the%2520New%2520N-7%2520Acyclic%2520Purine%2520Nucleoside%2520Analogues%2520with%2520Natural%2520N-9%2520Regioisomers%26jtitle%3DHeterocycles%26date%3D2005%26volume%3D65%26spage%3D787%26epage%3D796%26doi%3D10.3987%2FCOM-04-10320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazivoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plavec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratulić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević-Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5624</span>– <span class="NLM_lpage">5634</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2008.03.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=18424155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5624-5634&author=T.+Gazivodaauthor=S.+Rai%C4%87-Mali%C4%87author=V.+Kri%C5%A1taforauthor=D.+Makucauthor=J.+Plavecauthor=S.+Bratuli%C4%87author=S.+Kraljevi%C4%87-Paveli%C4%87author=K.+Paveli%C4%87author=L.+Naesensauthor=G.+Andreiauthor=R.+Snoeckauthor=J.+Balzariniauthor=M.+Mintas&title=Synthesis%2C+cytostatic+and+anti-HIV+evaluations+of+the+new+unsaturated+acyclic+C-5+pyrimidine+nucleoside+analogues&doi=10.1016%2Fj.bmc.2008.03.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues</span></div><div class="casAuthors">Gazivoda, Tatjana; Raic-Malic, Silvana; Kristafor, Vedran; Makuc, Damjan; Plavec, Janez; Bratulic, Sinisa; Kraljevic-Pavelic, Sandra; Pavelic, Kresimir; Naesens, Lieve; Andrei, Graciela; Snoeck, Robert; Balzarini, Jan; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5624-5634</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of the novel C-5 alkynyl pyrimidine nucleoside analogs (1-14) in which the sugar moiety was replaced by the conformationally restricted Z- and E-2-butenyl spacer between the phthalimido and pyrimidine ring were synthesized by using Sonogashira cross-coupling reaction.  Cytostatic activity evaluation of the novel compds. showed that E-isomers exhibited, in general, better cytostatic activities than the corresponding Z-isomers.  E-isomer 14 exhibited the best cytostatic effect against all evaluated malignant cell lines, particularly against hepatocellular carcinoma (Hep G2, IC50 = 4.3 μM).  However, this compd. was also cytotoxic to human normal fibroblasts (WI 38).  Its Z-isomer 7 showed highly specific antiproliferative activity against Hep G2 (IC50 = 18 μM) and no cytotoxicity to WI 38.  Moreover, compds. 3, 4 and 14 expressed some marginal inhibitory activity against HIV-1 and HIV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1zT3PvEBHArVg90H21EOLACvtfcHk0lhryOy94Lcpdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVamsrY%253D&md5=6748d33614a42401a94dc61462a71a22</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.074%26sid%3Dliteratum%253Aachs%26aulast%3DGazivoda%26aufirst%3DT.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DMakuc%26aufirst%3DD.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DBratuli%25C4%2587%26aufirst%3DS.%26aulast%3DKraljevi%25C4%2587-Paveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520cytostatic%2520and%2520anti-HIV%2520evaluations%2520of%2520the%2520new%2520unsaturated%2520acyclic%2520C-5%2520pyrimidine%2520nucleoside%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5624%26epage%3D5634%26doi%3D10.1016%2Fj.bmc.2008.03.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kode, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phadtare, S.</span></span> <span> </span><span class="NLM_article-title">N9- and N7-(Chloromethyl Phenymethyl)Chloropurine Derivatives from α, α’-Dichloroxylenes: Synthesis and Anticancer Activity.</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1007/s00044-006-0150-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs00044-006-0150-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=445-474&author=L.+Chenauthor=N.+Kodeauthor=D.+Murthyauthor=S.+Phadtare&title=N9-+and+N7-%28Chloromethyl+Phenymethyl%29Chloropurine+Derivatives+from+%CE%B1%2C+%CE%B1%E2%80%99-Dichloroxylenes%3A+Synthesis+and+Anticancer+Activity.&doi=10.1007%2Fs00044-006-0150-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00044-006-0150-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-006-0150-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKode%26aufirst%3DN.%26aulast%3DMurthy%26aufirst%3DD.%26aulast%3DPhadtare%26aufirst%3DS.%26atitle%3DN9-%2520and%2520N7-%2528Chloromethyl%2520Phenymethyl%2529Chloropurine%2520Derivatives%2520from%2520%25CE%25B1%252C%2520%25CE%25B1%25E2%2580%2599-Dichloroxylenes%253A%2520Synthesis%2520and%2520Anticancer%2520Activity.%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2005%26volume%3D14%26spage%3D445%26epage%3D474%26doi%3D10.1007%2Fs00044-006-0150-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Džolić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergold-Brundić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvoš-Sermek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgemeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Structural Studies, and Biological Evaluation of Some Purine Substituted 1-Aminocyclopropane-1-carboxylic Acids and 1-Amino-1-hydroxymethylcyclopropanes</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1081/NCN-120022029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1081%2FNCN-120022029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=12885120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFaks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=373-389&author=Z.+D%C5%BEoli%C4%87author=V.+Kri%C5%A1taforauthor=M.+Cetinaauthor=A.+Naglauthor=A.+Hergold-Brundi%C4%87author=D.+Mrvo%C5%A1-Sermekauthor=T.+Burgemeisterauthor=M.+Grdi%C5%A1aauthor=N.+Sladeauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=M.+Mintas&title=Synthesis%2C+Structural+Studies%2C+and+Biological+Evaluation+of+Some+Purine+Substituted+1-Aminocyclopropane-1-carboxylic+Acids+and+1-Amino-1-hydroxymethylcyclopropanes&doi=10.1081%2FNCN-120022029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, structural studies, and biological evaluation of some purine substituted 1-aminocyclopropane-1-carboxylic acids and 1-amino-1-hydroxymethylcyclopropanes</span></div><div class="casAuthors">Dzolic, Zoran; Kristafor, Vedran; Cetina, Mario; Nagl, Ante; Hergold-Brundic, Antonija; Mrvos-Sermek, Draginja; Burgemeister, Thomas; Grdisa, Mira; Slade, Neda; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-389</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The novel purine derivs. of 1-aminocyclopropane-1-carboxylic acid and 1-amino-1-hydroxymethylcyclopropane with methylene spacer between the base and the cyclopropane ring were prepd. by multistep synthetic route involving alkylation of adenine and 6-(N-pyrrolyl)purine with a 2-hydroxymethyl-1-aminocyclopropane-1-carboxylic acid deriv. as a key reaction.  All novel compds. were racemic.  The N-9 substitution of the purine ring and the Z-configuration of the cyclopropane ring were deduced from their 1H and 13C NMR spectra by analyses of chem. shifts, H-H coupling consts. and connectivities in two-dimensional homo- and heteronuclear correlation spectra.  An unequivocal proof of the stereostructure of was obtained by their x-ray structure anal.  The novel compds. were evaluated on cytostatic and antiviral activities in several cell lines.  The 6-(N-pyrrolyl)purine deriv. of 1,2-aminocyclopropane alc. I exhibited a more pronounced inhibitory activity against the proliferation of cervical carcinoma (HeLa) and human fibroblast (WI-38) cells than other types of tumor cell lines.  None of the compds. showed inhibitory activities against cytomegalovirus, varicella-zoster virus or other viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJlt345DmlO7Vg90H21EOLACvtfcHk0lhbXO6K7X6HDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFaks7k%253D&md5=fad1133111da2e60e304d2acf0c2f0a9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1081%2FNCN-120022029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120022029%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C5%25BEoli%25C4%2587%26aufirst%3DZ.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DNagl%26aufirst%3DA.%26aulast%3DHergold-Brundi%25C4%2587%26aufirst%3DA.%26aulast%3DMrvo%25C5%25A1-Sermek%26aufirst%3DD.%26aulast%3DBurgemeister%26aufirst%3DT.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DSlade%26aufirst%3DN.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520Structural%2520Studies%252C%2520and%2520Biological%2520Evaluation%2520of%2520Some%2520Purine%2520Substituted%25201-Aminocyclopropane-1-carboxylic%2520Acids%2520and%25201-Amino-1-hydroxymethylcyclopropanes%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2003%26volume%3D22%26spage%3D373%26epage%3D389%26doi%3D10.1081%2FNCN-120022029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">The unsaturated acyclic nucleoside analogues bearing a sterically constrained (<i>Z</i>)-4’-benzamido-2’-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6249</span>– <span class="NLM_lpage">6257</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2010.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=20696582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKgsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6249-6257&author=K.+Benciauthor=K.+Wittineauthor=M.+Radanauthor=M.+Cetinaauthor=M.+Sedi%C4%87author=S.+Kraljevi%C4%87+Paveli%C4%87author=K.+Paveli%C4%87author=E.+De+Clercqauthor=M.+Mintas&title=The+unsaturated+acyclic+nucleoside+analogues+bearing+a+sterically+constrained+%28Z%29-4%E2%80%99-benzamido-2%E2%80%99-butenyl+moiety%3A+Synthesis%2C+X-ray+crystal+structure+study%2C+cytostatic+and+antiviral+activity+evaluations.&doi=10.1016%2Fj.bmc.2010.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations</span></div><div class="casAuthors">Benci, Kresimir; Wittine, Karlo; Radan, Malajka; Cetina, Mario; Sedic, Mirela; Kraljevic Pavelic, Sandra; Pavelic, Kresimir; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6249-6257</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of the novel acyclic unsatd. pyrimidine (1-12) and adenine (13) nucleoside analogs bearing conformationally restricted (Z)-2'-butenyl moiety were synthesized and evaluated for their antiviral and cytostatic activity potency against malignant tumor cell lines and normal human fibroblast (WI38).  The N-1 and/or N-3 acyclic side chain substitution in pyrimidine ring in N-3 substituted 5-trifluoromethyluracil deriv. (11), N-1, N-3 disubstituted 5-fluorouracil deriv. (12) and adenine deriv. (13) was deduced from their 1H and 13C NMR spectra and confirmed by single crystal x-ray structure anal.  The x-ray crystal structure anal. 11-13 revealed also supramol. self-assemblies, in which infinite chains or dimers built two- and three-dimensional networks.  The results of the in vitro cytostatic activity evaluations of 1-13 indicate that the majority of the compds. tested exhibited a non-specific and moderate antiproliferative effect at the highest concn. (100 μM).  Of all evaluated compds. on the cell lines tested only the N-1 4''-fluoro-substituted-benzamide uracil deriv. (7) showed rather marked and selective inhibitory activity against the growth of MCF-7 cells at a concn. of 2.7 μM and no cytotoxic effect on normal fibroblasts WI38.  This compd. can be therefore considered as a potential antitumor lead compd. for further synthetic structure modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokB0fgu_nuQrVg90H21EOLACvtfcHk0lhbXO6K7X6HDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKgsLbN&md5=3df07c6c7468114c8279729e3aa2a1e6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DBenci%26aufirst%3DK.%26aulast%3DWittine%26aufirst%3DK.%26aulast%3DRadan%26aufirst%3DM.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DSedi%25C4%2587%26aufirst%3DM.%26aulast%3DKraljevi%25C4%2587%2BPaveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DThe%2520unsaturated%2520acyclic%2520nucleoside%2520analogues%2520bearing%2520a%2520sterically%2520constrained%2520%2528Z%2529-4%25E2%2580%2599-benzamido-2%25E2%2580%2599-butenyl%2520moiety%253A%2520Synthesis%252C%2520X-ray%2520crystal%2520structure%2520study%252C%2520cytostatic%2520and%2520antiviral%2520activity%2520evaluations.%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6249%26epage%3D6257%26doi%3D10.1016%2Fj.bmc.2010.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meščić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novaković, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmanović, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Završnik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ametamey, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5104</span>– <span class="NLM_lpage">5124</span>, <span class="refDoi"> DOI: 10.3390/molecules18055104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.3390%2Fmolecules18055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23644977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFCqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=5104-5124&author=A.+Me%C5%A1%C4%8Di%C4%87author=S.+Kri%C5%A1taforauthor=I.+Novakovi%C4%87author=A.+Osmanovi%C4%87author=U.+M%C3%BCllerauthor=D.+Zavr%C5%A1nikauthor=S.+M.+Ametameyauthor=L.+Scapozzaauthor=S.+Rai%C4%87-Mali%C4%87&title=C-5+hydroxyethyl+and+hydroxypropyl+acyclonucleosides+as+substrates+for+thymidine+kinase+of+herpes+simplex+virus+type+1+%28HSV-1+TK%29%3A+syntheses+and+biological+evaluation&doi=10.3390%2Fmolecules18055104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation</span></div><div class="casAuthors">Mescic, Andrijana; Kristafor, Svjetlana; Novakovic, Ivana; Osmanovic, Amar; Muller, Ursina; Zavrsnik, Davorka; Ametamey, Simon M.; Scapozza, Leonardo; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5104-5124</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The efficient synthesis of 5-(2-hydroxyethyl)- and 5-(3-hydroxypropyl)-substituted pyrimidine derivs. bearing 2,3-dihydroxypropyl, acyclovir-, ganciclovir- and penciclovir-like side chains are reported.  A synthetic approach that included the alkylation of an N-anion 5-substituted pyrimidine intermediate provided the target acyclonucleosides in significantly higher overall yields in comparison to those obtained by another method using a silylation reaction.  The phosphorylation assays of novel compds. as potential substrates for thymidine kinase of human herpesvirus (herpes simplex virus type 1 HSV-1 TK) showed that solely pyrimidine 5-substituted acyclonucleosides with a penciclovir-like side chain acted as a fraudulent substrates of HSV-1 TK.  Moreover, a uracil deriv. with penciclovir-like side chain with less bulky 2-hydroxyethyl substituent at C-5 proved to be a better substrate than the corresponding one with a 3-hydroxypropyl substituent.  Therefore, this acyclonucleoside was selected as a lead compd. for the development of a positron emission tomog. HSV-1 TK activity imaging agent.  The title compds. thus formed included 5-(2-hydroxyethyl)-1-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-2,4(1H,3H)-pyrimidinedione (I) and related substances.  The synthesis of the target compds. was achieved using 2,4-dimethoxy-5-pyrimidineethanol 5-acetate, 5-(2-hydroxyethyl)-2,4(1H,3H)-pyrimidinedione, 5-(3-hydroxypropyl)-2,4(1H,3H)-pyrimidinedione as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUgfC3czriyrVg90H21EOLACvtfcHk0lgoTTmHs1Yydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFCqsLk%253D&md5=9ec093a32fe5481c2410989f9f655352</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18055104%26sid%3Dliteratum%253Aachs%26aulast%3DMe%25C5%25A1%25C4%258Di%25C4%2587%26aufirst%3DA.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DS.%26aulast%3DNovakovi%25C4%2587%26aufirst%3DI.%26aulast%3DOsmanovi%25C4%2587%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DZavr%25C5%25A1nik%26aufirst%3DD.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DC-5%2520hydroxyethyl%2520and%2520hydroxypropyl%2520acyclonucleosides%2520as%2520substrates%2520for%2520thymidine%2520kinase%2520of%2520herpes%2520simplex%2520virus%2520type%25201%2520%2528HSV-1%2520TK%2529%253A%2520syntheses%2520and%2520biological%2520evaluation%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D5104%26epage%3D5124%26doi%3D10.3390%2Fmolecules18055104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.-M.</span></span> <span> </span><span class="NLM_article-title">The development for the synthesis of chiral acyclic nucleosides and their phosphonates</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7156</span>– <span class="NLM_lpage">7166</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.tetlet.2014.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWhsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=7156-7166&author=M.-S.+Xieauthor=H.-Y.+Niuauthor=G.-R.+Quauthor=H.-M.+Guo&title=The+development+for+the+synthesis+of+chiral+acyclic+nucleosides+and+their+phosphonates&doi=10.1016%2Fj.tetlet.2014.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The development for the synthesis of chiral acyclic nucleosides and their phosphonates</span></div><div class="casAuthors">Xie, Ming-Sheng; Niu, Hong-Ying; Qu, Gui-Rong; Guo, Hai-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7156-7166</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyclic nucleosides and their phosphonates possess significantly antiviral and cytostatic activities.  For acyclic nucleosides and their phosphonates, the introduction of a chiral group to their side chain or the abs. configuration of the chiral atom could affect their biol. activities obviously.  Thus, the asym. synthesis of chiral acyclic nucleosides and their phosphonates has received continuous attention.  The previous reports mainly focus on employing the chiral pool and chiral auxiliary methods for the synthesis of chiral acyclic nucleosides and their phosphonates.  In contrast, the asym. catalysis methods for the synthesis of acyclic nucleosides and their phosphonates are still in the beginning.  This digest paper will serve to highlight the significant progress that has been made in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok80l9iLj3SLVg90H21EOLACvtfcHk0lgoTTmHs1Yydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWhsbnI&md5=0a6d43469d951ef320fdba5e1624ce0a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DM.-S.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DQu%26aufirst%3DG.-R.%26aulast%3DGuo%26aufirst%3DH.-M.%26atitle%3DThe%2520development%2520for%2520the%2520synthesis%2520of%2520chiral%2520acyclic%2520nucleosides%2520and%2520their%2520phosphonates%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D7156%26epage%3D7166%26doi%3D10.1016%2Fj.tetlet.2014.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, T.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.-R.</span></span> <span> </span><span class="NLM_article-title">Highly Enantioselective Synthesis of Designed Chiral Acyclonucleosides and Acyclonucleotides by Organocatalytic Aza-Michael Addition</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4095</span>– <span class="NLM_lpage">4098</span>, <span class="refDoi"> DOI: 10.1002/chem.201100435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fchem.201100435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=21387438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=4095-4098&author=H.-M.+Guoauthor=T.-F.+Yuanauthor=H.-Y.+Niuauthor=J.-Y.+Liuauthor=R.-Z.+Maoauthor=D.-Y.+Liauthor=G.-R.+Qu&title=Highly+Enantioselective+Synthesis+of+Designed+Chiral+Acyclonucleosides+and+Acyclonucleotides+by+Organocatalytic+Aza-Michael+Addition&doi=10.1002%2Fchem.201100435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Synthesis of Designed Chiral Acyclonucleosides and Acyclonucleotides by Organo-Catalytic Aza-Michael Addition</span></div><div class="casAuthors">Guo, Hai-Ming; Yuan, Teng-Fei; Niu, Hong-Ying; Liu, Jin-Ying; Mao, Run-Ze; Li, De-Yang; Qu, Gui-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4095-4098, S4095/1-S4095/46</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Acyclonucleosides, e.g. I, and acyclonucleotides were prepd. via organo-catalytic asym. aza-Michael addn. of purine bases with α,β-unsatd. aldehydes in high yields (82-89%) and up to 99% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUkIMrONEdLrVg90H21EOLACvtfcHk0lgoTTmHs1Yydg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVShtro%253D&md5=753e20c7b16f651eb3032ce96297c105</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fchem.201100435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201100435%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.-M.%26aulast%3DYuan%26aufirst%3DT.-F.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DMao%26aufirst%3DR.-Z.%26aulast%3DLi%26aufirst%3DD.-Y.%26aulast%3DQu%26aufirst%3DG.-R.%26atitle%3DHighly%2520Enantioselective%2520Synthesis%2520of%2520Designed%2520Chiral%2520Acyclonucleosides%2520and%2520Acyclonucleotides%2520by%2520Organocatalytic%2520Aza-Michael%2520Addition%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D4095%26epage%3D4098%26doi%3D10.1002%2Fchem.201100435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">Regio- and Enantioselective Allylic Amination of Aliphatic MBH Adducts with N-Heteroaromatics</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1430</span>, <span class="refDoi"> DOI: 10.1002/chem.201704772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fchem.201704772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=29125647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVejsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1425-1430&author=H.+Wangauthor=L.+Yuauthor=M.+Xieauthor=J.+Wuauthor=G.+Quauthor=K.+Dingauthor=H.+Guo&title=Regio-+and+Enantioselective+Allylic+Amination+of+Aliphatic+MBH+Adducts+with+N-Heteroaromatics&doi=10.1002%2Fchem.201704772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Regio- and Enantioselective Allylic Amination of Aliphatic MBH Adducts with N-Heteroaromatics</span></div><div class="casAuthors">Wang, Haixia; Yu, Lulu; Xie, Mingsheng; Wu, Jiang; Qu, Guirong; Ding, Kuiling; Guo, Haiming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1425-1430</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palladium-catalyzed regio- and enantioselective allylic amination of aliph. Morita-Baylis-Hillman (MBH) adducts with N-heteroarom. nucleophiles (e.g., benzimidazole, 4,5-diphenylimidazole, benzotriazole, and purines) was achieved by using a spiroketal-based diphosphine (SKP) ligand, and afforded a range of chiral, branched N-allyl products with high selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4zBGLU0fm5bVg90H21EOLACvtfcHk0lgWbhsxSsx4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVejsb7E&md5=14a954cd46ddbb81614567efad9b30b9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fchem.201704772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201704772%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DRegio-%2520and%2520Enantioselective%2520Allylic%2520Amination%2520of%2520Aliphatic%2520MBH%2520Adducts%2520with%2520N-Heteroaromatics%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26spage%3D1425%26epage%3D1430%26doi%3D10.1002%2Fchem.201704772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10329</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01268</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10329-1033&author=P.+Zhouauthor=Y.+Liuauthor=L.+Zhouauthor=K.+Zhuauthor=K.+Fengauthor=H.+Zhangauthor=Y.+Liangauthor=H.+Jiangauthor=C.+Luoauthor=M.+Liuauthor=Y.+Wang&title=Potent+Antitumor+Activities+and+Structure+Basis+of+the+Chiral+%CE%B2-Lactam+Bridged+Analogue+of+Combretastatin+A-4+Binding+to+Tubulin&doi=10.1021%2Facs.jmedchem.6b01268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin</span></div><div class="casAuthors">Zhou, Pengfei; Liu, Yan; Zhou, Lu; Zhu, Kongkai; Feng, Kechang; Zhang, Hao; Liang, Yuru; Jiang, Hualiang; Luo, Cheng; Liu, Mingming; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10329-10334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of chiral β-lactam bridged analogs (3-substituted 1,4-diaryl-2-azetidinones) of combretastatin A-4 (CA-4) were synthesized asym., and their antitumor activities were evaluated in vitro and in vivo.  The cocrystal structure of tubulin in complex with compd. I was detd. by X-ray crystallog., which showed that I binds to the same site as colchicine with similar binding mode, and the abs. configuration of its C-4 was first identified and demonstrated to be critically important for their antiproliferative activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosyMxgxjmUxbVg90H21EOLACvtfcHk0lgWbhsxSsx4oA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7zF&md5=e45dbe3b36f2ef6698895cb0933fd6be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01268%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPotent%2520Antitumor%2520Activities%2520and%2520Structure%2520Basis%2520of%2520the%2520Chiral%2520%25CE%25B2-Lactam%2520Bridged%2520Analogue%2520of%2520Combretastatin%2520A-4%2520Binding%2520to%2520Tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10329%26epage%3D1033%26doi%3D10.1021%2Facs.jmedchem.6b01268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00736</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00736" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1als77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6765-6784&author=J.+Zhangauthor=J.+Zhangauthor=G.+Haoauthor=W.+Xinauthor=F.+Yangauthor=M.+Zhuauthor=H.+Zhou&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationship+of+7-Propanamide+Benzoxaboroles+as+Potent+Anticancer+Agents&doi=10.1021%2Facs.jmedchem.9b00736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents</span></div><div class="casAuthors">Zhang, Jiong; Zhang, Jinyi; Hao, Guiyun; Xin, Weixiang; Yang, Fei; Zhu, Mingyan; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6765-6784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoxaboroles, as a novel class of bioactive mols. with unique physicochem. properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug.  Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far.  In this study, we report the design, synthesis, and anticancer structure-activity relationship of a series of 7-propanamide benzoxaboroles.  Compds. 103 and 115 showed potent activity against ovarian cancer cells with IC50 values of 33 and 21 nM, resp.  Apoptosis was induced by these compds. and colony formation was effectively inhibited.  Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkvie6d6TfrVg90H21EOLACvtfcHk0ljGNKTdNQ7jGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1als77I&md5=01b4937ef8eeb432fee175fb55610966</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00736%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationship%2520of%25207-Propanamide%2520Benzoxaboroles%2520as%2520Potent%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6765%26epage%3D6784%26doi%3D10.1021%2Facs.jmedchem.9b00736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, P.</span></span> <span> </span><span class="NLM_article-title">Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1007/s10495-012-0781-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs10495-012-0781-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23192364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1GntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=9-27&author=R.+Kapoorauthor=F.+Rizviauthor=P.+Kakkar&title=Naringenin+prevents+high+glucose-induced+mitochondria-mediated+apoptosis+involving+AIF%2C+Endo-G+and+caspases&doi=10.1007%2Fs10495-012-0781-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases</span></div><div class="casAuthors">Kapoor, Radhika; Rizvi, Fatima; Kakkar, Poonam</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-27</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Oxidative stress is implicated in hyperglycemia-induced alterations in cell signaling pathways.  We examd. the toxicity of high glucose in primary rat hepatocytes and its amelioration by naringenin.  Incubation of hepatocytes with 40 mM glucose for 1.5 h exhibited significant decrease in cell viability confirmed by MTT redn. and Alamar blue assay.  At the same time primary rat hepatocytes exhibited significant decrease in mitochondrial membrane potential indicating organelle dysfunction.  Enhanced translocation of Cyt-c from mitochondria to cytosol and AIF/Endo-G from mitochondria to nucleus, activation of caspase-9/3, DNA damage, and chromatin condensation were obsd. in glucose-stressed hepatocytes, indicating the involvement of mitochondrial pathway in high glucose-induced apoptosis.  Transcript levels of antioxidant enzymes were significantly altered along with corresponding changes in their enzymic activities.  The level of intracellular antioxidant glutathione as well as superoxide dismutase, catalase, and glutathione peroxidase activities were obsd. to be significantly decreased in hepatocytes treated with high concn. of glucose.  Naringenin, a flavanone, was effective in preventing loss of cell viability, reactive oxygen species generation, and decline in antioxidant defense.  Translocation of AIF, Endo-G, and Cyt-c from mitochondria was also inhibited by naringenin in glucose-stressed cells.  MRNA expression of anti-apoptotic and apoptotic genes, externalization of phosphatidyl serine, DNA damage, chromatin condensation, and sub-diploid cell population were effectively altered by naringenin indicating its anti-apoptotic potential in vitro.  Our data suggests that naringenin can prevent apoptosis induced by high glucose through scavenging of reactive oxygen species and modulation of mitochondria-mediated apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbcjQp53UY4bVg90H21EOLACvtfcHk0ljGNKTdNQ7jGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1GntQ%253D%253D&md5=dd816288dd3a02110171b9a7b774d65f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs10495-012-0781-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-012-0781-7%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DRizvi%26aufirst%3DF.%26aulast%3DKakkar%26aufirst%3DP.%26atitle%3DNaringenin%2520prevents%2520high%2520glucose-induced%2520mitochondria-mediated%2520apoptosis%2520involving%2520AIF%252C%2520Endo-G%2520and%2520caspases%26jtitle%3DApoptosis%26date%3D2013%26volume%3D18%26spage%3D9%26epage%3D27%26doi%3D10.1007%2Fs10495-012-0781-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-<i>d</i>]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2353</span>– <span class="NLM_lpage">2371</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01612</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2353-2371&author=Q.+Xunauthor=Z.+Zhangauthor=J.+Luoauthor=L.+Tongauthor=M.+Huangauthor=Z.+Wangauthor=J.+Zouauthor=Y.+Liuauthor=Y.+Xuauthor=H.+Xieauthor=Z.-C.+Tuauthor=X.+Luauthor=K.+Ding&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationship+Study+of+2-Oxo-3%2C4-dihydropyrimido%5B4%2C5-d%5Dpyrimidines+as+New+Colony+Stimulating+Factor+1+Receptor+%28CSF1R%29+Kinase+Inhibitors&doi=10.1021%2Facs.jmedchem.7b01612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors</span></div><div class="casAuthors">Xun, Qiuju; Zhang, Zhang; Luo, Jinfeng; Tong, Linjiang; Huang, Minhao; Wang, Zhen; Zou, Jian; Liu, Yingqiang; Xu, Yong; Xie, Hua; Tu, Zheng-Chao; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2353-2371</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colony stimulating factor-1 receptor kinase (CSF1R) is a well validated mol. target for anticancer drug discovery.  Herein, we report the design, synthesis and structure-activity relationship study of 2-oxo-3, 4-dihydropyrimido[4, 5-d] pyrimidines as new orally bioavailable CSF1R inhibitors.  One of the most promising compds., I, potently inhibits CSF1R kinase with an IC50 value of 3.0 nM, while is significantly less potent against structurally related epidermal growth factor receptor (EGFR) and other kinases.  The kinase inhibition of I was further validated by western blotting anal. in RAW264.7 macrophages.  The mol. also potently blocks macrophage infiltration, abrogates the pro-tumorigenic influences of macrophages, and exhibits reasonable pharmacokinetic profile.  Compd. I may serve as a new valuable lead compd. for future anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN1HUSH0HAH7Vg90H21EOLACvtfcHk0licE8UjXpLGuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKqsrg%253D&md5=c1535182f335de0c9d8f9367b65ce938</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01612%26sid%3Dliteratum%253Aachs%26aulast%3DXun%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DZ.-C.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationship%2520Study%2520of%25202-Oxo-3%252C4-dihydropyrimido%255B4%252C5-d%255Dpyrimidines%2520as%2520New%2520Colony%2520Stimulating%2520Factor%25201%2520Receptor%2520%2528CSF1R%2529%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2353%26epage%3D2371%26doi%3D10.1021%2Facs.jmedchem.7b01612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaswamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11218</span>– <span class="NLM_lpage">11231</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit12rtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11218-11231&author=X.+Hanauthor=L.+Zhaoauthor=W.+Xiangauthor=C.+Qinauthor=B.+Miaoauthor=T.+Xuauthor=M.+Wangauthor=C.-Y.+Yangauthor=K.+Chinnaswamyauthor=J.+Stuckeyauthor=S.+Wang&title=Discovery+of+Highly+Potent+and+Efficient+PROTAC+Degraders+of+Androgen+Receptor+%28AR%29+by+Employing+Weak+Binding+Affinity+VHL+E3+Ligase+Ligands&doi=10.1021%2Facs.jmedchem.9b01393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands</span></div><div class="casAuthors">Han, Xin; Zhao, Lijie; Xiang, Weiguo; Qin, Chong; Miao, Bukeyan; Xu, Tianfeng; Wang, Mi; Yang, Chao-Yie; Chinnaswamy, Krishnapriya; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11218-11231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Androgen receptor (AR) is a validated therapeutic target for the treatment of metastatic castration-resistant prostate cancer (mCRPC).  We report herein our design, synthesis, and biol. characterization of highly potent small-mol. proteolysis targeting chimera (PROTAC) AR degraders using a potent AR antagonist and E3 ligase ligands with weak binding affinities to VHL protein.  Our study resulted in the discovery of 11 (ARD-266), which effectively induces degrdn. of AR protein in AR-pos. (AR+) LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC50 values of 0.2-1 nM.  ARD-266 is capable of reducing the AR protein level by >95% in these AR+ prostate cancer cell lines and effectively reduces AR-regulated gene expression suppression.  For the first time, we demonstrated that an E3 ligand with micromolar binding affinity to its E3 ligase complex can be successfully employed for the design of highly potent and efficient PROTAC degraders and this finding may have a significant implication for the field of PROTAC research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM96gs2yAlzLVg90H21EOLACvtfcHk0licE8UjXpLGuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit12rtbvE&md5=92e4f17c75b488749fced14476552c07</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01393%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Efficient%2520PROTAC%2520Degraders%2520of%2520Androgen%2520Receptor%2520%2528AR%2529%2520by%2520Employing%2520Weak%2520Binding%2520Affinity%2520VHL%2520E3%2520Ligase%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11218%26epage%3D11231%26doi%3D10.1021%2Facs.jmedchem.9b01393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span> <span> </span><span class="NLM_article-title"><i>E. adenophorum</i> induces Cell Cycle Arrest and Apoptosis of Splenocytes through the Mitochondrial Pathway and Caspase Activation in Saanen Goats</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">15967</span> <span class="refDoi"> DOI: 10.1038/srep15967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fsrep15967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=26527166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=Y.+Heauthor=Q.+Moauthor=Y.+Huauthor=W.+Chenauthor=B.+Luoauthor=L.+Wuauthor=Y.+Qiaoauthor=R.+Xuauthor=Y.+Zhouauthor=Z.+Zuoauthor=J.+Dengauthor=W.+Heauthor=Y.+Wei&title=E.+adenophorum+induces+Cell+Cycle+Arrest+and+Apoptosis+of+Splenocytes+through+the+Mitochondrial+Pathway+and+Caspase+Activation+in+Saanen+Goats&doi=10.1038%2Fsrep15967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">E. adenophorum induces Cell Cycle Arrest and Apoptosis of Splenocytes through the Mitochondrial Pathway and Caspase Activation in Saanen Goats</span></div><div class="casAuthors">He, Yajun; Mo, Quan; Hu, Yanchun; Chen, Weihong; Luo, Biao; Wu, Lei; Qiao, Yan; Xu, Ruiguang; Zhou, Yancheng; Zuo, Zhicai; Deng, Junliang; He, Wei; Wei, Yahui</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15967</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The precise cytotoxicity of E. Adenophorum in relation to the cell cycle and apoptosis of splenocytes in Saanen goats remains unclear.  In the present study, 16 Saanen goats were randomly divided into four groups, which were fed on 0%, 40%, 60% and 80% E. adenophorum diets.  The results of TUNEL, DAPI and AO/EB staining, flow cytometry anal. and DNA fragmentation assays showed that E. adenophorum induced typical apoptotic features in splenocytes, suppressed splenocyte viability, and caused cell cycle arrest in a dose-dependent manner.  However, westernblot, ELISA, qRT-PCR and caspase activity analyses showed that E. adenophoruminhibited Bcl-2 expression, promoted Bax translocation to the mitochondria, triggered the release of Cytc from the mitochondria into the cytosol, and activated caspase-9 and -3 and the subsequent cleavage of PARP.  Moreover, in E. adenophorum-induced apoptosis, the protein levels of Fas, Bid, FasL and caspase-8 showed no significant changes.  E. adenophorum treatment induced the collapse of ΔΨm.  Moreover, these data suggested that E. adenophorum induces splenocyte apoptosis via the activation of the mitochondrial apoptosis pathway in splenocytes.  These findings provide new insights into the mechanisms underlying the effects of E. adenophorum cytotoxicity on splenocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZfS47AmJHrVg90H21EOLACvtfcHk0lgKkgaoVDmp6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOns73E&md5=5e77df50f284444f03f725a65f495f3d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsrep15967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep15967%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DMo%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DY.%26atitle%3DE.%2520adenophorum%2520induces%2520Cell%2520Cycle%2520Arrest%2520and%2520Apoptosis%2520of%2520Splenocytes%2520through%2520the%2520Mitochondrial%2520Pathway%2520and%2520Caspase%2520Activation%2520in%2520Saanen%2520Goats%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep15967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izpisúa Belmonte, J. C. I.</span></span> <span> </span><span class="NLM_article-title">Linking the p53 tumour suppressor pathway to somatic cell reprogramming</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">1140</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1038/nature08311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fnature08311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=19668186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=1140-1144&author=T.+Kawamuraauthor=J.+Suzukiauthor=Y.+V.+Wangauthor=S.+Menendezauthor=L.+B.+Moreraauthor=A.+Rayaauthor=G.+M.+Wahlauthor=J.+C.+I.+Izpis%C3%BAa+Belmonte&title=Linking+the+p53+tumour+suppressor+pathway+to+somatic+cell+reprogramming&doi=10.1038%2Fnature08311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Linking the p53 tumour suppressor pathway to somatic cell reprogramming</span></div><div class="casAuthors">Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Menendez, Sergio; Morera, Laura Batlle; Raya, Angel; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">7259</span>),
    <span class="NLM_cas:pages">1140-1144</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes, but the low frequency and tendency to induce malignant transformation compromise the clin. utility of this powerful approach.  We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells.  Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway.  Reducing signalling to p53 by expressing a mutated version of one of its neg. regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency.  Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimeric mice using only Oct4 (also known as Pou5f1) and Sox2.  Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells.  These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwLhGRZnLhybVg90H21EOLACvtfcHk0lgKkgaoVDmp6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1ahuro%253D&md5=e576219e57102e80c7eed0ba349045e6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature08311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08311%26sid%3Dliteratum%253Aachs%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BV.%26aulast%3DMenendez%26aufirst%3DS.%26aulast%3DMorera%26aufirst%3DL.%2BB.%26aulast%3DRaya%26aufirst%3DA.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%2BI.%26atitle%3DLinking%2520the%2520p53%2520tumour%2520suppressor%2520pathway%2520to%2520somatic%2520cell%2520reprogramming%26jtitle%3DNature%26date%3D2009%26volume%3D460%26spage%3D1140%26epage%3D1144%26doi%3D10.1038%2Fnature08311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Z.-Q.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Low-Molecular- Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.7150/ijbs.13988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.7150%2Fijbs.13988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=27194951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1Gqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=746-756&author=S.+Wangauthor=P.+Liauthor=S.-M.+Luauthor=Z.-Q.+Ling&title=Chemoprevention+of+Low-Molecular-+Weight+Citrus+Pectin+%28LCP%29+in+Gastrointestinal+Cancer+Cells&doi=10.7150%2Fijbs.13988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of low-molecular-weight citrus pectin (LCP) in gastrointestinal cancer cells</span></div><div class="casAuthors">Wang, Shi; Li, Pei; Lu, Sheng-Min; Ling, Zhi-Qiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">746-756</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Background & Aims: Low-mol.-wt. citrus pectin (LCP) is a complex polysaccharide that displays abundant galactosyl (i.e., sugar carbohydrate) residues.  In this study, we evaluated the anti-tumor properties of LCP that lead to Bcl-xL-mediated dampening of apoptosis in gastrointestinal cancer cells.  Methods: We used AGS gastric cancer and SW-480 colorectal cancer cells to elucidate the effects of LCP on cell viability, cell cycle and apoptosis in cultured cells and tumor xenografts.  Results: Significantly decreased cell viabilities were obsd. in LCP treated AGS and SW-480 cells (P<0.05).  Cell cycle-related protein expression, such as Cyclin B1, was also decreased in LCP treated groups as compared to the untreated group.  The AGS or SW-480 cell-line tumor xenografts were significantly smaller in the LCP treated group as compared the untreated group (P<0.05).  LCP treatment decreased Galectin-3 (GAL-3) expression levels, which is an important gene in cancer metastasis that results in reversion of the epithelial-mesenchymal transition (EMT), and increased suppression of Bcl-xL and Survivin to promote apoptosis.  Moreover, results demonstrated synergistic tumor suppressor activity of LCP and 5-FU against gastrointestinal cancer cells both in vivo and in vitro.  Conclusions: LCP effectively inhibits the growth and metastasis of gastrointestinal cancer cells, and does so in part by down-regulating Bcl-xL and Cyclin B to promote apoptosis, and suppress EMT.  Thus, LCP alone or in combination with other treatments has a high potential as a novel therapeutic strategy to improve the clin. therapy of gastrointestinal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOMF0zp5Fcl7Vg90H21EOLACvtfcHk0lgKkgaoVDmp6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1Gqurg%253D&md5=132fbfe81f3c1ced61d386784d15fc11</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.7150%2Fijbs.13988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.13988%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DS.-M.%26aulast%3DLing%26aufirst%3DZ.-Q.%26atitle%3DChemoprevention%2520of%2520Low-Molecular-%2520Weight%2520Citrus%2520Pectin%2520%2528LCP%2529%2520in%2520Gastrointestinal%2520Cancer%2520Cells%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2016%26volume%3D12%26spage%3D746%26epage%3D756%26doi%3D10.7150%2Fijbs.13988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q. Z.</span></span> <span> </span><span class="NLM_article-title">Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation <i>in vitro</i> and <i>in vivo</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.ejmech.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=27639364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=729-739&author=J.+B.+Shiauthor=L.+Z.+Chenauthor=Y.+Wangauthor=C.+Xiouauthor=W.+J.+Tangauthor=H.+P.+Zhouauthor=X.+H.+Liuauthor=Q.+Z.+Yao&title=Benzophenone-nucleoside+derivatives+as+telomerase+inhibitors%3A+Design%2C+synthesis+and+anticancer+evaluation+in+vitro+and+in+vivo&doi=10.1016%2Fj.ejmech.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo</span></div><div class="casAuthors">Shi, Jing Bo; Chen, Liu Zeng; Wang, Yang; Cheng, Xiou; Tang, Wen Jian; Zhou, Hai Pin; Liu, Xin Hua; Yao, Qi Zheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">729-739</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on telomerase, thirteen novel phenstatin moiety linked stavudine derivs., e.g. I, were synthesized.  The structures were detd. by NMR and TOF-HRMS.  The screening results showed that some compds. had better anti-cancer activity in vivo and in vitro.  Among them, Compd. 8d showed high inhibitory activity against telomerase and showed good antiproliferative activity against SGC-7901 cell with IC50 value 0.77 μM by inducing cell cycle arrest at G2 phase.  It also could improve SGC-7901 cell apoptosis, mitochondrial membrane potential assay indicated that the dissipation of MMP might participate in apoptosis induced by title compd.  In vivo studies showed that compd. 8d displayed potent anticancer activity with inhibition tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFPWDaOL5ES7Vg90H21EOLACvtfcHk0lilg6KgjU_LZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmtL7N&md5=6293f71570341df9e558afb9b9a6ab39</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%2BZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiou%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DW.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%2BP.%26aulast%3DLiu%26aufirst%3DX.%2BH.%26aulast%3DYao%26aufirst%3DQ.%2BZ.%26atitle%3DBenzophenone-nucleoside%2520derivatives%2520as%2520telomerase%2520inhibitors%253A%2520Design%252C%2520synthesis%2520and%2520anticancer%2520evaluation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D729%26epage%3D739%26doi%3D10.1016%2Fj.ejmech.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pineda
de las Infantas, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Rusillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Rubio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque-Gonzalez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Mochon, J. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1inhibitors</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5224</span>– <span class="NLM_lpage">5234</span>, <span class="refDoi"> DOI: 10.1039/C5OB00230C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1039%2FC5OB00230C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=25856731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVSmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=5224-5234&author=M.+J.+Pineda%0Ade+las+Infantasauthor=S.+Torres-Rusilloauthor=J.+D.+Unciti-Brocetaauthor=P.+Fernandez-Rubioauthor=M.+A.+Luque-Gonzalezauthor=M.+A.+Galloauthor=A.+Unciti-Brocetaauthor=I.+J.+Molinaauthor=J.+J.+Diaz-Mochon&title=Synthesis+of+6%2C8%2C9+poly-substituted+purine+analogue+libraries+as+pro-apoptotic+inducers+of+human+leukemic+lymphocytes+and+DAPK-1inhibitors&doi=10.1039%2FC5OB00230C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors</span></div><div class="casAuthors">Pineda de las Infantas, Maria J.; Torres-Rusillo, Sara; Unciti-Broceta, Juan Diego; Fernandez-Rubio, Pablo; Luque-Gonzalez, Maria Angelica; Gallo, Miguel A.; Unciti-Broceta, Asier; Molina, Ignacio J.; Diaz-Mochon, Juan J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5224-5234</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A 18-member library of 6,8,9-poly-substituted purines was prepd. from pyrimidines, primary alcs., and N,N-dimethylamides under basic conditions by a one-pot synthetic pathway controlled by amide sizes and the novel analogs were tested against two leukemia cell lines: Jurkat (acute T cell leukemia) and K562 (chronic erythroleukemia) cells.  Compds. having a benzyloxy group at C6 position of the arom. ring exhibited antiproliferative activity in Jurkat cells whereas all compds. induced a lower effect on K562 cells.  Anal. of cell cycle, Annexin-V staining, and cleavage of initiator caspases assays showed that the active purine analogs induce cell death by apoptosis.  Based on these results, a new purine deriv. was synthesized, 6-benzyloxy-9-tert-butyl-8-phenyl-9H-purine (6d), which displayed the highest activity of the series against Jurkat cell lines.  Finally, 33P-radiolabeled kinase assays using 96 recombinant human kinases known to be involved in apoptotic events were performed.  Just one of the kinases tested, DAPK-1, was inhibited 50% or more by the phenotypic hits at 10 μM, suggesting that the inhibition of this target could be responsible for the induction of cell death by apoptosis.  In agreement with the phenotypic results, the most active antiproliferative agent, displayed also the lowest IC50 value against recombinant death-assocd. protein kinase 1 (i.e., DAPK1 2.5 μM), further supporting the potential role of this protein on the obsd. functional response.  DAPK-1 inhibition provided a lead compd. together with its pro-apoptotic properties against a Jurkat line and thus, makes it an interesting candidate to further investigate the role of DAPK1 kinase in triggering apoptosis in cancer cells, a role which is attracting recent interest.  The synthesis of the the target compds. was achieved using 4,6-dichloro-5-nitropyrimidine, amines and alcs. as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVL97n567FprVg90H21EOLACvtfcHk0lilg6KgjU_LZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVSmsb4%253D&md5=f35fd384348f2d59879d1bf7ffc5277c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2FC5OB00230C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00230C%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%2Bde%2Blas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DTorres-Rusillo%26aufirst%3DS.%26aulast%3DUnciti-Broceta%26aufirst%3DJ.%2BD.%26aulast%3DFernandez-Rubio%26aufirst%3DP.%26aulast%3DLuque-Gonzalez%26aufirst%3DM.%2BA.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DUnciti-Broceta%26aufirst%3DA.%26aulast%3DMolina%26aufirst%3DI.%2BJ.%26aulast%3DDiaz-Mochon%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%25206%252C8%252C9%2520poly-substituted%2520purine%2520analogue%2520libraries%2520as%2520pro-apoptotic%2520inducers%2520of%2520human%2520leukemic%2520lymphocytes%2520and%2520DAPK-1inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D5224%26epage%3D5234%26doi%3D10.1039%2FC5OB00230C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><a href="https://go.drugbank.com/drugs/DB00544" class="extLink">https://go.drugbank.com/drugs/DB00544</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fgo.drugbank.com%2Fdrugs%2FDB00544."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawacki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaswamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin-MLL Interaction with Strong <i>In Vivo</i> Antitumor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4997</span>– <span class="NLM_lpage">5010</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVClsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4997-5010&author=S.+Xuauthor=A.+Aguilarauthor=L.+Huangauthor=T.+Xuauthor=K.+Zhengauthor=D.+McEachernauthor=S.+Przybranowskiauthor=C.+Fosterauthor=K.+Zawackiauthor=Z.+Liuauthor=K.+Chinnaswamyauthor=J.+Stuckeyauthor=S.+Wang&title=Discovery+of+M-808+as+a+Highly+Potent%2C+Covalent%2C+Small-Molecule+Inhibitor+of+the+Menin-MLL+Interaction+with+Strong+In+Vivo+Antitumor+Activity&doi=10.1021%2Facs.jmedchem.0c00547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin-MLL Interaction with Strong In Vivo Antitumor Activity</span></div><div class="casAuthors">Xu, Shilin; Aguilar, Angelo; Huang, Liyue; Xu, Tianfeng; Zheng, Ke; McEachern, Donna; Przybranowski, Sally; Foster, Caroline; Zawacki, Kaitlin; Liu, Zhaomin; Chinnaswamy, Krishnapriya; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4997-5010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting the menin-MLL protein-protein interaction is a new therapeutic strategy for the treatment of acute leukemia carrying MLL fusion (MLL leukemia).  We describe herein the structure-based optimization of a class of covalent menin inhibitors, which led to the discovery of M-808 (16)(I) as a highly potent and efficacious covalent menin inhibitor.  M-808 effectively inhibits leukemia cell growth at low nanomolar concns. and is capable of achieving partial tumor regression in an MV4;11 xenograft tumor model in mice at a well-tolerated dose schedule.  Detn. of the co-crystal structure of M-808 in complex with menin provides a structural basis for their high-affinity, covalent interactions.  M-808 represents a promising, covalent menin inhibitor for further optimization and evaluation toward developing a new therapy for the treatment of MLL leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCh0XqIp3vpLVg90H21EOLACvtfcHk0lilg6KgjU_LZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVClsrg%253D&md5=168b2c21b9222ee72120f6680e7f60db</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00547%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DZawacki%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520M-808%2520as%2520a%2520Highly%2520Potent%252C%2520Covalent%252C%2520Small-Molecule%2520Inhibitor%2520of%2520the%2520Menin-MLL%2520Interaction%2520with%2520Strong%2520In%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4997%26epage%3D5010%26doi%3D10.1021%2Facs.jmedchem.0c00547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.ejmech.2019.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=31185410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKqs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2019&pages=177-194&author=F.+Gaoauthor=Y.+Liangauthor=P.+Zhouauthor=J.+Chengauthor=K.+Dingauthor=Y.+Wang&title=Design%2C+synthesis%2C+antitumor+activities+and+biological+studies+of+novel+diaryl+substituted+fused+heterocycles+as+dual+ligands+targeting+tubulin+and+katanin&doi=10.1016%2Fj.ejmech.2019.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin</span></div><div class="casAuthors">Gao, Feng; Liang, Yuru; Zhou, Pengfei; Cheng, Jiayi; Ding, Kuiling; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-194</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Microtubule is one of the important targets for cancer treatment.  A novel class of diaryl substituted imidazo[4,5-c]pyridin-2-ones and imidazo[4,5-c]pyridines were designed based on combination principles by merging the structures of β-lactams and purine-type compds. known as tubulin polymn. inhibitor and katanin activity up-regulator, resp.  Their antitumor activities were evaluated in vitro and the mechanism was elucidated, leading to the identification of 1,6-diaryl-1H-imidazo[4,5-c]pyridin-2(3H)-one I as the first bifunctional agent that can target both tubulin and katanin simultaneously.  The in vivo assays verified that compd. I significantly inhibited xenograft tumor growth with good pharmacokinetic characteristics, demonstrating a promising potential for further development into anti-tumor drug candidates with a unique mechanism of dual-targeting microtubule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwI1A_To45rVg90H21EOLACvtfcHk0liXH8fXAan7aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKqs7fI&md5=4b71536c807d513c707371370dd966a0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520antitumor%2520activities%2520and%2520biological%2520studies%2520of%2520novel%2520diaryl%2520substituted%2520fused%2520heterocycles%2520as%2520dual%2520ligands%2520targeting%2520tubulin%2520and%2520katanin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D178%26spage%3D177%26epage%3D194%26doi%3D10.1016%2Fj.ejmech.2019.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span> <span> </span><span class="NLM_article-title">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6945</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6945-6963&author=J.+R.+Hillauthor=A.+A.+B.+Robertson&title=Fishing+for+Drug+Targets%3A+A+Focus+on+Diazirine+Photoaffinity+Probe+Synthesis&doi=10.1021%2Facs.jmedchem.7b01561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span></div><div class="casAuthors">Hill, James R.; Robertson, Avril A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6945-6963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Target identification is a high-priority, albeit challenging, aspect of drug discovery.  Diazirine-based photoaffinity probes (PAPs) can facilitate the process by covalently capturing transient mol. interactions.  This can help identify target proteins and map the ligand's interactome.  Diazirine probes have even been incorporated by cellular machinery into proteins.  Embarking on the synthesis of customized PAPs, contg. either an aliph. or trifluoromethyl Ph diazirine, can be a considerable endeavor, particularly for medicinal chemists and chem. biologists new to the field.  This review takes a synthetic focus, aiming to summarize available routes, propose new avenues, and illuminate recent advances in diazirine synthesis.  Select examples of diazirine photoaffinity labeling applications have been included throughout to provide instructive definition of the advantages and limitations of the technol. while simultaneously highlighting how these reagents can be applied in a practical sense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFaJOZyNuB67Vg90H21EOLACvtfcHk0liXH8fXAan7aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D&md5=37266e26bdd6a2028dddffc3ead4390d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01561%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26atitle%3DFishing%2520for%2520Drug%2520Targets%253A%2520A%2520Focus%2520on%2520Diazirine%2520Photoaffinity%2520Probe%2520Synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6945%26epage%3D6963%26doi%3D10.1021%2Facs.jmedchem.7b01561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Acyclic nucleoside and nucleotide drugs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Design of acyclic nucleosides.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0012.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Syntheses of <b>1a</b>–<b>13a</b>, <b>1b</b>–<b>16b</b>, <b>4c</b>–<b>9c</b>, <b>4d</b>–<b>11d</b>, <b>5e</b>–<b>11e</b>, <b>5f</b>–<b>11f</b>, <b>4g</b>–<b>11g</b>, <b>5h</b>–<b>11h</b>, <b>5i</b>–<b>9i</b>, <b>4j</b>–<b>6j</b>, and <b>5k</b>–<b>10k</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0011.jpeg jm0c01717_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0013.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Asymmetric Syntheses of (<i>R</i>)- and (<i>S</i>)-configurations of the compounds <b>7b</b>, <b>8b</b>, and <b>9b</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0014.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Syntheses of Compounds <b>9ba</b>–<b>9bf</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Toxicity of compound <b>9b</b> on NCM460.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Induction of apoptosis on SW480 cells by compound <b>9b</b>. Flow cytometry analysis of apoptotic SW480 cells induced by compound <b>9b</b> at different concentrations. Cells were treated with vehicle or compound <b>9b</b> at 2, 4, 8, 16, and 32 μM for 48 h.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (A) Western blotting analysis of cell-apoptosis-related proteins after treatment with compound <b>9b</b> at different concentrations. (B) Relative amount of protein after treatment with compound <b>9b</b> at different concentrations.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Collapse of the mitochondrial membrane potential on SW480 cells treated by compound <b>9b</b>. (A) Changes in the mitochondrial membrane potential were observed using the JC-1 kit under fluorescence microscopy. (B) Flow cytometry was used to detect the mitochondrial membrane potential on SW480 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0008.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Inhibitory effects of compound <b>9b</b> on colony formation of HCT-116 cells and SW480 cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0009.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <i>In vivo</i> anticancer activity of compound <b>9b</b> on the SW480 xenograft mice model. Female BALB/C nude mice were administered by intraperitoneal injection with the vehicle, compound <b>9b</b>, at dosages of 25 and 50 mg/kg, or 5-FU at a dosage of 50 mg/kg (<i>n</i> = 8 each group), once every 2 days for 12 days. Average tumor weight (A), average body weight (B), average tumor volume (C), and the isolated tumors (D) were measured. Data are expressed as the mean ± standard error (<i>n</i> = 8). * indicates <i>P</i> < 0.05, ** indicates <i>P</i> < 0.01, and *** indicates <i>P</i> < 0.001 vs control. H & E staining analysis of tumors in nude mice on the SW480 xenograft mice model (E).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0015.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of the Biotin-Annexed Probe <b>21</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0016.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of the Diazirine-Based Probe <b>23</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/medium/jm0c01717_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0010.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Western blotting and silver staining results of the pull-down samples. (A) Merger of bright field and chemiluminescence of the PVDF member. (B) and (C) Silver staining results of the SDS-PAGE gel.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.0c01717/20210218/images/large/jm0c01717_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01717&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i148">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 50 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span> <span> </span><span class="NLM_article-title">The acyclic nucleoside phosphonates from inception to clinical use: historical perspective</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>75</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">13</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2006.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.antiviral.2006.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=17116336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2sXksFWlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2007&pages=1-13&author=E.+De%0AClercq&title=The+acyclic+nucleoside+phosphonates+from+inception+to+clinical+use%3A+historical+perspective&doi=10.1016%2Fj.antiviral.2006.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The acyclic nucleoside phosphonates from inception to clinical use: Historical perspective</span></div><div class="casAuthors">De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-13</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  The collaboration between Antonin Holy [Institute of Org. Chem. and Biochem. (IOCB, Prague, Czech Republic)] and Erik De Clercq (Rega Institute for Medical Research, K.U. Leuven, Belgium) started exactly 30 years ago.  It led to the discovery of a (rather small) series of acyclic nucleoside analogs (prototype: DHPA), followed by the discovery of a large no. of nucleotide analogs [acyclic nucleoside phosphonates (ANPs)] (prototype: HPMPA).  From HPMPA originated three compds., which have been approved by regulatory agencies worldwide for clin. use: (i) HPMPC [cidofovir (Vistide)] for the treatment of cytomegalovirus (CMV) retinitis in AIDS patients, and "off label" for the treatment of polyoma-, papilloma-, adeno-, herpes- and poxvirus infections; (ii) PMEA [adefovir (in its oral prodrug form, adefovir dipivoxil (Hepsera))] for the treatment of chronic HBV (hepatitis B virus) infections, and (iii) PMPA [tenofovir (in its oral prodrug form, tenofovir disoproxil fumarate (Viread))] for the treatment of HIV infections (AIDS).  The latter has also been approved, in combination with emtricitabine (Truvada), and in combination with emtricitabine and efavirenz (Atripla) for the treatment of HIV infections.  Many other ANPs such as the DAP derivs. HPMPDAP, PMEDAP and PMPDAP, and the DAPy derivs. HPMPO-DAPy, PMEO-DAPy, and PMPO-DAPy, were found to exhibit an antiviral activity spectrum and potency comparable to that of the parent compds. HPMPA (and HPMPC), PMEA and PMPA, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJky28pToCfrVg90H21EOLACvtfcHk0ljNcSrQCji1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXksFWlu70%253D&md5=fc42d2e7dc8ca7736d94f13d877dea49</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2006.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2006.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DThe%2520acyclic%2520nucleoside%2520phosphonates%2520from%2520inception%2520to%2520clinical%2520use%253A%2520historical%2520perspective%26jtitle%3DAntiviral%2520Res.%26date%3D2007%26volume%3D75%26spage%3D1%26epage%3D13%26doi%3D10.1016%2Fj.antiviral.2006.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baszczyňski, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span> <span> </span><span class="NLM_article-title">Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1304</span>– <span class="NLM_lpage">1344</span>, <span class="refDoi"> DOI: 10.1002/med.21296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fmed.21296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23893552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2hu7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=1304-1344&author=O.+Baszczy%C5%88skiauthor=Z.+Janeba&title=Medicinal+Chemistry+of+Fluorinated+Cyclic+and+Acyclic+Nucleoside+Phosphonates&doi=10.1002%2Fmed.21296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal Chemistry of Fluorinated Cyclic and Acyclic Nucleoside Phosphonates</span></div><div class="casAuthors">Baszczynski, Ondrej; Janeba, Zlatko</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1304-1344</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">In this paper, we review the biol. properties of cyclic and acyclic nucleoside phosphonates modified by the attachment of one or more fluorine atoms to various parts of the mol., namely to nucleobases, alkylphosphonate groups, cyclic or acyclic linkers, or to prodrug moieties.  The fluorine atom plays an important role in medicinal chem. because fluorine substitution has a strong impact on the phys., chem., and biol. properties of bioactive compds.  Such fluorine modifications have also been extensively studied among the pharmaceutically important class of nucleoside phosphonates, nucleotide analogs in which the phosphate group is replaced by the enzymically and chem. stable phosphonate moiety.  The fluorinated nucleoside phosphonates abound with antiviral, antiparasitic, and anticancer properties because they are able to act as inhibitors of important enzymes of nucleoside/nucleotide metab.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq5rIQx12Lg7Vg90H21EOLACvtfcHk0ljNcSrQCji1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2hu7nK&md5=c9a571c64d13ecb876a43a0b23bab270</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1002%2Fmed.21296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.21296%26sid%3Dliteratum%253Aachs%26aulast%3DBaszczy%25C5%2588ski%26aufirst%3DO.%26aulast%3DJaneba%26aufirst%3DZ.%26atitle%3DMedicinal%2520Chemistry%2520of%2520Fluorinated%2520Cyclic%2520and%2520Acyclic%2520Nucleoside%2520Phosphonates%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D1304%26epage%3D1344%26doi%3D10.1002%2Fmed.21296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroeder, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, R. G.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bloch, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological effects of acyclic pyrimidine nucleoside analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1078</span>– <span class="NLM_lpage">1083</span>, <span class="refDoi"> DOI: 10.1021/jm00141a012</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00141a012" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL3MXlt1Gruro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1981&pages=1078-1083&author=A.+C.+Schroederauthor=R.+G.+Hughesauthor=A.+Bloch&title=Synthesis+and+biological+effects+of+acyclic+pyrimidine+nucleoside+analogues&doi=10.1021%2Fjm00141a012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological effects of acyclic pyrimidine nucleoside analogs</span></div><div class="casAuthors">Schroeder, Alan C.; Hughes, Robert G., Jr.; Bloch, Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1078-83</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Twenty-two nucleoside analogs, most which are represented by I and II (R = H, Me, F, or Ac; R1 = CH2OCH2CH2O2CPh, CH2OCH2CH2N3, CH2OCH2CH2OH, etc.) were synthesized and tested for various biol. effects.  At 10-4M, none of the compds. inhibited leukemia α-1210 cell growth in culture.  Several compds. did inhibit the in vitro growth of Escherichia coli K-12.  II (R = F, R1 = CH2OCH2CH2OH)  [77474-50-1] was the most active with an IC50 (concn. for 50% inhibition) of 1.2 μM.  Some of the analogs also selectively interfered with Herpes Simplex virus replication in vitro.  None of the I analogs tested were either substrates or inhibitors of human liver nucleoside deaminase  [9073-42-1].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoH4wuQ1-vDXrVg90H21EOLACvtfcHk0ljNcSrQCji1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXlt1Gruro%253D&md5=e84514136b3ddb53e1dcb80c4b689352</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1021%2Fjm00141a012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00141a012%26sid%3Dliteratum%253Aachs%26aulast%3DSchroeder%26aufirst%3DA.%2BC.%26aulast%3DHughes%26aufirst%3DR.%2BG.%26aulast%3DBloch%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520effects%2520of%2520acyclic%2520pyrimidine%2520nucleoside%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1981%26volume%3D24%26spage%3D1078%26epage%3D1083%26doi%3D10.1021%2Fjm00141a012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hernández, A.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karlsson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camarasa, M.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Pérez, M.-J.</span></span> <span> </span><span class="NLM_article-title">Acyclic Nucleoside Analogues as Novel Inhibitors of Human Mitochondrial Thymidine Kinase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">4254</span>– <span class="NLM_lpage">4263</span>, <span class="refDoi"> DOI: 10.1021/jm011128+</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm011128%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD38XmtFSrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4254-4263&author=A.-I.+Hern%C3%A1ndezauthor=J.+Balzariniauthor=A.+Karlssonauthor=M.-J.+Camarasaauthor=M.-J.+P%C3%A9rez-P%C3%A9rez&title=Acyclic+Nucleoside+Analogues+as+Novel+Inhibitors+of+Human+Mitochondrial+Thymidine+Kinase&doi=10.1021%2Fjm011128%2B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Analogs as Novel Inhibitors of Human Mitochondrial Thymidine Kinase</span></div><div class="casAuthors">Hernandez, Ana-Isabel; Balzarini, Jan; Karlsson, Anna; Camarasa, Maria-Jose; Perez-Perez, Maria-Jesus</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4254-4263</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside analogs of 5'-O-tritylthymidine have been synthesized and evaluated as potential human mitochondrial thymidine kinase (TK-2) inhibitors.  In this series, the sugar moiety of the parent 5'-O-tritylthymidine has been replaced by aliph. chains including (E)- and (Z)-butenol, butynol, or butanol.  Among them the (Z)-butenyl deriv. [I, Q = (Z)-CH:CH] showed an IC50 against TK-2 of 1.5 μM, being 1 order of magnitude more potent than the parent 5'-O-tritylthymidine.  This lead compd. has been further modified by replacing the thymine base by other pyrimidine bases such as 5-iodouracil, 5-ethyluracil, 5-methylcytosine, 3-N-methylthymine, or 5,6-dihydrothymine, as well as by the purine base guanine.  The trityl group has also been replaced by different aliph. and arom. acyl moieties including tert-butylacetyl, hexanoyl, decanoyl, and diphenylacetyl moieties.  The evaluation of the compds. against TK-2 and the phylogenetically close HSV-1 TK has shown that the base moiety plays a crucial role in their interaction against these pyrimidine nucleoside kinases.  Also, the presence of a lipophilic substituent, preferentially an arom. moiety such as diphenylmethyl or triphenylmethyl, is required for efficient TK-2 inhibition.  Whereas some compds. showed marked specificity for either TK-2 (i.e, the 5,6-dihydrothymine deriv.) or HSV-1 TK [i.e., the butynyl deriv., I (Q = C≡C)], some others, including the (Z)-and (E)-butenyl derivs., showed significant inhibition against both enzymes.  They also proved to be inhibitory against HSV-1 TK in intact human osteosarcoma cells that were transduced with the HSV-1 TK gene.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbJDxFPEtCb7Vg90H21EOLACvtfcHk0lhUFVoal9ftLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmtFSrsbg%253D&md5=f606dadd93a5c1b8abae057de0796e8f</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm011128%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm011128%252B%26sid%3Dliteratum%253Aachs%26aulast%3DHern%25C3%25A1ndez%26aufirst%3DA.-I.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DKarlsson%26aufirst%3DA.%26aulast%3DCamarasa%26aufirst%3DM.-J.%26aulast%3DP%25C3%25A9rez-P%25C3%25A9rez%26aufirst%3DM.-J.%26atitle%3DAcyclic%2520Nucleoside%2520Analogues%2520as%2520Novel%2520Inhibitors%2520of%2520Human%2520Mitochondrial%2520Thymidine%2520Kinase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4254%26epage%3D4263%26doi%3D10.1021%2Fjm011128%2B" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Properties of a Novel Type of Acyclic Nucleoside Phosphonates: 2-(Purin-9-yl)ethoxyphenylphosphonic Acids</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2010</i></span>,  <span class="NLM_fpage">2885</span>– <span class="NLM_lpage">2892</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fejoc.201000061" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2010&publication_year=2010&pages=2885-2892&author=D.+Hockov%C3%A1author=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=A.+Hol%C3%BD&title=Synthesis+and+Properties+of+a+Novel+Type+of+Acyclic+Nucleoside+Phosphonates%3A+2-%28Purin-9-yl%29ethoxyphenylphosphonic+Acids&doi=10.1002%2Fejoc.201000061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201000061%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520Properties%2520of%2520a%2520Novel%2520Type%2520of%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%25202-%2528Purin-9-yl%2529ethoxyphenylphosphonic%2520Acids%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2010%26volume%3D2010%26spage%3D2885%26epage%3D2892%26doi%3D10.1002%2Fejoc.201000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Špaček, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tichý, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vrbková, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slavětínská, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">2513</span>– <span class="NLM_lpage">2526</span>, <span class="refDoi"> DOI: 10.1021/jm301893b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301893b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=2513-2526&author=D.+T.+Keoughauthor=P.+%C5%A0pa%C4%8Dekauthor=D.+Hockov%C3%A1author=T.+Tich%C3%BDauthor=S.+Vrbkov%C3%A1author=L.+Slav%C4%9Bt%C3%ADnsk%C3%A1author=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=T.-H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+Are+Potent+Inhibitors+of+6-Oxopurine+Phosphoribosyltransferases+and+Have+Antimalarial+Activity&doi=10.1021%2Fjm301893b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine Phosphoribosyltransferases and Have Antimalarial Activity</span></div><div class="casAuthors">Keough, Dianne T.; Spacek, Petr; Hockova, Dana; Tichy, Tomas; Vrbkova, Silvie; Slavetinska, Lenka; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2513-2526</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) that contain a 6-oxopurine base are good inhibitors of the Plasmodium falciparum (Pf) and Plasmodium vivax (Pv) 6-oxopurine phosphoribosyltransferases (PRTs).  Chem. modifications based on the crystal structure of 2-(phosphonoethoxy)ethylguanine (PEEG) in complex with human HGPRT have led to the design of new ANPs.  These novel compds. contain a second phosphonate group attached to the ANP scaffold.  {[(2-[(Guanine-9H-yl)methyl]propane-1,3-diyl)bis(oxy)]bis(methylene)}diphosphonic acid (I) exhibited a Ki value of 30 nM for human HGPRT and 70 nM for Pf HGXPRT.  The crystal structure of this compd. in complex with human HGPRT shows that it fills or partially fills three crit. locations in the active site: the binding sites of the purine base, the 5'-phosphate group, and pyrophosphate.  This is the first HG(X)PRT inhibitor that has been able to achieve this result.  Prodrugs have been synthesized resulting in IC50 values as low as 3.8 μM for Pf grown in cell culture, up to 25-fold lower compared to the parent compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOIyMCQRsPnrVg90H21EOLACvtfcHk0lhUFVoal9ftLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtlWgsrw%253D&md5=f57c4cfd4f9bcb94e6ce93894bfd4d0f</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm301893b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301893b%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DTich%25C3%25BD%26aufirst%3DT.%26aulast%3DVrbkov%25C3%25A1%26aufirst%3DS.%26aulast%3DSlav%25C4%259Bt%25C3%25ADnsk%25C3%25A1%26aufirst%3DL.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAcyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520Are%2520Potent%2520Inhibitors%2520of%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Have%2520Antimalarial%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D2513%26epage%3D2526%26doi%3D10.1021%2Fjm301893b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L. M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skinner-Adams, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Hypoxanthine-Guanine Phosphoribosy- ltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">4391</span>– <span class="NLM_lpage">4399</span>, <span class="refDoi"> DOI: 10.1021/jm900267n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm900267n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4391-4399&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=A.+Hol%C3%BDauthor=L.+M.+J.+Naesensauthor=T.+S.+Skinner-Adamsauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Inhibition+of+Hypoxanthine-Guanine+Phosphoribosy-+ltransferase+by+Acyclic+Nucleoside+Phosphonates%3A+A+New+Class+of+Antimalarial+Therapeutics&doi=10.1021%2Fjm900267n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of Hypoxanthine-Guanine Phosphoribosyltransferase by Acyclic Nucleoside Phosphonates: A New Class of Antimalarial Therapeutics</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Holy, Antonin; Naesens, Lieve M. J.; Skinner-Adams, Tina S.; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">4391-4399</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The purine salvage enzyme hypoxanthine-guanine-xanthine phosphoribosyltransferase (HGXPRT) is essential for purine nucleotide and hence nucleic acid synthesis in the malaria parasite, Plasmodium falciparum.  Acyclic nucleoside phosphonates (ANPs) are analogs of the nucleotide product of the reaction, comprising a purine base joined by a linker to a phosphonate moiety.  Ki values for 19 ANPs were detd. for Pf HGXPRT and the corresponding human enzyme, HGPRT.  Values for Pf HGXPRT were as low as 100 nM, with selectivity for the parasite enzyme of up to 58.  Structures of human HGPRT in complex with three ANPs are reported.  On binding, a large mobile loop in the free enzyme moves to partly cover the active site.  For three ANPs, the IC50 values for Pf grown in cell culture were 1, 14, and 46 μM, while the cytotoxic concn. for the first compd. was 489 μM.  These results provide a basis for the design of potent and selective ANP inhibitors of Pf HGXPRT as antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn8rPcoy0EBbVg90H21EOLACvtfcHk0li502BQ-zTpnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Ons7w%253D&md5=76746f78ec791a08ba2376beba86fa2b</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm900267n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900267n%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26aulast%3DNaesens%26aufirst%3DL.%2BM.%2BJ.%26aulast%3DSkinner-Adams%26aufirst%3DT.%2BS.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DInhibition%2520of%2520Hypoxanthine-Guanine%2520Phosphoribosy-%2520ltransferase%2520by%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520A%2520New%2520Class%2520of%2520Antimalarial%2520Therapeutics%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4391%26epage%3D4399%26doi%3D10.1021%2Fjm900267n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Topalis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pradère, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roy, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caillat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azzouzi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Broggi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eriksson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alexandre, J. A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Amri, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deville-Bonne, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agrofoglio, L. A.</span></span> <span> </span><span class="NLM_article-title">Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">222</span>– <span class="NLM_lpage">232</span>, <span class="refDoi"> DOI: 10.1021/jm1011462</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1011462" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFaku7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=222-232&author=D.+Topalisauthor=U.+Prad%C3%A8reauthor=V.+Royauthor=C.+Caillatauthor=A.+Azzouziauthor=J.+Broggiauthor=R.+Snoeckauthor=G.+Andreiauthor=J.+Linauthor=S.+Erikssonauthor=J.+A.+C.+Alexandreauthor=C.+El-Amriauthor=D.+Deville-Bonneauthor=P.+Meyerauthor=J.+Balzariniauthor=L.+A.+Agrofoglio&title=Novel+Antiviral+C5-Substituted+Pyrimidine+Acyclic+Nucleoside+Phosphonates+Selected+as+Human+Thymidylate+Kinase+Substrates&doi=10.1021%2Fjm1011462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Antiviral C5-Substituted Pyrimidine Acyclic Nucleoside Phosphonates Selected as Human Thymidylate Kinase Substrates</span></div><div class="casAuthors">Topalis, Dimitri; Pradere, Ugo; Roy, Vincent; Caillat, Christophe; Azzouzi, Ahmed; Broggi, Julie; Snoeck, Robert; Andrei, Graciela; Lin, Jay; Eriksson, Staffan; Alexandre, Julie A. C.; El-Amri, Chahrazade; Deville-Bonne, Dominique; Meyer, Philippe; Balzarini, Jan; Agrofoglio, Luigi A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">222-232</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside phosphonates (ANPs) are at the cornerstone of DNA virus and retrovirus therapies.  They reach their target, the viral DNA polymerase, after two phosphorylation steps catalyzed by cellular kinases.  New pyrimidine ANPs have been synthesized with unsatd. acyclic side chains (prop-2-enyl-, but-2-enyl-, pent-2-enyl-) and different substituents at the C5 position of the uracil nucleobase.  Several derivs. in the but-2-enyl- series, with (E) but not with (Z) configuration, were efficient substrates for human thymidine monophosphate (TMP) kinase, but not for uridine monophosphate-cytosine monophosphate (UMP-CMP) kinase, which is in contrast to cidofovir.  Human TMP kinase was successfully crystd. in a complex with phosphorylated (E)-thymidine-but-2-enyl phosphonate and ADP.  The bis-pivaloyloxymethyl (POM) esters were synthesized and shown to exert activity against herpes virus in vitro (IC50 = 3 μM) and against varicella zoster virus in vitro (IC50 = 0.19 μM), in contrast to the corresponding inactive (Z) derivs.  Thus, their antiviral activity correlates with their ability to act as thymidylate kinase substrates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHGHHytzlkwbVg90H21EOLACvtfcHk0li502BQ-zTpnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFaku7vL&md5=c8bfe5cadc1ac2d873eb53e554175385</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Fjm1011462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011462%26sid%3Dliteratum%253Aachs%26aulast%3DTopalis%26aufirst%3DD.%26aulast%3DPrad%25C3%25A8re%26aufirst%3DU.%26aulast%3DRoy%26aufirst%3DV.%26aulast%3DCaillat%26aufirst%3DC.%26aulast%3DAzzouzi%26aufirst%3DA.%26aulast%3DBroggi%26aufirst%3DJ.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DEriksson%26aufirst%3DS.%26aulast%3DAlexandre%26aufirst%3DJ.%2BA.%2BC.%26aulast%3DEl-Amri%26aufirst%3DC.%26aulast%3DDeville-Bonne%26aufirst%3DD.%26aulast%3DMeyer%26aufirst%3DP.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DAgrofoglio%26aufirst%3DL.%2BA.%26atitle%3DNovel%2520Antiviral%2520C5-Substituted%2520Pyrimidine%2520Acyclic%2520Nucleoside%2520Phosphonates%2520Selected%2520as%2520Human%2520Thymidylate%2520Kinase%2520Substrates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D222%26epage%3D232%26doi%3D10.1021%2Fjm1011462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nath, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saffran, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrrell, D. L. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Antiviral Activity of Novel Acyclic Nucleoside Analogues of 5-(1-Azido-2-haloethyl) uracils</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">4225</span>– <span class="NLM_lpage">4229</span>, <span class="refDoi"> DOI: 10.1021/jm010227k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm010227k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3MXnvVOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=4225-4229&author=R.+Kumarauthor=N.+Sharmaauthor=M.+Nathauthor=H.+A.+Saffranauthor=D.+L.+J.+Tyrrell&title=Synthesis+and+Antiviral+Activity+of+Novel+Acyclic+Nucleoside+Analogues+of+5-%281-Azido-2-haloethyl%29+uracils&doi=10.1021%2Fjm010227k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Antiviral Activity of Novel Acyclic Nucleoside Analogues of 5-(1-Azido-2-haloethyl)uracils</span></div><div class="casAuthors">Kumar, Rakesh; Sharma, Neerja; Nath, Mahendra; Saffran, Holly A.; Tyrrell, D. Lorne J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4225-4229</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors present the discovery of a novel category of 5-substituted acyclic pyrimidine nucleosides as potent antiviral agents.  A series of 1-[(2-hydroxyethoxy)methyl], 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl], and 1-[4-hydroxy-3-(hydroxymethyl)-1-butyl] derivs. of 5-(1-azido-2-haloethyl)uracil were synthesized and evaluated for their biol. activity in cell culture.  1-[4-Hydroxy-3-(hydroxymethyl)-1-butyl]-5-(1-azido-2-chloroethyl)uracil was the most effective antiviral agent in the in vitro assays against DHBV (EC50 = 0.31-1.55 μM) and HCMV (EC50 = 3.1 μM).  None of the compds. investigated showed any detectable toxicity to several stationary and proliferating host cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2UohEtR0kIbVg90H21EOLACvtfcHk0li502BQ-zTpnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXnvVOiurg%253D&md5=fb6f2db86abcb3c802d23a0e757e061b</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm010227k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm010227k%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DNath%26aufirst%3DM.%26aulast%3DSaffran%26aufirst%3DH.%2BA.%26aulast%3DTyrrell%26aufirst%3DD.%2BL.%2BJ.%26atitle%3DSynthesis%2520and%2520Antiviral%2520Activity%2520of%2520Novel%2520Acyclic%2520Nucleoside%2520Analogues%2520of%25205-%25281-Azido-2-haloethyl%2529%2520uracils%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2001%26volume%3D44%26spage%3D4225%26epage%3D4229%26doi%3D10.1021%2Fjm010227k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Derudas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanpouille, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zicari, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brancale, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margolis, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGuigan, C.</span></span> <span> </span><span class="NLM_article-title">Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7876</span>– <span class="NLM_lpage">7896</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01009</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlOksbzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7876-7896&author=M.+Derudasauthor=C.+Vanpouilleauthor=D.+Cartaauthor=S.+Zicariauthor=G.+Andreiauthor=R.+Snoeckauthor=A.+Brancaleauthor=L.+Margolisauthor=J.+Balzariniauthor=C.+McGuigan&title=Virtual+Screening+of+Acyclovir+Derivatives+as+Potential+Antiviral+Agents%3A+Design%2C+Synthesis%2C+and+Biological+Evaluation+of+New+Acyclic+Nucleoside+ProTides&doi=10.1021%2Facs.jmedchem.7b01009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Virtual Screening of Acyclovir Derivatives as Potential Antiviral Agents: Design, Synthesis, and Biological Evaluation of New Acyclic Nucleoside ProTides</span></div><div class="casAuthors">Derudas, Marco; Vanpouille, Christophe; Carta, Davide; Zicari, Sonia; Andrei, Graciela; Snoeck, Robert; Brancale, Andrea; Margolis, Leonid; Balzarini, Jan; McGuigan, Christopher</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7876-7896</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Following our findings on the anti-human immunodeficiency virus (HIV) activity of acyclovir (ACV) phosphate prodrugs, we herein report the ProTide approach applied to a series of acyclic nucleosides aimed at the identification of novel and selective antiviral, in particular anti-HIV agents.  Acyclic nucleoside analogs used in this study were identified through a virtual screening using HIV-reverse transcriptase (RT), adenylate/guanylate kinase, and human DNA polymerase γ.  A total of 39 new phosphate prodrugs were synthesized and evaluated against HIV-1 (in vitro and ex vivo human tonsillar tissue system) and human herpes viruses.  Several ProTide compds. showed substantial potency against HIV-1 at low micromolar range while the parent nucleosides were not effective.  Also, pronounced inhibition of herpesvirus replication was obsd.  A carboxypeptidase-mediated hydrolysis study was performed for a selection of compds. to assess the formation of putative metabolites and support the biol. activity obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUSy4loWCG37Vg90H21EOLACvtfcHk0ljBOamgwyN7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlOksbzK&md5=8ef7164c409ca381e464c3689592e81a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01009%26sid%3Dliteratum%253Aachs%26aulast%3DDerudas%26aufirst%3DM.%26aulast%3DVanpouille%26aufirst%3DC.%26aulast%3DCarta%26aufirst%3DD.%26aulast%3DZicari%26aufirst%3DS.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DBrancale%26aufirst%3DA.%26aulast%3DMargolis%26aufirst%3DL.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMcGuigan%26aufirst%3DC.%26atitle%3DVirtual%2520Screening%2520of%2520Acyclovir%2520Derivatives%2520as%2520Potential%2520Antiviral%2520Agents%253A%2520Design%252C%2520Synthesis%252C%2520and%2520Biological%2520Evaluation%2520of%2520New%2520Acyclic%2520Nucleoside%2520ProTides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7876%26epage%3D7896%26doi%3D10.1021%2Facs.jmedchem.7b01009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Luo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groaz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalkeri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schols, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Jonghe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herdewijn, P.</span></span> <span> </span><span class="NLM_article-title">Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6220</span>– <span class="NLM_lpage">6238</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00416</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00416" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFWksrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=6220-6238&author=M.+Luoauthor=E.+Groazauthor=G.+Andreiauthor=R.+Snoeckauthor=R.+Kalkeriauthor=R.+G.+Ptakauthor=T.+Hartmanauthor=R.+W.+Buckheitauthor=D.+Scholsauthor=S.+De+Jongheauthor=P.+Herdewijn&title=Expanding+the+Antiviral+Spectrum+of+3-Fluoro-2-%28phosphonomethoxy%29propyl+Acyclic+Nucleoside+Phosphonates%3A+Diamyl+Aspartate+Amidate+Prodrugs&doi=10.1021%2Facs.jmedchem.7b00416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs</span></div><div class="casAuthors">Luo, Min; Groaz, Elisabetta; Andrei, Graciela; Snoeck, Robert; Kalkeri, Raj; Ptak, Roger G.; Hartman, Tracy; Buckheit, Robert W.; Schols, Dominique; De Jonghe, Steven; Herdewijn, Piet</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6220-6238</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleosides contg. a 3-fluoro-2-(phosphonomethoxy)propyl (FPMP) side chain are known to be moderately potent antihuman immunodeficiency virus (HIV) agents, while being completely devoid of antiviral activity against a wide range of DNA viruses.  The derivatization of the phosphonic acid functionality of FPMPs with a diamyl aspartate phenoxyamidate group led to a novel generation of compds. that not only demonstrate drastically improved antiretroviral potency but also are characterized by an expanded spectrum of activity that also covers hepatitis B and herpes viruses.  The best compd., the (S)-FPMPA amidate prodrug, exerts anti-HIV-1 activity in TZM-bl and peripheral blood mononuclear cells at low nanomolar concns. and displays excellent potency against hepatitis B virus (HBV) and varicella-zoster virus (VZV).  This prodrug is stable in acid and human plasma media, but it is efficiently processed in human liver microsomes with a half-life of 2 min.  The (R) isomeric guanine deriv. emerged as a selectively active anti-HIV and anti-HBV inhibitor, while being nontoxic to human hepatoblastoma cells.  Notably, the pyrimidine contg. prodrug (S)-Asp-FPMPC is the only congener within this series to demonstrate micromolar anti-human cytomegalovirus (HCMV) potency.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGtv8LuFewrVg90H21EOLACvtfcHk0ljBOamgwyN7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFWksrrI&md5=679f9608498a9ed560ad5f4e90de892b</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00416%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DM.%26aulast%3DGroaz%26aufirst%3DE.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DKalkeri%26aufirst%3DR.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DHartman%26aufirst%3DT.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DSchols%26aufirst%3DD.%26aulast%3DDe%2BJonghe%26aufirst%3DS.%26aulast%3DHerdewijn%26aufirst%3DP.%26atitle%3DExpanding%2520the%2520Antiviral%2520Spectrum%2520of%25203-Fluoro-2-%2528phosphonomethoxy%2529propyl%2520Acyclic%2520Nucleoside%2520Phosphonates%253A%2520Diamyl%2520Aspartate%2520Amidate%2520Prodrugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D6220%26epage%3D6238%26doi%3D10.1021%2Facs.jmedchem.7b00416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robins, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatfield, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span> <span> </span><span class="NLM_article-title">Nucleic Acid Related Compounds. 47. Synthesis and Biological Activities of Pyrimidine and Purine “Acyclic” Nucleoside Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1486</span>– <span class="NLM_lpage">1492</span>, <span class="refDoi"> DOI: 10.1021/jm00377a018</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00377a018" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL2MXitVChs70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=1486-1492&author=M.+J.+Robinsauthor=P.+W.+Hatfieldauthor=J.+Balzariniauthor=E.+De+Clercq&title=Nucleic+Acid+Related+Compounds.+47.+Synthesis+and+Biological+Activities+of+Pyrimidine+and+Purine+%E2%80%9CAcyclic%E2%80%9D+Nucleoside+Analogues&doi=10.1021%2Fjm00377a018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nucleic acid related compounds.  47.  Synthesis and biological activities of pyrimidine and purine "acyclic" nucleoside analogs</span></div><div class="casAuthors">Robins, Morris J.; Hatfield, Peter W.; Balzarini, Jan; De Clercq, Erik</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1486-92</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Various acyclic, i.e., (2-hydroxyethoxy)methyl and (2-acetoxyethoxy)methyl, analogs of pyrimidine and purine nucleosides were prepd. and evaluated for their antiviral, antimetabolic, and cytotoxic properties.  All of the pyrimidine analogs, including (E)-5-(2-bromovinyl)-1-[(2-hydroxyethoxy)methyl]uracil and its O-acetyl deriv., were virtually devoid of antiviral, cytotoxic, and antimetabolic activities.  However, several of the 8-substituted derivs. of (I) had higher antiviral specificity in vitro than the parent drug.  The 8-methyl-, 8-bromo-, and 8-iodoacyclovir derivs. have sufficient activities to warrant further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmt5CF0CtvirVg90H21EOLACvtfcHk0ljBOamgwyN7-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitVChs70%253D&md5=a61f988f585e2499e335c7af36a9a601</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1021%2Fjm00377a018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00377a018%26sid%3Dliteratum%253Aachs%26aulast%3DRobins%26aufirst%3DM.%2BJ.%26aulast%3DHatfield%26aufirst%3DP.%2BW.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26atitle%3DNucleic%2520Acid%2520Related%2520Compounds.%252047.%2520Synthesis%2520and%2520Biological%2520Activities%2520of%2520Pyrimidine%2520and%2520Purine%2520%25E2%2580%259CAcyclic%25E2%2580%259D%2520Nucleoside%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D1486%26epage%3D1492%26doi%3D10.1021%2Fjm00377a018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, <i>Plasmodium falciparum</i> and <i>vivax</i> 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">827</span>– <span class="NLM_lpage">846</span>, <span class="refDoi"> DOI: 10.1021/jm501416t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501416t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=827-846&author=D.+T.+Keoughauthor=D.+Hockov%C3%A1author=Z.+Janebaauthor=T.-H.+Wangauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=M.+Chavchichauthor=L.+W.+Guddat&title=Aza-acyclic+Nucleoside+Phosphonates+Containing+a+Second+Phosphonate+Group+As+Inhibitors+of+the+Human%2C+Plasmodium+falciparum+and+vivax+6-Oxopurine+Phosphoribosyltransferases+and+Their+Prodrugs+As+Antimalarial+Agents&doi=10.1021%2Fjm501416t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Aza-acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group As Inhibitors of the Human, Plasmodium falciparum and vivax 6-Oxopurine Phosphoribosyltransferases and Their Prodrugs As Antimalarial Agents</span></div><div class="casAuthors">Keough, Dianne T.; Hockova, Dana; Janeba, Zlatko; Wang, Tzu-Hsuan; Naesens, Lieve; Edstein, Michael D.; Chavchich, Marina; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">827-846</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-[xanthine] phosphoribosyltransferase (HG[X]PRT) is considered an important target for antimalarial chemotherapy as it is the only pathway for the synthesis of the purine nucleoside monophosphates required for DNA/RNA prodn.  Thus, inhibition of this enzyme should result in cessation of replication.  The aza-acyclic nucleoside phosphonates (aza-ANPs) are good inhibitors of Plasmodium falciparum HGXPRT (PfHGXPRT), with Ki values as low as 0.08 and 0.01 μM for Plasmodium vivax HGPRT (PvHGPRT).  Prodrugs of these aza-ANPs exhibit antimalarial activity against Pf lines with IC50 values (0.8-6.0 μM) and have low cytotoxicity against human cells.  Crystal structures of six of these compds. in complex with human HGPRT have been detd.  These suggest that the different affinities of these aza-ANPs could be due to the flexibility of the loops surrounding the active site as well as the flexibility of the inhibitors, allowing them to adapt to fit into three binding pockets of the enzyme(s).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9eXB3S3z3v7Vg90H21EOLACvtfcHk0lgulsCAZrptDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyhsrzF&md5=c7d1dad69f99a1b4928b2a65fa411670</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm501416t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501416t%26sid%3Dliteratum%253Aachs%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DAza-acyclic%2520Nucleoside%2520Phosphonates%2520Containing%2520a%2520Second%2520Phosphonate%2520Group%2520As%2520Inhibitors%2520of%2520the%2520Human%252C%2520Plasmodium%2520falciparum%2520and%2520vivax%25206-Oxopurine%2520Phosphoribosyltransferases%2520and%2520Their%2520Prodrugs%2520As%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D827%26epage%3D846%26doi%3D10.1021%2Fjm501416t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Jersey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Novel <i>N</i>-Branched Acyclic Nucleoside Phosphonates As Potent and Selective Inhibitors of Human, <i>Plasmodium falciparum</i> and <i>Plasmodium vivax</i> 6-Oxopurine Phosphoribosyltransferases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">6209</span>– <span class="NLM_lpage">6223</span>, <span class="refDoi"> DOI: 10.1021/jm300662d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300662d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC38XptFSqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6209-6223&author=D.+Hockov%C3%A1author=D.+T.+Keoughauthor=Z.+Janebaauthor=T.-H.+Wangauthor=J.+de+Jerseyauthor=L.+W.+Guddat&title=Synthesis+of+Novel+N-Branched+Acyclic+Nucleoside+Phosphonates+As+Potent+and+Selective+Inhibitors+of+Human%2C+Plasmodium+falciparum+and+Plasmodium+vivax+6-Oxopurine+Phosphoribosyltransferases&doi=10.1021%2Fjm300662d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Novel N-Branched Acyclic Nucleoside Phosphonates As Potent and Selective Inhibitors of Human, Plasmodium falciparum and Plasmodium vivax 6-Oxopurine Phosphoribosyltransferases</span></div><div class="casAuthors">Hockova, Dana; Keough, Dianne T.; Janeba, Zlatko; Wang, Tzu-Hsuan; de Jersey, John; Guddat, Luke W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6209-6223</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Hypoxanthine-guanine-(xanthine) phosphoribosyltransferase (HG(X)PRT) is crucial for the survival of malarial parasites Plasmodium falciparum (Pf) and Plasmodium vivax (Pv).  Acyclic nucleoside phosphonates (ANPs), e.g. I, are inhibitors of HG(X)PRT and arrest the growth of Pf in cell culture.  Here, a novel class of ANPs contg. tri-substituted nitrogen (aza-ANPs) has been synthesized.  These compds. have a wide range of Ki values and selectivity for human HGPRT, Pf-HGXPRT, and Pv-HGPRT.  The most selective and potent inhibitor of PfHGXPRT is 9-[N-(3-methoxy-3-oxopropyl)-N-(2-phosphonoethyl)-2-aminoethyl]hypoxanthine (Ki = 100 nM): no inhibition could be detected against the human enzyme.  This compd. exhibits the highest ever reported selectivity for Pf-HGXPRT compared to human HGPRT.  For PvHGPRT, 9-[N-(2-carboxyethyl)-N-(2-phosphonoethyl)-2-aminoethyl]guanine has a Ki of 50 nM, the best inhibitor discovered for this enzyme to date.  Docking of these compds. into the known structures of human HGPRT in complex with ANP-based inhibitors suggests reasons for the variations in affinity, providing insights for the design of antimalarial drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAXg_dZCN5dLVg90H21EOLACvtfcHk0lgulsCAZrptDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XptFSqu7s%253D&md5=05843608636dee6cb3ef85c937d3cf3f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fjm300662d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300662d%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DT.-H.%26aulast%3Dde%2BJersey%26aufirst%3DJ.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26atitle%3DSynthesis%2520of%2520Novel%2520N-Branched%2520Acyclic%2520Nucleoside%2520Phosphonates%2520As%2520Potent%2520and%2520Selective%2520Inhibitors%2520of%2520Human%252C%2520Plasmodium%2520falciparum%2520and%2520Plasmodium%2520vivax%25206-Oxopurine%2520Phosphoribosyltransferases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6209%26epage%3D6223%26doi%3D10.1021%2Fjm300662d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Špaček, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keough, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chavchich, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dračínský, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janeba, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edstein, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guddat, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of <i>Plasmodium falciparum</i> and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7539</span>– <span class="NLM_lpage">7554</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00926</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00926" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlCgu7rP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7539-7554&author=P.+%C5%A0pa%C4%8Dekauthor=D.+T.+Keoughauthor=M.+Chavchichauthor=M.+Dra%C4%8D%C3%ADnsk%C3%BDauthor=Z.+Janebaauthor=L.+Naesensauthor=M.+D.+Edsteinauthor=L.+W.+Guddatauthor=D.+Hockov%C3%A1&title=Synthesis+and+Evaluation+of+Asymmetric+Acyclic+Nucleoside+Bisphosphonates+as+Inhibitors+of+Plasmodium+falciparum+and+Human+Hypoxanthine-Guanine-%28Xanthine%29+Phosphoribosyltransferase&doi=10.1021%2Facs.jmedchem.7b00926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Evaluation of Asymmetric Acyclic Nucleoside Bisphosphonates as Inhibitors of Plasmodium falciparum and Human Hypoxanthine-Guanine-(Xanthine) Phosphoribosyltransferase</span></div><div class="casAuthors">Spacek, Petr; Keough, Dianne T.; Chavchich, Marina; Dracinsky, Martin; Janeba, Zlatko; Naesens, Lieve; Edstein, Michael D.; Guddat, Luke W.; Hockova, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7539-7554</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Acyclic nucleoside bisphosphonates (ANbPs) have previously been shown to be good inhibitors of human hypoxanthine-guanine phosphoribosyltransferase (HGPRT) and Plasmodium falciparum (Pf) hypoxanthine-guanine-xanthine phosphoribosyltransferase (PfHGXPRT).  On the basis of this scaffold, a new series of ANbPs was synthesized.  One of these new ANbPs, [3-(guanine-9-yl)-2-((2-phosphonoethoxy)methyl)propoxy]methylphosphonic acid, exhibited Ki values of 6 and 70 nM for human HGPRT and Pf HGXPRT, resp.  These low Ki values were achieved by inserting an extra carbon atom in the linker connecting the N9 atom of guanine to one of the phosphonate groups.  The crystal structure of this ANbP in complex with human HGPRT was detd. at 2.0 Å resoln. and shows that it fills three key pockets in the active site.  The most potent phosphoramidate prodrugs of these compds. have IC50 values in the low micromolar range in Pf lines and low toxicity in human A549 cells, demonstrating that these ANbPs are excellent antimalarial drug leads.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnSzTuy4-WwrVg90H21EOLACvtfcHk0lgulsCAZrptDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlCgu7rP&md5=9c47d1dfc40b240ad2c152b3cb542eec</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00926%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0pa%25C4%258Dek%26aufirst%3DP.%26aulast%3DKeough%26aufirst%3DD.%2BT.%26aulast%3DChavchich%26aufirst%3DM.%26aulast%3DDra%25C4%258D%25C3%25ADnsk%25C3%25BD%26aufirst%3DM.%26aulast%3DJaneba%26aufirst%3DZ.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DEdstein%26aufirst%3DM.%2BD.%26aulast%3DGuddat%26aufirst%3DL.%2BW.%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26atitle%3DSynthesis%2520and%2520Evaluation%2520of%2520Asymmetric%2520Acyclic%2520Nucleoside%2520Bisphosphonates%2520as%2520Inhibitors%2520of%2520Plasmodium%2520falciparum%2520and%2520Human%2520Hypoxanthine-Guanine-%2528Xanthine%2529%2520Phosphoribosyltransferase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7539%26epage%3D7554%26doi%3D10.1021%2Facs.jmedchem.7b00926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chu, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cutler, S. J.</span></span> <span> </span><span class="NLM_article-title">Chemistry and antiviral activities of acyclonucleosides</span>. <i>J. Heterocycl. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">319</span>, <span class="refDoi"> DOI: 10.1002/jhet.5570230201</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fjhet.5570230201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaL28XltlChtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1986&pages=289-319&author=C.+K.+Chuauthor=S.+J.+Cutler&title=Chemistry+and+antiviral+activities+of+acyclonucleosides&doi=10.1002%2Fjhet.5570230201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry and antiviral activities of acyclonucleosides</span></div><div class="casAuthors">Chu, Chung K.; Cutler, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Heterocyclic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">289-319</span>CODEN:
                <span class="NLM_cas:coden">JHTCAD</span>;
        ISSN:<span class="NLM_cas:issn">0022-152X</span>.
    </div><div class="casAbstract">A review with 212 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrddxV4eb1sg7Vg90H21EOLACvtfcHk0liA4RpIjUxmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XltlChtrg%253D&md5=3ad93f073fe68af5e18d6310b9c21460</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1002%2Fjhet.5570230201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjhet.5570230201%26sid%3Dliteratum%253Aachs%26aulast%3DChu%26aufirst%3DC.%2BK.%26aulast%3DCutler%26aufirst%3DS.%2BJ.%26atitle%3DChemistry%2520and%2520antiviral%2520activities%2520of%2520acyclonucleosides%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1986%26volume%3D23%26spage%3D289%26epage%3D319%26doi%3D10.1002%2Fjhet.5570230201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jeffery, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiemer, D. F.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Acyclic Nucleoside and Nucleotide Analogues from Amino Acids: A Convenient Approach to a PMEA-PMPA Hybrid</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">5077</span>– <span class="NLM_lpage">5083</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(00)00422-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0040-4020%2800%2900422-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkslWks70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2000&pages=5077-5083&author=A.+L.+Jefferyauthor=J.-H.+Kimauthor=D.+F.+Wiemer&title=Synthesis+of+Acyclic+Nucleoside+and+Nucleotide+Analogues+from+Amino+Acids%3A+A+Convenient+Approach+to+a+PMEA-PMPA+Hybrid&doi=10.1016%2FS0040-4020%2800%2900422-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of Acyclic Nucleoside and Nucleotide Analogues from Amino Acids: A Convenient Approach to a PMEA-PMPA Hybrid</span></div><div class="casAuthors">Jeffery, A. L.; Kim, J.-H.; Wiemer, D. F.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">5077-5083</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Non-racemic amino alcs. derived from common amino acids have been used to assemble acyclic nucleoside and nucleotide analogs with control of abs. stereochem.  Both (R)- and (S)-2-amino-1-propanol, readily available from D- or L-alanine, were used to prep. the nucleoside analogs (R)- and (S)-9-[1-methyl-2-hydroxyethyl]adenine, and then the nucleotide analogs (R)- and (S)-9-[1-methyl-2-phosphonomethoxyethyl]adenine.  In a similar fashion, the CBz deriv. of L-threonine was used to prep. first (1R,2R)-9-[1-hydroxymethyl-2-hydroxypropyl]adenine, and then the bis phosphonomethoxy deriv.  The bis phosphonate derived from threonine represents a unique structural hybrid of PMEA and PMPA, both of which have well established antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9xzWkkc7n8LVg90H21EOLACvtfcHk0liA4RpIjUxmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkslWks70%253D&md5=8a7d82c6dcc825dda3c1f10ba7c5497f</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2800%2900422-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252800%252900422-1%26sid%3Dliteratum%253Aachs%26aulast%3DJeffery%26aufirst%3DA.%2BL.%26aulast%3DKim%26aufirst%3DJ.-H.%26aulast%3DWiemer%26aufirst%3DD.%2BF.%26atitle%3DSynthesis%2520of%2520Acyclic%2520Nucleoside%2520and%2520Nucleotide%2520Analogues%2520from%2520Amino%2520Acids%253A%2520A%2520Convenient%2520Approach%2520to%2520a%2520PMEA-PMPA%2520Hybrid%26jtitle%3DTetrahedron%26date%3D2000%26volume%3D56%26spage%3D5077%26epage%3D5083%26doi%3D10.1016%2FS0040-4020%2800%2900422-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">Acyclic nucleoside phosphonates: a key class of antiviral drugs</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">928</span>– <span class="NLM_lpage">940</span>, <span class="refDoi"> DOI: 10.1038/nrd1877</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fnrd1877" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=16264436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=928-940&author=E.+De%0AClercqauthor=A.+Hol%C3%BD&title=Acyclic+nucleoside+phosphonates%3A+a+key+class+of+antiviral+drugs&doi=10.1038%2Fnrd1877"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Case history: Acyclic nucleoside phosphonates: a key class of antiviral drugs</span></div><div class="casAuthors">De Clercq, Erik; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">928-940</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Almost 20 years after the broad antiviral activity spectrum of the first acyclic nucleoside phosphonates was described, several of these compds. have become important therapies for DNA virus and retrovirus infections.  Here, we review the discovery and development of acyclic nucleoside phosphonates, focusing on cidofovir and its potential in the treatment of various herpes-, papilloma-, polyoma-, adeno- and pox-virus infections, adefovir for the treatment of hepatitis B and tenofovir for the treatment of AIDS and the prevention of HIV infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNefpTEtM7I7Vg90H21EOLACvtfcHk0liA4RpIjUxmOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFKlsLfI&md5=435eccb35f6ebdf86452f583e9e5fb72</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrd1877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1877%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3DAcyclic%2520nucleoside%2520phosphonates%253A%2520a%2520key%2520class%2520of%2520antiviral%2520drugs%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2005%26volume%3D4%26spage%3D928%26epage%3D940%26doi%3D10.1038%2Fnrd1877" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furman, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fyfe, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span> <span> </span><span class="NLM_article-title">Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">5716</span>– <span class="NLM_lpage">5720</span>, <span class="refDoi"> DOI: 10.1073/pnas.74.12.5716</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1073%2Fpnas.74.12.5716" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=202961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXhvVanurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1977&pages=5716-5720&author=G.+B.+Elionauthor=P.+A.+Furmanauthor=J.+A.+Fyfeauthor=P.+De+Mirandaauthor=L.+Beauchampauthor=H.+J.+Schaeffer&title=Selectivity+of+action+of+an+antiherpetic+agent%2C+9-%282-hydroxyethoxymethyl%29guanine&doi=10.1073%2Fpnas.74.12.5716"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl)guanine</span></div><div class="casAuthors">Elion, Gertrude B.; Furman, Phillip A.; Fyfe, James A.; De Miranda, Paulo; Beauchamp, Lilia; Schaeffer, Howard J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5716-20</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">Acycloguanosine (I)  [59277-89-3] had potent antiviral activity (ED50 = 0.1 μM) against herpes simplex virus type I.  I was converted to a monophosphate  [66341-16-0] by a virus-specified thymidine kinase  [9002-06-6] and was subsequently converted to I di-  [66341-17-1] and I triphosphates  [66341-18-2].  In the uninfected host cell (Vero), these phosphorylations of I occurred at only a very limited extent.  I triphosphate inhibited herpes simplex virus DNA nucleotidyltransferase  [9012-90-2] 10-30 times more effectively than cellular (HeLa S3) DNA nucleotidyltransferase.  These factors contribute to I selectivity; inhibition of growth of the host cell requires a 3000-fold greater concn. of drug than does the inhibition of viral multiplication.  The identify of the kinase that phosphorylates I was detd. after sepn. of the cellular and virus-specified thymidine kinase activities by affinity chromatog., by reversal studies with thymidine, and by the lack of monophosphate formation in a temp.-sensitive, thymidine kinase-deficient mutant of the KOS strain of herpes simplex virus type 1 (tsA1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4WWPCnssW2bVg90H21EOLACvtfcHk0lgxeE2jmF_K3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXhvVanurw%253D&md5=ed4071cc91116c4f97715e203614b005</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1073%2Fpnas.74.12.5716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.74.12.5716%26sid%3Dliteratum%253Aachs%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DFurman%26aufirst%3DP.%2BA.%26aulast%3DFyfe%26aufirst%3DJ.%2BA.%26aulast%3DDe%2BMiranda%26aufirst%3DP.%26aulast%3DBeauchamp%26aufirst%3DL.%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26atitle%3DSelectivity%2520of%2520action%2520of%2520an%2520antiherpetic%2520agent%252C%25209-%25282-hydroxyethoxymethyl%2529guanine%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1977%26volume%3D74%26spage%3D5716%26epage%3D5720%26doi%3D10.1073%2Fpnas.74.12.5716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schaeffer, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beauchamp, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miranda, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elion, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bauer, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collins, P.</span></span> <span> </span><span class="NLM_article-title">9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group.</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>272</i></span>,  <span class="NLM_fpage">583</span>– <span class="NLM_lpage">585</span>, <span class="refDoi"> DOI: 10.1038/272583a0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2F272583a0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=205792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXltVSjsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=272&publication_year=1978&pages=583-585&author=H.+J.+Schaefferauthor=L.+Beauchampauthor=P.+de+Mirandaauthor=G.+B.+Elionauthor=D.+J.+Bauerauthor=P.+Collins&title=9-%282-Hydroxyethoxymethyl%29guanine+activity+against+viruses+of+the+herpes+group.&doi=10.1038%2F272583a0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">9-(2-Hydroxyethoxymethyl)guanine activity against viruses of the herpes group</span></div><div class="casAuthors">Schaeffer, H. J.; Beauchamp, Lilia; De Miranda, P.; Elion, Gertrude B.; Bauer, D. J.; Collins, P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">272</span>
        (<span class="NLM_cas:issue">5654</span>),
    <span class="NLM_cas:pages">583-5</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    </div><div class="casAbstract">Of a series of nucleoside analogs synthesized, 9-(2-hydroxyethoxymethyl)guanine (I)  [59277-89-3] had marked antiviral activity with low toxicity in animal models of herpes virus infections.  In mice the oral and i.p. LD50 values for I were >10,000 and 1000 mg/kg, resp.; no toxicity was obsd. in mice given oral I (450 mg/kg) daily for 30 days.  In mice given I, 14C-labeled at the 8-position of the guanine nucleus, 82 and 94% of label was excreted in urine by 4 and 24 h, resp., essentially as unmetabolized I.  No appreciable I binding to plasma or tissues was obsd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3OmyVfempg7Vg90H21EOLACvtfcHk0lgxeE2jmF_K3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXltVSjsr0%253D&md5=383b527f72528e860c4b21f2fdb7fccd</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1038%2F272583a0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F272583a0%26sid%3Dliteratum%253Aachs%26aulast%3DSchaeffer%26aufirst%3DH.%2BJ.%26aulast%3DBeauchamp%26aufirst%3DL.%26aulast%3Dde%2BMiranda%26aufirst%3DP.%26aulast%3DElion%26aufirst%3DG.%2BB.%26aulast%3DBauer%26aufirst%3DD.%2BJ.%26aulast%3DCollins%26aufirst%3DP.%26atitle%3D9-%25282-Hydroxyethoxymethyl%2529guanine%2520activity%2520against%2520viruses%2520of%2520the%2520herpes%2520group.%26jtitle%3DNature%26date%3D1978%26volume%3D272%26spage%3D583%26epage%3D585%26doi%3D10.1038%2F272583a0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">De
Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descamps, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Somer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holý, A.</span></span> <span> </span><span class="NLM_article-title">(S)-9-(2,3-Dihydroxypropyl)adenine: An Aliphatic Nucleoside Analog with Broad-Spectrum Antiviral Activity</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">563</span>– <span class="NLM_lpage">565</span>, <span class="refDoi"> DOI: 10.1126/science.200.4341.563</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1126%2Fscience.200.4341.563" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=17839440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaE1cXkvF2qtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=1978&pages=563-565&author=E.+De%0AClercqauthor=J.+Descampsauthor=P.+De+Somerauthor=A.+Hol%C3%BD&title=%28S%29-9-%282%2C3-Dihydroxypropyl%29adenine%3A+An+Aliphatic+Nucleoside+Analog+with+Broad-Spectrum+Antiviral+Activity&doi=10.1126%2Fscience.200.4341.563"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">(S)-9-(2,3-Dihydroxypropyl)adenine:  an aliphatic nucleoside analog with broad-spectrum antiviral activity</span></div><div class="casAuthors">De Clercq, Erik; Descamps, Johan; De Somer, Pierre; Holy, Antonin</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">200</span>
        (<span class="NLM_cas:issue">4341</span>),
    <span class="NLM_cas:pages">563-5</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">(S)-9-(2,3-Dihydroxypropyl)adenine (I)  [54262-83-8], a novel nucleoside analog, the sugar moiety of which is replaced by an aliph. chain, inhibited the replication in vitro of several DNA and RNA viruses, including vaccinia, herpes simplex (types 1 and 2), measles, and vesicular stomatitis.  It was also effective in vivo in reducing the mortality rate of mice inoculated intranasally with vesicular stomatitis virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkW_-BORiddbVg90H21EOLACvtfcHk0lgxeE2jmF_K3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXkvF2qtbk%253D&md5=fdeb3a0d1bf06684d4fd995f6879fae2</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1126%2Fscience.200.4341.563&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.200.4341.563%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DDescamps%26aufirst%3DJ.%26aulast%3DDe%2BSomer%26aufirst%3DP.%26aulast%3DHol%25C3%25BD%26aufirst%3DA.%26atitle%3D%2528S%2529-9-%25282%252C3-Dihydroxypropyl%2529adenine%253A%2520An%2520Aliphatic%2520Nucleoside%2520Analog%2520with%2520Broad-Spectrum%2520Antiviral%2520Activity%26jtitle%3DScience%26date%3D1978%26volume%3D200%26spage%3D563%26epage%3D565%26doi%3D10.1126%2Fscience.200.4341.563" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelic, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">405</span>– <span class="NLM_lpage">413</span>, <span class="refDoi"> DOI: 10.1016/S0223-5234(99)80090-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0223-5234%2899%2980090-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFert7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1999&pages=405-413&author=S.+Rai%C4%87-Mali%C4%87author=M.+Grdi%C5%A1aauthor=K.+Pavelicauthor=M.+Mintas&title=Synthesis+and+biological+evaluation+of+the+novel+purine+and+pyrimidine+nucleoside+analogues+containing+2%2C3-epoxypropyl%2C+3-amino-2-hydroxypropyl+or+2%2C3-epoxypropyl+ether+moieties&doi=10.1016%2FS0223-5234%2899%2980090-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties</span></div><div class="casAuthors">Raic-Malic, Silvana; Grdisa, Mira; Pavelic, Kresimir; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">405-413</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">The novel purine and pyrimidine nucleoside analogs possessing a 2,3-epoxypropyl, 2,3-epoxypropyl ether, or 3-amino-2-hydroxypropyl, e. g. I, moiety bonded at either N-9 of the C-6 substituted purine ring or N-1 and N-3 of the pyrimidine ring, were prepd. and evaluated on their antitumor and antiviral activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD_3d-KqmH7bVg90H21EOLACvtfcHk0linBz-ehgXlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFert7g%253D&md5=86e152aa98c60f5b73f2b6f97ab9067d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2FS0223-5234%2899%2980090-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0223-5234%252899%252980090-7%26sid%3Dliteratum%253Aachs%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPavelic%26aufirst%3DK.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520novel%2520purine%2520and%2520pyrimidine%2520nucleoside%2520analogues%2520containing%25202%252C3-epoxypropyl%252C%25203-amino-2-hydroxypropyl%2520or%25202%252C3-epoxypropyl%2520ether%2520moieties%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1999%26volume%3D34%26spage%3D405%26epage%3D413%26doi%3D10.1016%2FS0223-5234%2899%2980090-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prekupec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svedružić, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazivoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvoš-Sermek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkers, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Biological Evaluation of Iodinated and Fluorinated 9-(2-Hydroxypropyl) and 9-(2-Hydroxyethoxy)methyl Purine Nucleoside Analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5763</span>– <span class="NLM_lpage">5772</span>, <span class="refDoi"> DOI: 10.1021/jm0308747</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0308747" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptV2gu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=5763-5772&author=S.+Prekupecauthor=D.+Svedru%C5%BEi%C4%87author=T.+Gazivodaauthor=D.+Mrvo%C5%A1-Sermekauthor=A.+Naglauthor=M.+Grdi%C5%A1aauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=G.+Folkersauthor=L.+Scapozzaauthor=M.+Mintasauthor=S.+Rai%C4%87-Mali%C4%87&title=Synthesis+and+Biological+Evaluation+of+Iodinated+and+Fluorinated+9-%282-Hydroxypropyl%29+and+9-%282-Hydroxyethoxy%29methyl+Purine+Nucleoside+Analogues&doi=10.1021%2Fjm0308747"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Iodinated and Fluorinated 9-(2-Hydroxypropyl) and 9-(2-Hydroxyethoxy)methyl Purine Nucleoside Analogues</span></div><div class="casAuthors">Prekupec, Svjetlana; Svedruzic, Drazenka; Gazivoda, Tatjana; Mrvos-Sermek, Draginja; Nagl, Ante; Grdisa, Mira; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Folkers, Gerd; Scapozza, Leonardo; Mintas, Mladen; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">5763-5772</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel fluorinated and iodinated purine derivs. contg. 9-(2-hydroxypropyl) and 9-(2-hydroxyethoxymethyl) side chains were synthesized by a multistep synthetic route involving Baltz-Schiemann's fluorination and diazotation/iodination as key reactions.  An unequivocal proof for the stereostructure of 6-amino-9-[(2-hydroxyethoxy)methyl]-2-iodo-9H-purine was obtained by X-ray structure anal.  New compds. were evaluated for their cytostatic activity against murine leukemia (L1210); mammary carcinoma (FM3A); and human T-lymphocytes (Molt4/C8 and CEM), melanoma (HBL), cervical carcinoma (HeLa), colon carcinoma (HT29 and SW620), laryngeal carcinoma (Hep2), and pancreatic carcinoma (MiaPaCa2) as well as diploid fibroblasts (WI38).  Of all the compds., 9-(2-acetoxypropyl)-2-amino-1,9-dihydro-6H-purin-6-thione (I) showed the most pronounced inhibitory activity against human SW620 cells.  9-[(2-Acetoxyethoxy)methyl]-2-amino-1,9-dihydro-6H-purin-6-thione (II) exhibited the most selective inhibitory activity against human HeLa, Hep2, SW620, and murine L1210 cell proliferation as compared to normal fibroblast (WI38) cell proliferation.  None of the compds. showed inhibitory activities against HIV-1, HIV-2, HSV-1, and HSV-2, vaccinia, vesicular stomatitis, parainfluenza-3, reovirus-1, Sindbis, Coxsackie B4, or respiratory syncytial virus.  The new purine derivs., particularly I and II, appear to demonstrate sufficient cytostatic potency and selectivity to justify further evaluation of their potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMWBpV-Y7BwLVg90H21EOLACvtfcHk0linBz-ehgXlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptV2gu7w%253D&md5=e09236bd61bad05795dac00d6a1a19e2</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1021%2Fjm0308747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0308747%26sid%3Dliteratum%253Aachs%26aulast%3DPrekupec%26aufirst%3DS.%26aulast%3DSvedru%25C5%25BEi%25C4%2587%26aufirst%3DD.%26aulast%3DGazivoda%26aufirst%3DT.%26aulast%3DMrvo%25C5%25A1-Sermek%26aufirst%3DD.%26aulast%3DNagl%26aufirst%3DA.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DFolkers%26aufirst%3DG.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DMintas%26aufirst%3DM.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Biological%2520Evaluation%2520of%2520Iodinated%2520and%2520Fluorinated%25209-%25282-Hydroxypropyl%2529%2520and%25209-%25282-Hydroxyethoxy%2529methyl%2520Purine%2520Nucleoside%2520Analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D5763%26epage%3D5772%26doi%3D10.1021%2Fjm0308747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kralj, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Šuman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">8126</span>– <span class="NLM_lpage">8138</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2006.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2006.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=16889965" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLfE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=8126-8138&author=V.+Kri%C5%A1taforauthor=S.+Rai%C4%87-Mali%C4%87author=M.+Cetinaauthor=M.+Kraljauthor=L.+%C5%A0umanauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=M.+Mintas&title=Synthesis%2C+X-ray+crystal+structural+study%2C+antiviral+and+cytostatic+evaluations+of+the+novel+unsaturated+acyclic+and+epoxide+nucleoside+analogues&doi=10.1016%2Fj.bmc.2006.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, X-ray crystal structural study, antiviral and cytostatic evaluations of the novel unsaturated acyclic and epoxide nucleoside analogues</span></div><div class="casAuthors">Kristafor, Vedran; Raic-Malic, Silvana; Cetina, Mario; Kralj, Marijeta; Suman, Lidija; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">8126-8138</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of the novel purine and pyrimidine nucleoside analogs were synthesized in which the sugar moiety was replaced by the 4-amino-2-butenyl (2-6 and 10-18) and oxiranyl (8 and 20) spacer.  The Z- (2-6) and E-isomers (10-18) of unsatd. acyclic nucleoside analogs were synthesized by condensation of 2- and 6-substituted purine and 5-substituted uracil bases with Z- (1) or E-phthalimide (9) precursors.  The oxiranyl nucleoside analogs (8 and 20) were obtained by epoxidn. of 1 and 9 with m-chloroperoxybenzoic acid and subsequent coupling with adenine.  The new compds. were evaluated for their antiviral and antitumor cell activities.  Among the olefinic nucleoside analogs, Z-isomer of adenine contg. 4-amino-2-butenyl side chain (I) exhibited the best cytostatic activities, particularly against colon carcinoma (SW 620, IC50 = 26 μM).  Its E-isomer 15 did not show any antiproliferative activity against malignant tumor cell lines, except for a slight inhibition of colon carcinoma (SW 620, IC50 = 56.5 μM) cells.  In general, Z-isomers showed better cytostatic activities than the corresponding E-isomers.  (Z)-4-Amino-2-butenyl-adenine nucleoside analog I showed albeit modest but selective activity against HIV-1 (EC50 = 4.83 μg mL-1).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpswH9DmWXbCrVg90H21EOLACvtfcHk0linBz-ehgXlOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFSrtLfE&md5=9e90bffbbfe9f50e8df2a2c0d78332a7</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2006.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2006.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DKralj%26aufirst%3DM.%26aulast%3D%25C5%25A0uman%26aufirst%3DL.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520X-ray%2520crystal%2520structural%2520study%252C%2520antiviral%2520and%2520cytostatic%2520evaluations%2520of%2520the%2520novel%2520unsaturated%2520acyclic%2520and%2520epoxide%2520nucleoside%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D8126%26epage%3D8138%26doi%3D10.1016%2Fj.bmc.2006.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wittine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratulić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytostatic and anti-viral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (<i>Z</i>)-4-amino-2-butenyl moiety</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">280</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1007/s00044-010-9318-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs00044-010-9318-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXis1ertLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=280-286&author=K.+Wittineauthor=K.+Benciauthor=S.+Kraljevi%C4%87+Paveli%C4%87author=K.+Paveli%C4%87author=S.+Bratuli%C4%87author=K.+Hockauthor=J.+Balzariniauthor=M.+Mintas&title=Synthesis%2C+cytostatic+and+anti-viral+activity+evaluation+of+the+novel+acyclic+nucleoside+analogues+containing+a+sterically+constrained+%28Z%29-4-amino-2-butenyl+moiety&doi=10.1007%2Fs00044-010-9318-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytostatic and anti-viral activity evaluation of the novel acyclic nucleoside analogues containing a sterically constrained (Z)-4-amino-2-butenyl moiety</span></div><div class="casAuthors">Wittine, Karlo; Benci, Kresimir; Kraljevic Pavelic, Sandra; Pavelic, Kresimir; Bratulic, Sinisa; Hock, Karlo; Balzarini, Jan; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-286</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Boston</span>)
        </div><div class="casAbstract">A series of the novel pyrimidine I and II [R1 = CH2CH:CHCH2NH2-(Z), R5 = H, Me] and purine III [R2 = H, NH2, R6 = NH2, R9 = CH2CH:CHCH2NH2; R2 = NH2, R6 = Cl, R9 = CH2CH:CHCH2NH2.HCl-(Z); R2 = NH2, R6 = NH2, R9 = (CH2)2NH2; R2 = H, R6 = 1-pyrrolyl, R9 = (CH2)4NH2.HCl] and IV [R2 = H, NH2, R9 = CH2CH:CHCH2NH2.HCl-(Z)] acyclic nucleoside analogs in which the sugar moiety was replaced by a sterically constrained Z-4-amino-, 4-aminohydrochloride-2-butenyl, or aliph. 4-aminohydrochloride-2-Bu moiety was synthesized and evaluated for their anti-viral and cytostatic activity potency.  Cytostatic evaluation of the novel compds. on selected panel of human tumor-cell lines showed that the majority of compds. exerted a non-specific anti-proliferative effect at the highest tested concn. (i.e. 1 × 10-4 M) against all cell lines.  Nevertheless, a rather moderate but selective anti-proliferative effects on HeLa cell cultures in comparison to normal fibroblasts WI 38, were obsd. for compds. III [R2 = NH2, R6 = Cl, R9 = CH2CH:CHCH2NH2.HCl-(Z); R2 = H, R6 = 1-pyrrolyl, R9 = (CH2)4NH2.HCl].  No anti-viral activity was obsd., except for compds. I [R1 = CH2CH:CHCH2NH2-(Z), R5 = H, Me], II [R1 = CH2CH:CHCH2NH2-(Z), R5 = Me] and IV [R2 = NH2, R9 = CH2CH:CHCH2NH2.HCl-(Z)] that showed anti-HIV activity at 50% effective concn. ranging between 10 and 96 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLsjsp6bhYR7Vg90H21EOLACvtfcHk0lgzFEPlY6PcBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXis1ertLc%253D&md5=cc2db30af924c431bb5377d8380fc1a5</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs00044-010-9318-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-010-9318-1%26sid%3Dliteratum%253Aachs%26aulast%3DWittine%26aufirst%3DK.%26aulast%3DBenci%26aufirst%3DK.%26aulast%3DKraljevi%25C4%2587%2BPaveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBratuli%25C4%2587%26aufirst%3DS.%26aulast%3DHock%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520cytostatic%2520and%2520anti-viral%2520activity%2520evaluation%2520of%2520the%2520novel%2520acyclic%2520nucleoside%2520analogues%2520containing%2520a%2520sterically%2520constrained%2520%2528Z%2529-4-amino-2-butenyl%2520moiety%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2011%26volume%3D20%26spage%3D280%26epage%3D286%26doi%3D10.1007%2Fs00044-010-9318-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meščić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harej, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klobučar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glavač, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of New Acid Ceramidase-Targeted Acyclic 5-Alkynyl and 5-Heteroaryl Uracil Nucleosides.</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1150</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.5b00298</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.5b00298" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1SlsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=1150-1155&author=A.+Me%C5%A1%C4%8Di%C4%87author=A.+Harejauthor=M.+Klobu%C4%8Darauthor=D.+Glava%C4%8Dauthor=M.+Cetinaauthor=S.+K.+Paveli%C4%87author=S.+Rai%C4%87-Mali%C4%87&title=Discovery+of+New+Acid+Ceramidase-Targeted+Acyclic+5-Alkynyl+and+5-Heteroaryl+Uracil+Nucleosides.&doi=10.1021%2Facsmedchemlett.5b00298"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of new acid ceramidase-targeted acyclic 5-alkynyl and 5-heteroaryl uracil nucleosides</span></div><div class="casAuthors">Mescic, Andrijana; Harej, Anja; Klobucar, Marko; Glavac, Danijel; Cetina, Mario; Pavelic, Sandra Kraljevic; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1150-1155</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of novel N-acyclic uracil analogs with linear, branched, arom., and cyclopropyl-alkynyl as well as heteroaryl moieties at C-5 were prepd. using palladium catalyzed Sonogashira and Stille cross-coupling and evaluated against malignant tumor cell lines.  C-5-Furan-2-yl uracil deriv. (I) was shown to be more potent against MCF-7 than the ref. drug 5-fluorouracil (5-FU), while C-5-alkynyl uracil derivs. (II) (R1 = p-pentyl-C6H4 and cyclopropyl) exhibited antibreast cancer activities comparable to 5-FU.  Selected compds. induced cell death, partially due to apoptosis, of MCF-7 breast cancer cells.  Abrogation of acid ceramidase (ASAH1) expression of II (R1 = p-pentyl-C6H4 and cyclopropyl) indicated that these compds. could perturb ASAH1-mediated sphingolipid signaling.  The selective activity of II (R1 = p-pentyl-C6H4 and cyclopropyl) against breast cancer cells via the ASAH1-mediated signaling, as a mol. target, might have a great advantage for potential future therapeutic use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJrjivXVrsErVg90H21EOLACvtfcHk0lgzFEPlY6PcBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1SlsbvN&md5=0bbee8a604043417877e7f88992aba49</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.5b00298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.5b00298%26sid%3Dliteratum%253Aachs%26aulast%3DMe%25C5%25A1%25C4%258Di%25C4%2587%26aufirst%3DA.%26aulast%3DHarej%26aufirst%3DA.%26aulast%3DKlobu%25C4%258Dar%26aufirst%3DM.%26aulast%3DGlava%25C4%258D%26aufirst%3DD.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DS.%2BK.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520New%2520Acid%2520Ceramidase-Targeted%2520Acyclic%25205-Alkynyl%2520and%25205-Heteroaryl%2520Uracil%2520Nucleosides.%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D1150%26epage%3D1155%26doi%3D10.1021%2Facsmedchemlett.5b00298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hocková, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hocek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dvořáková, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Votruba, I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and cytostatic activity of nucleosides and acyclic nucleoside analogues derived from 6-(trifluoromethyl)purines</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">11109</span>– <span class="NLM_lpage">11118</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(99)00615-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2FS0040-4020%2899%2900615-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADyaK1MXls12qtLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1999&pages=11109-11118&author=D.+Hockov%C3%A1author=M.+Hocekauthor=H.+Dvo%C5%99%C3%A1kov%C3%A1author=I.+Votruba&title=Synthesis+and+cytostatic+activity+of+nucleosides+and+acyclic+nucleoside+analogues+derived+from+6-%28trifluoromethyl%29purines&doi=10.1016%2FS0040-4020%2899%2900615-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and cytostatic activity of nucleosides and acyclic nucleoside analogues derived from 6-(trifluoromethyl)purines</span></div><div class="casAuthors">Hockova, Dana; Hocek, Michal; Dvorakova, Hana; Votruba, Ivan</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">11109-11118</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Glycosylation and alkylation of 6-(trifluoromethyl)purine by several protected halogenoses or hydroxyalkyl chlorides afforded regio- and stereoselectively the 9-β-nucleosides or 9-alkylated purine derivs. in good yields.  Deprotection of these intermediates gave a series of nucleoside (β-D-ribofuranosyl, 2-deoxy-β-D-ribofuranosyl and β-D-arabinofuranosyl) and acyclonucleoside (2,3-dihydroxypropyl and (2-hydroxyethyl)oxymethyl) derivs. of 6-(trifluoromethyl)purine.  While 9-(β-D-ribofuranosyl)-6-(trifluoromethyl)purine showed significant cytostatic activity, the other derivs. were inactive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUwDWNqib82rVg90H21EOLACvtfcHk0lgzFEPlY6PcBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXls12qtLw%253D&md5=eddd6caa8b03f469e815b51a2e84b3ef</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2899%2900615-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252899%252900615-8%26sid%3Dliteratum%253Aachs%26aulast%3DHockov%25C3%25A1%26aufirst%3DD.%26aulast%3DHocek%26aufirst%3DM.%26aulast%3DDvo%25C5%2599%25C3%25A1kov%25C3%25A1%26aufirst%3DH.%26aulast%3DVotruba%26aufirst%3DI.%26atitle%3DSynthesis%2520and%2520cytostatic%2520activity%2520of%2520nucleosides%2520and%2520acyclic%2520nucleoside%2520analogues%2520derived%2520from%25206-%2528trifluoromethyl%2529purines%26jtitle%3DTetrahedron%26date%3D1999%26volume%3D55%26spage%3D11109%26epage%3D11118%26doi%3D10.1016%2FS0040-4020%2899%2900615-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prekupec, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalokira, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and Comparative Cytostatic Activity of the New N-7 Acyclic Purine Nucleoside Analogues with Natural N-9 Regioisomers</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">787</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.3987/COM-04-10320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.3987%2FCOM-04-10320" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjs12qsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=787-796&author=S.+Prekupecauthor=B.+Kalokiraauthor=M.+Grdi%C5%A1aauthor=K.+Paveli%C4%87author=E.+De+Clercqauthor=M.+Mintasauthor=S.+Rai%C4%87-Mali%C4%87&title=Synthesis+and+Comparative+Cytostatic+Activity+of+the+New+N-7+Acyclic+Purine+Nucleoside+Analogues+with+Natural+N-9+Regioisomers&doi=10.3987%2FCOM-04-10320"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and comparative cytostatic activity of the new N-7 acyclic purine nucleoside analogues with natural N-9 regioisomers</span></div><div class="casAuthors">Prekupec, Svjetlana; Kalokira, Blanka; Grdisa, Mira; Pavelic, Kresimir; De Clereq, Erik; Mintas, Mladen; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">787-796</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The synthesis of purine derivs. alkylated at N-7 and N-9 with 2-acetoxyethoxymethyl side chain, and chem. transformations of keto to chloro, chloro to thio at C-6, and amino to fluoro derivs. at the C-2 position of the purine ring were described.  The N-7 regioisomers were evaluated for their cytostatic activities and their inhibitory effects were compared with those of the corresponding N-9 isomers.  A 2-aminopurine-6-thione showed the highest cytostatic activity, particularly against murine leukemia (L1210).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_V1OWLKCfsrVg90H21EOLACvtfcHk0lghPIdtXplEsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjs12qsro%253D&md5=2a4ea50dc0ef304339069daaef41c590</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.3987%2FCOM-04-10320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-04-10320%26sid%3Dliteratum%253Aachs%26aulast%3DPrekupec%26aufirst%3DS.%26aulast%3DKalokira%26aufirst%3DB.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520Comparative%2520Cytostatic%2520Activity%2520of%2520the%2520New%2520N-7%2520Acyclic%2520Purine%2520Nucleoside%2520Analogues%2520with%2520Natural%2520N-9%2520Regioisomers%26jtitle%3DHeterocycles%26date%3D2005%26volume%3D65%26spage%3D787%26epage%3D796%26doi%3D10.3987%2FCOM-04-10320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gazivoda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makuc, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plavec, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bratulić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević-Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrei, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snoeck, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5624</span>– <span class="NLM_lpage">5634</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2008.03.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2008.03.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=18424155" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsVamsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=5624-5634&author=T.+Gazivodaauthor=S.+Rai%C4%87-Mali%C4%87author=V.+Kri%C5%A1taforauthor=D.+Makucauthor=J.+Plavecauthor=S.+Bratuli%C4%87author=S.+Kraljevi%C4%87-Paveli%C4%87author=K.+Paveli%C4%87author=L.+Naesensauthor=G.+Andreiauthor=R.+Snoeckauthor=J.+Balzariniauthor=M.+Mintas&title=Synthesis%2C+cytostatic+and+anti-HIV+evaluations+of+the+new+unsaturated+acyclic+C-5+pyrimidine+nucleoside+analogues&doi=10.1016%2Fj.bmc.2008.03.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytostatic and anti-HIV evaluations of the new unsaturated acyclic C-5 pyrimidine nucleoside analogues</span></div><div class="casAuthors">Gazivoda, Tatjana; Raic-Malic, Silvana; Kristafor, Vedran; Makuc, Damjan; Plavec, Janez; Bratulic, Sinisa; Kraljevic-Pavelic, Sandra; Pavelic, Kresimir; Naesens, Lieve; Andrei, Graciela; Snoeck, Robert; Balzarini, Jan; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5624-5634</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A series of the novel C-5 alkynyl pyrimidine nucleoside analogs (1-14) in which the sugar moiety was replaced by the conformationally restricted Z- and E-2-butenyl spacer between the phthalimido and pyrimidine ring were synthesized by using Sonogashira cross-coupling reaction.  Cytostatic activity evaluation of the novel compds. showed that E-isomers exhibited, in general, better cytostatic activities than the corresponding Z-isomers.  E-isomer 14 exhibited the best cytostatic effect against all evaluated malignant cell lines, particularly against hepatocellular carcinoma (Hep G2, IC50 = 4.3 μM).  However, this compd. was also cytotoxic to human normal fibroblasts (WI 38).  Its Z-isomer 7 showed highly specific antiproliferative activity against Hep G2 (IC50 = 18 μM) and no cytotoxicity to WI 38.  Moreover, compds. 3, 4 and 14 expressed some marginal inhibitory activity against HIV-1 and HIV-2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1zT3PvEBHArVg90H21EOLACvtfcHk0lghPIdtXplEsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsVamsrY%253D&md5=6748d33614a42401a94dc61462a71a22</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2008.03.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2008.03.074%26sid%3Dliteratum%253Aachs%26aulast%3DGazivoda%26aufirst%3DT.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DMakuc%26aufirst%3DD.%26aulast%3DPlavec%26aufirst%3DJ.%26aulast%3DBratuli%25C4%2587%26aufirst%3DS.%26aulast%3DKraljevi%25C4%2587-Paveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DAndrei%26aufirst%3DG.%26aulast%3DSnoeck%26aufirst%3DR.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520cytostatic%2520and%2520anti-HIV%2520evaluations%2520of%2520the%2520new%2520unsaturated%2520acyclic%2520C-5%2520pyrimidine%2520nucleoside%2520analogues%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D5624%26epage%3D5634%26doi%3D10.1016%2Fj.bmc.2008.03.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kode, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murthy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phadtare, S.</span></span> <span> </span><span class="NLM_article-title">N9- and N7-(Chloromethyl Phenymethyl)Chloropurine Derivatives from α, α’-Dichloroxylenes: Synthesis and Anticancer Activity.</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1007/s00044-006-0150-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs00044-006-0150-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=445-474&author=L.+Chenauthor=N.+Kodeauthor=D.+Murthyauthor=S.+Phadtare&title=N9-+and+N7-%28Chloromethyl+Phenymethyl%29Chloropurine+Derivatives+from+%CE%B1%2C+%CE%B1%E2%80%99-Dichloroxylenes%3A+Synthesis+and+Anticancer+Activity.&doi=10.1007%2Fs00044-006-0150-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2Fs00044-006-0150-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-006-0150-6%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DKode%26aufirst%3DN.%26aulast%3DMurthy%26aufirst%3DD.%26aulast%3DPhadtare%26aufirst%3DS.%26atitle%3DN9-%2520and%2520N7-%2528Chloromethyl%2520Phenymethyl%2529Chloropurine%2520Derivatives%2520from%2520%25CE%25B1%252C%2520%25CE%25B1%25E2%2580%2599-Dichloroxylenes%253A%2520Synthesis%2520and%2520Anticancer%2520Activity.%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2005%26volume%3D14%26spage%3D445%26epage%3D474%26doi%3D10.1007%2Fs00044-006-0150-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Džolić, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergold-Brundić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrvoš-Sermek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgemeister, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grdiša, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slade, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balzarini, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, Structural Studies, and Biological Evaluation of Some Purine Substituted 1-Aminocyclopropane-1-carboxylic Acids and 1-Amino-1-hydroxymethylcyclopropanes</span>. <i>Nucleosides, Nucleotides Nucleic Acids</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">389</span>, <span class="refDoi"> DOI: 10.1081/NCN-120022029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1081%2FNCN-120022029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=12885120" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlsFaks7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2003&pages=373-389&author=Z.+D%C5%BEoli%C4%87author=V.+Kri%C5%A1taforauthor=M.+Cetinaauthor=A.+Naglauthor=A.+Hergold-Brundi%C4%87author=D.+Mrvo%C5%A1-Sermekauthor=T.+Burgemeisterauthor=M.+Grdi%C5%A1aauthor=N.+Sladeauthor=K.+Paveli%C4%87author=J.+Balzariniauthor=E.+De+Clercqauthor=M.+Mintas&title=Synthesis%2C+Structural+Studies%2C+and+Biological+Evaluation+of+Some+Purine+Substituted+1-Aminocyclopropane-1-carboxylic+Acids+and+1-Amino-1-hydroxymethylcyclopropanes&doi=10.1081%2FNCN-120022029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, structural studies, and biological evaluation of some purine substituted 1-aminocyclopropane-1-carboxylic acids and 1-amino-1-hydroxymethylcyclopropanes</span></div><div class="casAuthors">Dzolic, Zoran; Kristafor, Vedran; Cetina, Mario; Nagl, Ante; Hergold-Brundic, Antonija; Mrvos-Sermek, Draginja; Burgemeister, Thomas; Grdisa, Mira; Slade, Neda; Pavelic, Kresimir; Balzarini, Jan; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides, Nucleotides & Nucleic Acids</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">373-389</span>CODEN:
                <span class="NLM_cas:coden">NNNAFY</span>;
        ISSN:<span class="NLM_cas:issn">1525-7770</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">The novel purine derivs. of 1-aminocyclopropane-1-carboxylic acid and 1-amino-1-hydroxymethylcyclopropane with methylene spacer between the base and the cyclopropane ring were prepd. by multistep synthetic route involving alkylation of adenine and 6-(N-pyrrolyl)purine with a 2-hydroxymethyl-1-aminocyclopropane-1-carboxylic acid deriv. as a key reaction.  All novel compds. were racemic.  The N-9 substitution of the purine ring and the Z-configuration of the cyclopropane ring were deduced from their 1H and 13C NMR spectra by analyses of chem. shifts, H-H coupling consts. and connectivities in two-dimensional homo- and heteronuclear correlation spectra.  An unequivocal proof of the stereostructure of was obtained by their x-ray structure anal.  The novel compds. were evaluated on cytostatic and antiviral activities in several cell lines.  The 6-(N-pyrrolyl)purine deriv. of 1,2-aminocyclopropane alc. I exhibited a more pronounced inhibitory activity against the proliferation of cervical carcinoma (HeLa) and human fibroblast (WI-38) cells than other types of tumor cell lines.  None of the compds. showed inhibitory activities against cytomegalovirus, varicella-zoster virus or other viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJlt345DmlO7Vg90H21EOLACvtfcHk0lh3l0NngI5Vzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlsFaks7k%253D&md5=fad1133111da2e60e304d2acf0c2f0a9</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1081%2FNCN-120022029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1081%252FNCN-120022029%26sid%3Dliteratum%253Aachs%26aulast%3DD%25C5%25BEoli%25C4%2587%26aufirst%3DZ.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DV.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DNagl%26aufirst%3DA.%26aulast%3DHergold-Brundi%25C4%2587%26aufirst%3DA.%26aulast%3DMrvo%25C5%25A1-Sermek%26aufirst%3DD.%26aulast%3DBurgemeister%26aufirst%3DT.%26aulast%3DGrdi%25C5%25A1a%26aufirst%3DM.%26aulast%3DSlade%26aufirst%3DN.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DBalzarini%26aufirst%3DJ.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520Structural%2520Studies%252C%2520and%2520Biological%2520Evaluation%2520of%2520Some%2520Purine%2520Substituted%25201-Aminocyclopropane-1-carboxylic%2520Acids%2520and%25201-Amino-1-hydroxymethylcyclopropanes%26jtitle%3DNucleosides%252C%2520Nucleotides%2520Nucleic%2520Acids%26date%3D2003%26volume%3D22%26spage%3D373%26epage%3D389%26doi%3D10.1081%2FNCN-120022029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Benci, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittine, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Radan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cetina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedić, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraljević Pavelić, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavelić, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Clercq, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mintas, M.</span></span> <span> </span><span class="NLM_article-title">The unsaturated acyclic nucleoside analogues bearing a sterically constrained (<i>Z</i>)-4’-benzamido-2’-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations.</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">6249</span>– <span class="NLM_lpage">6257</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.07.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.bmc.2010.07.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=20696582" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVKgsLbN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=6249-6257&author=K.+Benciauthor=K.+Wittineauthor=M.+Radanauthor=M.+Cetinaauthor=M.+Sedi%C4%87author=S.+Kraljevi%C4%87+Paveli%C4%87author=K.+Paveli%C4%87author=E.+De+Clercqauthor=M.+Mintas&title=The+unsaturated+acyclic+nucleoside+analogues+bearing+a+sterically+constrained+%28Z%29-4%E2%80%99-benzamido-2%E2%80%99-butenyl+moiety%3A+Synthesis%2C+X-ray+crystal+structure+study%2C+cytostatic+and+antiviral+activity+evaluations.&doi=10.1016%2Fj.bmc.2010.07.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">The unsaturated acyclic nucleoside analogues bearing a sterically constrained (Z)-4'-benzamido-2'-butenyl moiety: Synthesis, X-ray crystal structure study, cytostatic and antiviral activity evaluations</span></div><div class="casAuthors">Benci, Kresimir; Wittine, Karlo; Radan, Malajka; Cetina, Mario; Sedic, Mirela; Kraljevic Pavelic, Sandra; Pavelic, Kresimir; De Clercq, Erik; Mintas, Mladen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">6249-6257</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of the novel acyclic unsatd. pyrimidine (1-12) and adenine (13) nucleoside analogs bearing conformationally restricted (Z)-2'-butenyl moiety were synthesized and evaluated for their antiviral and cytostatic activity potency against malignant tumor cell lines and normal human fibroblast (WI38).  The N-1 and/or N-3 acyclic side chain substitution in pyrimidine ring in N-3 substituted 5-trifluoromethyluracil deriv. (11), N-1, N-3 disubstituted 5-fluorouracil deriv. (12) and adenine deriv. (13) was deduced from their 1H and 13C NMR spectra and confirmed by single crystal x-ray structure anal.  The x-ray crystal structure anal. 11-13 revealed also supramol. self-assemblies, in which infinite chains or dimers built two- and three-dimensional networks.  The results of the in vitro cytostatic activity evaluations of 1-13 indicate that the majority of the compds. tested exhibited a non-specific and moderate antiproliferative effect at the highest concn. (100 μM).  Of all evaluated compds. on the cell lines tested only the N-1 4''-fluoro-substituted-benzamide uracil deriv. (7) showed rather marked and selective inhibitory activity against the growth of MCF-7 cells at a concn. of 2.7 μM and no cytotoxic effect on normal fibroblasts WI38.  This compd. can be therefore considered as a potential antitumor lead compd. for further synthetic structure modification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokB0fgu_nuQrVg90H21EOLACvtfcHk0lh3l0NngI5Vzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVKgsLbN&md5=3df07c6c7468114c8279729e3aa2a1e6</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.07.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.07.035%26sid%3Dliteratum%253Aachs%26aulast%3DBenci%26aufirst%3DK.%26aulast%3DWittine%26aufirst%3DK.%26aulast%3DRadan%26aufirst%3DM.%26aulast%3DCetina%26aufirst%3DM.%26aulast%3DSedi%25C4%2587%26aufirst%3DM.%26aulast%3DKraljevi%25C4%2587%2BPaveli%25C4%2587%26aufirst%3DS.%26aulast%3DPaveli%25C4%2587%26aufirst%3DK.%26aulast%3DDe%2BClercq%26aufirst%3DE.%26aulast%3DMintas%26aufirst%3DM.%26atitle%3DThe%2520unsaturated%2520acyclic%2520nucleoside%2520analogues%2520bearing%2520a%2520sterically%2520constrained%2520%2528Z%2529-4%25E2%2580%2599-benzamido-2%25E2%2580%2599-butenyl%2520moiety%253A%2520Synthesis%252C%2520X-ray%2520crystal%2520structure%2520study%252C%2520cytostatic%2520and%2520antiviral%2520activity%2520evaluations.%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D6249%26epage%3D6257%26doi%3D10.1016%2Fj.bmc.2010.07.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meščić, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krištafor, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novaković, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osmanović, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Završnik, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ametamey, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scapozza, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raić-Malić, S.</span></span> <span> </span><span class="NLM_article-title">C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">5104</span>– <span class="NLM_lpage">5124</span>, <span class="refDoi"> DOI: 10.3390/molecules18055104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.3390%2Fmolecules18055104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23644977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXosFCqsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=5104-5124&author=A.+Me%C5%A1%C4%8Di%C4%87author=S.+Kri%C5%A1taforauthor=I.+Novakovi%C4%87author=A.+Osmanovi%C4%87author=U.+M%C3%BCllerauthor=D.+Zavr%C5%A1nikauthor=S.+M.+Ametameyauthor=L.+Scapozzaauthor=S.+Rai%C4%87-Mali%C4%87&title=C-5+hydroxyethyl+and+hydroxypropyl+acyclonucleosides+as+substrates+for+thymidine+kinase+of+herpes+simplex+virus+type+1+%28HSV-1+TK%29%3A+syntheses+and+biological+evaluation&doi=10.3390%2Fmolecules18055104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">C-5 hydroxyethyl and hydroxypropyl acyclonucleosides as substrates for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK): syntheses and biological evaluation</span></div><div class="casAuthors">Mescic, Andrijana; Kristafor, Svjetlana; Novakovic, Ivana; Osmanovic, Amar; Muller, Ursina; Zavrsnik, Davorka; Ametamey, Simon M.; Scapozza, Leonardo; Raic-Malic, Silvana</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5104-5124</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The efficient synthesis of 5-(2-hydroxyethyl)- and 5-(3-hydroxypropyl)-substituted pyrimidine derivs. bearing 2,3-dihydroxypropyl, acyclovir-, ganciclovir- and penciclovir-like side chains are reported.  A synthetic approach that included the alkylation of an N-anion 5-substituted pyrimidine intermediate provided the target acyclonucleosides in significantly higher overall yields in comparison to those obtained by another method using a silylation reaction.  The phosphorylation assays of novel compds. as potential substrates for thymidine kinase of human herpesvirus (herpes simplex virus type 1 HSV-1 TK) showed that solely pyrimidine 5-substituted acyclonucleosides with a penciclovir-like side chain acted as a fraudulent substrates of HSV-1 TK.  Moreover, a uracil deriv. with penciclovir-like side chain with less bulky 2-hydroxyethyl substituent at C-5 proved to be a better substrate than the corresponding one with a 3-hydroxypropyl substituent.  Therefore, this acyclonucleoside was selected as a lead compd. for the development of a positron emission tomog. HSV-1 TK activity imaging agent.  The title compds. thus formed included 5-(2-hydroxyethyl)-1-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-2,4(1H,3H)-pyrimidinedione (I) and related substances.  The synthesis of the target compds. was achieved using 2,4-dimethoxy-5-pyrimidineethanol 5-acetate, 5-(2-hydroxyethyl)-2,4(1H,3H)-pyrimidinedione, 5-(3-hydroxypropyl)-2,4(1H,3H)-pyrimidinedione as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUgfC3czriyrVg90H21EOLACvtfcHk0lh3l0NngI5Vzg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXosFCqsLk%253D&md5=9ec093a32fe5481c2410989f9f655352</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18055104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18055104%26sid%3Dliteratum%253Aachs%26aulast%3DMe%25C5%25A1%25C4%258Di%25C4%2587%26aufirst%3DA.%26aulast%3DKri%25C5%25A1tafor%26aufirst%3DS.%26aulast%3DNovakovi%25C4%2587%26aufirst%3DI.%26aulast%3DOsmanovi%25C4%2587%26aufirst%3DA.%26aulast%3DM%25C3%25BCller%26aufirst%3DU.%26aulast%3DZavr%25C5%25A1nik%26aufirst%3DD.%26aulast%3DAmetamey%26aufirst%3DS.%2BM.%26aulast%3DScapozza%26aufirst%3DL.%26aulast%3DRai%25C4%2587-Mali%25C4%2587%26aufirst%3DS.%26atitle%3DC-5%2520hydroxyethyl%2520and%2520hydroxypropyl%2520acyclonucleosides%2520as%2520substrates%2520for%2520thymidine%2520kinase%2520of%2520herpes%2520simplex%2520virus%2520type%25201%2520%2528HSV-1%2520TK%2529%253A%2520syntheses%2520and%2520biological%2520evaluation%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D5104%26epage%3D5124%26doi%3D10.3390%2Fmolecules18055104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.-M.</span></span> <span> </span><span class="NLM_article-title">The development for the synthesis of chiral acyclic nucleosides and their phosphonates</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7156</span>– <span class="NLM_lpage">7166</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2014.11.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.tetlet.2014.11.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVWhsbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=7156-7166&author=M.-S.+Xieauthor=H.-Y.+Niuauthor=G.-R.+Quauthor=H.-M.+Guo&title=The+development+for+the+synthesis+of+chiral+acyclic+nucleosides+and+their+phosphonates&doi=10.1016%2Fj.tetlet.2014.11.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">The development for the synthesis of chiral acyclic nucleosides and their phosphonates</span></div><div class="casAuthors">Xie, Ming-Sheng; Niu, Hong-Ying; Qu, Gui-Rong; Guo, Hai-Ming</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">52</span>),
    <span class="NLM_cas:pages">7156-7166</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Acyclic nucleosides and their phosphonates possess significantly antiviral and cytostatic activities.  For acyclic nucleosides and their phosphonates, the introduction of a chiral group to their side chain or the abs. configuration of the chiral atom could affect their biol. activities obviously.  Thus, the asym. synthesis of chiral acyclic nucleosides and their phosphonates has received continuous attention.  The previous reports mainly focus on employing the chiral pool and chiral auxiliary methods for the synthesis of chiral acyclic nucleosides and their phosphonates.  In contrast, the asym. catalysis methods for the synthesis of acyclic nucleosides and their phosphonates are still in the beginning.  This digest paper will serve to highlight the significant progress that has been made in these areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok80l9iLj3SLVg90H21EOLACvtfcHk0lg2K4RcPSpyNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVWhsbnI&md5=0a6d43469d951ef320fdba5e1624ce0a</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2014.11.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2014.11.060%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DM.-S.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DQu%26aufirst%3DG.-R.%26aulast%3DGuo%26aufirst%3DH.-M.%26atitle%3DThe%2520development%2520for%2520the%2520synthesis%2520of%2520chiral%2520acyclic%2520nucleosides%2520and%2520their%2520phosphonates%26jtitle%3DTetrahedron%2520Lett.%26date%3D2014%26volume%3D55%26spage%3D7156%26epage%3D7166%26doi%3D10.1016%2Fj.tetlet.2014.11.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yuan, T.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, R.-Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.-R.</span></span> <span> </span><span class="NLM_article-title">Highly Enantioselective Synthesis of Designed Chiral Acyclonucleosides and Acyclonucleotides by Organocatalytic Aza-Michael Addition</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">4095</span>– <span class="NLM_lpage">4098</span>, <span class="refDoi"> DOI: 10.1002/chem.201100435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fchem.201100435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=21387438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvVShtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=4095-4098&author=H.-M.+Guoauthor=T.-F.+Yuanauthor=H.-Y.+Niuauthor=J.-Y.+Liuauthor=R.-Z.+Maoauthor=D.-Y.+Liauthor=G.-R.+Qu&title=Highly+Enantioselective+Synthesis+of+Designed+Chiral+Acyclonucleosides+and+Acyclonucleotides+by+Organocatalytic+Aza-Michael+Addition&doi=10.1002%2Fchem.201100435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Highly Enantioselective Synthesis of Designed Chiral Acyclonucleosides and Acyclonucleotides by Organo-Catalytic Aza-Michael Addition</span></div><div class="casAuthors">Guo, Hai-Ming; Yuan, Teng-Fei; Niu, Hong-Ying; Liu, Jin-Ying; Mao, Run-Ze; Li, De-Yang; Qu, Gui-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4095-4098, S4095/1-S4095/46</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Acyclonucleosides, e.g. I, and acyclonucleotides were prepd. via organo-catalytic asym. aza-Michael addn. of purine bases with α,β-unsatd. aldehydes in high yields (82-89%) and up to 99% ee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUkIMrONEdLrVg90H21EOLACvtfcHk0lg2K4RcPSpyNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvVShtro%253D&md5=753e20c7b16f651eb3032ce96297c105</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1002%2Fchem.201100435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201100435%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DH.-M.%26aulast%3DYuan%26aufirst%3DT.-F.%26aulast%3DNiu%26aufirst%3DH.-Y.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DMao%26aufirst%3DR.-Z.%26aulast%3DLi%26aufirst%3DD.-Y.%26aulast%3DQu%26aufirst%3DG.-R.%26atitle%3DHighly%2520Enantioselective%2520Synthesis%2520of%2520Designed%2520Chiral%2520Acyclonucleosides%2520and%2520Acyclonucleotides%2520by%2520Organocatalytic%2520Aza-Michael%2520Addition%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2011%26volume%3D17%26spage%3D4095%26epage%3D4098%26doi%3D10.1002%2Fchem.201100435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, H.</span></span> <span> </span><span class="NLM_article-title">Regio- and Enantioselective Allylic Amination of Aliphatic MBH Adducts with N-Heteroaromatics</span>. <i>Chem. – Eur. J.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1430</span>, <span class="refDoi"> DOI: 10.1002/chem.201704772</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1002%2Fchem.201704772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=29125647" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitVejsb7E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=1425-1430&author=H.+Wangauthor=L.+Yuauthor=M.+Xieauthor=J.+Wuauthor=G.+Quauthor=K.+Dingauthor=H.+Guo&title=Regio-+and+Enantioselective+Allylic+Amination+of+Aliphatic+MBH+Adducts+with+N-Heteroaromatics&doi=10.1002%2Fchem.201704772"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Regio- and Enantioselective Allylic Amination of Aliphatic MBH Adducts with N-Heteroaromatics</span></div><div class="casAuthors">Wang, Haixia; Yu, Lulu; Xie, Mingsheng; Wu, Jiang; Qu, Guirong; Ding, Kuiling; Guo, Haiming</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry - A European Journal</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1425-1430</span>CODEN:
                <span class="NLM_cas:coden">CEUJED</span>;
        ISSN:<span class="NLM_cas:issn">0947-6539</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Palladium-catalyzed regio- and enantioselective allylic amination of aliph. Morita-Baylis-Hillman (MBH) adducts with N-heteroarom. nucleophiles (e.g., benzimidazole, 4,5-diphenylimidazole, benzotriazole, and purines) was achieved by using a spiroketal-based diphosphine (SKP) ligand, and afforded a range of chiral, branched N-allyl products with high selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4zBGLU0fm5bVg90H21EOLACvtfcHk0lg2K4RcPSpyNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitVejsb7E&md5=14a954cd46ddbb81614567efad9b30b9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1002%2Fchem.201704772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fchem.201704772%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DXie%26aufirst%3DM.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DQu%26aufirst%3DG.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DGuo%26aufirst%3DH.%26atitle%3DRegio-%2520and%2520Enantioselective%2520Allylic%2520Amination%2520of%2520Aliphatic%2520MBH%2520Adducts%2520with%2520N-Heteroaromatics%26jtitle%3DChem.%2520%25E2%2580%2593%2520Eur.%2520J.%26date%3D2018%26volume%3D24%26spage%3D1425%26epage%3D1430%26doi%3D10.1002%2Fchem.201704772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">10329</span>– <span class="NLM_lpage">1033</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01268</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01268" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhslygt7zF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=10329-1033&author=P.+Zhouauthor=Y.+Liuauthor=L.+Zhouauthor=K.+Zhuauthor=K.+Fengauthor=H.+Zhangauthor=Y.+Liangauthor=H.+Jiangauthor=C.+Luoauthor=M.+Liuauthor=Y.+Wang&title=Potent+Antitumor+Activities+and+Structure+Basis+of+the+Chiral+%CE%B2-Lactam+Bridged+Analogue+of+Combretastatin+A-4+Binding+to+Tubulin&doi=10.1021%2Facs.jmedchem.6b01268"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin</span></div><div class="casAuthors">Zhou, Pengfei; Liu, Yan; Zhou, Lu; Zhu, Kongkai; Feng, Kechang; Zhang, Hao; Liang, Yuru; Jiang, Hualiang; Luo, Cheng; Liu, Mingming; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10329-10334</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of chiral β-lactam bridged analogs (3-substituted 1,4-diaryl-2-azetidinones) of combretastatin A-4 (CA-4) were synthesized asym., and their antitumor activities were evaluated in vitro and in vivo.  The cocrystal structure of tubulin in complex with compd. I was detd. by X-ray crystallog., which showed that I binds to the same site as colchicine with similar binding mode, and the abs. configuration of its C-4 was first identified and demonstrated to be critically important for their antiproliferative activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosyMxgxjmUxbVg90H21EOLACvtfcHk0liaRseTYEjF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhslygt7zF&md5=e45dbe3b36f2ef6698895cb0933fd6be</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01268%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DH.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DPotent%2520Antitumor%2520Activities%2520and%2520Structure%2520Basis%2520of%2520the%2520Chiral%2520%25CE%25B2-Lactam%2520Bridged%2520Analogue%2520of%2520Combretastatin%2520A-4%2520Binding%2520to%2520Tubulin%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D10329%26epage%3D1033%26doi%3D10.1021%2Facs.jmedchem.6b01268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">6765</span>– <span class="NLM_lpage">6784</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00736</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00736" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1als77I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=6765-6784&author=J.+Zhangauthor=J.+Zhangauthor=G.+Haoauthor=W.+Xinauthor=F.+Yangauthor=M.+Zhuauthor=H.+Zhou&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationship+of+7-Propanamide+Benzoxaboroles+as+Potent+Anticancer+Agents&doi=10.1021%2Facs.jmedchem.9b00736"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship of 7-Propanamide Benzoxaboroles as Potent Anticancer Agents</span></div><div class="casAuthors">Zhang, Jiong; Zhang, Jinyi; Hao, Guiyun; Xin, Weixiang; Yang, Fei; Zhu, Mingyan; Zhou, Huchen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">6765-6784</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Benzoxaboroles, as a novel class of bioactive mols. with unique physicochem. properties, have been shown to possess excellent antimicrobial activities with tavaborole approved in 2014 as an antifungal drug.  Although urgently needed, the investigation of benzoxaboroles as anticancer agents has been lacking so far.  In this study, we report the design, synthesis, and anticancer structure-activity relationship of a series of 7-propanamide benzoxaboroles.  Compds. 103 and 115 showed potent activity against ovarian cancer cells with IC50 values of 33 and 21 nM, resp.  Apoptosis was induced by these compds. and colony formation was effectively inhibited.  Furthermore, they also showed excellent efficacy in ovarian tumor xenograft mouse model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOkvie6d6TfrVg90H21EOLACvtfcHk0liaRseTYEjF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1als77I&md5=01b4937ef8eeb432fee175fb55610966</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00736&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00736%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DHao%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationship%2520of%25207-Propanamide%2520Benzoxaboroles%2520as%2520Potent%2520Anticancer%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D6765%26epage%3D6784%26doi%3D10.1021%2Facs.jmedchem.9b00736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kapoor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizvi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakkar, P.</span></span> <span> </span><span class="NLM_article-title">Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases</span>. <i>Apoptosis</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">9</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1007/s10495-012-0781-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1007%2Fs10495-012-0781-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=23192364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpt1GntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=9-27&author=R.+Kapoorauthor=F.+Rizviauthor=P.+Kakkar&title=Naringenin+prevents+high+glucose-induced+mitochondria-mediated+apoptosis+involving+AIF%2C+Endo-G+and+caspases&doi=10.1007%2Fs10495-012-0781-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Naringenin prevents high glucose-induced mitochondria-mediated apoptosis involving AIF, Endo-G and caspases</span></div><div class="casAuthors">Kapoor, Radhika; Rizvi, Fatima; Kakkar, Poonam</div><div class="citationInfo"><span class="NLM_cas:title">Apoptosis</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-27</span>CODEN:
                <span class="NLM_cas:coden">APOPFN</span>;
        ISSN:<span class="NLM_cas:issn">1360-8185</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Oxidative stress is implicated in hyperglycemia-induced alterations in cell signaling pathways.  We examd. the toxicity of high glucose in primary rat hepatocytes and its amelioration by naringenin.  Incubation of hepatocytes with 40 mM glucose for 1.5 h exhibited significant decrease in cell viability confirmed by MTT redn. and Alamar blue assay.  At the same time primary rat hepatocytes exhibited significant decrease in mitochondrial membrane potential indicating organelle dysfunction.  Enhanced translocation of Cyt-c from mitochondria to cytosol and AIF/Endo-G from mitochondria to nucleus, activation of caspase-9/3, DNA damage, and chromatin condensation were obsd. in glucose-stressed hepatocytes, indicating the involvement of mitochondrial pathway in high glucose-induced apoptosis.  Transcript levels of antioxidant enzymes were significantly altered along with corresponding changes in their enzymic activities.  The level of intracellular antioxidant glutathione as well as superoxide dismutase, catalase, and glutathione peroxidase activities were obsd. to be significantly decreased in hepatocytes treated with high concn. of glucose.  Naringenin, a flavanone, was effective in preventing loss of cell viability, reactive oxygen species generation, and decline in antioxidant defense.  Translocation of AIF, Endo-G, and Cyt-c from mitochondria was also inhibited by naringenin in glucose-stressed cells.  MRNA expression of anti-apoptotic and apoptotic genes, externalization of phosphatidyl serine, DNA damage, chromatin condensation, and sub-diploid cell population were effectively altered by naringenin indicating its anti-apoptotic potential in vitro.  Our data suggests that naringenin can prevent apoptosis induced by high glucose through scavenging of reactive oxygen species and modulation of mitochondria-mediated apoptotic pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbcjQp53UY4bVg90H21EOLACvtfcHk0liaRseTYEjF3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpt1GntQ%253D%253D&md5=dd816288dd3a02110171b9a7b774d65f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1007%2Fs10495-012-0781-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-012-0781-7%26sid%3Dliteratum%253Aachs%26aulast%3DKapoor%26aufirst%3DR.%26aulast%3DRizvi%26aufirst%3DF.%26aulast%3DKakkar%26aufirst%3DP.%26atitle%3DNaringenin%2520prevents%2520high%2520glucose-induced%2520mitochondria-mediated%2520apoptosis%2520involving%2520AIF%252C%2520Endo-G%2520and%2520caspases%26jtitle%3DApoptosis%26date%3D2013%26volume%3D18%26spage%3D9%26epage%3D27%26doi%3D10.1007%2Fs10495-012-0781-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span> <span> </span><span class="NLM_article-title">Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-<i>d</i>]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">2353</span>– <span class="NLM_lpage">2371</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01612</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01612" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjslKqsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2353-2371&author=Q.+Xunauthor=Z.+Zhangauthor=J.+Luoauthor=L.+Tongauthor=M.+Huangauthor=Z.+Wangauthor=J.+Zouauthor=Y.+Liuauthor=Y.+Xuauthor=H.+Xieauthor=Z.-C.+Tuauthor=X.+Luauthor=K.+Ding&title=Design%2C+Synthesis%2C+and+Structure-Activity+Relationship+Study+of+2-Oxo-3%2C4-dihydropyrimido%5B4%2C5-d%5Dpyrimidines+as+New+Colony+Stimulating+Factor+1+Receptor+%28CSF1R%29+Kinase+Inhibitors&doi=10.1021%2Facs.jmedchem.7b01612"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Structure-Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors</span></div><div class="casAuthors">Xun, Qiuju; Zhang, Zhang; Luo, Jinfeng; Tong, Linjiang; Huang, Minhao; Wang, Zhen; Zou, Jian; Liu, Yingqiang; Xu, Yong; Xie, Hua; Tu, Zheng-Chao; Lu, Xiaoyun; Ding, Ke</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2353-2371</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Colony stimulating factor-1 receptor kinase (CSF1R) is a well validated mol. target for anticancer drug discovery.  Herein, we report the design, synthesis and structure-activity relationship study of 2-oxo-3, 4-dihydropyrimido[4, 5-d] pyrimidines as new orally bioavailable CSF1R inhibitors.  One of the most promising compds., I, potently inhibits CSF1R kinase with an IC50 value of 3.0 nM, while is significantly less potent against structurally related epidermal growth factor receptor (EGFR) and other kinases.  The kinase inhibition of I was further validated by western blotting anal. in RAW264.7 macrophages.  The mol. also potently blocks macrophage infiltration, abrogates the pro-tumorigenic influences of macrophages, and exhibits reasonable pharmacokinetic profile.  Compd. I may serve as a new valuable lead compd. for future anticancer drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN1HUSH0HAH7Vg90H21EOLACvtfcHk0lhsmwB1LDWz0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjslKqsrg%253D&md5=c1535182f335de0c9d8f9367b65ce938</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01612&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01612%26sid%3Dliteratum%253Aachs%26aulast%3DXun%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZou%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DH.%26aulast%3DTu%26aufirst%3DZ.-C.%26aulast%3DLu%26aufirst%3DX.%26aulast%3DDing%26aufirst%3DK.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Structure-Activity%2520Relationship%2520Study%2520of%25202-Oxo-3%252C4-dihydropyrimido%255B4%252C5-d%255Dpyrimidines%2520as%2520New%2520Colony%2520Stimulating%2520Factor%25201%2520Receptor%2520%2528CSF1R%2529%2520Kinase%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D2353%26epage%3D2371%26doi%3D10.1021%2Facs.jmedchem.7b01612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Han, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaswamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">11218</span>– <span class="NLM_lpage">11231</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01393</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01393" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXit12rtbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=11218-11231&author=X.+Hanauthor=L.+Zhaoauthor=W.+Xiangauthor=C.+Qinauthor=B.+Miaoauthor=T.+Xuauthor=M.+Wangauthor=C.-Y.+Yangauthor=K.+Chinnaswamyauthor=J.+Stuckeyauthor=S.+Wang&title=Discovery+of+Highly+Potent+and+Efficient+PROTAC+Degraders+of+Androgen+Receptor+%28AR%29+by+Employing+Weak+Binding+Affinity+VHL+E3+Ligase+Ligands&doi=10.1021%2Facs.jmedchem.9b01393"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands</span></div><div class="casAuthors">Han, Xin; Zhao, Lijie; Xiang, Weiguo; Qin, Chong; Miao, Bukeyan; Xu, Tianfeng; Wang, Mi; Yang, Chao-Yie; Chinnaswamy, Krishnapriya; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">11218-11231</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Androgen receptor (AR) is a validated therapeutic target for the treatment of metastatic castration-resistant prostate cancer (mCRPC).  We report herein our design, synthesis, and biol. characterization of highly potent small-mol. proteolysis targeting chimera (PROTAC) AR degraders using a potent AR antagonist and E3 ligase ligands with weak binding affinities to VHL protein.  Our study resulted in the discovery of 11 (ARD-266), which effectively induces degrdn. of AR protein in AR-pos. (AR+) LNCaP, VCaP, and 22Rv1 prostate cancer cell lines with DC50 values of 0.2-1 nM.  ARD-266 is capable of reducing the AR protein level by >95% in these AR+ prostate cancer cell lines and effectively reduces AR-regulated gene expression suppression.  For the first time, we demonstrated that an E3 ligand with micromolar binding affinity to its E3 ligase complex can be successfully employed for the design of highly potent and efficient PROTAC degraders and this finding may have a significant implication for the field of PROTAC research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM96gs2yAlzLVg90H21EOLACvtfcHk0lhsmwB1LDWz0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXit12rtbvE&md5=92e4f17c75b488749fced14476552c07</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01393%26sid%3Dliteratum%253Aachs%26aulast%3DHan%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DXiang%26aufirst%3DW.%26aulast%3DQin%26aufirst%3DC.%26aulast%3DMiao%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520Highly%2520Potent%2520and%2520Efficient%2520PROTAC%2520Degraders%2520of%2520Androgen%2520Receptor%2520%2528AR%2529%2520by%2520Employing%2520Weak%2520Binding%2520Affinity%2520VHL%2520E3%2520Ligase%2520Ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D11218%26epage%3D11231%26doi%3D10.1021%2Facs.jmedchem.9b01393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span> <span> </span><span class="NLM_article-title"><i>E. adenophorum</i> induces Cell Cycle Arrest and Apoptosis of Splenocytes through the Mitochondrial Pathway and Caspase Activation in Saanen Goats</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">15967</span> <span class="refDoi"> DOI: 10.1038/srep15967</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fsrep15967" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=26527166" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslOns73E" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&author=Y.+Heauthor=Q.+Moauthor=Y.+Huauthor=W.+Chenauthor=B.+Luoauthor=L.+Wuauthor=Y.+Qiaoauthor=R.+Xuauthor=Y.+Zhouauthor=Z.+Zuoauthor=J.+Dengauthor=W.+Heauthor=Y.+Wei&title=E.+adenophorum+induces+Cell+Cycle+Arrest+and+Apoptosis+of+Splenocytes+through+the+Mitochondrial+Pathway+and+Caspase+Activation+in+Saanen+Goats&doi=10.1038%2Fsrep15967"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">E. adenophorum induces Cell Cycle Arrest and Apoptosis of Splenocytes through the Mitochondrial Pathway and Caspase Activation in Saanen Goats</span></div><div class="casAuthors">He, Yajun; Mo, Quan; Hu, Yanchun; Chen, Weihong; Luo, Biao; Wu, Lei; Qiao, Yan; Xu, Ruiguang; Zhou, Yancheng; Zuo, Zhicai; Deng, Junliang; He, Wei; Wei, Yahui</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15967</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The precise cytotoxicity of E. Adenophorum in relation to the cell cycle and apoptosis of splenocytes in Saanen goats remains unclear.  In the present study, 16 Saanen goats were randomly divided into four groups, which were fed on 0%, 40%, 60% and 80% E. adenophorum diets.  The results of TUNEL, DAPI and AO/EB staining, flow cytometry anal. and DNA fragmentation assays showed that E. adenophorum induced typical apoptotic features in splenocytes, suppressed splenocyte viability, and caused cell cycle arrest in a dose-dependent manner.  However, westernblot, ELISA, qRT-PCR and caspase activity analyses showed that E. adenophoruminhibited Bcl-2 expression, promoted Bax translocation to the mitochondria, triggered the release of Cytc from the mitochondria into the cytosol, and activated caspase-9 and -3 and the subsequent cleavage of PARP.  Moreover, in E. adenophorum-induced apoptosis, the protein levels of Fas, Bid, FasL and caspase-8 showed no significant changes.  E. adenophorum treatment induced the collapse of ΔΨm.  Moreover, these data suggested that E. adenophorum induces splenocyte apoptosis via the activation of the mitochondrial apoptosis pathway in splenocytes.  These findings provide new insights into the mechanisms underlying the effects of E. adenophorum cytotoxicity on splenocytes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHZfS47AmJHrVg90H21EOLACvtfcHk0lhsmwB1LDWz0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslOns73E&md5=5e77df50f284444f03f725a65f495f3d</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1038%2Fsrep15967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep15967%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DMo%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DLuo%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DDeng%26aufirst%3DJ.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWei%26aufirst%3DY.%26atitle%3DE.%2520adenophorum%2520induces%2520Cell%2520Cycle%2520Arrest%2520and%2520Apoptosis%2520of%2520Splenocytes%2520through%2520the%2520Mitochondrial%2520Pathway%2520and%2520Caspase%2520Activation%2520in%2520Saanen%2520Goats%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26doi%3D10.1038%2Fsrep15967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menendez, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morera, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raya, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahl, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izpisúa Belmonte, J. C. I.</span></span> <span> </span><span class="NLM_article-title">Linking the p53 tumour suppressor pathway to somatic cell reprogramming</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>460</i></span>,  <span class="NLM_fpage">1140</span>– <span class="NLM_lpage">1144</span>, <span class="refDoi"> DOI: 10.1038/nature08311</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1038%2Fnature08311" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=19668186" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BD1MXps1ahuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=460&publication_year=2009&pages=1140-1144&author=T.+Kawamuraauthor=J.+Suzukiauthor=Y.+V.+Wangauthor=S.+Menendezauthor=L.+B.+Moreraauthor=A.+Rayaauthor=G.+M.+Wahlauthor=J.+C.+I.+Izpis%C3%BAa+Belmonte&title=Linking+the+p53+tumour+suppressor+pathway+to+somatic+cell+reprogramming&doi=10.1038%2Fnature08311"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Linking the p53 tumour suppressor pathway to somatic cell reprogramming</span></div><div class="casAuthors">Kawamura, Teruhisa; Suzuki, Jotaro; Wang, Yunyuan V.; Menendez, Sergio; Morera, Laura Batlle; Raya, Angel; Wahl, Geoffrey M.; Izpisua Belmonte, Juan Carlos</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">460</span>
        (<span class="NLM_cas:issue">7259</span>),
    <span class="NLM_cas:pages">1140-1144</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reprogramming somatic cells to induced pluripotent stem (iPS) cells has been accomplished by expressing pluripotency factors and oncogenes, but the low frequency and tendency to induce malignant transformation compromise the clin. utility of this powerful approach.  We address both issues by investigating the mechanisms limiting reprogramming efficiency in somatic cells.  Here we show that reprogramming factors can activate the p53 (also known as Trp53 in mice, TP53 in humans) pathway.  Reducing signalling to p53 by expressing a mutated version of one of its neg. regulators, by deleting or knocking down p53 or its target gene, p21 (also known as Cdkn1a), or by antagonizing reprogramming-induced apoptosis in mouse fibroblasts increases reprogramming efficiency.  Notably, decreasing p53 protein levels enabled fibroblasts to give rise to iPS cells capable of generating germline-transmitting chimeric mice using only Oct4 (also known as Pou5f1) and Sox2.  Furthermore, silencing of p53 significantly increased the reprogramming efficiency of human somatic cells.  These results provide insights into reprogramming mechanisms and suggest new routes to more efficient reprogramming while minimizing the use of oncogenes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwLhGRZnLhybVg90H21EOLACvtfcHk0lispmgcRqCnpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXps1ahuro%253D&md5=e576219e57102e80c7eed0ba349045e6</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1038%2Fnature08311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature08311%26sid%3Dliteratum%253Aachs%26aulast%3DKawamura%26aufirst%3DT.%26aulast%3DSuzuki%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BV.%26aulast%3DMenendez%26aufirst%3DS.%26aulast%3DMorera%26aufirst%3DL.%2BB.%26aulast%3DRaya%26aufirst%3DA.%26aulast%3DWahl%26aufirst%3DG.%2BM.%26aulast%3DIzpis%25C3%25BAa%2BBelmonte%26aufirst%3DJ.%2BC.%2BI.%26atitle%3DLinking%2520the%2520p53%2520tumour%2520suppressor%2520pathway%2520to%2520somatic%2520cell%2520reprogramming%26jtitle%3DNature%26date%3D2009%26volume%3D460%26spage%3D1140%26epage%3D1144%26doi%3D10.1038%2Fnature08311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, S.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Z.-Q.</span></span> <span> </span><span class="NLM_article-title">Chemoprevention of Low-Molecular- Weight Citrus Pectin (LCP) in Gastrointestinal Cancer Cells</span>. <i>Int. J. Biol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">746</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.7150/ijbs.13988</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.7150%2Fijbs.13988" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=27194951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2sXms1Gqurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2016&pages=746-756&author=S.+Wangauthor=P.+Liauthor=S.-M.+Luauthor=Z.-Q.+Ling&title=Chemoprevention+of+Low-Molecular-+Weight+Citrus+Pectin+%28LCP%29+in+Gastrointestinal+Cancer+Cells&doi=10.7150%2Fijbs.13988"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Chemoprevention of low-molecular-weight citrus pectin (LCP) in gastrointestinal cancer cells</span></div><div class="casAuthors">Wang, Shi; Li, Pei; Lu, Sheng-Min; Ling, Zhi-Qiang</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Biological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">746-756</span>CODEN:
                <span class="NLM_cas:coden">IJBSB9</span>;
        ISSN:<span class="NLM_cas:issn">1449-2288</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Background & Aims: Low-mol.-wt. citrus pectin (LCP) is a complex polysaccharide that displays abundant galactosyl (i.e., sugar carbohydrate) residues.  In this study, we evaluated the anti-tumor properties of LCP that lead to Bcl-xL-mediated dampening of apoptosis in gastrointestinal cancer cells.  Methods: We used AGS gastric cancer and SW-480 colorectal cancer cells to elucidate the effects of LCP on cell viability, cell cycle and apoptosis in cultured cells and tumor xenografts.  Results: Significantly decreased cell viabilities were obsd. in LCP treated AGS and SW-480 cells (P<0.05).  Cell cycle-related protein expression, such as Cyclin B1, was also decreased in LCP treated groups as compared to the untreated group.  The AGS or SW-480 cell-line tumor xenografts were significantly smaller in the LCP treated group as compared the untreated group (P<0.05).  LCP treatment decreased Galectin-3 (GAL-3) expression levels, which is an important gene in cancer metastasis that results in reversion of the epithelial-mesenchymal transition (EMT), and increased suppression of Bcl-xL and Survivin to promote apoptosis.  Moreover, results demonstrated synergistic tumor suppressor activity of LCP and 5-FU against gastrointestinal cancer cells both in vivo and in vitro.  Conclusions: LCP effectively inhibits the growth and metastasis of gastrointestinal cancer cells, and does so in part by down-regulating Bcl-xL and Cyclin B to promote apoptosis, and suppress EMT.  Thus, LCP alone or in combination with other treatments has a high potential as a novel therapeutic strategy to improve the clin. therapy of gastrointestinal cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOMF0zp5Fcl7Vg90H21EOLACvtfcHk0lispmgcRqCnpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXms1Gqurg%253D&md5=132fbfe81f3c1ced61d386784d15fc11</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.7150%2Fijbs.13988&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fijbs.13988%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DS.-M.%26aulast%3DLing%26aufirst%3DZ.-Q.%26atitle%3DChemoprevention%2520of%2520Low-Molecular-%2520Weight%2520Citrus%2520Pectin%2520%2528LCP%2529%2520in%2520Gastrointestinal%2520Cancer%2520Cells%26jtitle%3DInt.%2520J.%2520Biol.%2520Sci.%26date%3D2016%26volume%3D12%26spage%3D746%26epage%3D756%26doi%3D10.7150%2Fijbs.13988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Q. Z.</span></span> <span> </span><span class="NLM_article-title">Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation <i>in vitro</i> and <i>in vivo</i></span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>124</i></span>,  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">739</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.ejmech.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=27639364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFCmtL7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=124&publication_year=2016&pages=729-739&author=J.+B.+Shiauthor=L.+Z.+Chenauthor=Y.+Wangauthor=C.+Xiouauthor=W.+J.+Tangauthor=H.+P.+Zhouauthor=X.+H.+Liuauthor=Q.+Z.+Yao&title=Benzophenone-nucleoside+derivatives+as+telomerase+inhibitors%3A+Design%2C+synthesis+and+anticancer+evaluation+in+vitro+and+in+vivo&doi=10.1016%2Fj.ejmech.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo</span></div><div class="casAuthors">Shi, Jing Bo; Chen, Liu Zeng; Wang, Yang; Cheng, Xiou; Tang, Wen Jian; Zhou, Hai Pin; Liu, Xin Hua; Yao, Qi Zheng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">124</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">729-739</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on telomerase, thirteen novel phenstatin moiety linked stavudine derivs., e.g. I, were synthesized.  The structures were detd. by NMR and TOF-HRMS.  The screening results showed that some compds. had better anti-cancer activity in vivo and in vitro.  Among them, Compd. 8d showed high inhibitory activity against telomerase and showed good antiproliferative activity against SGC-7901 cell with IC50 value 0.77 μM by inducing cell cycle arrest at G2 phase.  It also could improve SGC-7901 cell apoptosis, mitochondrial membrane potential assay indicated that the dissipation of MMP might participate in apoptosis induced by title compd.  In vivo studies showed that compd. 8d displayed potent anticancer activity with inhibition tumor growth.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFPWDaOL5ES7Vg90H21EOLACvtfcHk0lispmgcRqCnpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFCmtL7N&md5=6293f71570341df9e558afb9b9a6ab39</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DShi%26aufirst%3DJ.%2BB.%26aulast%3DChen%26aufirst%3DL.%2BZ.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DXiou%26aufirst%3DC.%26aulast%3DTang%26aufirst%3DW.%2BJ.%26aulast%3DZhou%26aufirst%3DH.%2BP.%26aulast%3DLiu%26aufirst%3DX.%2BH.%26aulast%3DYao%26aufirst%3DQ.%2BZ.%26atitle%3DBenzophenone-nucleoside%2520derivatives%2520as%2520telomerase%2520inhibitors%253A%2520Design%252C%2520synthesis%2520and%2520anticancer%2520evaluation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D124%26spage%3D729%26epage%3D739%26doi%3D10.1016%2Fj.ejmech.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pineda
de las Infantas, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres-Rusillo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Rubio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luque-Gonzalez, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unciti-Broceta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Molina, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Mochon, J. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1inhibitors</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">5224</span>– <span class="NLM_lpage">5234</span>, <span class="refDoi"> DOI: 10.1039/C5OB00230C</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1039%2FC5OB00230C" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=25856731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVSmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2015&pages=5224-5234&author=M.+J.+Pineda%0Ade+las+Infantasauthor=S.+Torres-Rusilloauthor=J.+D.+Unciti-Brocetaauthor=P.+Fernandez-Rubioauthor=M.+A.+Luque-Gonzalezauthor=M.+A.+Galloauthor=A.+Unciti-Brocetaauthor=I.+J.+Molinaauthor=J.+J.+Diaz-Mochon&title=Synthesis+of+6%2C8%2C9+poly-substituted+purine+analogue+libraries+as+pro-apoptotic+inducers+of+human+leukemic+lymphocytes+and+DAPK-1inhibitors&doi=10.1039%2FC5OB00230C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6,8,9 poly-substituted purine analogue libraries as pro-apoptotic inducers of human leukemic lymphocytes and DAPK-1 inhibitors</span></div><div class="casAuthors">Pineda de las Infantas, Maria J.; Torres-Rusillo, Sara; Unciti-Broceta, Juan Diego; Fernandez-Rubio, Pablo; Luque-Gonzalez, Maria Angelica; Gallo, Miguel A.; Unciti-Broceta, Asier; Molina, Ignacio J.; Diaz-Mochon, Juan J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">5224-5234</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A 18-member library of 6,8,9-poly-substituted purines was prepd. from pyrimidines, primary alcs., and N,N-dimethylamides under basic conditions by a one-pot synthetic pathway controlled by amide sizes and the novel analogs were tested against two leukemia cell lines: Jurkat (acute T cell leukemia) and K562 (chronic erythroleukemia) cells.  Compds. having a benzyloxy group at C6 position of the arom. ring exhibited antiproliferative activity in Jurkat cells whereas all compds. induced a lower effect on K562 cells.  Anal. of cell cycle, Annexin-V staining, and cleavage of initiator caspases assays showed that the active purine analogs induce cell death by apoptosis.  Based on these results, a new purine deriv. was synthesized, 6-benzyloxy-9-tert-butyl-8-phenyl-9H-purine (6d), which displayed the highest activity of the series against Jurkat cell lines.  Finally, 33P-radiolabeled kinase assays using 96 recombinant human kinases known to be involved in apoptotic events were performed.  Just one of the kinases tested, DAPK-1, was inhibited 50% or more by the phenotypic hits at 10 μM, suggesting that the inhibition of this target could be responsible for the induction of cell death by apoptosis.  In agreement with the phenotypic results, the most active antiproliferative agent, displayed also the lowest IC50 value against recombinant death-assocd. protein kinase 1 (i.e., DAPK1 2.5 μM), further supporting the potential role of this protein on the obsd. functional response.  DAPK-1 inhibition provided a lead compd. together with its pro-apoptotic properties against a Jurkat line and thus, makes it an interesting candidate to further investigate the role of DAPK1 kinase in triggering apoptosis in cancer cells, a role which is attracting recent interest.  The synthesis of the the target compds. was achieved using 4,6-dichloro-5-nitropyrimidine, amines and alcs. as starting materials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrVL97n567FprVg90H21EOLACvtfcHk0lhyV-hrl9TsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVSmsb4%253D&md5=f35fd384348f2d59879d1bf7ffc5277c</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1039%2FC5OB00230C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5OB00230C%26sid%3Dliteratum%253Aachs%26aulast%3DPineda%2Bde%2Blas%2BInfantas%26aufirst%3DM.%2BJ.%26aulast%3DTorres-Rusillo%26aufirst%3DS.%26aulast%3DUnciti-Broceta%26aufirst%3DJ.%2BD.%26aulast%3DFernandez-Rubio%26aufirst%3DP.%26aulast%3DLuque-Gonzalez%26aufirst%3DM.%2BA.%26aulast%3DGallo%26aufirst%3DM.%2BA.%26aulast%3DUnciti-Broceta%26aufirst%3DA.%26aulast%3DMolina%26aufirst%3DI.%2BJ.%26aulast%3DDiaz-Mochon%26aufirst%3DJ.%2BJ.%26atitle%3DSynthesis%2520of%25206%252C8%252C9%2520poly-substituted%2520purine%2520analogue%2520libraries%2520as%2520pro-apoptotic%2520inducers%2520of%2520human%2520leukemic%2520lymphocytes%2520and%2520DAPK-1inhibitors%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2015%26volume%3D13%26spage%3D5224%26epage%3D5234%26doi%3D10.1039%2FC5OB00230C" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><a href="https://go.drugbank.com/drugs/DB00544" class="extLink">https://go.drugbank.com/drugs/DB00544</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=https%3A%2F%2Fgo.drugbank.com%2Fdrugs%2FDB00544."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguilar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McEachern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Przybranowski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zawacki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chinnaswamy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuckey, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin-MLL Interaction with Strong <i>In Vivo</i> Antitumor Activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">4997</span>– <span class="NLM_lpage">5010</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00547</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00547" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnvVClsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=4997-5010&author=S.+Xuauthor=A.+Aguilarauthor=L.+Huangauthor=T.+Xuauthor=K.+Zhengauthor=D.+McEachernauthor=S.+Przybranowskiauthor=C.+Fosterauthor=K.+Zawackiauthor=Z.+Liuauthor=K.+Chinnaswamyauthor=J.+Stuckeyauthor=S.+Wang&title=Discovery+of+M-808+as+a+Highly+Potent%2C+Covalent%2C+Small-Molecule+Inhibitor+of+the+Menin-MLL+Interaction+with+Strong+In+Vivo+Antitumor+Activity&doi=10.1021%2Facs.jmedchem.0c00547"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin-MLL Interaction with Strong In Vivo Antitumor Activity</span></div><div class="casAuthors">Xu, Shilin; Aguilar, Angelo; Huang, Liyue; Xu, Tianfeng; Zheng, Ke; McEachern, Donna; Przybranowski, Sally; Foster, Caroline; Zawacki, Kaitlin; Liu, Zhaomin; Chinnaswamy, Krishnapriya; Stuckey, Jeanne; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4997-5010</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Targeting the menin-MLL protein-protein interaction is a new therapeutic strategy for the treatment of acute leukemia carrying MLL fusion (MLL leukemia).  We describe herein the structure-based optimization of a class of covalent menin inhibitors, which led to the discovery of M-808 (16)(I) as a highly potent and efficacious covalent menin inhibitor.  M-808 effectively inhibits leukemia cell growth at low nanomolar concns. and is capable of achieving partial tumor regression in an MV4;11 xenograft tumor model in mice at a well-tolerated dose schedule.  Detn. of the co-crystal structure of M-808 in complex with menin provides a structural basis for their high-affinity, covalent interactions.  M-808 represents a promising, covalent menin inhibitor for further optimization and evaluation toward developing a new therapy for the treatment of MLL leukemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCh0XqIp3vpLVg90H21EOLACvtfcHk0lhyV-hrl9TsLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnvVClsrg%253D&md5=168b2c21b9222ee72120f6680e7f60db</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00547&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00547%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DAguilar%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DT.%26aulast%3DZheng%26aufirst%3DK.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DPrzybranowski%26aufirst%3DS.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DZawacki%26aufirst%3DK.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DChinnaswamy%26aufirst%3DK.%26aulast%3DStuckey%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520M-808%2520as%2520a%2520Highly%2520Potent%252C%2520Covalent%252C%2520Small-Molecule%2520Inhibitor%2520of%2520the%2520Menin-MLL%2520Interaction%2520with%2520Strong%2520In%2520Vivo%2520Antitumor%2520Activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D4997%26epage%3D5010%26doi%3D10.1021%2Facs.jmedchem.0c00547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>178</i></span>,  <span class="NLM_fpage">177</span>– <span class="NLM_lpage">194</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=10.1016%2Fj.ejmech.2019.05.072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=31185410" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFKqs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=178&publication_year=2019&pages=177-194&author=F.+Gaoauthor=Y.+Liangauthor=P.+Zhouauthor=J.+Chengauthor=K.+Dingauthor=Y.+Wang&title=Design%2C+synthesis%2C+antitumor+activities+and+biological+studies+of+novel+diaryl+substituted+fused+heterocycles+as+dual+ligands+targeting+tubulin+and+katanin&doi=10.1016%2Fj.ejmech.2019.05.072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, antitumor activities and biological studies of novel diaryl substituted fused heterocycles as dual ligands targeting tubulin and katanin</span></div><div class="casAuthors">Gao, Feng; Liang, Yuru; Zhou, Pengfei; Cheng, Jiayi; Ding, Kuiling; Wang, Yang</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">178</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">177-194</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Microtubule is one of the important targets for cancer treatment.  A novel class of diaryl substituted imidazo[4,5-c]pyridin-2-ones and imidazo[4,5-c]pyridines were designed based on combination principles by merging the structures of β-lactams and purine-type compds. known as tubulin polymn. inhibitor and katanin activity up-regulator, resp.  Their antitumor activities were evaluated in vitro and the mechanism was elucidated, leading to the identification of 1,6-diaryl-1H-imidazo[4,5-c]pyridin-2(3H)-one I as the first bifunctional agent that can target both tubulin and katanin simultaneously.  The in vivo assays verified that compd. I significantly inhibited xenograft tumor growth with good pharmacokinetic characteristics, demonstrating a promising potential for further development into anti-tumor drug candidates with a unique mechanism of dual-targeting microtubule.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmwI1A_To45rVg90H21EOLACvtfcHk0lg8SwccFxeEsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFKqs7fI&md5=4b71536c807d513c707371370dd966a0</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.072%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DCheng%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DDesign%252C%2520synthesis%252C%2520antitumor%2520activities%2520and%2520biological%2520studies%2520of%2520novel%2520diaryl%2520substituted%2520fused%2520heterocycles%2520as%2520dual%2520ligands%2520targeting%2520tubulin%2520and%2520katanin%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D178%26spage%3D177%26epage%3D194%26doi%3D10.1016%2Fj.ejmech.2019.05.072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hill, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, A. A. B.</span></span> <span> </span><span class="NLM_article-title">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">6945</span>– <span class="NLM_lpage">6963</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01561</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01561" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;key=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=6945-6963&author=J.+R.+Hillauthor=A.+A.+B.+Robertson&title=Fishing+for+Drug+Targets%3A+A+Focus+on+Diazirine+Photoaffinity+Probe+Synthesis&doi=10.1021%2Facs.jmedchem.7b01561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe Synthesis</span></div><div class="casAuthors">Hill, James R.; Robertson, Avril A. B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6945-6963</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Target identification is a high-priority, albeit challenging, aspect of drug discovery.  Diazirine-based photoaffinity probes (PAPs) can facilitate the process by covalently capturing transient mol. interactions.  This can help identify target proteins and map the ligand's interactome.  Diazirine probes have even been incorporated by cellular machinery into proteins.  Embarking on the synthesis of customized PAPs, contg. either an aliph. or trifluoromethyl Ph diazirine, can be a considerable endeavor, particularly for medicinal chemists and chem. biologists new to the field.  This review takes a synthetic focus, aiming to summarize available routes, propose new avenues, and illuminate recent advances in diazirine synthesis.  Select examples of diazirine photoaffinity labeling applications have been included throughout to provide instructive definition of the advantages and limitations of the technol. while simultaneously highlighting how these reagents can be applied in a practical sense.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFaJOZyNuB67Vg90H21EOLACvtfcHk0lg8SwccFxeEsQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXotFart7g%253D&md5=37266e26bdd6a2028dddffc3ead4390d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01561%26sid%3Dliteratum%253Aachs%26aulast%3DHill%26aufirst%3DJ.%2BR.%26aulast%3DRobertson%26aufirst%3DA.%2BA.%2BB.%26atitle%3DFishing%2520for%2520Drug%2520Targets%253A%2520A%2520Focus%2520on%2520Diazirine%2520Photoaffinity%2520Probe%2520Synthesis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D6945%26epage%3D6963%26doi%3D10.1021%2Facs.jmedchem.7b01561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i144"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01717">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_07821"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01717?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01717</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Experimental procedures, spectral data and purity table of target compounds, biological evaluation assay, and crystallographic data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_002.csv">CSV</a>)</p></li><li><p class="inline">Recommended compound characterization checklist (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_003.xls">XLS</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_001.pdf">jm0c01717_si_001.pdf (11.65 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_002.csv">jm0c01717_si_002.csv (6.79 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c01717/suppl_file/jm0c01717_si_003.xls">jm0c01717_si_003.xls (354.5 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01717&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01717%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01717" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679ac4a28a383cee","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
